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African trypanosomes (Trypanosoma brucei sp.) are single-celled extracellular 
protozoan parasites that are transmitted via the tsetse fly vector across sub-
Saharan Africa. T. brucei subspecies cause trypanosomiasis in both humans 
and animals, inflicting substantial disease and economic strains in affected 
regions. Mammalian infection begins when the tsetse fly takes a blood meal 
and injects trypanosomes into the dermal layer of skin. The parasites then 
invade the circulatory and lymphatic systems, reaching the draining lymph 
nodes and disseminate systemically. Little is understood about the host-
pathogen interactions which influence the establishment of host infection at 
the initial bite site in the skin. Most experimental transmissions of African 
trypanosomiasis have studied the intraperitoneal or intravenous routes of 
exposure. However, these by-pass the natural route of infection via the skin. 
Therefore the aim of this thesis is to investigate the pathogenesis of African 
trypanosome infection via the skin. 
Chemokines play important roles in attracting leukocytes towards the 
lymphatics and lymph nodes. To investigate how trypanosomes migrate from 
the bite site to the draining lymph nodes, the hypothesis that chemokines may 
act as chemoattractants for trypanosomes was tested. Chemokines can also 
possess antimicrobial properties, including against the related protozoan 
parasite Leishmania mexicana, therefore their potential cytotoxic effects 
against T. brucei were tested. Data presented in this thesis shows that these 
chemokines do not induce the chemotaxis of T. brucei. The motility 
x 
 
characteristics of the parasites were also not affected by chemokine exposure. 
Nor did these chemokines exert any trypanostatic effects on trypanosomes. 
These data suggest trypanosomes use alternative cues to reach the 
lymphatics post-infection. 
The skin is an overlooked area of research for African trypanosome infections. 
Therefore work in this thesis sought to investigate the hypothesis that the 
infection kinetics would be different in a host infected by the natural intradermal 
route when compared with the routinely-researched intraperitoneal route. 
Experiments in this thesis revealed clear differences in the infection kinetics 
and disease progression in mice infected intradermally when compared with 
those infected by the intraperitoneal route. These data imply that further 
infection models should utilise intradermal injections and investigate the 
overlooked skin stage of disease which occurs naturally in the wild.  
Upon deposition in the skin the trypanosomes home towards the lymphatic 
system before migrating systemically. Lymphotoxin-β-receptor signalling 
(LTβR) is essential for lymphoid organogenesis and the maintenance of 
secondary lymphoid tissue microarchitecture. For example, LTβ-/- mice lack 
most lymph nodes and have grossly disturbed splenic microarchitecture. As a 
consequence of these disturbances LTβ-/- mice have impaired antibody isotype 
class-switching. Experiments in this thesis were performed to test the 
hypothesis that deficiencies in lymph node development and antibody isotype 
class-switching would influence disease pathogenesis. These data show that 
disease susceptibility and pathogenesis were exacerbated in LTβ-/- mice, 
which lacked class-switched antibody isotypes in their sera. This disease 
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profile was then reversed in LTβ-/- mice which received wild-type bone-marrow 
transfers after their haematopoietic system was ablated through lethal 
irradiation. These data could identify the importance of the class-switching 
capability of the adaptive immune system to combat trypanosome infection.  
Little is known of the early host-parasite interactions following injection of T. 
brucei into the dermis of the skin. Macrophages are key players in the innate 
immune response against African trypanosome infection, and manipulating 
these cells during infection may help our understanding of the disease 
pathogenesis. To address their potential role in disease susceptibility, 
experiments were designed to manipulate the density and inflammatory status 
of the macrophages in the skin prior to infection with T. brucei. These data 
show, that manipulation of the inflammatory status of the skin reduced 
susceptibility to infection with T. brucei via the skin. A greater understanding 
of the macrophage-parasite interactions which occur during the early stages 
of African trypanosome infection is important for understanding how the 
immune system responds to infection and how we can boost immunity to 
combat infection. 
A thorough identification of the mechanisms involved in establishing African 
trypanosome infections in the skin and their systemic dissemination will aid the 




African trypanosomes (of the species Trypanosoma brucei) are blood-dwelling 
parasites that are transmitted between people and animals by the tsetse fly 
across sub-Saharan Africa. These parasites causes a substantial disease 
known as African trypanosomiasis, which leads to great economic strains in 
the region. Infections in mammals begin when the tsetse fly takes a blood meal 
and injects the parasites into the layer of skin known as the dermis. The 
parasites then enter the blood circulatory system and the lymphatic system, 
reaching organs known as the draining lymph nodes which they use as routes 
to spread throughout the body. Little is understood about the interactions 
between the parasites and the host during the period of infection from the initial 
bite to establishing infection in the skin. Most studies of African 
trypanosomiasis have researched the transmission of the parasites after 
infection into the peritoneal cavity (the internal lining of the abdomen) or 
intravenously. However, these by-pass the natural route of infection via the 
skin. Therefore the aim of this thesis is to investigate the pathogenesis of 
African trypanosome infection via the skin. 
Chemokines are proteins produced inside the body which play important roles 
in attracting blood cells towards the lymphatic system and lymph node organs. 
To investigate how trypanosomes migrate from the bite site in the skin to the 
draining lymph nodes, the hypothesis that chemokines may act as attractants 
for the parasites was tested. Chemokines can also possess antimicrobial 
properties and kill certain harmful infectious organisms. This includes against 
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the relative of the African trypanosome, the Leishmania parasite. Therefore it 
was tested whether any of these chemokines could harm the trypanosomes, 
and potentially be used as a treatment. The data presented in this thesis show 
that these chemokines do not attract trypanosomes nor affect their movement. 
The chemokines also had no effect on trypanosome viability. These data 
suggest that trypanosomes use different means to reach the lymphatics from 
the skin upon infection.  
The skin is an overlooked area of research for the disease. Work in this thesis 
therefore sought to investigate the hypothesis that the infection would be 
different in a host infected by the natural intradermal route as opposed to the 
routinely-researched intraperitoneal route. The data produced highlights clear 
differences in the infection between mammals infected by the two routes. 
These data also show that the infection dose has an effect on the disease 
progression, as the incidence and degree of parasitaemia is decreased at 
lower doses. These findings imply that future infection studies should use 
intradermal infection to investigate the overlooked skin stage of disease which 
occurs naturally in the wild. 
Recent studies have suggested that upon entry in to the skin, trypanosomes 
migrate to the lymphatic system before migrating throughout the body. A 
protein known as lymphotoxin-beta (LT-beta) has an important role in the 
development of lymph nodes and the spleen. Mice which lack LT-beta also 
lack most lymph nodes and have abnormal spleens. These mice are known as 
LT-beta-deficient mice. As a consequence of these abnormalities these mice 
have an impaired ability to produce antibodies. Experiments in this thesis were 
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performed to test the hypothesis that deficiencies in lymph node organ 
development would drastically influence disease progression. These data 
show that LT-beta-deficient mice had increased susceptibility to African 
trypanosome infection. These mice also lacked antibodies in their blood, which 
are important for combating the infection. The increased susceptibility in LT-
beta-deficient mice was reversed by giving LT-beta-deficient mice healthy 
bone-marrow transfers to recover the cells required for enhanced antibody 
production. These data identify the importance of certain antibody types during 
trypanosome infection.  
The early immune response to trypanosome infection in the dermis layer of the 
skin remains poorly understood. Cells known as macrophages are key players 
in the early immune response to fighting African trypanosome infection. 
Manipulating the activity of these cells during infection may help our 
understanding of how our body responds to the disease. To address their 
potential role in the outcome of disease, experiments were performed to 
manipulate the density and activity of macrophages in the skin prior to infection 
with trypanosomes. A better understanding of the role of macrophage cells in 
combating trypanosomes during the early skin stage of disease is important 
for understanding how the immune system responds to infection and how we 
can boost the immune system to fight the infection. 
More thorough research into the mechanisms involved during the early African 
trypanosome infections in the skin and their journey around the body will help 
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1.1 African trypanosomes 
African trypanosomes are single-cell haemoflagellate protozoan parasites 
(Figure 1.1) (order Kinetoplastida), and are the etiological agents of African 
Trypanosomiasis (Barrett, Burchmore et al. 2003, Brun, Blum et al. 2010, 
Morrison, Vezza et al. 2016, Aksoy, Buscher et al. 2017). The parasites cause 
sleeping sickness in humans and nagana in livestock, living extracellularly 
within the mammalian host. The species of African trypanosomes that cause 
major disease are Trypanosoma brucei, T. congolense and T. vivax. T. brucei 
are transmitted via tsetse flies, with the subspecies T. b. rhodesiense and T. 
b. gambiense causing human African trypanosomiasis (HAT) in endemic 
regions across sub-Saharan Africa with more than 57 million people at risk 
within the African tsetse belt (Brun, Blum et al. 2010, Organization 2013). 
Animal African trypanosomiasis (AAT) is caused by T. congolense, T. vivax, 
and T. brucei, inflicting substantial economic strains on the African livestock 
industry as the prevalence of the livestock disease is 1000 to1500-fold higher 
than HAT (Baral 2010, Morrison, Vezza et al. 2016). This disease inflicts a 
massive $4.5 billion strain on the African economy, livestock industry and 





Figure 1.1: Micrograph of T. brucei 
Microscopy image of bloodstream form T. b. brucei parasites in culture.  
 
1.2 Life cycle 
1.2.1 Life cycle in the mammalian host 
The parasitic life cycle (Figure 1.2) in the mammalian host begins with the 
intradermal (i.d) injection of metacyclic trypomastigotes into the skin by the 
tsetse fly vector of the genus Glossina (Van Den Abbeele, Caljon et al. 2010, 
Aksoy, Weiss et al. 2014, Caljon, Van Reet et al. 2016). The metacyclic 
parasites then transform into the blood-stage long slender form 
trypomastigotes which rapidly proliferate, dividing by binary fission and 
cytokinesis (Matthews 2005, Baral 2010, Farr and Gull 2012). The parasites 
are highly motile in the bloodstream of the mammalian host where they utilise 
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glucose as their primary energy source, using an ancient specialised organelle 
known as the glycosome to perform glycolysis (Barnard, Reynafarje et al. 
1993). In the bloodstream the parasites express high levels of a surface protein 
coat known as variant-surface glycoprotein (VSG), which can be targeted by 
host antibodies for immunoclearance (Dempsey and Mansfield 1983, Rifkin 
and Landsberger 1990, Taylor 1998, Shi, Wei et al. 2004). The parasites also 
switch the type of VSG they express to evade host immune responses 
(described in detail in section 1.8.7). However, as the blood parasitaemia 
increases within the mammalian host, the parasite population uses quorum 
sensing to prevent overwhelming of the host (Vassella, Reuner et al. 1997, 
Seed and Wenck 2003, Mony and Matthews 2015). This is achieved through 
the production of stumpy induction factor (SIF), which involves cAMP signalling 
to induce their differentiation to non-proliferative short stumpy forms (Vassella, 
Reuner et al. 1997, Seed and Wenck 2003, Mony and Matthews 2015). This 
transition is required for their transmission to the tsetse fly vector (Seed and 
Wenck 2003, Matthews 2005).  
 
1.2.2 Life cycle in the fly vector 
Trypanosomes are transmitted back into the tsetse fly following a blood meal 
on an infected mammalian host. Within the midgut of the tsetse fly, 
bloodstream form parasites alter their metabolism to survive within the 
arthropod host and differentiate into rapidly dividing procyclic trypanosomes 
that express a procyclin outer protein coat (Aksoy, Weiss et al. 2014). The 
trypanosome’s metabolism radically changes from glucose consumption and 
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glycolysis, to proline consumption utilising the mitochondrion (Mantilla, 
Marchese et al. 2017). Procyclic trypanosomes rapidly colonise the fly’s midgut 
ectoperitrophic space, growing exponentially (Gibson and Bailey 2003). 
Procyclic trypanosomes then transmigrate through the wall of the midgut (Ooi 
and Bastin 2013) before becoming mesocyclic trypanosomes in the alimentary 
tract (Rotureau, Ooi et al. 2013). The mesocyclic forms undergo cell cycle 
arrest and from the alimentary tract the parasites migrate towards the lumen 
of the proventriculus (Sharma, Gluenz et al. 2009). The parasites then invade 
the salivary glands (Sharma, Gluenz et al. 2009), and differentiate into the 
rapidly proliferating epimastigote trypanosomes (Rotureau, Ooi et al. 2013, 
Schuster, Krüger et al. 2017). Trypanosome motility is crucial for parasite 
development within the vector (Rotureau, Ooi et al. 2013). These proliferative 
epimastigote forms then differentiate into non-proliferative metacyclic 
trypanosomes ready to be deposited into the dermal layer of the skin of a new 
mammalian host when the fly takes another blood meal (Vickerman, Tetley et 
al. 1988, Van Den Abbeele, Claes et al. 1999, Brice, Subota et al. 2012, Brice 





Figure 1.2: The life cycle of T. brucei spp. 
Diagram showing scanning electron micrographs of developmental life cycle stages 
of T. brucei parasites in the mammalian host and the tsetse fly. The mammalian host 
is infected upon tsetse fly vector bite and feeding. Metacyclic form trypanosomes are 
injected into the dermis layer of skin in the host. Metacyclic forms differentiate into 
long slender bloodstream forms in the blood. Long slender bloodstream forms 
express a variant surface glycoprotein (VSG) coat and rapidly proliferate, consuming 
substantial amounts of glucose through glycolytic metabolism. Quorum sensing and 
the production of stumpy induction factor (SIF) induces the differentiation of long 
slender forms into non-proliferative short stumpy forms. Short stumpy parasites are 
taken up by the tsetse fly during blood meal feeding. Parasites become procyclic 
forms in the midgut of the tsetse fly. Procyclic forms express a procyclin protein coat 
and consume proline utilising the mitochondrion for metabolism. Procyclic forms 
rapidly proliferate before transforming into mesocyclic forms in the alimentary tract. 
Parasites then invade the salivary glands and transform into the rapidly proliferating. 
epimastigotes, which then differentiate into  transmissible metacylic forms. Adapted 




1.3 Human African trypanosomiasis  
Human African trypanosomiasis has caused many epidemics throughout 
history, as millions of people died from the disease in the early 20th Century 
across sub-Saharan Africa (de Raadt 2005, Steverding 2008). The T. b. 
rhodesiense and T. b. gambiense subspecies cause HAT and disease occurs 
in two stages: the haemolymphatic stage, followed by the meningoencephalitic 
stage. 
 
1.3.1 Haemolymphatic stage 
The haemolymphatic stage occurs when the extracellular parasites invade the 
circulatory and lymphatic systems, and disseminate systemically (Tabel, Wei 
et al. 2013, Caljon, Van Reet et al. 2016, Alfituri, Ajibola et al. 2018). In the 
human skin after the tsetse fly bite a trypanosome-filled lesion known as a 
chancre develops around 5-15 days post-injection (d.p.i) (Sternberg 2004, 
Kennedy 2013), and similar lesions occur in cattle (Akol and Murray 1982). 
Following the migration of the parasites from the skin towards the lymphatics, 
the infected host develops swollen lymph nodes, which can be especially 
visible around the back of the neck (Winterbottom’s sign) (E Ormerod 1991, 
Brun, Blum et al. 2010). Fever is also induced as the parasites spread 
systemically throughout the bloodstream (Sternberg 2004, Brun, Blum et al. 
2010). During the invasion of the circulatory and lymphatic systems, symptoms 
develop in the host including general malaise, anaemia, headaches, pruritus, 
pyrexia and cachexia (Sternberg 2004, Brun, Blum et al. 2010). The parasites 
then invade multiple tissues and organs, including the spleen, liver, kidney and 
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heart, causing pathology (Sternberg 2004, Brun, Blum et al. 2010, Kennedy 
2013, Büscher, Cecchi et al. 2017). If left untreated, systemic infection can 
lead to significant tissue damage, severe anaemia, as well as cardiac, kidney 
and endocrine dysfunction (Fèvre, Wissmann et al. 2008, Kennedy 2013, 
Büscher, Cecchi et al. 2017).  
The current treatment strategies for the haemolymphatic stage of disease 
involves use of the drugs Suramin and Pentamidine for early T. b. rhodesiense 
and T. b. gambiense infections, respectively (Brun, Blum et al. 2010, Kennedy 
2013, Büscher, Cecchi et al. 2017). Pentamidine is administered either 
intramuscularly daily for 7 days or intravenously (i.v) over 2 hours in saline 
(Brun, Blum et al. 2010, Büscher, Cecchi et al. 2017). Pentamidine is a potent 
trypanolytic drug (95-98% efficacy), inducing high toxicity within trypanosomes 
partly through disruption of the kinetoplast (Barrett, Boykin et al. 2007, Baker, 
de Koning et al. 2013, Büscher, Cecchi et al. 2017). Since its introduction in 
the 1930s, Pentamidine has been the main drug used against T. b. gambiense 
infection, as drug resistance has been rarely reported (Baker, de Koning et al. 
2013). Suramin is administered i.v once a week for 5 weeks to treat T. b. 
rhodesiense infections (Brun, Blum et al. 2010, Büscher, Cecchi et al. 2017). 
Suramin’s mode of trypanolytic action is likely due to inhibiting crucial 
trypanosome glycolytic enzymes, and drug resistance against human infection 
is rare (Barrett, Boykin et al. 2007, Wiedemar, Graf et al. 2017). Uptake of the 
drug by trypanosome cells occurs by endocytosis, and downregulation of this 





1.3.2 Meningoencephalitic stage 
If the infection is left untreated, individuals will develop the 
meningoencephalitic stage of disease, as the parasites pass through the 
blood-brain-barrier (BBB) and invade the central nervous system (CNS) 
(Rodgers 2010, Frevert, Movila et al. 2012, Laperchia, Palomba et al. 2016, 
Rodgers, Bradley et al. 2017). Invasion of the brain causes inflammation, 
resulting in sleeping sickness which manifests as disruption to sleep and 
circadian rhythms (Sternberg 2004, Kennedy 2008, Brun, Blum et al. 2010, 
Büscher, Cecchi et al. 2017). Neurological abnormalities, motor weakness and 
limb paralysis are also observed and late-stage disease can lead to coma, 
organ failure and death. Treatments for late-stage HAT include the drugs 
melarsoprol and eflornithine for T. b. rhodesiense and T. b. gambiense 
infections (Barrett, Boykin et al. 2007, Brun, Blum et al. 2010, Kennedy 2013, 
Büscher, Cecchi et al. 2017). Melarsoprol is administered i.v daily for 10 days, 
and rapidly lyses trypanosomes, although the mode of action is uncertain 
(Fairlamb and Horn 2018). However, melarsoprol treatment is highly toxic, and 
5-10% of treated patients have a high mortality risk (Barrett, Boykin et al. 2007, 
Fairlamb and Horn 2018). Widespread melarsoprol drug resistance was 
established in the 1990s, causing concerns for future treatment strategies 
(Barrett, Boykin et al. 2007, Fairlamb and Horn 2018). In the last 50 years, only 
eflornithine has emerged as a new drug against African trypanosomes, and 
works well in combination with the drug nifurtimox (Brun, Blum et al. 2010, 
Büscher, Cecchi et al. 2017). Eflornithine is administered i.v daily for 1-2 
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weeks, and nifurtimox is administered orally three-times daily for 10 days. 
Eflornithine inhibits the polyamine biosynthetic enzyme ornithine 
decarboxylase, reducing polyamine synthesis in trypanosomes, and killing the 
parasites (Barrett, Boykin et al. 2007). Nifurtimox is believed to induce 
oxidative stress in the trypanosomes (Wilkinson, Taylor et al. 2008). Although 
development of drug resistance towards this combination therapy is a risk 
(Vincent, Creek et al. 2010). Alternatively, orally-administered fexinidazole is 
an effective treatment for late-stage T. b. gambiense HAT (Pollastri 2018). 
 
1.4 Animal African trypanosomiasis 
Animal African trypanosomiasis (AAT) is largely caused by T. congolense, T. 
vivax and T. brucei species. AAT affects approximately 150 million cattle and 
260 million sheep and goats in sub-Saharan Africa per year (Figure 1.3) 
(Swallow, Kristjanson et al. 1999, Leigh, Emikpe et al. 2015, Giordani, 
Morrison et al. 2016, Morrison, Vezza et al. 2016, Yaro, Munyard et al. 2016). 
African trypanosomes can also cause disease in pigs, horses, donkeys, 
camels, and dogs (Desquesnes, Holzmuller et al. 2013, Giordani, Morrison et 
al. 2016). During AAT disease, large skin chancres form at the bite site, and 
lymphadenopathy, hepatosplenomegaly, anaemia and fever develop causing 
severe pathology (Leigh, Emikpe et al. 2015, Giordani, Morrison et al. 2016, 
Yaro, Munyard et al. 2016). Other symptoms include: cachexia; oedema; 
olfactory discharge; ataxia; lachrymation; keratitis, abortion, and reduction in 
milk yields (Health 2009, Giordani, Morrison et al. 2016, Yaro, Munyard et al. 
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2016). The financial impact of AAT on sub-Saharan Africa is estimated to incur 
a yearly $4.5 billion strain on the African economy (Adamu, Nwosu et al. 2009). 
Infection can inflict a devastating financial burden on local farmers 
(Muhanguzi, Picozzi et al. 2014). This is due to reduced meat and milk 
production, reduced crop yields due to loss of draft power, reduced birth rates, 
and increased mortality (Holt, Selby et al. 2016). AAT is treated using drugs 
such as: diminazene aceturate; ethidium bromide; isometamidium chloride; 
pentamidine and suramin, but drug resistance issues remain problematic (Roy 
Chowdhury, Bakshi et al. 2010, Baker, de Koning et al. 2013, Giordani, 
Morrison et al. 2016, Morrison, Vezza et al. 2016, Yaro, Munyard et al. 2016).  
 
Figure 1.3: Distribution of tsetse fly 
Map showing the distribution of tsetse fly vectors and approximate cattle herds across 
sub-Saharan Africa. Credit: IAEA (International Atomic Energy Agency). 
http://www.irinnews.org/photo/200905121658410828/200905121658410828jpg.   
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1.5 Control strategies 
The prevalence of HAT has significantly declined in recent years due to the 
World Health Organisation launching a strategy for disease control, mediated 
via a program of active surveillance in humans (Simarro, Diarra et al. 2011, 
Aksoy, Buscher et al. 2017). As a result of increased health screenings, 
improved treatment programs and vector control in affected regions, HAT 
prevalence has plummeted, with fewer than 3,000 reported cases in 2015, and 
only 2,500 in 2016 (Simarro, Diarra et al. 2011, Organization 2013, Auty, 
Morrison et al. 2016, Lehane, Alfaroukh et al. 2016, Aksoy, Buscher et al. 
2017, Organization 2017). The WHO aims to eliminate HAT caused by T. b. 
gambiense by 2030, as it is largely an anthroponotic disease between vector 
and humans, so breaking the cycle of transmission could prove more 
amenable than if an extensive animal reservoir was involved.  
The incidence of AAT remains problematic. Control strategies for preventing 
AAT also involve increased diagnostics, treatments and vector controls. 
However, the breeding of genetically resistant livestock may have potential to 
control the incidence of AAT among livestock. Certain breeds of cattle, such 
as N’Dama, Baoule, and Muturu are more trypanotolerant to infection, whereas 
the Boran and Zebu breeds are more trypanosusceptible (Murray, Trail et al. 
1984, Naessens, Teale et al. 2002, Morrison, McLellan et al. 2010, Smetko, 
Soudre et al. 2015, Morrison, Vezza et al. 2016, Yaro, Munyard et al. 2016). 
These trypanotolerant cattle better control their parasitaemias and anaemias 
during trypanosomiasis disease, and as a consequence have greater growth 
and production yields (Murray, Trail et al. 1984, Smetko, Soudre et al. 2015).   
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Humans and certain species of apes have innate resistance to the 
trypanosome species that cause AAT, due to their expression of trypanosome 
lytic factors (TLFs). These comprise a subset of high density lipoproteins found 
in sera that are cytotoxic towards all species of African trypanosomes, except 
T. b. gambiense and T. b. rhodesiense (Kieft, Capewell et al. 2010, 
Vanhollebeke and Pays 2010, Wheeler 2010, Thomson and Finkelstein 2015). 
TLFs induce the lysis of all other trypanosome species which infect other 
animals by forming pores in the lysosome and inducing osmotic swelling of the 
trypanosomes (Wheeler 2010). T. b. gambiense and T. b. rhodesiense are 
resistant to TLFs due to their expression of serum resistance-associated 
proteins (Wheeler 2010). The main TLFs are apolipoprotein L1 (APOL1) and 
haptoglobin-related protein (Hpr) (Vanhollebeke and Pays 2010, Wheeler 
2010). APOL1 and Hpr function via their interactions with haemoglobin and 
these complexes bind the haptoglobin receptor of the parasites, inhibiting 
essential haem uptake whilst allowing uptake of the TLFs to lyse the parasites 
(Vanhollebeke and Pays 2010, Wheeler 2010, Thomson and Finkelstein 
2015).  
Administration of APOL1 and transgenic expression of the APOL1 resistance 
gene in mice reduces their susceptibility to infection with T. b. brucei, T. 
congolense, and T. evansi (Molina-Portela, Samanovic et al. 2008). A study 
has also identified a variant of APOL1 found in primates that displayed 
trypanolytic properties against human-infective T. b. gambiense (Cooper, 
Capewell et al. 2016). These trypanocidal properties could be used for future 
therapeutics. For example, the generation of transgenic livestock expressing 
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TLFs may help reduce disease incidence and transmission (Thomson, Molina-
Portela et al. 2009). 
 
1.6. Tsetse fly 
Tsetse flies are the vectors of African trypanosomes. There are 31 known 
tsetse fly species and subspecies of the genus Glossina, family of Glossinidae, 
and order of Diptera (Bequaert 1956, Moloo 2011, Vreysen, Seck et al. 2013). 
Across 38 sub-Saharan African countries encompassing an area of 10 million 
km2, three main subgroups of tsetse fly are prevalent: G. mortisans; G. 
palpalis; and G. fusca (Moloo 2011, Vreysen, Seck et al. 2013, Wamwiri and 
Changasi 2016). All species of tsetse fly can transmit human-infective 
trypanosomes, but of these 31 known tsetse fly species, only 8-10 are 
considered to be of health and economic importance (Vreysen, Seck et al. 
2013, Wamwiri and Changasi 2016). The distribution of tsetse flies in sub-
Saharan Africa reflects their favoured vegetative habitat: G. mortisans, 
savannah; G. palpalis, riverine; and G. fusca, forest (Wamwiri and Changasi 
2016). The transmission of trypanosomes can be performed by both male and 
female tsetse flies following a blood meal on a mammalian host (Vreysen, Seck 
et al. 2013). 
 
1.7 Host immunity to African trypanosome infection 
African trypanosomes exist entirely extracellularly within the mammalian host, 
and are constantly exposed to the host’s innate and adaptive immune systems. 
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The ability of the host’s immune system to combat the rapidly increasing 
parasite burden is essential to control trypanosome infections. The innate 
immune system is a vital first response to infection, involving macrophages 
monocytes, dendritic cells, and natural killer (NK) cells (Veer, Kemp et al. 2007, 
Namangala 2012, Abbas, Lichtman et al. 2018, Stijlemans, De Baetselier et 
al. 2018, McDonald and Levy 2019). During the early stages of African 
trypanosomiasis, a strong pro-inflammatory cytokine response is induced 
(Mansfield and Paulnock 2005, Baral 2010, Ponte-Sucre 2016, Bakari, Ofori 
et al. 2017). 
 
1.7.1 Role of macrophages 
Macrophage cells are considered to play an essential role in combating African 
trypanosome infections in the mammalian host (Grosskinsky and Askonas 
1981, Fierer and Askonas 1982, Grosskinsky, Ezekowitz et al. 1983, 
Baetselier, Namangala et al. 2001, Paulnock and Coller 2001, Vincendeau and 
Bouteille 2006, Baral 2010, Paulnock, Freeman et al. 2010, Stijlemans, 
Vankrunkelsven et al. 2010, de Sousa, Atouguia et al. 2011, Kuriakose, Singh 
et al. 2016, Stijlemans, De Baetselier et al. 2018). Following infection, 
trypanosomal pathogen-associated molecular patterns (PAMPs) trigger the 
activation of these innate mononuclear phagocytes via interactions with the 
pattern recognition receptors (PRRs) on the surface of the host’s immune cells 
(Akol and Murray 1982, Grosskinsky, Ezekowitz et al. 1983, Paulnock and 
Coller 2001, Magez, Stijlemans et al. 2002, Drennan, Stijlemans et al. 2005, 
Leppert, Mansfield et al. 2007, Stijlemans, Vankrunkelsven et al. 2010, 
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Takeuchi and Akira 2010, Stijlemans, Caljon et al. 2016, Stijlemans, De 
Baetselier et al. 2018). Mononuclear phagocytic cells recognise PAMP 
components of trypanosomal antigens, such as CpG DNA binding to TLR-9 
and soluble glycosylphosphatidyl inositol (GPI)-anchored VSG binding to 
scavenger receptor PRRs. Stimulation of these signalling pathways activates 
these immune cells to rapidly respond to the invading trypanosomes (Akol and 
Murray 1982, Grosskinsky, Ezekowitz et al. 1983, Paulnock and Coller 2001, 
Magez, Stijlemans et al. 2002, Drennan, Stijlemans et al. 2005, Leppert, 
Mansfield et al. 2007, Stijlemans, Vankrunkelsven et al. 2010, Stijlemans, 
Caljon et al. 2016).  
Upon African trypanosome infection in the host, a strong pro-inflammatory type 
1 (Th1) immune response is initiated, and macrophage abundance is 
significantly increased in the spleen, liver, and bone-marrow (Vincendeau and 
Bouteille 2006). Macrophages and liver-resident Kupffer cells phagocytose 
trypanosomes that are opsonised by parasite-specific Immunoglobulin (Ig) 
(Dempsey and Mansfield 1983, Shi, Wei et al. 2004, Vincendeau and Bouteille 
2006). This can also involve co-operation with soluble components of the host 
complement system (Guirnalda, Murphy et al. 2007). Experiments using T. 
brucei-infected mice have shown that Kupffer cells in the liver are involved in 
the majority of parasite clearance via complement and antibody-mediated 
phagocytosis (Macaskill, Holmes et al. 1980). Expression of the cytokines IFN-
γ and TNF-α can result in the induction of classically activated macrophages. 
Classically activated macrophages utilise the inducible nitric oxide synthase 
(iNOS) enzyme to produce highly reactive and toxic nitric oxide (NO) via the L-
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arginine metabolic pathway (Figure 1.5) (Satriano 2004, Wijnands, 
Castermans et al. 2015). These mononuclear phagocytes can produce 
additional pro-inflammatory cytokines, such as TNF-α, IL-1, IL-6, IL-8 and IL-
12 (Arango Duque and Descoteaux 2014). The potent trypanolytic activities of 
NO and TNF-α are well established, and these effector molecules are 
important in controlling the initial peak of trypanosome parasitaemia 
(Vincendeau, Daulouede et al. 1992, Magez, Lucas et al. 1993, Magez, 
Geuskens et al. 1997, Hertz, Filutowicz et al. 1998, Sternberg 2004, Magez, 
Radwanska et al. 2006, Barkhuizen, Magez et al. 2007, Magez, Radwanska 
et al. 2007, Baral 2010, Namangala 2012, Stijlemans, Caljon et al. 2016). The 
mechanisms by which NO can inhibit trypanosomes include: the ability to 
readily bind to haemoglobin and interact with red blood cells.(Mabbott, 
Sutherland et al. 1994, Sternberg, Mabbott et al. 1994, Mabbott, Sutherland et 
al. 1995) and remove iron from important trypanosome enzymes, the latter 
being potentially effective in the extravascular spaces (Vincendeau and 
Daulouede 1991). However, not all interactions with cytokines are detrimental 
to trypanosomes. Trypanosomes secrete a factor known as trypanosome-
lymphocyte-triggering-factor (TLTF) which can trigger the production of IFN-γ 
from T cells (Hamadien, Lycke et al. 1999, Nishimura, Hamashita et al. 2004), 
thereby also inducing a potent classically activated macrophage response. 
However, it has been suggested that the secretion of TLTF and subsequent 
increase in IFN-γ levels enhances parasite growth by improving the uptake of 
[3H]thymidine in the trypanosomes (Bakhiet, Olsson et al. 1996, Hamadien, 




1.7.2 Role of B cells 
As African trypanosomes exist entirely extracellularly within the mammalian 
host, B cells and Ig provide protective immunity against trypanosome infection 
by producing VSG-specific Ig. Several studies have shown that B cell-deficient 
mice do not survive trypanosome infections (Campbell, Esser et al. 1977, 
Magez, Radwanska et al. 2006, Baral, De Baetselier et al. 2007, Magez, 
Schwegmann et al. 2008). Following infection of B cell-deficient mice, a 
gradual increase in parasitaemia were observed for the initial 4 weeks of the 
infection that eventually increased exponentially, killing the host (Magez, 
Schwegmann et al. 2008).  
The inability to produce trypanosome VSG-specific Ig renders the host 
incapable of effectively controlling the infection. The trypanosomes present 
within the mammalian host express a dense surface coat consisting of ~107 
molecules of VSG (Baral 2010, Pinger, Chowdhury et al. 2017). 
Immunoglobulin responses specific for these VSG antigens target the clones 
of parasites that express these proteins enabling a wave of parasite clearance 
(Guirnalda, Murphy et al. 2007, Magez, Schwegmann et al. 2008, Pinger, 
Chowdhury et al. 2017). Experiments have shown that significant levels of IgM 
immunoglobulins are produced 3-4 d.p.i (Vincendeau and Bouteille 2006). The 
production of Ig is critical in combating African trypanosome infections 
(Campbell, Esser et al. 1977, Magez, Radwanska et al. 2006, Magez, 
Schwegmann et al. 2008). Many studies have shown that early production of 
innate IgM dominates the process of trypanosome clearance during the first 5 
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days of infection (Dempsey and Mansfield 1983, Dempsey and Mansfield 
1983, Reinitz and Mansfield 1990, Pan, Ogunremi et al. 2006). Natural IgM is 
known to play a major role in bridging the innate and adaptive immune systems 
together, through immunoclearance, antibody-mediated cellular phagocytosis, 
inflammation, B cell maintenance, and activating the complement cascade 
(Panda and Ding 2015).  
Protection against late-stage African trypanosome infection relies on the 
production of parasite VSG-specific Ig responses, and can occur 
independently of complement activity (Guirnalda, Murphy et al. 2007). The 
mechanism of antibody class-switching is important for inducing waves of 
VSG-specific parasite clearance, which can occur around 4-7 d.p.i. (Pinger, 
Chowdhury et al. 2017). A study has also showed that the full switching of the 
VSG coat occurs within 4.5 d.p.i (Pinger, Chowdhury et al. 2017). The class-
switched IgG isotypes have been shown to be heavily involved in VSG-specific 
and high-affinity targeting of trypanosomes (Guirnalda, Murphy et al. 2007, 
Magez, Schwegmann et al. 2008, Stijlemans, Radwanska et al. 2017). The co-
operative activities of T and B lymphocytes enables antibody class-switching, 
with mouse models showing that during T. brucei infection IgG1 antibodies 
work with type 2 cytokines to boost the level of parasite clearance, extending 
host survival (Namangala, de Baetselier et al. 2000). Studies have also 
demonstrated that differences in the resistance and susceptibility of different 
strains of mice and cattle to trypanosome infection are in part due to 
differences in the host’s ability to produce potent class-switched Ig responses. 
Relatively resistant C57BL/6 mice are capable of producing significant 
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amounts of parasite-specific IgG in comparison to more susceptible A/J mice 
(Morrison 1985, Uzonna, Kaushik et al. 1999). During trypanosome infections 
of different cattle breeds, the more resistant N’Dama breed produced 
significantly higher levels of parasite-specific class-switched IgG, in 
comparison to the more susceptible Boran breed (Taylor, Lutje et al. 1996, 
Taylor 1998). In contrast, the susceptible Boran cattle produced significantly 
higher levels of parasite-specific IgM. Controlling earlier parasitaemia during 
T. brucei infections in cattle relies heavily on high amounts of both parasite-
specific IgM and IgG immunoglobulins (Musoke, Nantulya et al. 1981). 
However, studies in mice have shown that parasite-specific IgM is not 
essential for survival during African trypanosome infections (DeGee and 
Mansfield 1984, Magez, Schwegmann et al. 2008). The capacity of mice to 
produce class-switched Ig has been shown crucial in their ability to control 
African trypanosome infection (Magez, Radwanska et al. 2006).  
 
1.7.3 Immunoglobulin class-switching 
Upon stimulation, B cells can differentiate into short-lived plasma cells, or enter 
germinal centres within secondary lymphoid organs (SLOs) for further clonal 
expansion, Ig class-switch recombination and somatic hypermutation 
(Vazquez, Catalan-Dibene et al. 2015). This process alters the Ig isotype 
produced by B cells from IgM to IgA, IgD, IgE, or an IgG.  
Germinal centres enable B cells to undergo clonal expansion, class-switch 
recombination, somatic hypermutation and affinity maturation, to produce high 
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affinity class-switched Ig (Figure 1.4) (Hamel, Liarski et al. 2012, Victora and 
Nussenzweig 2012, Basso and Dalla-Favera 2015, De Silva and Klein 2015, 
Vazquez, Catalan-Dibene et al. 2015). Class-switch recombination occurs via 
changes to the Ig heavy chain, while maintaining the variant region to retain 
specific affinity for antigens. Within the germinal centres, antigen drives B cells 
to undergo somatic hypermutation and affinity maturation, improving the 
antigen binding capacity of their Ig variable regions (Jacob, Kelsoe et al. 1991, 
Bannard and Cyster 2017). The enzyme, activation-induced cytidine 
deaminase, initiates these processes (Stavnezer, Guikema et al. 2008, Kumar, 
DiMenna et al. 2014), which are co-ordinated in the germinal centre via co-
stimulation by T follicular helper (Tfh) cells and antigen presentation by 
follicular dendritic cells (FDCs) (Bannard and Cyster 2017). A network of FDCs 
within B cell follicles retains antigen for prolonged periods, for presentation to 
B cells (Hamel, Liarski et al. 2012, De Silva and Klein 2015). This allows 
antigen-stimulated B cells to interact with antigen-specific T cells. These B and 
T cells differentiate into germinal centre B and Tfh cells, respectively. The 
combined antigen presentation by FDCs and co-stimulatory signals from Tfh 
cells enables the production of high affinity class-switched Ig by activated 
germinal centre B cells (Hamel, Liarski et al. 2012, De Silva and Klein 2015). 
If these structures are disorganised or absent, then protective humoral 






Figure 1.4: Germinal centre reactions within B cell follicles 
Diagram showing antigen-activated naïve B cells undergoing germinal centre 
reactions within B cell follicles. Antigen-stimulated naïve B cells enter the dark zone 
of the germinal centre, where they proliferate and undergo somatic hypermutation, 
allowing the rearrangement of their Ig variable region genes. B cells then enter the 
light zone. B cells then receive selection of their B cell receptor through interactions 
with follicular dendritic cells (FDCs) that present antigen peptides and T follicular 
helper (Tfh) cells. These B cells are positively selected for having higher affinity for 
antigens. Selected B cells can differentiate into plasmablasts (plasma cell precursors) 
or memory B cells. B cells can also recirculate through the dark zone back into the 
light zone for further proliferation, somatic hypermutation, and selection. Prior to 
recirculation, B cells can undergo class-switch recombination. This allows for the 
production of high-affinity class-switched Ig.   
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1.8 Immune evasion and suppression by African 
trypanosomes 
1.8.1 Immunosuppression during African trypanosomiasis 
The suppression of the host immune response is fundamental for parasite 
survival during African trypanosome infections (Mabbott, Sutherland et al. 
1995, Vincendeau and Bouteille 2006, Radwanska, Guirnalda et al. 2008, 
Gomez-Rodriguez, Stijlemans et al. 2009, Baral 2010, Black, Guirnalda et al. 
2010, Namangala 2011, Tabel, Wei et al. 2013, Cnops, De Trez et al. 2015, 
Frenkel, Zhang et al. 2016, Stijlemans, Caljon et al. 2016, Stijlemans, De 
Baetselier et al. 2018). This immunosuppression affects both the cellular and 
humoral arms of the immune system.  
 
1.8.2 Effects of trypanosomiasis on lymphoid organs 
During the early stages of infection, the host experiences significant 
enlargement of the lymph nodes and the spleen (Murray, Jennings et al. 1974, 
Murray, Jennings et al. 1974, Morrison, Murray et al. 1981, E Ormerod 1991, 
Omeke and Ugwu 1991). In the spleen, the significant proliferation of plasma 
cells and lymphoblasts, and infiltration of polymorphonuclear leukocytes, 
resulted in hyperplasia, haemorrhaging, necrosis, and the disruption and 
disorganisation of the splenic microarchitecture. The rapid accumulation of 
these leukocytes in the white pulp (T cell region) causes enlargement and 
disruption, that can extend into the red pulp (B cell area)(Murray, Jennings et 
al. 1974). Abundant and brief increases in plasma cells in the spleen can also 
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cause the marginal zone region to disappear, disrupting the organisation of the 
white and red pulp (Radwanska, Guirnalda et al. 2008, Black, Guirnalda et al. 
2010). Further destruction of the B cell follicles and germinal centres also 
occurs. In the lymph nodes, significant accumulation of macrophages and 
polymorphonuclear leukocytes can occur, resulting in hyperplasia, necrosis, 
haemorrhaging, and disruption to the reticulum cellular network. The disruption 
of the primary and secondary lymphoid follicles was also observed, with 
disruption to germinal centres and reductions in their size (Murray, Jennings 
et al. 1974, Omeke and Ugwu 1991). These disruptions can significantly affect 
the host’s ability to produce class-switched Ig.  
 
1.8.3 Activation of suppressor macrophages 
The induction of suppressor macrophages is a prominent feature of the 
immunosuppression which occurs during T. brucei infections. Studies have 
shown that trypanosomes trigger a switch in macrophage activation from pro-
inflammatory classically activated to a more anti-inflammatory alternatively 
activated state (Namangala, de Baetselier et al. 2000, Baetselier, Namangala 
et al. 2001, Noël, Hassanzadeh et al. 2002, Kuriakose, Singh et al. 2016, 
Stijlemans, De Baetselier et al. 2018). Macrophages can become alternatively 
activated through stimulation by macrophage colony stimulating factor 
(CSF),IL-4, IL-10, IL-13 and transforming growth factor-β (TGF-β) cytokines 
(Figure 1.5) (Arango Duque and Descoteaux 2014, Murray, Allen et al. 2014, 
Hume 2015, Roszer 2015). Upon stimulation, arginase enzymes compete with 
iNOS, and induce ornithine and urea production via the L-arginine pathway 
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instead of NO and citrulline (Rath, Müller et al. 2014). Alternatively activated 
macrophages induce an anti-inflammatory, Th2 immune response, and are 
active in wound healing and tissue repair (Hume and MacDonald 2012, Arango 
Duque and Descoteaux 2014, Hamilton, Zhao et al. 2014, Boulakirba, Pfeifer 
et al. 2018). 
 
Figure 1.5: The classical and alternative activation of macrophages 
Diagram shows the classical and alternative pathways of macrophage cell activation. 
(Left) Pro-inflammatory stimuli, such as IFN-γ, TNF-α, and LPS, classically activates 
macrophages. Classically activated macrophages induce the expression of the 
inducible nitric oxide synthase (iNOS) enzyme, which catabolises the substrate L-
arginine to produce NO and citrulline. This results in a pro-inflammatory response. 
(Right) Anti-inflammatory stimuli, such as CSF, IL-4, IL-10, IL-13, and TGF-β, 
alternatively activates macrophages. Alternatively activated macrophages induce the 
expression of the arginase enzyme, which catabolises the substrate L-arginine to 
produce ornithine. The enzyme ornithine decarboxylase (ODC) catalyses the 
breakdown of ornithine for the production of polyamines. This results in an anti-
inflammatory response and tissue repair.   
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Studies have identified trypanosomal factors which may trigger the 
macrophage cell switch to alternative activation. Research of T. brucei have 
characterised a produced factor (Kinesin heavy chain isoform, TbKHC1) which 
actively induces IL-10 production and arginase activity, resulting in decreased 
NO production (De Muylder, Daulouède et al. 2013). When WT mice were 
infected with TbKHC1 KO trypanosomes , parasitaemia levels were reduced 
and survival of the host was enhanced (De Muylder, Daulouède et al. 2013). 
These data suggest the release of TbKHC1 by T. brucei enables the parasites 
to manipulate the host cell metabolism through biasing the L-arginine pathway 
towards arginase enzyme activity. Therefore, this manipulation may lead to the 
switching of macrophage activation from classical to alternative, thus skewing 
the host towards a type 2 immune response, reducing pro-inflammatory 
responses, and allowing the parasite to thrive within the host.  
Following the initial parasitaemia wave, T. brucei parasites have been shown 
to produce a factor known as trypanosome suppression immunomodulating 
factor (TSIF), which has been shown to trigger the induction of suppressor 
macrophages (Gomez-Rodriguez, Stijlemans et al. 2009, Stijlemans, Caljon et 
al. 2016). Production of TSIF occurs following the peak of the initial wave of 
parasitaemia, and functions by inhibiting T cell proliferation, which may 
consequently inhibit protective B cell activation and Ig production. 
Trypanosomes deficient for TSIF have been shown to not survive (Stijlemans, 
Caljon et al. 2016). T. brucei produce another immunosuppressive factor, the 
metabolite indolepyruvate, that inhibits the LPS-induced activation of 
classically activated macrophages, resulting in decreased production of pro-
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inflammatory molecules, thereby suppressing the host immune response 
(McGettrick, Corcoran et al. 2016). It has also been shown that upon 
phagocytosis by Kupffer cells in the liver, T. brucei parasites are induced to 
activate trypanosomal adenylate cyclase, which results in the inhibition of 
trypanolytic TNF-α cytokine production by these Kupffer cells (Salmon, 
Vanwalleghem et al. 2012). When adenylate cyclase activity was reduced, 
trypanosomes remained viable, yet the early innate response against the 
parasites was enhanced. This suggests that lysed trypanosomes release 
adenylate cyclase to enhance the survival of live parasites through 
suppressing protective immunity. Studies of T. congolense-infected mice have 
shown that resistant C57BL/6 mice produce a pro-inflammatory type 1 cytokine 
response, while susceptible BALB/c mice have a mixed Th1/Th2 response 
(Noël, Hassanzadeh et al. 2002). It has been suggested that during 
intradermal infection, the immunosuppression in the skin is mediated by the 
combination of a mixed classical/alternative macrophage response and 
suppressor T cell response (Tabel, Wei et al. 2013). 
However, it has been suggested that a type 2 cytokine response may maintain 
the infection in the long-term (Namangala, de Baetselier et al. 2000, Baetselier, 
Namangala et al. 2001, Noël, Raes et al. 2004), as T. congolense infected 
mice induce a change from early classically activated macrophages to an 




1.8.4 Impairment of T cell function during trypanosomiasis 
Due to the induction of suppressor macrophage activity, a reduction in IL-2 
secretion leads to an inhibition of T cell responses during T. brucei and T 
congolense infections in mice and cattle (Sileghem, Darji et al. 1989, Sileghem 
and Flynn 1992, Darji, Beschin et al. 1996, Uzonna, Kaushik et al. 1998, 
Stijlemans, Radwanska et al. 2017). During tsetse fly transmitted T. 
congolense infections of cattle, it has been shown that suppressor 
macrophage cells block IL-2 secretion and expression of the α chain of the IL-
2 cytokine receptor by lymph node T cells (Sileghem and Flynn 1992). When 
macrophages were removed and separated using FACS cell sorting from 
lymph node cell co-cultures, the T cell suppression was lessened. Similar 
responses were observed during T. brucei infections of mice (Sileghem, Darji 
et al. 1989). African trypanosomes have also been found to induce TNF-α 
production by macrophages resulting in significant overproduction of IFN-γ by 
CD8+ T cells which, together, inhibit both CD8+ and CD4+ T cell responses 
(Darji, Beschin et al. 1996).  
It has also been shown that the large amounts of NO induced in response to 
T. brucei infection can induce the suppression of T cells both in vitro and in 
vivo (Sternberg and McGuigan 1992, Schleifer and Mansfield 1993, Mabbott 
and Sternberg 1995, Mabbott, Sutherland et al. 1995, Sternberg and Mabbott 
1996, Mabbott, Coulson et al. 1998, Millar, Sternberg et al. 1999). This resulted 
in decreased splenic CD4+ T cell proliferation and activation, and reduced Th1 
cell responses required to control parasitaemia once the adaptive immune 
response takes effect, leading to parasite survival. (Sternberg and McGuigan 
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1992, Sternberg and Mabbott 1996, Millar, Sternberg et al. 1999). Therefore, 
African trypanosomes induce the immunosuppression of effector T cell 
responses.  
 
1.8.5 Impairment of B cell function during trypanosomiasis 
B cells are at the fulcrum of protective immunity against African trypanosomes, 
producing parasite VSG-specific Ig which target the parasites for 
immunoclearance. B cells are actively suppressed by trypanosomes during 
infection (Radwanska, Guirnalda et al. 2008, Bockstal, Guirnalda et al. 2011, 
Cnops, De Trez et al. 2015, Frenkel, Zhang et al. 2016, Stijlemans, Caljon et 
al. 2016, Stijlemans, Radwanska et al. 2017). Studies in mice infected with T. 
brucei and T. congolense have shown that the parasites trigger an early 
expansion of polyclonal B cells within a few days of infection (Diffley 1983, 
Oka, Ito et al. 1984, Bockstal, Guirnalda et al. 2011, Silva-Barrios, Charpentier 
et al. 2018), which reduces the abundance of parasite-specific Ig. It has been 
suggested that T. vivax produces an enzyme, known as T. vivax proline 
racemase (TvPRAC), which can trigger the expansion of non-antigen-specific 
polyclonal B cells (Chamond, Cosson et al. 2010). This allows for early 
expansion of B cells that produce non-specific Ig, before the host can produce 
sufficient levels of parasite-specific high-affinity class-switched Ig (Magez and 
Radwanska 2009, Stijlemans, Caljon et al. 2016). African trypanosomes have 
also been shown to induce the disruption of B cell compartments in lymphoid 
tissues, and the killing of marginal zone and follicular B cells (as discussed in 
section 1.8.2) (Radwanska, Guirnalda et al. 2008, Cnops, De Trez et al. 2015, 
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Frenkel, Zhang et al. 2016, Stijlemans, Caljon et al. 2016). Experiments 
involving T. brucei infection in mice have shown that lymphoid follicles and B 
cells are depleted due to enhanced NK cell-mediated cytotoxicity, contributing 
to humoral immunosuppression and early death (Frenkel, Zhang et al. 2016). 
This effect may be driven by an early production of IFN-γ as mice deficient in 
IFN-γ activity and production do not exhibit this B cell destruction (Cnops, De 
Trez et al. 2015).  
Trypanosomes have also been shown to affect B cell lymphopoiesis in both 
the bone marrow and the spleen (Radwanska, Guirnalda et al. 2008, Bockstal, 
Guirnalda et al. 2011, Stijlemans, Caljon et al. 2016, Stijlemans, Radwanska 
et al. 2017). During T. brucei infection, expression of anti-apoptotic B cell 
lymphoma 2 protein and B cell activating factor receptor activity is significantly 
reduced in the spleen, resulting in B cell apoptosis (Radwanska, Guirnalda et 
al. 2008). Trypanosome infection reduces the generation of B cells in the bone 
marrow, and trypanosome surface coats can induce the apoptosis of 
transitional B cells in a contact-dependent and TNF- and prostaglandin-
independent manner (Bockstal, Guirnalda et al. 2011). The depletion of B cells 
induced by trypanosome infection has been shown to also hinder protective 
immunity to Bordetella pertussis infection following vaccination (Radwanska, 
Guirnalda et al. 2008). Interestingly, a study using macrophage migration 
inhibitory factor (MIF)-deficient mice showed that T. congolense-specific class-
switched Ig responses and germinal centre formations were preserved, and B 
cell apoptosis was interrupted (Stijlemans, Brys et al. 2016). This implies that 
trypanosomes may utilise host MIF for their own immunosuppressive means. 
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T. brucei has also been shown to induce the apoptosis of malignant plasma 
cells in immunodeficient mice which develop multiple myelomas (De Beule, 
Menu et al. 2017). It was shown that IFN-γ plays a partial role in this 
immunosuppression, as blocking IFN-γ activity using anti-INF-γ antibodies 
only partly reduces this effect. These immunosuppressive mechanisms impair 
the production of protective humoral responses during T. brucei infection. 
However, it has been suggested that the magnitude of B cell suppression and 
deletion during human infections may not be as potent as that observed during 
mouse infections (Lejon, Mumba Ngoyi et al. 2014). 
 
1.8.6 Impairment of MHC presentation during trypanosomiasis 
Murine models of African trypanosome infections have shown that MHC 
presentation is suppressed in the host (Namangala, Brys et al. 2000, Garzon, 
Holzmuller et al. 2013, Geiger, Bossard et al. 2016). During T. brucei infections 
of mice, macrophage antigen presentation is significantly reduced, due to 
lower expression of the MHC peptide complex on their plasma membrane 
(Namangala, Brys et al. 2000). These macrophages also expressed an 
alternatively activated state, producing IL-10 and inhibiting T cells. A study of 
T. b. gambiense infected rodents has identified an excreted-secreted protein 
of T. b. gambiense which abrogates dendritic cell maturation, cytokine 
production, and MHC expression following LPS induction (Garzon, Holzmuller 
et al. 2013). Therefore, dendritic cells would be unable to stimulate Th cells to 
produce further cytokines, adding to the immunosuppressive state.  
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The suppression of these cellular responses and the integrity of the lymphoid 
tissues inhibits the capacity to produce parasite-specific high-affinity class-
switched Ig.  
 
1.8.7 VSG antigenic variation 
African trypanosomes can survive for large periods in the bloodstream of the 
host by effectively evading targeting by the host’s humoral immune response. 
Trypanosomes accomplish this via a process known as antigenic variation, 
which was originally described in 1905 (Ponte-Sucre 2016). Within the 
mammalian host, trypanosomes express a dense surface coat consisting of 
~107 molecules of VSG, which are the major parasite antigens that are 
targeted by the host’s immune system (Baral 2010, Pinger, Chowdhury et al. 
2017). These VSG antigens are specifically activated upon infection in the 
mammalian host, to protect the parasites from the host immune system, and 
then are inactivated during infection of the tsetse fly midgut (Horn 2014).  
Antigen variation by African trypanosomes is the process by which a proportion 
of the parasite population undergoes switching of their VSG coats to a different 
antigen, thus evading Ig targeting from the immune system, allowing these 
alternative variant parasites to proliferate rapidly and survive (Horn 2014, 
McCulloch, Morrison et al. 2015, Pinger, Chowdhury et al. 2017). African 
trypanosomes possess a substantial number of VSG genes, with >2,000 in the 
T. brucei genome (Morrison, Marcello et al. 2009, Glover, Hutchinson et al. 
2013, Matthews, McCulloch et al. 2015, McCulloch, Morrison et al. 2015), but 
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trypanosomes only express one VSG on their cell surface at any one time 
(Horn 2014). The repertoire of VSG is vast and changes in VSG expression 
are detectable during parasite proliferation (Cross, Kim et al. 2014, Matthews, 
McCulloch et al. 2015). The major component of successfully evading 
humoral-mediated clearance in the host relies on switching VSG expression 
from one clone-specific VSG to a different variant (Horn 2014). Trypanosomes 
co-ordinate the transcriptional switching of their VSG genes to allow the 
expression of a new VSG to which the host’s Ig response must respond to 
(Horn 2014). Despite possessing thousands of VSG genes, only a minority are 
completely functional with the majority considered to be pseudogenes 
(Morrison, Marcello et al. 2009, Baral 2010). These pseudogenes are a crucial 
resource for successfully performing antigenic variation (Matthews, McCulloch 
et al. 2015). In the genome of T. brucei, around 90% of the VSG genes are 
pseudogenes (Horn 2014).  
Trypanosomes possess unique aneuploidy chromosomes, including 
megabase, intermediate, and mini chromosomes (Morrison, Marcello et al. 
2009, Glover, Hutchinson et al. 2013). Hundreds of minichromosomes are 
present in each cell, containing VSG genes at their telomeres, creating a 
significant expansion of the VSG repertoire. The VSG expression sites (VSG 
ESs) are located in the subtelomeres of the megabase chromosomes, and the 
majority of the VSG repertoire exists in gene arrays in the internal regions of 
these chromosomes. The transcription of VSG genes occurs from one of 
approximately 20 VSG ESs (Pays, Lips et al. 2001), resulting in monoallelic 
expression. Repetitive sequences are utilised, and DNA double-strand break 
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repairing is involved in the VSG switching (Glover, Hutchinson et al. 2013). 
Transcription at the VSG ESs is meditated by RNA polymerase 1 (Pol-I), in 
combination with the expression of several expression site-associated genes 
(ESAGs) (Morrison, Marcello et al. 2009, Horn and McCulloch 2010, Glover, 
Hutchinson et al. 2013, Horn 2014, Matthews, McCulloch et al. 2015, 
McCulloch, Morrison et al. 2015). Antigenic variation can be achieved through 
the switching on of certain VSG genes and the silencing of others, through 
changing the identity of the active VSG ES (10% of switching events), or via 
DNA recombination mediated gene conversion of the VSG at the active ES 
(90% of switching events) (Robinson, Burman et al. 1999). This can involve 
the transposition of VSG genes from the chromosomal internal arrays to an 
active VSG ES, or the reciprocal recombination of VSG ESs between active 
and inactive VSG ESs. Therefore, trypanosomes will only express one variant 
of VSG molecules on their protein coat surface, which creates a homogenous 
antigen target for the host’s humoral immune response. Parasite-specific Ig 
will target predominant variant antigen types (VAT) expressed on the surface 
of trypanosomes, which opsonises the trypanosomes for effective 
phagocytosis and killing by macrophages. 
The process of antigenic variation and altering the outer VSG protein coat 
allows for waves of rapid trypanosome re-emergence in the bloodstream 
following waves of Ig-mediated immunoclearance. Some T. b. brucei strains 
have been shown to double their population approximately every 5-8 hours in 
vitro (Haanstra, van Tuijl et al. 2012).The host cannot effectively clear the 
trypanosome burden as quickly as the parasite population switches their 
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expressed VSG coat and evade immune detection (Matthews, McCulloch et 
al. 2015). Therefore, the host is unable to completely clear the trypanosome 
infection as there are sequential waves of emerging parasite populations that 
switch their VSG coats at a faster rate than the host immune system can 
recognise and destroy them (Figure 1.6) (Morrison, Marcello et al. 2009). 
Antigenic variation of the VSG surface coat greatly hinders vaccine 
development, however the trypanosome flagellar pocket contains non- or less 
variable surface proteins (La Greca and Magez 2011). Therefore, antigens 
expressed on the surface of the flagellar pocket may be appealing targets for 
vaccine design.  
 
 
Figure 1.6: Waves of VSG-switching and parasitaemia 
Trypanosomes evade complete clearance and ensure chronicity within the host. 
Waves of parasitaemia progresses, with rapidly dividing slender forms, before 
peaking with non-proliferating stumpy form parasites. Trypanosome populations 
express the same variant of surface coat (VSG), and are targeted by the humoral 
immune response for waves of parasite clearance. However, subsequent waves of 
trypanosomes that have undergone antigen variation of their VSG coats enables the 
successful emergence of antigenically distinct trypanosomes, to evade the humoral 





1.9 The skin is an important stage of African trypanosomiasis 
1.9.1 Skin-resident trypanosomes 
During early infection, T. brucei parasites can amass within adipose tissues in 
the dermal and fatty subcutaneous (s.c) layers, where they are able to thrive 
and divide (Trindade, Rijo-Ferreira et al. 2016). The parasites can remain 
active in these sites for prolonged periods. It has been shown that these 
parasite populations establish themselves immediately upon infection, rather 
than from re-entry from the bloodstream (Caljon, Van Reet et al. 2016). The 
parasites have been shown to interact with the adipocytes in the skin, using 
their anterior end to embed themselves within host fat cells, allowing their 
receptor-rich flagellar pocket to maintain contact with the extracellular 
environment and take up nutrients (Caljon, Van Reet et al. 2016). This 
interaction has been notably observed within the s.c fatty layer (Trindade, Rijo-
Ferreira et al. 2016). The parasites are able to successfully grow within the 
adipose tissues, with evidence indicating an alteration of metabolic gene 
expression towards those that metabolise fatty acids through β-oxidation. The 
parasite therefore survive on the tricarboxylic acid (TCA) metabolic pathway in 
the skin, compared to the glycolytic pathway in the blood. (Trindade, Rijo-
Ferreira et al. 2016). Such a phenotype is similar to the procyclic trypanosome 
forms found in the tsetse fly midgut, as they primarily utilise proline metabolism 
via the TCA pathway for their energy production (Mantilla, Marchese et al. 
2017). Many of the skin-residing parasites remain in a non-proliferative state, 
and are capable of transmission to a new mammalian host to establish new 
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infections (Caljon, Van Reet et al. 2016, Capewell, Cren-Travaille et al. 2016, 
Trindade, Rijo-Ferreira et al. 2016, Tanowitz, Scherer et al. 2017).  
Skin-dwelling trypanosomes have been highlighted as a means for 
undiagnosed and asymptomatic human patients being reservoirs for disease 
transmission in the field (Capewell, Cren-Travaille et al. 2016). This hypothesis 
is further backed by data from imaging experiments that show how 
trypanosome infections can induce a temperature rise within the dermis that 
appears to trigger specific feeding behaviours from tsetse flies (Caljon, Van 
Reet et al. 2016). Other protozoan parasites, such as T. cruzi and Plasmodium 
spp. are also known to reside within these areas, both extracellularly and 
intracellularly (Tanowitz, Scherer et al. 2017). 
 
1.9.2 Route of trypanosome infection 
Studies have also established how the route of parasite infection can 
significantly impact on the infection dynamics. Wei, Bull et al. (2011) have 
shown that the percentage of BALB/c mice showing detectable parasitaemia 
upon infection by T. brucei differs in intraperitoneal (i.p) infections compared 
with i.d infections. They found that i.d infected mice were 100 times less 
susceptible to trypanosome infection than i.p infected mice, in a dose-
dependent manner. This highlights the importance of the initial skin stage of 




1.9.3 Tsetse fly feeding and saliva 
Following tsetse fly feeding on a mammalian host, trypanosomes are 
specifically deposited into the dermis of the host’s skin (Caljon, Van Reet et al. 
2016). During the process of feeding, the tsetse fly proboscis will also cause 
substantial damage to the host’s skin and surrounding tissues, while at the 
same time introduce a concoction of active compounds into the host’s skin 
(Somda, Bengaly et al. 2013). Tsetse fly saliva helps to create a distinct 
environment to enable the trypanosomes to adhere to epithelial surfaces, 
initiate binary fission and trigger their transformation into infective metacyclic 
forms (Van Den Abbeele, Caljon et al. 2007). The fly’s saliva also acts as a 
fluid vehicle for transmission and skews the host towards an anti-inflammatory 
immune response at the bite site for the rapid enhancement of trypanosome 
infection being established (Caljon, Van Den Abbeele et al. 2006, Caljon, Van 
Den Abbeele et al. 2006, Van Den Abbeele, Caljon et al. 2007, Awuoche 
2012). Several salivary compounds connected with blood feeding have been 
identified, such as 5′nucleotidase-related (5′Nuc), tsetse thrombin inhibitor 
(TTI), and thrombin serine protease and esterase inhibitors (Parker and Mant 
1979, Cappello, Bergum et al. 1996, Cappello, Li et al. 1998, Van Den 
Abbeele, Caljon et al. 2007, Caljon, De Ridder et al. 2010). These salivary 
compounds possess anti-coagulative and anti-inflammatory functions which 
can dampen local immune responses and repair (Caljon, Van Den Abbeele et 
al. 2006, Van Den Abbeele, Caljon et al. 2007, Caljon, De Ridder et al. 2010). 
Data from mouse transmission studies show that tsetse fly saliva can 
accelerate the onset of T. brucei infection. This could be attributed to a 
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reduction in the host’s inflammatory response as lower levels of pro-
inflammatory and trypanocidal interleukin-6 (IL-6) and IL-12 mRNA were 
detected, as well as lower levels of tumour necrosis factor-α (TNF-α) in the 
sera of the host (Caljon, Van Den Abbeele et al. 2006). In comparison with 
naïve tsetse flies, tsetse flies infected with trypanosomes showed significantly 
reduced thrombin inhibition and less anticoagulation, resulting in a more 
prolonged feeding process by the fly that increased the chance of parasite 
transmission (Van Den Abbeele, Caljon et al. 2010). Together these processes 
act to increase the efficiency of parasite transmission from the fly vector to the 
mammalian host (Caljon, Van Den Abbeele et al. 2006).  
Other blood-feeding insects also elicit a milieu of highly active compounds in 
their saliva that can modulate various responses in the host (Ribeiro, Mans et 
al. 2010). These products could potentially be exploited for therapeutic or 
diagnostic usage. For example, much research has been undertaken on the 
sandfly insect vector (Phlebotomus and Lutzomyia genera) that is responsible 
for the transmission of closely-related Leishmania parasites. Advancements in 
transcriptomics and proteomics have enabled the role sandfly saliva has in 
host haemostasis, inflammation and immunity to infection to be determined 
(Abdeladhim, Kamhawi et al. 2014). Further research into vector salivary 
proteins may also reveal opportunities to utilise these components as vaccine 




1.10 Immunity to African trypanosomes in the skin 
Most of what is known regarding immunity to African trypanosome infection, 
as described above, originates from research which has mainly used the i.p or 
i.v infection routes. As African trypanosomes are delivered into the dermal 
layer of the skin (Caljon, Van Reet et al. 2016), these studies have overlooked 
the specific immunological processes and host-parasite interactions that could 
occur in the skin upon infection.  
Understanding the local immune responses taking effect in the skin is crucial 
to help combat transmission and disease (Caljon, Van Reet et al. 2016). The 
skin is a large, highly complex immune organ, which functions as a protective 
barrier between the internal components of the host and the external 
environment (Salmon, Armstrong et al. 1994, Richmond and Harris 2014). This 
external environment can pose a threat to the host through exposure to a 
multitude of harmful pathogens, toxins, substances and physical trauma 
(Salmon, Armstrong et al. 1994). The mechanisms by which the skin protects 
the host are not simply physical, but also involve a complex collection of 
immune cells, biological factors, layers of tissue, and networks of lymphatic 
and blood vessels (Nestle, Di Meglio et al. 2009, Heath and Carbone 2013, 
Richmond and Harris 2014). The main layers of skin comprise the epidermis, 
dermis and s.c layers. These contain various immune cells involved in innate 
responses, inflammation and surveillance (Figure 1.7) (Pasparakis, Haase et 
al. 2014, Richmond and Harris 2014). The dermis mainly comprises 
connective tissue produced by dermal fibroblasts, and local immune 
responses within it initiated by dermal macrophages, dermal dendritic cells, 
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NK cells, mast cells, αβ/γδ T cells, and NKT cells (Kupper and Fuhlbrigge 
2004, Summerfield, Meurens et al. 2015). The skin also contains blood and 
lymphatic vessels, nerves, and sweat glands (not present in mice) (Heath and 





Figure 1.7: Mouse skin-resident cells 
The cellular composition in the epidermal, dermal, and subcutaneous layer of the 
mouse skin. The outermost epidermal layer consists of a layer of corneocytes above 
a layer of keratinocytes. These cells manage the tight junctions and the stratum 
corneum. Langerhans cells and intraepithelial T cells survey the epidermis for antigen. 
The middle dermal layer contains fibroblasts which produce extracellular matrix 
proteins to provide structural support and elasticity. Immune responses are initiated 
by dermal macrophages, dermal dendritic cells, NK cells, and T cells. The inner 
subcutaneous layer is mainly made up of adipocytes (fat cells). Local lymphatic and 
blood vessels allows for the trafficking of cells, proteins, and waste.  
 
1.10.1 Role of neutrophils 
The initial cellular responders to trypanosome injection in the skin are 
neutrophils, NK cells, and NKT cells (Baral 2010, Stijlemans, Caljon et al. 
2016, Caljon, Mabille et al. 2018). Neutrophils are the most ubiquitous 
leukocytes in the human circularity system, and kill pathogens through 
phagocytosis, the release of reactive oxygen species or neutrophil 
extracellular traps (Summers, Rankin et al. 2010, Perobelli, Galvani et al. 
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2015). They are also important mediators of tissue repair and wound healing. 
Neutrophils produce pro-inflammatory cytokines, such as IFN-γ, TGF-β, IL-4, 
IL-12, and IL-13 (Perobelli, Galvani et al. 2015). In trypanosome infection, 
neutrophils have been shown to be the primary responders to tsetse fly bites, 
becoming recruited to the dermal bite site within 4.5 hours (Caljon, Mabille et 
al. 2018). The recruited neutrophils produce pro-inflammatory IL-1β and IL-6 
cytokines, as well as anti-inflammatory IL-10 (Caljon, Mabille et al. 2018). 
Neutrophils may also produce trypanolytic antimicrobial peptides such as 
cathelicidins and defensins (Harrington 2011). However, this early neutrophil 
response does not appear to contribute to trypanosome killing in the skin 
(Caljon, Mabille et al. 2018).  
 
1.10.2 Role of natural killer cells 
The role of NK cells during trypanosome infection remains poorly understood. 
The activation of neutrophils, NK and NKT cells in the skin following exposure 
to trypanosomal PAMPs, results in the production of IFN-γ and TNF-α which 
can induce the activation of classically activated macrophages (Arango Duque 
and Descoteaux 2014). NK cell activity in trypanotolerant mice infected with T. 
congolense has been suggested to be attributed to this increased production 




1.10.3 Role of macrophages 
The skin contains an abundance of macrophages with the potential to combat 
infection. Most of what is known about the role of macrophages during African 
trypanosomiasis stems from research involving i.p or i.v infections. The role of 
macrophages in the skin during trypanosome infection remains poorly 
understood.  
 
1.10.4 Role of dendritic cells 
Dendritic cells (DCs) are a group of antigen-presenting cells (APCs) that 
recognise and capture antigen, which they process for presentation to T 
lymphocytes (Klechevsky 2015, Waisman, Lukas et al. 2017). Skin-residing 
DCs include the epidermal Langerhans cells and dermal DCs (Malissen, 
Tamoutounour et al. 2014, Haniffa, Gunawan et al. 2015, Nirschl and 
Anandasabapathy 2016). Langerhans cells sample and present antigen from 
the epidermis to promote the adaptive immune response (Kaplan 2017, 
Deckers, Hammad et al. 2018). Dermal DCs also sample antigens in the 
dermis. Langerhans cells and dermal DCs migrate from the epidermis and 
dermis, respectively, to the local cutaneous draining lymph nodes to present 
sampled pathogen antigen to T cells (Malissen, Tamoutounour et al. 2014, 
Haniffa, Gunawan et al. 2015, Nirschl and Anandasabapathy 2016, Deckers, 
Hammad et al. 2018). Dermal DCs have been shown to act rapidly to dermis 
invading protozoan parasites (Ng, Hsu et al. 2008). Dermal DCs rapidly 
respond to and engulf L. major parasites (Ng, Hsu et al. 2008). The role of 
these DC subsets during trypanosome infection remains elusive. 
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1.10.5 Role of T cells 
Skin-resident T cells are another group of immune cells that survey the skin 
tissues for pathogens. The epidermal layer is patrolled by αβ effector T cells 
but also more innate-like γδ T cells (Strid, Tigelaar et al. 2009, Paul, Shilpi et 
al. 2015). These dermal γδ T cells survey the integrity of the epidermal layer 
of the skin, express many receptors and produce many cytokines which can 
alter the promotion of Th1 and Th17 responses (Mueller, Zaid et al. 2014, 
O'Brien and Born 2015, Lawand, Déchanet-Merville et al. 2017). 
A study in cattle has shown that tsetse-transmitted T. congolense infections 
lead to the promotion of γδ T cells, and that these cells are activated in the 
trypanotolerant N’Dama breed of cattle, but not in the susceptible Boran 
breeds (Flynn and Sileghem 1994). However, the role these cells play during 
African trypanosome infection remains largely unknown. During infection with 
the protozoa L. donovani however, it has been shown that γδ T cell activation 
is increased in people suffering from visceral leishmaniasis, with these patients 
having high levels of B cell growth factor and B cell differentiation factor which 
would induce Ig production by B cells (Raziuddin, Telmasani et al. 1992). More 




1.11 Thesis aims 
Most experimental transmissions of African trypanosomiasis have studied the 
i.p or i.v routes of exposure. However, these by-pass the natural route of 
infection via the skin. Therefore, the aims of the research in this thesis were to 
investigate the pathogenesis of African trypanosome infection via the skin. 
Using both in vitro and in vivo systems, experiments were undertaken to: i) 
investigate the effects of host-derived chemokines on the motility and viability 
of T. brucei; ii) investigate the effect of infection route and dose on 
susceptibility to T. brucei infection; iii) determine the role of the draining lymph 
node and Ig class-switching in susceptibility to i.d T. brucei infection; iv) and 
investigate the effects of local alterations of macrophage abundance and 
activation on susceptibility to i.d T. brucei infections. These studies are located 
in the following sections of this thesis: 
Chapter 3: In vitro systems were used to determine whether certain 
chemokines could act as chemoattractants for T. brucei, to determine whether 
trypanosomes use these host-derived cues for lymphatic invasion within the 
skin. Chemokines previously shown to be highly expressed in the mouse skin 
were selected for experimentation, including: CCL8, CCL19, CCL21, CCL27, 
and CXCL12. Furthermore, previous reports have demonstrated that certain 
chemokines possess antimicrobial properties against certain pathogens. The 
ability of selected chemokines (CCL8, CCL19, CCL21, CCL27, CCL28 and 




Chapters 4, 5, and 6: In vivo systems were then used to investigate host-
pathogen interactions which influence the establishment of T. brucei infection 
following injection into the skin. 
Chapter 4: Most studies of African trypanosome infections use i.p or i.v 
infection routes. However, the natural route of infection by the tsetse fly vector 
is i.d. Therefore, the effect of infection route and trypanosome dose was 
investigated. In this chapter, mice were infected with T. brucei via the i.p, s.c, 
and i.d routes, and the effects on the infection kinetics were compared.  
Chapter 5: In vivo experiments aimed to determine the role of the draining 
lymph node and Ig class-switching in susceptibility to T. brucei infection via the 
skin. This was achieved by observing i.d trypanosome infection in LTβ-/- mice 
which lacked most peripheral lymph nodes, had disturbed splenic 
microarchitecture and B cell follicle formations, and had impaired Ig class-
switching. Bone-marrow reconstitution experiments were also undertaken 
where: LTβ-/- mice were transferred WT mouse bone-marrow donors (WT-
>LTβ-/- mice); LTβ-/- mice were transferred LTβ-/- mouse bone-marrow donors 
(LTβ-/--> LTβ-/- mice); and WT mice were left unreconstituted as a control. 
These bone-marrow reconstitution experiments aimed to determine whether 
following the restoration of the splenic microarchitecture in lymphotoxin-β-/- 
mice administered WT mouse bone-marrow (WT->LTβ-/- mice) Ig class-
switching capabilities would be recovered, and whether disease pathogenesis 
would be reduced, when compared to lymphotoxin-β-/- mice administered 
lymphotoxin-β-/- mouse bone-marrow (LTβ-/--> LTβ-/- mice).  
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Chapter 6: Finally, experiments were undertaken to determine whether 
alteration to the abundance or activation state of dermal macrophages would 
influence the susceptibility to i.d T. brucei infection. Mice were pre-treated with 
one of two stimulators of macrophage activation: CSF1; or LPS. The mice were 
then infected i.d with T. brucei and the effects of these treatments on T. brucei 
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2.1 African trypanosome strains and culture 
2.1.1 Trypanosome strains 
Monomorphic wild-type (WT) Trypanosoma brucei brucei Lister 427 strain 
(hereafter referred to as ’Lister 427’), and pleiomorphic WT STIB 247 T. b. 
brucei strain (hereafter referred to as ‘STIB 247’) were used in this study. Lister 
427 was originally isolated from sheep blood in South East Uganda in 1960 
(Cunningham, Harley et al. 1962). STIB247 was originally isolated from a 
hartebeest (Alcelaphus buselaphus) in Tanzania’s Serengeti National Park in 
1971 (Jenni 1977).  
 
2.1.2 Culturing T. b. brucei 
Bloodstream-form (BSF) parasites were axenically cultivated in vitro using 
HMI9 media, as previously described by Hirumi and Hirumi (Hirumi and Hirumi 
1994). The parasites were cultured in 25cm2 culture flasks in a final volume of 
10 mL and incubated at 37°C in 5% CO2. When the parasites reached a 
concentration of 5x106 trypanosomes/mL, the cultures were typically sub-
passaged by inoculating 10 mL of fresh HMI9 medium with approximately 
5x105 trypanosomes. Pleiomorphic WT STIB247 T. brucei parasites were 
similarly cultivated using modified HMI9 (mHMI9) media (Tables 2.1 and 2.2). 
Parasite density was determined by microscopy using an improved Neubauer 




2.1.3 Preparing trypanosome stabilates 
For long-term storage, the trypanosomes were cryopreserved. Cryostabilates 
were prepared by resuspending the parasites in 20% w/v of sterile glycerol 
dissolved in media at a cell density of approximately 5x106/mL. The mixture 
was allowed to equilibrate, and 1 mL aliquots were then added to 1 mL 
cryotubes (Starlab, UK) for cryopreservation. The aliquots were then placed 
into a 1°C insulated Mr Frosty freezing container (containing 100% Isopropyl 
alcohol) (Thermo Scientific) and stored at -80°C overnight before being placed 
in liquid nitrogen for storage. All cryostabilates were assigned with a unique 
number code, which along with sample metadata was recorded in the Roslin 
SAPO sample database. During cryostabilate resuscitation from liquid 
nitrogen, cells were defrosted at 37 °C in a water bath and placed into 5 mL of 
appropriate HMI9 media for between 3-5 days. Thereafter, cultures were 
















370 mL - Invitrogen 
Hypoxanthine 
(100x)* 





5 mL 28 mM Sigma-Aldrich 
Thymidine 5 mL 33 mM Sigma-Aldrich 
Sodium pyruvate 5 mL 220 mM Sigma-Aldrich 
L-cysteine 5 mL 182 mM Sigma-Aldrich 
β-mercaptoethanol 7 µL 14 M Invitrogen 
H₂O 25 mL - - 





2.5 mL 5000 
μg/mL 
Invitrogen 
FBS 50 mL - Invitrogen 
Serum-Plus 50 mL - Sigma-Aldrich 
* 100x hypoxanthine: dissolve 4 g NaOH in 1 L H₂O, 




Table 2.2: Recipe to prepare 500 mL of modified HMI9 media for STIB 247 
T. brucei.   
 
2.2 In vivo procedures 
All procedures using experimental mice were carried out under the authority of 
the appropriate project and personal licences, in accordance with the Roslin 
Institute’s Protocols and Ethics Committee, the United Kingdom Home Office 
regulations and the Animals (Scientific Procedures) Act 1986. All animals were 
kept in individually ventilated cages and provided food and water ad libitum. 








250ml - Invitrogen 
Hypoxanthine 
(100x) (Table 2.1) 
5ml - Invitrogen 
Penicillin/Strepto
mycin  
5ml 5000 μg/mL Invitrogen 
Glucose 5 mL 
  
1 M Sigma-Aldrich 
Adenosine 5 mL 
  
134 mM Sigma-Aldrich 
Guanosine 5 mL 
  
142 mM Sigma-Aldrich 
Methyl Cellulose 5 mL 
  






28 mM Sigma-Aldrich 
Thymidine 5 mL 
  
33 mM Sigma-Aldrich 
Sodium Pyruvate 5 mL 
  
220 mM Sigma-Aldrich 
L-cysteine 5 mL 
  
182 mM Sigma-Aldrich 
β-
mercaptoethanol 
7 μl 14 M Invitrogen 
FBS 100 mL - Sigma-Aldrich 
Serum-Plus 100 mL - Sigma-Aldrich 
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Where indicated, female 6-8 week old C57BL/6J (Charles Rivers, Harlow, 
England), LTβ-/- (Lymphotoxin-β-deficient), and Csf1r-EGFP+ mice were used. 
 
2.2.1 LTβ-/- mice 
The Lymphotoxin-β-deficient transgenic mouse line, hereafter referred to as 
LTβ-/- (Alimzhanov, Kuprash et al. 1997), were bred in-house. Mice were 
maintained on a C57BL/6 background. Age matched C57BL/6J mice were 
used as non-transgenic controls throughout the experiments. 
 
2.2.2 Csf1r-EGFP+ mice 
The C57BL/6 Csf1r-EGFP+ mouse line (Sauter, Pridans et al. 2014) were 
kindly gifted by D. Hume, The Roslin Institute, Edinburgh, UK. Mice were 
maintained on a C57BL/6 background. Age matched C57BL/6J were used as 
non-transgenic controls throughout the experiments.   
 
2.2.3 Genotyping animals 
The transgenic Csf1r-EGFP+ mice were routinely genotyped prior to their use 
in studies. Ear biopsies were digested in 400 µL Proteinase K (PK) digestion 
buffer (100mM TrisHCl pH 8.5, 0.2% SDS, 200mM NaCl, 5mM EDTA, 
20mg/mL PK) and incubated at 55°C overnight. Debris was pelleted by 
centrifugation at 13,500 x g for 15 minutes in 1.5 mL microcentrifuge tubes. To 
precipitate the DNA 200 µL of supernatant was removed and added to 200 µL 
of isopropanol, before further centrifugation at 6,000 x g for 10 minutes in fresh 
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1.5 mL microcentrifuge tubes. The DNA pellet was washed by adding 500 µL 
80% ice-cold ethanol and centrifuged at 6,000 x g for 5 minutes in fresh 1.5 
mL microcentrifuge tubes. Ethanol was decanted and samples resuspended 
in 200 µL sterile H2O. The DNA samples were then subjected to polymerase 
chain reaction (PCR) using the primers listed in Table 2.3 in order to confirm 
the presence of the egfp gene in the target tissue. The PCR products were 
resolved by electrophoresis in a 2% agarose gel and visualised under UV 
illumination. DNA from a previously confirmed EGFP+ animal was used as a 
positive control and water as a negative control. Primers for the fatty acid 
binding protein 2 (Fabpi) gene were included in the PCR assays to act as a 




Table 2.3: Oligonucleotide primer sequences used for the genotyping of 
transgenic animals for breeding and maintenance.  
PCR Forward Primer (3’ - 5’) Reverse Primer (5’ – 3’) 
Fabpi CCT CCG GAG AGC AGC GAT 
TAA AAG TGT CAG 
TAG AGC TTT GCC ACA TCA 
CAG GTC ATT CAG 
EGFP GCA GCA CGA CTT CTT CAA 
GTC CGC CAT GCC 
GTG GCG GAT CTT GAA GTT 
GGC CTT GAT GCC 
 
 
2.2.4 Trypanosome infections 
6-8 week old female C57/BL6J mice were used for initial amplification of 
trypanosomes, either from in vitro culture or from cryostabilates in order to 
generate a healthy population of parasites (relevant for cryostabilates where 
viability is variable between cryostabilate preparation) that is considered to be 
adapted to the in vivo environment in the relevant host species (particularly 
relevant for the in vitro-derived trypanosomes). These mice were infected via 
intraperitoneal injection (i.p) (approximately 1x105 - 1x104 parasites) and the 
resulting infection used as the source of parasites for infecting mice for further 
experimental studies. Mice were monitored through daily blood sampling of the 
lateral tail vein by venesection in order to assess the parasitaemia via the rapid 
matching method (section 2.2.5) (Herbert and Lumsden 1976) as well as daily 
monitoring of clinical scores, appearance, and body weight. At the first peak of 
parasitaemia (approximately 1x107/mL or above), the mice were euthanized 
by a schedule 1 method and blood samples collected in serum collection micro 
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tubes containing heparin beads (Sarstedt AG & Co. KG, Nümbrecht, Germany) 
for preparation of further blood cryostabilates, as well as being used to infect 
the ‘experiment mice’. Mice were infected with trypanosomes either through 
intradermal (i.d), subcutaneous (s.c) (both in 10 µL volumes), or i.p (in 100 µL 
volumes) infection. STIB 247 T. brucei were resuspended to the appropriate 
dose in 1% phosphate buffered saline-glucose (PBS-G) (Sigma-Aldrich, 
Dorset, UK). For i.d and s.c infections, mice were injected into the shaven ear 
pinna using a 29G needle whilst immobilized by gaseous anaesthetic 
(Isoflurane) for ~5 minutes. Mice were monitored until recovery from 
anaesthesia. The parasitaemia and clinical signs of ‘experiment mice’ were 
monitored as above for the times indicated before being euthanized by a 
schedule 1 method. 
 
2.2.5 Parasitaemia quantification 
For determination of parasite burden, the lateral tail veins of mice were pricked 
with a sterile lancet and 10 µL of blood was placed onto a glass slide using a 
pipette (Gilson, Bedfordshire, UK). These slides were covered by 22mm2 cover 
slips and viewed under a phase contrast Leica brightfield microscope (x40) 
and the rapid matching method used to estimate parasite burden (Herbert and 
Lumsden 1976). For determining a more precise estimate of parasite burden, 
10 µL of blood was lysed in equal volume of 0.8% ammonium chloride in PBS 




2.2.6 Enumeration of LTβ-/- mouse lymph nodes 
For the macroscopial investigation of lymphoid tissues, mice were i.p injected 
with 0.3 mL of 1% Chicago Sky Blue 6B (Sigma-Aldrich, Dorset, UK) in sterile 
PBS. One week post-injection, the mice were culled and the presence of their 
lymphoid tissues assessed.   
 
2.2.7 Bone-marrow reconstitution of LTβ-/- mice 
6-8 week old female LTβ-/- mice (~20 g each) were lethally irradiated twice (5 
Grays each) at 4 hour intervals, and approximately 18 hours later received 
fresh bone-marrow donor in 0.2 mL PBS via intravenous tail vein injection of 
1-2 x 106 cells. Donor bone-marrow were extracted from the thigh bones of 
donor mice under sterile conditions before suspension in 0.2 mL PBS. 
Recipient mice were allowed to recover for 10 weeks to allow time for 
repopulation of the complete haematopoietic system and recovery of lymphoid 
organ microarchitecture. A cohort of age-matched unirradiated WT mice were 
used as a control.  
 
2.2.8 Treatment with CSF1-Fc 
To manipulate macrophage numbers, 6-8 week old female C57BL/6J and 
Csf1r-EGFP+ mice were injected i.d with 1 mg/kg porcine CSF1-Fc into the ear 
pinna for three consecutive days. All experiments included strain-, age- and 
sex-matched control mice which were i.d injected with volume-matched PBS. 
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The mice were used in subsequent experiments 24 hours after treatment as 
described in Chapter 6 
 
2.2.9 Treatment with LPS 
6-8 week old female C57/BL6J and Csf1r-EGFP+ mice were injected i.d with 
10 µg /10 µL LPS in PBS (Sigma-Alrich, strain 0111:B4) into the ear pinna. All 
experiments included strain-, age- and sex-matched control mice which were 
i.d injected with volume-matched PBS. The mice were used in subsequent 
experiments 24 hours after treatment as described in Chapter 6.   
 
2.3 In vitro assays 
2.3.1 Analysis of microarray data  
Candidate chemokine genes were selected on the basis of their high 
expression in mouse skin. The NCBI Gene Expression Omnibus database 
(http://www.ncbi.nlm.nih.gov) was searched for mouse skin expression data 
sets on the Affymetrix mouse genome 430 2.0 microarray platform.  Three 
independent studies using normal, uninfected, WT mouse skin were selected 
(GSE17511, GSE7694, GSE27628) and raw data sets (.cel files) downloaded.  
The quality of the raw data was analysed and normalised using Robust 
Multichip Analysis (RMA EXPRESS; http://rmaexpress.bmbolstad.com/), and 
annotated using the latest library available from Affymetrix 
(http://www.affymetrix.com/) (Affymetrix, Santa Clara, CA, USA). Samples 
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were organised into type of skin region and the Log2 of their expression values 
were ascertained and displayed using a heat map.    
 
2.3.2 Chemokines  
The following recombinant murine chemokines were used: CCL8 (MCP-2); 
CCL19 (MIP-3β); CCL21 (exodus-2); CCL27 (CTACK); CCL28 (MEC); and 
CXCL12 (SDF-1). All were obtained from PeproTech (London, UK). 
 
2.3.3 Chemotaxis assays 
To quantify the efficiency of trypanosomal migration under chemokine 
influence, in vitro chemotaxis assays were performed.  CCL8, CCL19, CCL21, 
CCL27 and CXCL12 chemokines were selected as candidates, where 
indicated, to assess their effects on the parasite strains. HMI9 media was 
heated up in a water bath set at 37°C for 10 minutes. 600 µL of chemokine 
media was added to the corresponding well in 12-well plates (Thermo 
Scientific). The chemokine media consisted of chemokine candidates 
suspended in HMI9 media. The chemokine groups were as follows: 500 and 
100 ng/mL and heat-inactivated variants (boiled at 95°C for 5 minutes). There 
were also no chemokine control groups. 3 µm transwell inserts (polyethylene 
terephthalate membranes) (Millipore Europe) were added to each chemokine 
treated well and the plates were placed in an incubator (37°C and humidified 
at 5% CO2) for 10 minutes. 1x106 trypanosomes were added to the top of each 
transwell insert and the plates were incubated at 37°C (humidified at 5% CO2) 
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for 2 hours. The number of trypanosomes which had passed through the 
transwell insert pore towards the chemokine media was counted using the 
haemocytometer (section 2.1.2). 
Mouse splenocytes were also assessed as positive chemotaxis controls. 
Mouse spleens were extracted and splenocytes were isolated in fresh RPMI 
1640 media (5000 μg/mL penicillin/streptomycin, 2 mM L-glutamine and 0.1% 
fatty acid free BSA (Sigma-Aldrich) in 0.5 L of RPMI solution) by gentle 
mashing through a 70 µM cell EASYstrainer cell sieve (Greiner). 1x105 
splenocytes suspended in 100 µL of media were added to the upper wells of 
3 µM pore inserts (Millipore Europe). 600 µL of chemokine media or RPMI 
1640 media was added to the bottom wells. The plates were incubated for 2 
hours at 37°C in the presence of 5% CO2, and the splenocytes which passed 
through the transwell insert pore and into the lower chamber were collected. 
These cells were stained for FACS analysis (section 2.4.5). Antibodies used 
were: anti-B220/CD45R-BV605; anti-CD3-PB; and anti-CD11c-PE (Table 
2.4). Cells were acquired on a BD Fortessa LSR flow cytometer running 
FACSDiva and analysed using FlowJo 10.1 analysis software (FlowJo LLC). 
Experiments were repeated three times.   
 
2.3.4 Flow-cytometry 
To identify cell populations, cell suspensions were incubated with fluorescently 
conjugated antibodies and analysed using a Fortessa LSR flow-cytometer (BD 
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Biosciences, USA) (Table 2.4). The gating procedures are outlined in Figure 
2.1. 




B220/CD45R Bright Violet 
605 
BioLegend RA3-6B2 
CD3 Pacific Blue BioLegend 145-2c11 




Figure 2.1: Describes the gating procedures during FACS analysis 
(A) Forward vs side scatter gating was plotted to exclude dead cells and debris. (B) 
The height of forward vs the area of forward scatter was plotted to exclude any double 




2.3.5 Chemokine cytotoxicity assays  
Chemokine cytotoxicity assays were performed using CCL8, CCL19, CCL21, 
CCL27, CCL28 and CXCL12 where indicated. Triplicate cultures were 
established as follows. 8x105 trypanosomes in 100 µL medium were added to 
each well of a 96-well plate.  Chemokine-containing medium (200 µL/well) was 
then added to each well at a final concentration of 10, 100 or 500 ng/mL. Heat-
inactivated chemokines (treatment at 95°C for 5 minutes) or medium alone 
were used as controls.  The plates were incubated for 2 hours at 37°C in the 
presence of 5% CO2, and the number of viable trypanosomes counted using 
a haemocytometer as described in section 2.1.2. Experiments were repeated 
three times. 
 
2.3.6 RAW264.7 Cells 
Macrophage-like RAW264.7 cells (Raschke, Baird et al. 1978) were cultured 
in 100 mm2 sterilin plates in 18 mL complete RPMI media (RPMI-1640, 5% 
heat-inactivated foetal bovine serum, 200 mM glutamax, 5000 μg/mL penicillin-
streptomycin), to a cell density of 2x106/10 mL medium to avoid overgrowth 
and media exhaustion. Cells were incubated at 37°C and humidified at 5% 
CO2. Cells were passaged every 3-4 days.  
 
2.3.7 Co-culturing of RAW264.7 and trypanosome cells 
1x105 RAW264.7 cells were co-cultured alongside 1x106/mL STIB 247 
trypanosomes per well in 24 well plates. The cells were either: (1) treated for 
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3 days with 10 µL of 3.693 mg/mL porcine CSF1-Fc prior to trypanosome 
addition; (2) treated with 10 µg/10µL LPS alongside trypanosome addition; or 
(3) were given 10 µL of PBS alongside trypanosome addition. Control wells 
were set up containing media with added CSF1-Fc, LPS or PBS as above, 
without any RAW264.7 cells, alongside trypanosome addition. In some 
experiments the wells were also treated with a nitric oxide synthase inhibitor, 
NG-methyl-L-arginine acetate salt (L-NMMA) at either 1 mM, 2mM or 5 mM 
concentrations. The plates were then incubated for 24 hours at 37°C and 
humidified at 5% CO2, and then the number of viable trypanosomes were 
counted using a haemocytometer as described in 2.1.2. Experiments were 
repeated three times on three separate days.     
 
2.3.8 Assessment of nitrite concentration (Griess Assay) 
Tissue culture supernatants were assessed for nitrite accumulation using a 
Griess assay (Promega, WI, USA). To prepare the nitrite standard reference 
curve for each plate, 100 µL of 100 µM sodium nitrite solution was added to 
wells A1-3, and 50 µL of PBS was added to wells 1-3 of rows B-H. Doubling 
dilutions of sodium nitrite solution were then set up in triplicate, ranging from 
100 to 1.56 μM including 0 μM negative control wells. 50 µL of supernatants 
were added to each well of a 96 well tissue culture plate in triplicate. Then 50 
µL of sulfanilamide solution (1% sulfanilamide in 5% phosphoric acid) was 
added to each well and the plates were left to incubate at room temperature 
for 10 minutes protected from light. Then 50 µL of 0.1% N-1-
napthylethylenediamine dihydrochloride in water solution was added to each 
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well and left to incubate at room temperature for 10 minutes, protected from 
light exposure. The absorbance at 530 nm was measured using a Cytation 3 
cell imaging plate reader (BioTek, UK). The assays were repeated three times 
on three separate days.  
 
2.4 Enzyme-Linked Immunosorbent Assays (ELISAs) 
2.4.1 Quantification of serum total immunoglobulin levels by ELISA 
Mouse whole blood was transferred into 1 mL Eppendorf tubes, allowed to clot 
for 1 hour, and centrifuged at 20,000 x g for 20 minutes at 4°C (Eppendorf UK 
Limited, UK). The serum was collected and stored at -20°C before use. For 
total immunoglobulin (Ig) determination, 96 well plates (Immulon 4HBX 96-
Well Micro Plate, SLS, UK) were coated with 50 µL (5ug/ml in p-Nitrophenyl 
Phosphate (NPP) substrate buffer; 1/100 dilution) of either purified rat anti-
mouse IgM coating antibody (BD 553435 (II/41), BD Biosciences, USA) or 
purified polyclonal goat anti-mouse coating Ig antibody (BD 553998, BD 
Biosciences, USA). The plates were sealed and incubated overnight at 4 °C. 
The plates were then blocked by adding 100 µL of 1% bovine serum albumin 
(BSA)/PBS (Sigma-Aldrich) to each well and incubated at 37 °C for 1 hour. 
The plates were then washed 5 times using 0.05% PBS/Tween. 50 µL of sera 
was added to each plate at 1/1000 dilution in 0.1% BSA/PBS. 50 µL of 
standard isotype controls (Table 2.6) were set up at 200 ng/mL. Doubling 
dilutions were performed up to 1/128 dilution. Plates were incubated at 37 °C 
for 1 hour. After washing, 50 µL of biotinylated secondary antibody was applied 
in 1% skimmed milk/0.1% BSA/PBS (1/500 dilution), and incubated at 37 °C 
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for 1 hour (Table 2.6). After another washing step, 50 µL streptavidin 
conjugated horse radish peroxidase (HRP) was added (1/1000 dilution) and 
incubated at 37 °C for 1 hour. After a final wash, 50 µL of SureBlue TMB 
microwell Peroxidase Substrate was added (KPL, SeraCare 5120-0075, 
Massachusetts, USA). After 1-5 minutes, the reaction was stopped by adding 
50 µL of 1 molar hydrochloric acid (HCL) and the plates were read using a 
Perkin Elmer Wallac 1420 Victor2 Microplate Reader (GMI, USA) at 450 nm 
with a 620 nm reference to obtain optical density (O.D) values.  
 
2.4.2 Preparing trypanosome lysate for ELISAs 
Trypanosome lysates were prepared by centrifuging 6x107 trypanosomes/mL 
at 13,000 x g for 10 minutes at 4°C in PBS, and supernatants were discarded. 
Protein content in the pellet was measured using a commercial Pierce 
microplate bicinchoninic acid protein assay kit (Thermo Scientific) according to 
the manufacturer’s instructions. The lysate was used as the antigen for 
trypanosome-specific Ig ELISAs.  
 
2.4.3 Quantification of serum anti-trypanosome Ig levels by ELISAs  
For trypanosome-specific ELISAs of infected mouse sera, trypanosomes were 
centrifuged at 20,000 x g for 10 minutes and the lysates were resuspended in 
NPP buffer. Trypanosome lysates were stored at -20°C until use. 96-well 
ELISA plates were coated overnight at 4°C with 100 μL of 0.7 μg/mL 
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trypanosome lysate in NPP buffer. The ELISAs were then performed as 
described in section 2.4.1. 




Source Cat. No. Clone 



















































2.5 Microscopy and Bio-imaging 
2.5.1 Transmission Electron Microscopy (TEM) 
Trypanosomes (1x106/mL) were washed and spun at 405 x g three times in 
PBS to remove excess media and resuspended in 3% glutaraldehyde using 
0.2 M phosphate buffer in 1 mL Eppendorf tubes. Trypanosome pellets were 
then processed for TEM. Fixed samples were treated in 0.1 M sodium 
cacodylate buffer (pH 7.2) for 2 hours, before being washed three times for 10 
minutes in fresh 0.1 M sodium cacodylate buffer. The samples were then post-
fixed in 1% osmium tetroxide in 0.1 M sodium cacodylate for 45 minutes and 
washed a further three times for 10 minutes in fresh 0.1 M sodium cacodylate 
buffer. The samples were then dehydrated in increasing concentrations of 
ethanol (30-90%), then 100% three times for 15 minutes each and processed 
with two 10 minute treatments of propylene oxide. The samples were then 
embedded in TAAB 812 resin (TAAB Laboratories Equipment Ltd), and 
sections were cut (1 µm thick) using a Leica Ultracut ultramicrotome (Leica 
Biosystems, UK), and stained with toluidine blue to be viewed under a light 
microscope for areas of interest. Ultra-thin sections (60 nm thick) were then 
cut from these areas and stained in uranyl acetate and lead citrate for viewing 
with a JEOL JEM-1400 series 120kV transmission electron microscope (JEOL 
USA, Inc., USA) and representative images were collected on a GATAN 
OneView camera and were analysed using Gatan Digital Micrograph (Gatan, 





2.5.2 Membrane permeability assays 
Lister 427 trypanosomes were treated with 500 ng/ml of chemokines or 10 µM 
of the anti-trypanosome drug diminazene aceturate (Sigma-Aldrich) (positive 
control) in 100 µl of media for 2 hours as described in section 2.3.5. The 
parasites were then diluted 1:2 in PBS containing 4% propidium iodide (PI) 
(Thermo Fisher Scientific, UK) and incubated in the dark for 30 minutes on ice. 
Uptake of PI into cells was then determined using a BD FACS Calibur 
cytometer and FlowJo 10.1 analysis software (FlowJo LLC).    
Trypan blue-exclusion was used to determine the number of live or dead 
trypanosomes present following treatment. Approximately 8x105 
trypanosomes in 100 µl medium were added to each well of a 96-well plate.  
Chemokine-containing medium (200 µl/well) was then added to each well at a 
final concentration of 500 ng/ml. The anti-trypanosome drug diminazene 
aceturate was used as a control at concentrations of 1, 2 and 10 µM. The 
plates were incubated for 2 hours at 37°C in the presence of 5% CO2. 
Afterwards, the parasites were suspended in trypan blue dye and the number 
of live and dead trypanosomes counted using a haemocytometer.   
 
2.5.3 Motility experiments  
600 µL of chemokine-containing media and HMI9 media were added to 
relevant wells in 6-well plates. 1x106 trypanosomes were then added, and the 
plates incubated at 37°C and humidified at 5% CO2 for 2 hours. The 
trypanosomes where then transferred to chambered slides (Lab-Tek 
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Chambered Coverslip no. 1.5; Thermo Scientific), placed on a heated stage, 
and viewed using a Zeiss Axiovert 100 inverted microscope.  Videos of 
trypanosome motility in each condition (30 secs long, 50 frames/sec) were 
recorded using a Hamamatsu digital camera (Low-light, Hamamatsu 
Photonics) and Micro-manager 18.1.14 imaging software (ImageJ plug-in, 
NIH).  Trypanosome motility in the videos was then subsequently analysed 
using Imaris 8.1.2 software (Bitplane, Oxford Instruments).  For each treatment 
condition data for 90 individual trypanosomes were collected (30 
trypanosomes/condition for each of 3 independent experiments).     
 
2.5.4 Motility image analysis 
Images were analysed using Imaris 8.1.2 software (Bitplane, Oxford 
Instruments). A region of interest was created around individual parasites 
throughout their migration. The software then deleted any artefacts and unified 
parasite features at each time frame. The time-lapsed videos were analysed 
at 50 frames per second. The analysis parameters (speed, velocity, 
acceleration, displacement track length and meandering index) were then 






2.5.5 Two-photon whole-mount microscopy 
Mouse ears from CSF1-Fc and LPS treated animal experiments were excised 
and immobilised on the imaging platform using tissue adhesive glue (3M 
Vetbond) and suspended in PBS before being imaged using multiphoton 
microscopy (Zeiss LSM7MP 2-photon microscope). The microscope was 
equipped with a 20X/1.0NA water-immersion objective lens (Zeiss), a Coherent 
titanium-sapphire laser and optical parametric oscillator (wavelength range 




2.6.1 Haematoxylin and Eosin staining 
Spleens were fixed in 10% formal saline for 1 hour. Once processed (Table 
2.5) and embedded in hot wax, 8 μm thick sections were cut using a Thermo 
Microtome (ThermoFisher Scientific HM325, Massachusetts, USA) and 
mounted on to Super Frost Plus slides (VWR, Lutherworth, UK). Sections were 
then stained with haematoxylin and eosin dyes (H&E) using a Leica ST5010 
Autostainer XL (Leica Biosystems, UK). Sections were then mounted using 
mounting media (CellPath, UK) and coverslips were applied before viewing 
under a Nikon E600 bright field microscope (Nikon Instruments, Surrey, UK).     
78 
 
Table 2.5: Automated tissue-processing program. 
Reagent Time 
70% IMS* 30 minutes 
90% IMS 30 minutes 
95% IMS 30 minutes 
99% IMS 35 minutes 
99% IMS 35 minutes 
99% IMS 30 minutes 
Xylene 30 minutes 
Xylene 20 minutes 
Xylene 20 minutes 
Wax 10 minutes 
Wax 15 minutes 
Wax 15 minutes 
*IMS = Industrial methylated spirit 
 
2.6.2 Immunohistochemical and immunofluorescent histochemical 
analysis of frozen tissues 
For Immunohistochemical analysis spleens were snap frozen in liquid nitrogen 
and 10 μm thick sections were cut using a Leica cryostat CM1900 (Leica 
Biosystems, UK). Sections were then immunostained to detect follicular 
dendritic cell (FDC) and B cells using the antibodies listed in Table 2.6. 
Following the addition of primary and secondary antibodies, cell nuclei were 
stained using 4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) 
(Thermofisher Scientific, UK). The sections were then mounted using 
fluorescent mounting medium (Dako, Ely, UK) and examined using a Zeiss 




Table 2.6: Primary antibodies and secondary conjugates used for 
immunofluorescent analysis. 




FDCs CD35 mAB rat anti-mouse 
CD35/ 8C12/ BD 
Biosciences 
Alexa-Fluora 594 Goat anti-
rat IgG (H+L)/ Invitrogen 
B cells CD45R 
(B220) 





2.7 Statistical Analysis 
2.7.1 In vitro statistical analysis 
Statistical analysis of in vitro assay experiments were performed using 
GraphPad Prism 6.01. Student’s t-tests compared differences between two 
groups from independent experiments. Multiple comparisons between multiple 
groups (more than two) from independent experiments were performed using 
ANOVA with Tukey’s multiple comparisons test. Assay data was also analysed 
using Minitab 17 Statistical software to analyse the effects of concentration, 
activation state and experiment day. The data was transformed to Log10 values 
and the residuals were normalised. Data are presented as mean ± standard 
deviations (SD). The P values and significance levels are indicated as follows 
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in this thesis: *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001. Not 
significant (ns), ≥0.05.   
 
2.7.2 In vivo statistical analysis 
Linear mixed effects models were performed using RStudio to statistically 
analyse the quadratic (squared) and cubic curve effect of infected mouse 
parasitaemia over the specified observation period. Differences in mouse 
percentage body weight changes were also analysed using RStudio using the 
linear mixed effect model statistical tests. Mean peak of parasitaemia for 
specific waves were analysed using Student’s t-test or Tukey’s multiple 
comparisons test where indicated. The P values and significance levels are 
indicated as follows in this thesis: *, P<0.05; **, P<0.01; ***, P<0.001; ****, 
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African trypanosome infection in mammals begins when the tsetse fly vector 
injects trypanosomes into the skin during blood feeding. The trypanosomes 
then invade the lymphatics before reaching the draining lymph nodes and 
disseminating systemically. However, the mechanism that mediates this 
tropism towards lymphatic vessels is uncertain. Chemokines mediate the 
attraction of leukocytes towards the lymphatics and lymph nodes. This chapter 
investigated whether chemokines might act as chemoattractants for 
trypanosomes. Microarray data suggested the chemokines CCL8, CCL19, 
CCL21, CCL27 and CXCL12 were highly expressed in mouse skin, therefore 
in vitro chemotaxis assays were performed on trypanosomes using these 
chemokine candidates. The investigated chemokines did not stimulate the 
chemotaxis of T. brucei. Certain chemokines also possess potent antimicrobial 
properties against a range of different pathogens. Cytotoxicity assays were 
also performed on trypanosomes cultured in chemokine-containing media 
using the selected chemokine candidates with the addition of CCL28. 
However, these chemokines did not exert any parasiticidal effects on T. brucei. 
Thus, although T. brucei has been shown to display highly directed movement 
towards lymphatic vessels in the skin, data in this chapter suggest that 





The parasitic life cycle within the mammalian host is initiated by the intradermal 
(i.d) injection of metacyclic trypomastigotes by the tsetse fly vector.  Soon after 
injection into the skin the metacyclic forms undergo morphological adaptation 
for survival within the mammalian host. The extracellular parasites then reach 
the draining lymph nodes, presumably via invasion of the afferent lymphatics 
and disseminate systemically from these secondary lymphoid organs (Theis 
and Bolton 1980, Barry and Emergy 1984, Tabel, Wei et al. 2013, Caljon, Van 
Reet et al. 2016). Studies have shown that ruminants infected with T. vivax-
infected blood exhibited significantly greater parasite levels in the efferent 
lymphatics than in the peripheral blood during the initial few weeks of infection, 
in both cattle and goats (Adams 1936, Emery, Barry et al. 1980). Since these 
initial studies it has been shown that upon deposition in the skin, trypanosomes 
invade the dermal lymphatic vessels with parasites observed both 
extravascularly and intravascularly in these vessels (Alfituri, Ajibola et al. 
2018). This study showed that trypanosomes display a highly directional 
tropism for the lymphatic vessels, whilst not interacting with the blood vessels. 
However, how the parasites reach the lymphatics from the skin remains 
uncertain.  
It has been shown that certain helminth worms use chemotaxis in response to 
specific cues. For example, the nematode worm Caenorhabditis elegans 
responds to chemicals such as O2 and CO2 concentrations, salt levels, 
pheromones, and alcohol, in a chemotactic manner (Chaisson and Hallem 
2012). Furthermore, the roundworms Strongyloides stercoralis and S. ratti 
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respond to NaCl gradients. Evidence for male Nippostrongylus brasiliensis 
worms being attracted by host intestinal chyme, has also been documented 
(Ward, Nordstrom et al. 1984). The motility of bacteria and specifically their 
potential chemotaxis has been widely studied also, especially in Escherichia 
coli and Helicobacter pylori. It has been shown that chemotaxis-deficient H. 
pylori mutants, which lack the chemotaxis response regulator CheY, are 
selectively eliminated from the stomach of the host when compared with wild-
type bacteria (Sweeney and Guillemin 2011). This is due to their failure to 
establish efficient infection of tissues, as chemotaxis is vital to their successful 
colonization in the gastrointestinal tract. There is also evidence of the 
bacterium specifically targeting injured or damaged gastric sites for 
colonisation (Aihara, Closson et al. 2014). In addition, certain protozoan 
parasites and viruses have been found to utilise chemokines and their 
receptors for their own chemotaxis and invasion of specific host organs, 
tissues and cells, such as certain Plasmodium species and human 
immunodeficiency virus-1 (HIV-1) (Chensue 2001). It has been postulated that 
African trypanosomes possess chemosensory capabilities through the 
flagellum and flagellar pocket (Ralston, Kabututu et al. 2009), therefore it is 
plausible that they may respond to chemokine gradients within the host in the 
same way host immune cells are attracted towards SLOs. 
To successfully survive extracellularly within the hostile environment of the 
host’s bloodstream the trypanosomes must be able to integrate host- and 
parasite-derived signals to coordinate the migration of the parasite and the 
optimal timing of their developmental transformations (Ralston, Kabututu et al. 
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2009). For example, in order to traverse the microvasculature in the brain the 
trypanosomes trigger calcium ion (Ca2+) fluxes in brain microvascular 
endothelial cells (Nikolskaia, de et al. 2006). How the trypanosomes sense the 
presence of the endothelium and coordinate their migration towards it is not 
known. In the parasite Ca2+ and cyclic nucleotide signalling pathways have 
been localized to the flagellum and flagellar pocket (Oberholzer, Marti et al. 
2007). This suggests that the trypanosome flagellum may play an important 
role in sensing environmental stimuli (Ralston, Kabututu et al. 2009). In several 
bacterial species, such as Vibrio spp., Proteus mirabilis, Caulobacter 
crescentus, and Bacillus subtilis, a sensory role for the flagellum is well 
established (Harshey 2016), and the chemotaxis of mammalian sperm is 
dependent on flagellar cyclic nucleotide and Ca2+ signalling (Eisenbach and 
Giojalas 2006).  
Chemokines comprise a superfamily of 7-15 kDa globular proteins that play 
important roles in the attraction of lymphocytes and leukocytes towards the 
lymphatics and lymphoid tissues and coordinate the positioning of these cells 
within them (Chensue 2001, Griffith, Sokol et al. 2014, Palomino and Marti 
2015). Chemokines mediate their activities through interactions with specific G 
protein-coupled chemokine receptors, which trigger intracellular pathways 
involved in cell motility and activation (Allen, Crown et al. 2007). SLO, such as 
the spleen and lymph nodes, rely on the expression of certain chemokines and 
cytokines for their development, maintenance and deployment of immune 
responses (Ruddle and Akirav 2009). It is now well established that chemokine 
proteins induce the directional migration (chemotaxis) of immune cells towards 
89 
 
the SLO and lymphatics via chemokine gradients (Cyster 1999). The 
chemokines CCL19 and CCL21 are involved in T and B cell and DC 
chemotaxis towards the lymphatics and SLO (Gunn, Tangemann et al. 1998, 
Cyster 1999, Gunn, Kyuwa et al. 1999, Haesslera, Pisanoa et al. 2011). The 
homing of skin DCs to lymphatic vessels in order to access lymphoid tissues 
is partly mediated by the chemokines CCL19 and CCL21 released locally by 
lymphatic endothelial cells, which interacts with the corresponding chemokine 
receptor CCR7 expressed on DCs (Russo, Teijeira et al. 2016). This raised 
the hypothesis that the sensing of host-derived chemokines by T. brucei might 
play a similar role in stimulating parasite migration towards the lymphatics. 
Therefore, to test this hypothesis, publicly-available microarray data sets were 
analysed to identify chemokine-encoding genes that were highly expressed in 
mouse skin (at least at the mRNA level). In vitro chemotaxis assays were 
performed using these chemokines to test their ability to act as 
chemoattractants for T. brucei. The known role of the candidate chemokines 

















































trafficking to/from SLO 
(Gunn, Tangemann et 
al. 1998, Cyster 1999, 
Gunn, Kyuwa et al. 
1999, Haesslera, 
Pisanoa et al. 2011, 



















trafficking to/from SLO 
(Gunn, Tangemann et 
al. 1998, Cyster 1999, 
Gunn, Kyuwa et al. 
1999, Haesslera, 
Pisanoa et al. 2011, 












inflammation of the 












































In addition to their role in coordinating the chemotaxis and positioning of cells 
within tissues, many chemokines also possess potent antimicrobial properties, 
especially against certain pathogenic bacteria and fungi (Yang, Chen et al. 
2003, Yount, Waring et al. 2007, Nguyen and Vogel 2012, Yung and Murphy 
2012, Dai, Basilico et al. 2015). These antimicrobial chemokines are 
considered to mediate their antimicrobial activities predominantly through the 
disruption and lysis of the pathogen cell membrane (Nguyen and Vogel 2012). 
For example, CCL20 has been shown to function similarly to the β-defensin 
antimicrobial peptide as both activate the CCR6 chemokine receptor and both 
are potent antimicrobials (Nguyen and Vogel 2012). Truncated variants of 
some CXC chemokines have also been reported to be directly bactericidal for 
B. subtilis, E. coli, Lactococcus lactis and Staphylococcus aureus, and 
fungicidal against Cryptococcus neoformans (Krijgsveld, Zaat et al. 2000). A 
study has shown that the platelet-derived human defence peptide CXCL4 can 
kill erythrocyte-inhabiting malaria parasites through lysing the parasitic 
digestive vacuole (Valdivia-Silva, Medina-Tamayo et al. 2015). The human 
chemokines CXCL2, CXCL6, CXCL9, CXCL10, CCL20 and CCL28 have also 
been shown to significantly dampen mitochondrial activity (>50% reduction) in 
Leishmania mexicana (Sobirk, Morgelin et al. 2013), a kinetoplastid protozoan 
related to T. brucei. However T. brucei blood-stream forms lack substantial 
mitochondrial activity, therefore these chemokines would be predicted to incur 
much less of an effect compared to L. Mexicana. The chemokine CCL28 on 
the other hand has also been shown to have direct antimicrobial activity 
against bacteria and fungi, as well as L. Mexicana where it induced substantial 
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plasma membrane damage (Sobirk, Morgelin et al. 2013). A selection of 
chemokines shown to have antimicrobial properties are shown in Table 3.2. 
Therefore, in this chapter in vitro assays were also used to determine whether 
certain chemokines (and in particular CCL28 due to its potent effects against 
L. mexicana) mediated any direct parasiticidal effects against T. brucei.   
 
Table 3.2: Known antimicrobial properties of selected chemokine 
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3.3.1 Chemokine-encoding gene expression in mouse skin 
Experiments were designed to test the hypothesis that T .brucei parasites 
respond to host chemokines in the skin to help mediate lymphatic invasion. 
Chemotaxis assays were performed using chemokines which were selected 
on the basis of their high gene expression in mouse skin, as described in 
Section 2.3.1. Data from three independent published studies were analysed 
(GEO accession codes: GSE17511; GSE7694; GSE27628) comprising a total 
of 11 individual microarrays (data sets) performed on the Affymetrix mouse 
genome 430 2.0 platform. This analysis showed that genes encoding the 
chemokines CCL6, CCL8, CCL21, CCL27, CXCL12, CXCL14 and CXCL16 
were expressed highly in mouse back, ear and tail skin data sets (Figure 
3.1a&b). Of these, the chemokines CCL8, CCL21, CCL27 and CXCL12 were 
selected for use in subsequent experiments, due to their high expression levels 
in the mouse skin regions as well as having strong chemotactic activity towards 
lymphocytes. We also included CCL19, since this chemokine together with 
CCL21, contributes to the homing of lymphocytes and leukocytes across the 







Figure 3.1: Retrospective comparison of chemokine gene expression in 
mouse skin 
Heat maps showing the expression profile of multiple CCL (A) or CXCL (B) 
chemokine-encoding genes in microarray data sets derived from samples of murine 
back, ear and tail skin (GEO accession codes: GSE17511; GSE7694; GSE27628).  
These data were produced using Affymetrix MOE430_2 mouse genome expression 
arrays (Affymetrix, Santa Clara, CA). Each column represents the mean probe set 
intensity (log2) for individual data sets (samples) from each source.  Representative 
probe sets are shown when multiple probe sets for a gene were present on the arrays.  
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3.3.2 Chemokines do not mediate the chemotaxis of T. brucei in vitro 
To determine whether certain chemokines may act as chemoattractants for T. 
brucei, in vitro transwell chemotaxis assays were performed. Viable 
monomorphic T. brucei Lister 427 trypanosomes (1x106) were placed in the 
upper chamber of each well, which was separated from the lower chamber by 
a 3 µm pore membrane. Differing concentrations of each chemokine were then 
added to the medium in the lower chamber and the number of trypanosomes 
that had migrated into the lower chamber was determined 2 hours later. Heat-
inactivated chemokines and medium alone were used as controls. The data 
show that chemokines CCL8, CCL19, CCL21, CCL27 and CXCL12 did not 
stimulate significant chemoattraction of T. brucei when compared to controls, 
irrespective of the concentration of the chemokines used (100 - 500 ng/mL) 
(Figure 3.2). This observation was not specific to the monomorphic T. brucei 
Lister 427 parasite strain since a parallel set of experiments showed that 
CCL21 also exerted no significant chemoattraction towards the pleomorphic 
T. brucei STIB 247 strain (Figure 3.2f). CCL21 was selected for testing with 
STIB 247 trypanosomes due the chemokine’s importance in lymphocyte 
circulation and trafficking to the lymph nodes (Gunn, Kyuwa et al. 1999). These 
data indicate that T. brucei do not utilise CCL8, CCL19, CCL21, CCL27 or 
CXCL12 chemokines as chemotactic cues. As anticipated, these chemokines 
mediated significant chemoattraction towards mouse splenocytes (Figure 





Figure 3.2: Effect of in vitro chemokines on trypanosome chemotaxis 
1x106 viable monomorphic T. brucei Lister 427 trypanosomes (A-E) or pleomorphic 
T. brucei STIB 247 trypanosomes (F) were placed in the upper chamber of each well 
which was separated from the lower chamber by a 3 µm pore membrane. The 
respective concentration of (A) CCL8, (B) CCL19, (C&F) CCL21, (D) CCL27 and (E) 
CXCL12 were then added to the medium in the lower chamber and the number of 
trypanosomes which had migrated into the lower chamber determined 2 hours later.  
Heat-inactivated chemokine (i500, i100) or medium alone were used as negative 
controls. Each point represents the mean from triplicate wells, the horizontal bar 
represents the mean ± SD. All experiments were repeated three times on different 




Figure 3.3: Effect of in vitro chemokine exposure on the chemotaxis of 
mouse splenocytes   
Splenocytes (1x106) were placed in the upper chamber of each well which was 
separated from the lower chamber by a 3 µm pore membrane. (A) Total splenocytes, 
(B) B cells, (C) T cells, (D) APCs. The chemokines CCL8, CCL19, CCL21, CCL27 
and CXCL12 were then added to the medium in the lower chamber at a concentration 
of either 100 or 500 ng/ml and the number of cells which had migrated into the lower 
chamber determined 2 hours later by flow cytometry.  Foetal bovine serum (FBS) or 
medium alone were used as negative controls.  Each point represents the mean from 
triplicate wells, the horizontal bar represents the mean ± SD.*, P < 0.05; **, P < 0.01; 




3.3.3 Chemokine exposure has no effect on T. brucei motility in vitro 
Although exposure to the chemokines in section 3.3.2 did not exert any 
chemoattractive activity towards the trypanosomes in vitro, we also assessed 
whether they might alter the characteristics of parasite motility. The chemokine 
CCL21 was used in these studies due to its role in stimulating the homing of 
lymphocytes/leukocytes to lymphoid tissues and their migration across the 
vascular endothelium (Forster, Davalos-Misslitz et al. 2008). CCL27 was also 
used due to its role in the chemotaxis of lymphocytes in the skin (Hocking 
2015), while CCL28 was selected due to its cytotoxic effect against L. 
mexicana (Sobirk, Morgelin et al. 2013). Monomorphic Lister 427 
trypanosomes were incubated in medium containing CCL21 for 2 hours and 
the motility of 90 individual parasites recorded by live cell imaging. Imaris 
software was then used to determine the effects of treatment on trypanosome 
speed, acceleration, displacement track length, and meandering index, as well 
as their velocities in the X, Y, and Z axes. The analysis clearly showed that 
CCL21 exposure did not significantly affect trypanosome speed, velocity, 
acceleration, displacement track length or meandering index when compared 
to control-treated trypanosomes (Figures 3.4 and 3.5). To test that the lack of 
impact of chemokine exposure on trypanosome motility was not restricted to 
monomorphic Lister 427 trypanosomes, the effects of CCL21, CCL27 and 
CCL28 on the motility of pleomorphic STIB 247 trypanosomes were also 
tested. Experiments showed that these chemokines also did not affect the 
speed, velocity, acceleration, displacement track length or meandering index 
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of the pleomorphic STIB 247 trypanosomes when compared to control-treated 
trypanosomes (Figures 3.6 and 3.7).  
 
 
Figure 3.4: Effect of in vitro CCL21 exposure on trypanosome motility.   
Monomorphic T. brucei Lister 427 trypanosomes were incubated in medium 
containing CCL21 for 2 hours and the motility of 90 individual parasites recorded by 
live cell imaging.  Imaris software was then used to determine the effects of treatment 
on trypanosome speed (A-C), and velocities in the X, Y, and Z axes (D-F). Each point 
represents data from the analysis of individual trypanosomes, the horizontal bar 




Figure 3.5: Effect of in vitro CCL21 exposure on trypanosome motility 
Monomorphic T. brucei Lister 427 trypanosomes were incubated in medium 
containing CCL21 for 2 hours and the motility of 90 individual parasites recorded by 
live cell imaging.  Imaris software was then used to determine the effects of treatment 
on trypanosome acceleration (A), displacement track length (B), and meandering 
index (C). Each point represents data from the analysis of individual trypanosomes, 





Figure 3.6: Effect of in vitro CCL21, CCL27 and CCL28 exposure on 
trypanosome motility 
Pleomorphic T. brucei STIB 247 trypanosomes were incubated in medium containing 
CCL21, CCL27 or CCL28 for 2 hours and the motility of 30 individual parasites 
recorded by live cell imaging.  Imaris software was then used to determine the effects 
of treatment on trypanosome speed (A-C) velocities in the X, Y, and Z axes (D-F). 
Each point represents data from the analysis of individual trypanosomes, the 




Figure 3.7: Effect of in vitro CCL21, CCL27 and CCL28 exposure on 
trypanosome motility 
Pleomorphic T. brucei STIB 247 trypanosomes were incubated in medium containing 
CCL21, CCL27 or CCL28 for 2 hours and the motility of 30 individual parasites 
recorded by live cell imaging.  Imaris software was then used to determine the effects 
of treatment on trypanosome acceleration (A), displacement track length, (B), and 
meandering index (C).  Each point represents data from the analysis of individual 




3.3.4 Chemokine exposure has no effect on T. brucei viability in vitro 
As well as regulating the migration and position of certain host cell populations 
within tissues, studies have shown that some chemokines display antimicrobial 
activities towards a range of microbial pathogens (Kotarsky, Sitnik et al. 2010, 
Sobirk, Morgelin et al. 2013, Dai, Basilico et al. 2015, Pallister, Mason et al. 
2015). Experiments were therefore performed to determine whether certain 
chemokines might also exhibit any direct parasiticidal effects against T. brucei. 
To do so, T. brucei blood-stream forms (8x105/1 mL well) were incubated with 
differing concentrations of each chemokine and the number of viable 
trypanosomes determined 2 hours later. In these experiments the chemokine 
CCL28 was also included since it had been shown in an independent study to 
exert potent antimicrobial effects towards bacteria and fungi (Hieshima, Ohtani 
et al. 2003, Pallister, Mason et al. 2015) and the related protozoan parasite L. 
mexicana (Sobirk, Morgelin et al. 2013). Heat-inactivated chemokines and 
medium alone were used as controls. These data show that the viability of T. 
brucei was not significantly affected after in vitro exposure to CCL8, CCL19, 
CCL21, CCL27, CCL28 and CXCL12 (Figure 3.8). As above, this was not 
specific to the monomorphic T. brucei Lister 427 strain of trypanosomes as 
CCL21 and CCL28 also exerted no significant effect on the pleomorphic T. 





Figure 3.8: Effect of in vitro chemokine exposure on trypanosome 
viability 
Viable monomorphic T. brucei Lister 427 trypanosomes (A-F) or pleomorphic T. 
brucei STIB 247 trypanosomes (G-H) (8x105/1 ml well) were incubated in medium 
containing differing concentrations of (A) CCL8, (B) CCL19, (C&G) CCL21, (D) 
CCL27, (E) CXCL12 and (F&H) CCL28 were then added to the medium and the 
number of viable trypanosomes determined 2 hours later. Heat-inactivated chemokine 
(i500, i100, i10) or medium alone were used as control. Each point represents the 
mean from triplicate wells, the horizontal bar represents the mean ± SD. All 
experiments were repeated three times on different days.    
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3.3.5 Chemokine exposure has no effect on T. brucei membrane 
permeability and integrity in vitro 
Some chemokines have been shown to mediate their antimicrobial effects by 
causing direct damage to the plasma membranes of the target microorganism, 
including the protozoan parasite L. mexicana (Sobirk, Morgelin et al. 2013). 
Therefore, experiments were performed to determine whether the membrane 
integrity of chemokine-treated T. brucei parasites was affected by assessing 
their uptake of the vital dyes propidium iodide (PI) and trypan blue. Flow 
cytometry was used to determine the number of trypanosomes that were 
sufficiently permeabilized after treatment to allow entry of PI (Figures 3.9a-c), 
whereas trypan blue-exclusion was used to compare the effects of treatment 
on the number of live or dead trypanosomes (Figure 3.9d). Trypanosomes 
exposed to medium alone were used as controls. When trypanosomes were 
treated with the trypanocidal drug diminazene aceturate (as a positive control) 
membrane integrity and trypanosome viability was dramatically affected as 
anticipated (Figure 3.9). However, exposure to the chemokines CCL8, CCL19, 
CCL21, CCL27, CCL28 and CXCL12 had no significant effect on membrane 
integrity when compared to control-treated trypanosomes (Figure 3.9). 
Finally, TEM was used to determine whether chemokine exposure caused 
morphological damage to the plasma membranes of the trypanosomes. As 
anticipated, substantial trypanosome destruction was observed following in 
vitro treatment with the trypanocidal drug diminazene aceturate (Figure 3.10). 
However, no observable effects on membrane integrity were observed 
106 
 
following treatment with the chemokines CCL21, CCL27 or CCL28 when 





Figure 3.9: Effect of in vitro chemokine exposure on trypanosome 
membrane permeability and viability   
(A) Flow cytometric analysis of PI-uptake by trypanosomes after chemokine 
exposure.  T. brucei Lister 427 trypanosomes were exposed for 2 hours to 500 ng/mL 
of CCL21, CCL27 or CCL28, or 10 µM of the anti-trypanosome drug diminazene 
aceturate before analysis.  The percentage PI-positive cells in the gated regions of 
each scatter plot are shown.  (B) Histoplot shows the relative cell count vs. PI uptake 
following exposure of T. brucei Lister 427 trypanosomes to medium alone (control, 
red), CCL21 (light blue), CCL27 (dark blue), CCL28 (green) or diminazene aceturate 
(shaded).  (C) Histogram shows the % PI-positive trypanosomes following in vitro 
exposure to chemokines or the trypanocidal drug diminazene aceturate.  Each bar 
represents the mean from three independent experiments ± SD.  (D) Histogram shows 
the percentage live and dead trypanosomes after exposure to chemokines or the anti-
trypanosome drug diminazene aceturate.  All experiments were repeated three times 




Figure 3.10: TEM analysis shows in vitro chemokine exposure does not 
adversely affect trypanosome membrane integrity 
T. brucei Lister 427 trypanosomes were exposed to medium alone (control), or 
CCL21, CCL27 or CCL28 (500 ng/ml), or the anti-trypanosome drug diminazene 
aceturate (10 µM) for 2 hours before analysis. Whereas substantial parasite 
destruction was observed following diminazene aceturate treatment, no observable 
effects on membrane integrity were observed after chemokine treatment.    
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3.3.6 Absence of homologues of mammalian chemokine receptor-
encoding genes in the T. brucei genome 
The U.S National Library of Medicine’s National Center for Biotechnology 
Information’s (NCBI) Basic Local Alignment Search Tool (BLAST) program 
was used to compare protein sequences on their databases. A protein-protein 
sequence BLAST search found no obvious matches for homologues of murine 
chemokine receptors in T. brucei (see Table 3.3). Table 3.3 shows the nearest 
conserved amino acid sequence (protein) in the T. brucei genome for the 
murine chemokine receptors. Glyceraldehyde-3-phosphate-dehydrogenase 
(GAPDH) and actin A were used as conserved controls. An amino acid query 
sequence of a protein sequence database provides a more informative 
conserved putative sequence to assess, than a comparison of a nucleotide 
sequence database (Singer and Hickey 2000, Lipman, Souvorov et al. 2002). 
The database search for the chemokine receptor proteins also produced no 
close identity match in T. brucei TREU 927, except CCR3 (receptor for 
CCL28). This receptor matched a carbon catabolite repressor protein 4 
(CCR4) associated factor (CAF) in the parasite genome at 64% identity match, 
which is above the conserved control threshold of GAPDH (61%). However 
CCL28, the chemokine ligand for CCR3, was shown not to be highly expressed 
in mouse skin and had no effect on T. brucei motility, but was instead selected 




Table 3.3: An NCBI protein-protein BLAST search highlighting nearest 






Soon after the i.d injection of African trypanosomes into the skin by the tsetse 
fly vector, the extracellular parasites invade the afferent lymphatics before 
disseminating systemically from the draining lymph node (Emery, Barry et al. 
1980, Theis and Bolton 1980, Barry and Emergy 1984, Tabel, Wei et al. 2013, 
Caljon, Van Reet et al. 2016). The host-derived cues that are used by the 
trypanosomes to enable them to home to the local lymphatics within the skin 
and on towards the draining lymph node are unknown. 
Data in this this chapter show that the chemokines CCL8, CCL19, CCL21, 
CCL27, CCL28 and CXCL12 do not stimulate the chemotaxis or influence the 
motility of T. brucei. These data suggest that African trypanosomes use 
alternative cues to reach the host lymphatics from the bite site in the skin, but 
the mechanism by which this is achieved therefore remains unknown. 
However, the experiments in this thesis involved the use of blood-stage form 
trypanosomes rather than the metacyclic forms that are introduced by the 
tsetse fly into the mammalian host skin. This may have had a potential impact 
on the host-parasite interactions that were being investigated. A study 
published during the drafting of this thesis has shown that following T. brucei-
infected tsetse fly bites on mice, increases in the expression of the neutrophil 
chemokines CXCL1 and CXCL5 were observed at the bite site in the skin 
(Caljon, Mabille et al. 2018). Therefore, it is plausible that the chemokines 
CXCL1 or CXCL5 may act as a chemoattractant for T. brucei in the skin. 
Despite the African trypanosome flagellum being known to possess 
chemosensory properties (Ralston, Kabututu et al. 2009), the data produced 
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from the NCBI protein-protein sequence search found no definitive identity 
match for a conserved murine chemokine receptor in T. brucei. Therefore 
suggesting that either such receptors are highly divergent or T. brucei reacts 
to alternative cues. 
Perhaps entry into the lymphatics is driven by the physical properties and 
structure of the vessels themselves. Lymphatic vessels utilise hydrostatic and 
colloidal osmotic pressure gradients to drive the entry of interstitial fluids, 
macromolecules, immune cells and absorbed lipids into the lymphatic 
capillaries (Schmid-Schonbein 1990, Wang and Simons 2014). It has been 
shown that junctions are present between the endothelial cells of the initial 
lymphatics allowing for fluid entry, with these sites able to open and close 
(Baluk, Fuxe et al. 2007). The endothelium of the collecting initial lymphatics 
typically has incomplete or absent intercellular junctions. The loosely 
connected, overlapping borders of these lymphatic endothelial cells is 
considered to facilitate the unidirectional entry of tissue fluid and proteins into 
the lymphatics along hydrostatic pressure and protein gradients (Casley-Smith 
1985, Baluk, Fuxe et al. 2007). These open lymphatic endothelial cell junctions 
are believed to function via the displacement of anchoring filaments due to 
increased interstitial fluid pressure (Yao, Baluk et al. 2012). While it is plausible 
that African trypanosomes migrate towards the lymphatics by sensing lymph 
flow, this current is insufficient to push leukocytes such as classical dendritic 
cells towards the initial lymphatics (Tal, Lim et al. 2011). Leukocytes and 
lymphocytes, in contrast, are specifically attracted to lymphatic endothelial 
cells along chemokine gradients and their interactions with specific adhesion 
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molecules coordinate their adhesion to and migration across the endothelium 
(Randolph, Angeli et al. 2005, Tal, Lim et al. 2011). A study has also shown, 
through live-cell imaging, that tumour cells in the skin dermis migrate towards 
and cluster around these lymphatic vessel junctions, allowing for their drainage 
into the lymph nodes (Dadiani, Kalchenko et al. 2006).  
Analysis of other pathogenic microorganisms has provided examples of cues 
that stimulate chemotaxis. For example, the zoospores of Batrachochytrium 
dendrobatidis, an important fungal pathogen of amphibians, have been shown 
to exhibit chemotaxis towards nutritional cues including sugars, proteins and 
amino acids (Moss, Reddy et al. 2008). Within the mammalian host T. brucei 
derives its metabolic energy from blood glucose using a compartmentalised 
and high-throughput form of glycolysis (Creek, Mazet et al. 2015). Since the 
concentration of glucose in the lymph has been shown to be higher than the 
bloodstream (Hendrix and Sweet 1917), it is plausible that glucose may act as 
a molecular cue for African trypanosomes following injection into the skin.  
Increasing evidence shows that many chemokines can also act as 
antimicrobial peptides (Yung and Murphy 2012). All of the chemokines tested 
for cytotoxicity in this chapter are considered to demonstrate this activity: CCL8 
and CCL19 are bactericidal against the Gram-negative bacterium E. coli 
(Yang, Chen et al. 2003); CCL21 is bactericidal against E. coli and the Gram-
positive bacterium S. aureus (Yang, Chen et al. 2003); CCL27 has fungicidal 
activity against Candida albicans (Hieshima, Ohtani et al. 2003); and CXCL12 
is bactericidal against S. aureus and E. coli (Yang, Chen et al. 2003). The 
chemokine CCL28 was of particular interest since it has been shown to exert 
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broad-spectrum antimicrobial effects towards Gram-positive bacteria and 
Gram-negative bacteria (Hieshima, Ohtani et al. 2003, Pallister, Mason et al. 
2015), fungicidal activity towards C. albicans (Hieshima, Ohtani et al. 2003) 
and parasiticidal activity towards the protozoan parasite L. mexicana (Sobirk, 
Morgelin et al. 2013). However, none of the chemokines tested exerted any 
observable parasiticidal effects on T. brucei. Many of these antimicrobial 
chemokines mediate their activities through the disruption and lysis of the 
pathogen cell membrane (Yung and Murphy 2012). In addition, the data in this 
chapter shows that the membrane integrity of T. brucei was not adversely 
affected after chemokine exposure. The human chemokines CXCL2, CXCL6, 
CXCL9, CXCL10, CCL20 and CCL28 have been shown to exert their 
parasiticidal effects against L. mexicana by adversely affecting mitochondrial 
activity (Sobirk, Morgelin et al. 2013). However, a similar mode of action 
against bloodstream T. brucei is unlikely since this life cycle stage lacks 
significant mitochondrial function (Barnard, Reynafarje et al. 1993). Although 
the above Leishmania study investigated the effects of chemokines on the 
promastigote forms of parasite which share similar dimensions, flagellar 
motility and extracellular niche to that of T. brucei, it is plausible that 
antimicrobial chemokines may be more effective against intracellular 
pathogens. Within cells the intracellular chemokine concentrations may be 
much higher, or the chemokine may disturb the intracellular niches in which 
the pathogens reside. For example, human CXCL4 can kill erythrocyte-
inhabiting malaria parasites by selectively lysing the parasitic digestive vacuole 
(Love, Millholland et al. 2012). 
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Together, these data suggest that host chemokines do not exert any 
observable chemotactic or antiparasiticidal effects on African trypanosomes 
such as T. brucei. Identification of the mechanisms used by African 
trypanosome to enable their systemic dissemination after injection in the host 
will aid the development of novel prophylactic approaches to block disease 
pathogenesis. The following chapters in this thesis will describe experiments 
investigating host-pathogen interactions which influence the establishment of 
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African trypanosomes enter the mammalian host following injection by the 
tsetse fly vector into the dermis layer of the skin. From there the parasites 
establish infection in the lymphatics and bloodstream, before causing a 
systemic infection in the host. The details of how this progression occurs 
remain poorly understood. Most studies of African trypanosome infections in 
mammalian hosts involve intraperitoneal (i.p) or intravenous (i.v) inoculations, 
however this overlooks the natural route of infection via the dermal layer of the 
skin. This chapter investigates how the route of infection and parasite dose 
can affect susceptibility to T. brucei infection. Groups of C57BL/6J mice were 
infected with T. brucei STIB 247 parasites via i.p, subcutaneous (s.c), and 
intradermal (i.d) routes. These experiments were repeated using differing 
doses of trypanosomes, from 1x104-1x102. The animals were then assessed 
for 14 days following infection, with peripheral blood parasitaemia and body 
weight being measured daily. Data from this chapter show that both the route 
of infection and the parasite dose significantly affect the infection kinetics of T. 
brucei infection. At lower parasite doses the s.c and i.d infection routes were 
much less efficient at establishing a patent infection than the i.p infection 
routes. These data highlight the importance of investigating the natural 





The importance of the skin-stage of disease in African trypanosome infections 
has been widely overlooked in experimental studies. This is despite the fact 
that the infection in the mammalian host begins when a tsetse fly takes a blood 
meal from a mammalian host, allowing for the trypanosomes to be specifically 
deposited inside the dermal region of the host skin (Caljon, Van Reet et al. 
2016). Studies have shown that from the skin the parasites reach the lymphatic 
system within hours post-injection (Caljon, Van Reet et al. 2016, Alfituri, Ajibola 
et al. 2018), and also that the skin acts as a reservoir for further transmission 
(Caljon, Van Reet et al. 2016, Capewell, Cren-Travaille et al. 2016, Trindade, 
Rijo-Ferreira et al. 2016, Tanowitz, Scherer et al. 2017).  
Studies have also established that the route of inoculation can significantly 
impact on the infection dynamics. Wei, Bull et al. (2011) have shown that the 
percentage of BALB/c mice showing detectable parasitaemia upon infection 
by T. brucei differs in i.p infections compared with i.d infections. They found 
that i.d infected mice were 100 times less susceptible to trypanosome infection 
than i.p infected mice, in a dose-dependent manner (Wei, Bull et al. 2011). 
This highlights the importance of the initial skin stage of infection, which cannot 
be replicated in studies using i.p and i.v transmission. Therefore, in this 
chapter, C57BL/6J mice were infected with differing doses of T. brucei STIB 
247 via the i.p, s.c, and i.d routes. The animals were then assessed daily for 
14 days, for peripheral blood parasitaemia and body weight, in order to 
understand the relevance of the route of infection and the infection dose in this 
host and parasite genotype combination. Data from this chapter show 
121 
 
differences in the infection kinetics between i.p infected mice in comparison 
with both the s.c and i.d infected mice. At lower parasite doses the s.c and i.d 
infection routes were also less efficient at establishing a patent infection than 
the i.p infection route. These data suggest that frequently studied i.p infections 
with T. brucei do not accurately model the natural i.d infection route which 
occurs in the wild. Data from this chapter were then used to inform the design 
of the experiments in the subsequent chapters, which aim to study the 
important host-pathogen interactions which occur following transmission of T. 




4.3.1 Infection characteristics following infection with 1x104 T. brucei 
parasites 
To investigate the impact of different routes and doses in African trypanosome 
infections, groups of C57BL/6J mice were infected with T. brucei STIB 427 
parasites via i.p, s.c, and i.d routes (i.d and s.c T. brucei injections were 
delivered in the ear pinna) at doses ranging from 1x104 to 1x102 
trypanosomes, as described in section 2.2.4. The animals were assessed 
daily for 14 days, with blood parasitaemia counted using the rapid matching 
method (Herbert and Lumsden 1976). This method has a detection limit of 
4x105 parasites/mL of blood (given as 5.4 on the Log10 scale). Mice with 
parasitaemia values below this threshold were classified as undetectable (UD). 
Daily body weights were also recorded, and the specific spleen weight index 
calculated on the day of culling at the end of the experiment. Mice were initially 
infected with T. brucei at a dose of 1x104 parasites by the i.p, s.c, and i.d routes 
(8 mice/group). These infections demonstrated clear differences in 
parasitaemia levels and the onset of detectable parasitaemia in both skin 
infection routes (s.c and i.d) when compared with the i.p infection route (Figure 
4.1). All the mice showed patent blood parasitaemia (Table 4.1), yet the 
parasite burden at the peak of parasitaemia in the i.p infected group exceeded 
both the s.c and i.d groups by between 10 to 100-fold: mean peak parasitaemia 
for i.p mice being 1x108/mL; s.c and i.d mice being 5x106/mL and 8x106/mL, 
respectively. The onset of detectable parasitaemia also differed between 
infection route groups. This ranged from 2-4 days post-injection (d.p.i) in the 
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i.p infected group, and 5-7 d.p.i in the skin infected groups. Furthermore, only 
the i.p infected mice showed a relapse in blood parasitaemia within the 14-day 
infection period, in 50% of the animals. The differences in parasitaemia over 
the 14-day observation period were statistically significant between the i.p 
infected group and the skin infected groups: both P <0.001 (linear mixed 
effects model, n = 8). 
 
Table 4.1: Difference in incidence of detectable parasitaemia between 
different injection routes and inoculum doses. 
 
The table shows the number of mice (out of 8/group) which displayed detectable 
parasitaemia for the i.p, s.c and i.d infected groups administered 1x104, 1x103, and 




Figure 4.1: Heatmap showing parasitaemia levels in mice administered a 
1x104 dose of T. brucei 
Heatmap showing the blood parasitaemia levels/mL of blood detected by microscopy 
in mice after being infected with a 1x104 dose of T. brucei STIB 247 parasites via the 
i.p, s.c, and i.d infection routes. Each row represents an individual mouse (M). The 
blood parasitaemia is displayed as the log10 number of trypanosomes/mL of blood 
(e.g. 5.4 = 4x105 trypanosomes/mL). UD = below detection limit of 5.4 log10 
parasites/mL. n = 8 mice/infection group.  
 
 
The infection had a negative impact on body weight and coincided with the 
time of onset of parasitaemia across the groups (Figures 4.1 and 4.2). The 
body weights of the i.p infected group declined between 5-6 d.p.i, just after the 
initial peak of parasitaemia, to a 5.1% and 5.3% average body weight decrease 
respectively. A decline in body weight in the s.c and i.d infected groups also 
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correlated with their observed parsaitaemia. Here the largest percentage 
decrease in body weight occurred at 8 d.p.i to -5.7% in the s.c infected group 
and -5% in the i.d infected group. These decreases in body weight occured 
directly following the emergence of peak parsaitaemia in all groups. Therefore, 
as observed with the difference in the onset of peak parasitaemia in Figure 
4.1, there is a difference in the timing and degree of body weight loss in the i.p 
group in comparison to both the s.c and i.d groups (Figure 4.2). However, the 
differences in body weight changes were not significantly different between the 
i.p infected group and both skin infected groups: P = 0.446, s.c; P = 0.750, i.d 
(linear mixed effects model, n = 8). 
The spleen specific weight index was determined by calculating the spleen 
weight in mg/g of mouse body weight (Figure 4.3), on the day of culling. This 
analysis suggests that the calculated spleen weight indices were not 





Figure 4.2: Percentage changes in body weights in mice administered a 
1x104 dose of T. brucei 
Percentage body weight changes (relative to 0 d.p.i) of mice over 14-day T. brucei 
infections initiated by i.p, s.c and i.d inoculations of 1x104 trypanosomes. Data are 
shown as the mean ± SD for 8 mice/group. Linear mixed effect models were used to 




Figure 4.3: Specific spleen weight index of mice administered a 1x104 
dose of T. brucei 
Specific spleen weight indices (calculated as the spleen weight in mg/g of mouse body 
weight) of mice after 14-day T. brucei infections initiated by i.p, s.c and i.d inoculations 
of 1x104 trypanosomes. Data are shown as the mean ± SD for 8 mice/group. Student’s 
t-tests were used to compare differences between i.p and s.c and i.d infection groups. 
 
 
4.3.2 Infection characteristics following infection with 1x103 T. brucei 
parasites 
Next, groups of 8 mice were infected with 1x103 T. brucei parasites via i.p, s.c, 
or i.d routes and their infection kinetics observed daily for 14 days, as 
described in sections 2.2.4 and 4.3.1. As observed when infecting with 1x104 
dose of parasites (section 4.3.1), differences in parasitaemia levels and onset 
of detectable parasitaemia where observed in both skin infection routes (s.c 
and i.d) when compared to the i.p infection route (Figure 4.4). All the mice 
developed detectable blood parasitaemia (Table 4.1), but the magnitude of the 
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peak of the parasitaemia in the i.p infected group exceeded both the s.c and 
i.d groups by around 10-fold: mean peak parasitaemia of the i.p infected mice 
2x107/mL; s.c, 1x106/mL; i.d, 2x106/mL. The timing of the onset of the 
detectable parasitaemia also differed between the groups. The onset of 
parasitaemia in the i.p infected group ranged from 3-4 d.p.i, whereas in the s.c 
and i.d groups the initial parasitaemia was detected at 5-6 d.p.i. The 1x103 
dose i.p infected animals did not show any relapse of parasitaemia after the 
initial wave, indicating a difference in infection kinetics when the infectious 
dose is lowered 10-fold. The differences in parasitaemia over the 14-day 
observation period were statistically significant between the i.p infected group 
and the skin infected groups: both P = 0.001 (linear mixed effects model, n = 




Figure 4.4: Heatmap showing parasitaemia levels in mice administered a 
1x103 dose of T. brucei 
Heatmap showing the blood parasitaemia levels/mL of blood detected by microscopy 
in mice after being infected with a 1x103 dose of T. brucei STIB 247 parasites via the 
i.p, s.c, and i.d infection routes. Each row represents an individual mouse (M). The 
blood parasitaemia is displayed as the log10 number of trypanosomes/mL of blood 
(e.g. 5.4 = 4x105 trypanosomes/mL). UD = below detection limit of 5.4 log10 
parasites/mL. n = 8 mice/infection group. 
 
Following infection by the i.p route, the percentage change in body weights 
significantly declined between 2-4 d.p.i, just before the peak of parasitaemia 
to an average peak decrease of 3.4%. In contrast, body weights were not 
negatively impaired when infected by the s.c or i.d routes with a 1x103 dose of 
parasites. This difference was signifant for the i.d infected group (P = 0.001), 
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but not significant for the s.c infected group (P = 0.629) (linear mixed effects 
model, n = 8). This may be due to decreased parasite burden in comparison 
with the 1x104 infection study. Therefore, as observed with the difference in 
the onset of peak parasitaemia in Figure 4.4, there is a difference in the onset 
of peak body weight loss in the i.p infected group only (Figure 4.5), while both 
the s.c and i.d infected groups did not lose weight for large durations of the 
infection. 
The specific spleen weight indices of the s.c infected mice were not signifcantly 
different from the i.p infected group (Figure 4.6). However the specific spleen 
weight index of the i.d infected group was significantly lower than the i.p 
infected group. These data not only highlight that the route of trypanosome 
injection affects the infections kinetics of the parasitaemia and body weight, 




Figure 4.5: Percentage change in body weights in mice administered a 
1x103 dose of T. brucei 
Percentage body weight changes (relative to 0 d.p.i) of mice over 14-day T. brucei 
infections initiated by i.p, s.c and i.d inoculations of 1x103 trypanosomes. Data are 
shown as the mean ± SD for 8 mice/group. Linear mixed effect models were used to 




Figure 4.6: Specific spleen weight index of mice administered a 1x103 
dose of T. brucei 
Specific spleen weight indices (calculated as the spleen weight in mg/g of mouse body 
weight) of mice after 14-day T. brucei infections initiated by i.p, s.c and i.d inoculations 
of 1x103 trypanosomes. Data are shown as the mean ± SD for 8 mice/group. Student’s 
t-tests were used to compare differences between i.p and s.c and i.d infection groups. 
 
 
4.3.3 Infection characteristics following infection with 1x102 T. brucei 
parasites  
Mice were infected with 1x102 T. brucei parasites via the i.p, s.c, or i.d routes 
and the infections monitored daily for 14 days, as described in sections 2.2.4, 
4.3.1 and 4.3.2. The i.p infected group experienced an earlier onset of 
detectable parasitaemia (4-5 d.p.i) than the s.c and i.d infected groups (6-7 
d.p.i) (Figure 4.7). The i.p infected group also displayed higher mean parasite 
levels at the peak of parasitaemia when compared to those infected with 
trypanosomes via the skin: 5x106/mL (i.p) compared to 4x106/mL (s.c) and 
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2x106/mL (i.d). The differences in parasitaemia over the 14-day observation 
period were statistically significant between the i.p infected group and the skin 
infected groups: both P <0.001 (linear mixed effects model, n = 8). 
The most striking observation from the parasitaemia profiles of the s.c and i.d 
infected groups was that many of the animals showed no detectable 
parasitaemia during the 14 day infection period (Table 4.1), whereas 100% of 
the i.p infected mice displayed a patent parasitaemia. At this low dose, only 
4/8 (50%) of the s.c infected mice and 3/8 (38%) of the i.d infected mice 
showed any detectable parasitaemia during the 14 day observation period. 
Therefore, these data show a decrease in the incidence of the detectable 






Figure 4.7: Heatmap showing parasitaemia levels in mice administered a 
102 dose of T. brucei 
Heatmap showing the blood parasitaemia levels/mL of blood detected by microscopy 
in mice after being infected with a 1x102 dose of T. brucei STIB 247 parasites via the 
i.p, s.c, and i.d infection routes. Each row represents an individual mouse (M). The 
blood parasitaemia is displayed as the log10 number of trypanosomes/mL of blood 
(e.g. 5.4 = 4x105 trypanosomes/mL). UD = below detection limit of 5.4 log10 
parasites/mL. n = 8 mice/infection group. 
 
 
The body weight changes during a 1x102 dose infection revealed a pattern of 
weight gain across all injection route groups (Figure 4.8). The difference in 
weight gain during the infection period between the i.p infected group was 
significant when compared to the s.c infected group (P = 0.006) and the i.d 
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infected group (P = 0.001) (linear mixed effects model, n = 8). This is in 
contrast to what was observed for the 1x104 and 1x103 doses, where a 
decrease in body weight was observed during the i.p infection (Figures 4.2 
and 4.5). This suggests the lower infecting parasite dose has a reduced impact 
upon body weight during infection.  
The calculated spleen weight indices were not significantly different across the 
infection route groups at the day of culling (Figure 4.9), following infection with 





Figure 4.8: Percentage change in body weights in mice administered a 
1x102 dose of T. brucei 
Percentage body weight changes (relative to 0 d.p.i) of mice over 14-day T. brucei 
infections initiated by i.p, s.c and i.d inoculations of 1x102 trypanosomes. Data are 
shown as the mean ± SD for 8 mice/group. Linear mixed effect models were used to 




Figure 4.9; Specific spleen weight index of mice administered a 1x102 
dose of T. brucei 
Specific spleen weight indices (calculated as the spleen weight in mg/g of mouse body 
weight) of mice after 14-day T. brucei infections initiated by i.p, s.c and i.d inoculations 
of 1x102 trypanosomes. Data are shown as the mean ± SD for 8 mice/group. Student’s 





This chapter investigated whether the route of infection and the dose of 
infecting parasites affected the infection kinetics of T. brucei infection in the 
mouse. Data presented in this chapter highlight clear differences in the 
infection kinetics of mice injected with T. brucei parasites by the i.p, s.c, or i.d 
routes. Regardless of the parasite dose the i.p infected mice presented with 
parasitaemia days in advance of both the s.c and i.d infected group. The i.p 
infected mice also displayed higher parasitaemia during the observed infection 
waves and peaks, and at the high dose of 1x104 a relapse of parasitaemia was 
seen in 50% of the animals. These data clearly give evidence for striking 
differences in the parasitaemia profiles in mice when infected with African 
trypanosomes by the frequently administered i.p routes when compared to the 
s.c and i.d skin routes. The infected mice also showed differences in body 
weight changes between the i.p and both skin route groups. The s.c and i.d 
percentage body weight change profiles appeared similar to each other yet 
less reduced to the i.p infected group. However, it has been previously 
suggested that parasite burden does not correlate with body weight loss, and 
these body weight changes may be due to specific inflammatory cytokine 
responses (Magez, Truyens et al. 2004). Furthermore, the specific spleen 
weight indices suggested a trend towards decreased splenomegaly in the skin 
routes than the i.p routes. It should be noted that the infections carried out in 
this thesis used blood-stage form trypanosomes instead of metacyclic forms 
which would naturally be introduced into the skin by the tsetse fly. Therefore, 
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it should be considered that if metacyclic trypanosomes were used for the 
infections, then the infection profiles may have potentially been different. 
Data in this chapter also show that the infectious dose affects the disease 
susceptibility. As anticipated, the magnitude of the peak of parasitaemia 
across all infection route groups decreased as the infectious dose decreased 
from 1x104 to 1x102, infecting parasites. Experiments showed that 100% of the 
i.p infected mice had detectable parasitaemia across all doses, whilst the s.c 
and i.d injected mice displayed decreased disease susceptibility at the lower 
1x102 dose. A 10-fold decrease in trypanosome inoculum from 1x103 to 1x102 
resulted in a decreased incidence of detectable parasitaemia from 100% - 38% 
(Table 4.1), in the i.d infection group that more mimics natural infections. 
Interestingly, there were no obvious differences between the s.c and i.d 
infection groups across all dose experiments. These data reveal a threshold 
for attaining 100% detectable parasitaemia in mice of at least 1x103 parasites 
when infected via the skin. These data are concurrent with studies of tsetse fly 
feeding which show that the fly vector extrudes trypanosomes in the hundreds 
to low thousands in number, and that the minimum infectious dose of metacylic 
trypanosomes to establish infections in humans is around 300-450 parasites 
(Fairbairn and Burtt 1946). Therefore, the data in this chapter shows that route 
and dose does affects the infection kinetics and disease pathogenesis of 
African trypanosome infection, and that the frequently studied i.p infection 
routes may not be representative of natural i.d infections. These data suggest 




Other researchers have also analysed the importance of route and dose in the 
establishment of trypanosome infection in mice. A similar study investigating 
the innate immune response during i.d trypanosome infection, showed that 
mice infected with either T. brucei strain 10-26 or T. congolense clone TC13 
by the i.d route were 100 times less susceptible to infection than mice infected 
via the i.p route (Wei, Bull et al. 2011). This study also showed that C57BL/6 
mice infected with 1x102 T. brucei strain 10-26 by the i.d route displayed no 
parasitaemia, while all the mice infected by the i.p route did result in patent 
parasitaemia. A similar finding was also observed following infection of 
C57BL/6 mice with T. congolense clone TC13. Interestingly, in more 
susceptible BALB/c mice, all mice infected with T. congolense clone TC13 by 
i.p route with a 1x104-1x101 dose developed parasitaemia, while those infected 
by i.d route with 1x102-1x101 showed no parasitaemia. In addition, mice 
infected with 1x104 or 1x103 parasites displayed a delay in the onset of 
parasitaemia in the i.d infected mice by ≥2 days compared with the i.p mice. 
These data are similar to data presented in this chapter.  
Another study examining i.d infection of goats with T. congolense showed a 
delay in the onset and a decrease in the size of the local skin reaction (chancre 
formation) as the inoculum dose decreases (Dwinger, Lamb et al. 1987). Wei, 
Bull et al. (2011) also showed that BALB/c mice infected with T. brucei strain 
10-26 showed decreased disease susceptibility at lower doses in i.d infected 
animals. All the mice infected by the i.d route with a 1x105 or 1x104 dose of T. 
brucei 10-26 strain developed a detectable parasitaemia. However only 50% 
had detectable patent parasitaemia when infected with a 1x103 dose. None of 
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the mice developed a detectable patent parasitaemia with a 1x102 dose. 
However all the mice infected by i.p route with a 1x102 dose of parasites 
developed a detectable parasitaemia.  
Data from this chapter show that both the route of infection and the parasite 
dose significantly affects the infection pathogenesis of T. brucei in mice. These 
data thus highlight the importance of investigating the natural progression of 
disease from the initial skin infection site. As the data from this chapter 
revealed no differences between s.c and i.d infected mice, the s.c route was 
omitted from further experiments in Chapters 5 and 6. In this regard the 
experiments described in Chapters 5 and 6 involving in vivo infections utilised 
i.d injections to mimic the natural route of trypanosome infection. Therefore, 
this information was used to inform the design of the in vivo experiments in 
Chapter 5 which aimed to study the role of the draining lymph nodes in disease 

















Chapter 5. Determining the role of the draining lymph 
node and immunoglobulin class-switching in 
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After injection into the skin the African trypanosomes first infect the draining 
lymph node before disseminating systemically. Whether this accumulation 
within the draining lymph node is important for the trypanosomes to establish 
disease was not known. Therefore, in this chapter lymphotoxin-β-deficient 
mice (LTβ-/- mice) which lack most peripheral lymph nodes (but retain the 
spleen and mesenteric lymph nodes) were used to test the hypothesis that 
disease susceptibility after intradermal (i.d) T. brucei infection would be 
impeded in the absence of the draining lymph node. However, experiments 
revealed that the susceptibility of LTβ-/- mice to i.d T. brucei infection was 
significantly higher than in WT mice, indicating that the early accumulation of 
the trypanosomes in the draining lymph nodes was not essential for them to 
establish systemic infection. In addition to its role in lymphoid organogenesis, 
LTβ-receptor (LTβR) signalling is also essential for the maintenance of B cell 
follicles and germinal centres in secondary lymphoid tissue. As a consequence 
of these abnormalities, LTβ-/- mice have impaired immunoglobulin isotype 
class-switching capabilities. Whether host parasite-specific IgG 
immunoglobulin responses also provide important protection against i.d 
infections with T. brucei mice was not known. Therefore, additional 
experiments were undertaken to determine whether the increased 
susceptibility of LTβ-/- mice to i.d T. brucei infection was due to their inability to 
mount effective parasite-specific IgG immunoglobulin responses. When the 
disturbed microarchitecture of the B cell follicles in LTβ-/- mice was restored by 
reconstitution with wild-type bone marrow their susceptibility to i.d T. brucei 
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infection was similar to that of wild-type control mice and coincided with their 
ability to produce significant levels of serum parasite-specific IgG 
immunoglobulins. Thus, data in this chapter show that following i.d infection, 
the early accumulation of African trypanosomes within the draining lymph node 
is not essential for the establishment of systemic disease.  In contrast, intact 
splenic microarchitecture (organised B cell follicles) and the ability to induce 
strong serum parasite-specific IgG immunoglobulins are essential for the 




Upon infection into the dermis of the host following tsetse fly bite, African 
trypanosomes have been shown to invade the afferent lymphatics before 
disseminating systemically (Emery, Barry et al. 1980, Barry and Emergy 1984, 
Tabel, Wei et al. 2013, Caljon, Van Reet et al. 2016, Alfituri, Ajibola et al. 2018). 
Studies of Trypanosoma equiperdum infection in dogs have shown that the 
parasites leave the dermis via the afferent lymphatics and first spread to the 
draining lymph nodes. The parasites then invade the bloodstream before 
disseminating systemically via the efferent lymphatics (Theis and Bolton 
1980). However, little is known of the contribution of the draining lymph nodes 
in the establishment of i.d African trypanosome infections.  
The lymphatic system is a crucial component of the circulatory and immune 
system of the host, monitoring homeostasis, regulating extracellular fluids, and 
controlling infections (Pepper and Skobe 2003, Margaris and Black 2012, Liao 
and von der Weid 2015). The lymphatic system is involved in the trafficking of 
immunes cells, proteins, waste, and interstitial fluids, and is carried within 
lymph fluid (Reddy and Murthy 2002, Ikomi, Kawai et al. 2012, Sevick-Muraca, 
Kwon et al. 2014). This lymph fluid passes through lymph vessels, lymph 
nodes, and the right lymphatic and thoracic ducts before reaching the blood 
circulatory system (Margaris and Black 2012, Sevick-Muraca, Kwon et al. 
2014). Lymph nodes are secondary lymphoid organs (SLOs), where 
macrophages, DCs, and T and B cells interact to present and process 
antigens, initiating antigen-specific immune responses against pathogens 
(Buettner and Bode 2012). Lymph nodes contain a network of fibroblastic 
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reticular cells, T and B cell zones, lymphatic vessels, high endothelial venules, 
and germinal centres that are supported by a network of FDCs (Fletcher, Acton 
et al. 2015). Cells, antigen, and debris can be drained from the skin to local 
draining lymph nodes (Figure 5.1).  
 
Figure 5.1: The skin draining lymphatics and lymph nodes 
Diagram showing how cells, antigen and waste is drained from the skin to the local 
draining lymph nodes. Skin-resident cells capture and process antigen in the skin, 
before presenting to lymphocytes. Afferent lymphatic vessels in the skin allows for the 
drainage of leukocytes and antigen, contained in lymph fluid, to the draining lymph 
node. Lymph enters the subcapsular sinus. Antigen-activated B cells can undergo 
immunoglobulin class-switching in the germinal centres of secondary B cell follicles. 
Lymph, containing activated T and B cells, plasma cells, and antibody, then passes 
into the medullary sinus, before exiting via efferent lymphatic vessels.   
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Lymphotoxin-α (LTα) and lymphotoxin-β (LTβ) are members of the TNF 
superfamily and form a heterotrimer (LTα1β2) to allow signaling through the 
LTβ receptor (LTβR) (Fu, Molina et al. 1997). This signaling pathway allows for 
the development of lymphoid organs and tissues. LTα (TNF-β) and LTβ are 
pro-inflammatory TNF-super family cytokines, and are produced by a milieu of 
cells including CD4+ and CD8+ T cells, B cells, natural killer (NK) cells and 
lymphoid tissue inducer (LTi) cells (Ruddle 2014). LTα is released as a 
homotrimer through the action of TNF converting enzyme (TACE). The 
homotrimer can bind the TNF-receptor 1 (TNFR1) and TNFR2, as well as 
Herpes Virus Entry Mediator (HVEM). However, LTβ is membrane-bound and 
crucially requires LTα to form the heterotrimer (LTα1β2) complex which can bind 
LTβR. These interactions activate signaling via canonical and non-canonical 
nuclear factor-κB (NF-κB) pathway, which regulates immune responses, 
apoptosis, cell survival, and development and maintenance of SLOs (Wolf, 
Seleznik et al. 2010).  
During prenatal development vitamin A converts to retinoic acid and in turn 
triggers stromal lymphoid organizer (LTo) cells to produce the chemokine 
CXCL13, which attracts early LTi cells to the site of lymphoid tissue formation. 
LTi cells can produce LT which will act on LTo cells and stimulate LTβR 
signaling. This stimulation is mediated by expression of the heterotrimeric 
ligand LTα1β2 on LTi cells (Fu, Molina et al. 1997). This signalling induces 
these cells to express a variety of adhesion molecules and chemokines which 
promote the recruitment and clustering of leukocytes and the expansion and 
differentiation of the stromal network (Heesters, Myers et al. 2014). Follicular 
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dendritic cells are vital for the microarchitecture and plasticity of lymphoid 
follicles (Glaysher and Mabbott 2007).  
Therefore, mice deficient in LTα, LTβ, or LTβR (LTα-/-, LTβ-/-, and LTβR-/- mice) 
lack lymphoid organogenesis, and therefore lack lymph node development and 
have irregular splenic structure (De Togni, Goellner et al. 1994, Banks, Rouse 
et al. 1995, Ettinger, Browning et al. 1996, Alimzhanov, Kuprash et al. 1997, 
Fu, Molina et al. 1997, Koni, Sacca et al. 1997, Futterer, Mink et al. 1998, 
Glaysher and Mabbott 2007). LTα-/- mice lack peripheral lymph nodes, Peyer’s 
Patches, splenic germinal centres, and FDCs. LTβ-/- mice are almost similar 
except that mesenteric and cervical lymph nodes are present in most LTβ-/- 
mice (Alimzhanov, Kuprash et al. 1997, Koni, Sacca et al. 1997). LTα-/-, LTβ-/-, 
and LTβR-/- mice have disturbed B cell follicles and lack germinal centres, 
resulting in an inability to produce high affinity class-switched immunoglobulins 
(Ig) (Ettinger, Browning et al. 1996, Futterer, Mink et al. 1998). 
African trypanosomes initially infect the draining lymph node after i.d injection 
(Tabel, Wei et al. 2013, Caljon, Van Reet et al. 2016, Alfituri, Ajibola et al. 
2018). Therefore, LTβ-/- mice (which lack most peripheral lymph nodes) were 
used in this chapter to determine whether this early accumulation in the 
draining lymph node was essential for T. brucei to establish systemic infection 
after i.d injection. 
Studies using the i.p and i.v routes of infection have shown that B cells and Ig 
play an essential role in protective immunity against African trypanosome 
infections (Campbell, Esser et al. 1977, Musoke, Nantulya et al. 1981, 
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Dempsey and Mansfield 1983, Magez, Radwanska et al. 2006, Vincendeau 
and Bouteille 2006, Magez, Schwegmann et al. 2008, Baral 2010, Stijlemans, 
Radwanska et al. 2017). In particular high antigen-affinity class-switched IgG 
immunoglobulins against the trypanosome’s variant surface glycoprotein 
(VSG) coat target the parasites for immunoclearance by macrophages (Shi, 
Wei et al. 2004, Magez, Schwegmann et al. 2008, Black, Guirnalda et al. 
2010). The germinal centres in the B cell follicles of the SLOs are the sites 
where B cells mature, differentiate and produce immunoglobulin class-
switched antibodies with high affinity through somatic hypermutation of their Ig 
genes (Stavnezer, Guikema et al. 2008, De Silva and Klein 2015, Hwang, Alt 
et al. 2015, Zhang, Garcia‐Ibanez et al. 2016). Through this process, hosts 
infected with African trypanosomes attempt to control successive parasitaemia 
waves through the production of class-switched IgG antibodies with strong 
affinity for the parasites’ VSG proteins (Shi, Wei et al. 2004, Magez, 
Schwegmann et al. 2008, Black, Guirnalda et al. 2010) (section 1.7.3). 
Therefore, an additional set of experiments was undertaken to test the 
hypothesis that the disturbed tissue microarchitecture and reduced ability to 
produce high antigen-affinity class-switched IgG immunoglobulin responses in 




5.3 Results  
5.3.1 LTβ-/- mice lack most peripheral lymph nodes and Peyer’s patches 
First, the macroscopic presence of lymphoid tissues was determined in groups 
of four C57BL/6J wild-type (WT) control mice and LTβ-/- mice as described in 
Section 2.2.6. The presence of cervical, inguinal, auxiliary inguinal and 
mesenteric lymphoid tissues were identified, as shown in Figure 5.2. The 
number of mandibular, sub-mandibular, superficial parotid, inguinal, auxiliary 
inguinal, and mesenteric lymph nodes, and Peyer’s patches detected in mice 
from each group is shown in Table 5.1. The mandibular, sub-mandibular, and 
superficial parotid lymph nodes are considered to be the cervical lymphoid 
tissues. These are the local lymph nodes which drain the experimental 
injection site of the ear pinna used in the i.d infections of mice throughout this 
thesis.  
Each of the WT mice typically had 6 cervical lymph nodes per mouse: 
mandibular, 2 per mouse; sub-mandibular, 2 per mouse; superficial parotid, 2 
per mouse. However in the four LTβ-/- mice analysed only 1 cervical lymph 
node was observed: mandibular, 0; sub-mandibular, 0; superficial parotid, 1. A 
lack of lymphoid tissues in the LTβ-/- mice was further highlighted in other areas 
of the body. The four WT mice possessed 2 inguinal, 2 auxiliary inguinal, and 
5 mesenteric lymph nodes each, as well as Peyer’s patches in their small 
intestines. In contrast, three of the LTβ-/- mice did not have any inguinal, 
auxiliary inguinal or mesenteric lymph nodes, and also lacked the Peyer’s 
patches. One LTβ-/- mouse did possess 1 superficial parotid, 1 inguinal and 1 
mesenteric lymph node. Similar data have also been reported in previous 
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analyses of LTβ-/- mice (Alimzhanov, Kuprash et al. 1997, Van den Broeck, 
Derore et al. 2006).  
 
Table 5.1: Incidence of lymphoid tissues in WT and LTβ-/- mice. 
 
Number of lymphoid tissues present macroscopically in WT and LTβ-/- mice 





Figure 5.2: Lymphoid tissues in WT and LTβ-/- mice 
Macroscopial images of mice one week after i.p injection with 0.3 mL of 1% Chicago 
Sky Blue 6B ink in sterile PBS. Ventral view of whole body of WT (A) and LTβ-/- mice 
(F), with areas of cervical (B&G), inguinal (C&H), auxiliary inguinal (D&I), and 
mesenteric (E&J) lymph nodes shown. m, mandibular; sm, submandibular; sp, 
superficial parotid.  
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5.3.2 LTβ-/- mice have irregular splenic microarchitecture and disturbed 
B cell follicle formation 
In agreement with previous studies of LTβ-/- mice, H&E staining of spleen 
sections showed that the LTβ-/- mice had disrupted splenic microarchitecture 
compared to the WT mice, with disturbed separation between the white pulp 
regions (containing lymphocytes and B cell follicles) from the red pulp regions 
(Figure 5.3a). Immunofluorescent antibody staining showed that in WT mice 
there were regular formations of CD35+ FDC networks and B cell follicles in 
the spleen. However, the spleens of LTβ-/- mice lacked FDCs and had 
disturbed B cell follicle formation presenting instead as ring-like structures 





Figure 5.3: Histological examination of WT and LTβ-/- mouse spleens 
(A) H&E staining of WT and LTβ-/- mouse spleen sections. WT mouse spleens display 
regular cellular compartmentalisation within white and red pulps. LTβ-/- mice display 
irregular compartmentalisation of cells within white and red pulps. wp, white pulp, rp, 
red pulp. (B). Immunohistochemical detection of FDCs within the spleens of WT and 
LTβ-/- mice. CD35-expressing FDCs (orange) and organised B cell follicles containing 
B cells expressing CD45R (B220) (green) were detected in WT mouse spleens. No 
FDCs were detected in LTβ-/- mouse spleens.  
 
5.3.3 LTβ-/- mice have impaired class-switched IgG production 
Enzyme Linked Immunosorbent Assays (ELISAs) were next used to compare 
the total concentration of IgM, IgG1, IgG2b, IgG2c, and IgG3 immunoglobulin 
isotypes in the sera of naïve WT and LTβ-/- mice, as described in section 2.4.1. 
C57BL6/J mice do not produce the IgG2a antibody isotype (Zhang, 
157 
 
Goldschmidt et al. 2012). As anticipated this analysis showed that LTβ-/- mice 
have significantly reduced serum levels of class-switched Ig isotypes (Figure 
5.4b-e). However, the sera of LTβ-/- mice contained similar levels of total non-
class-switched IgM antibody as WT mice (Figure 5.4a). These data confirm 
that LTβ-/- mice lack most peripheral lymph nodes and as a consequence of 
the disrupted B cell follicle formation in their spleens, have impaired Ig class-
switching. These mice will therefore be used in the subsequent sections of this 
chapter to determine the role of the draining cervical lymph nodes and Ig class-





Figure 5.4: Comparison of total Ig levels in the sera of naïve WT and LTβ-
/- mice 
Concentration (µg/mL) of total Ig isotypes detected by ELISA from sera of uninfected 
(naïve) WT and LTβ-/- mice. (A) IgM, (B) IgG1, (C) IgG2b, (D) IgG2c, (E) IgG3. Data 
shown as the mean ± SD for 8 mice/group. Student’s t-test comparing differences 




5.3.4 Disease pathogenesis is exacerbated in LTβ-/- mice following 
infection with T. brucei via the skin 
Groups of WT and LTβ-/- mice were injected i.d with T. brucei STIB 247 
parasites (delivered in to the ear pinna), as described in section 2.2.4. The 
animals were then assessed daily for 30 days. Blood parasitaemias were 
counted using the rapid matching method (Herbert and Lumsden 1976) which 
has a detection limit of 4x105 parasites per mL of blood (given as 5.4 on the 
Log10 scale). Mice with parasitaemia values below this threshold were 
classified as undetectable (UD). Daily body weights were also recorded, and 
the specific spleen weight index calculated on the day of culling at the end of 
the experiment. Chapter 4 has established the differences in infection kinetics 
between mice infected via different routes and doses of parasites. Therefore 
this chapter compares differences between WT and LTβ-/- mice infected with 
trypanosomes via the i.d route. 
First, LTβ-/- and WT mice (n = 8) were infected with 1x105 T. brucei parasites. 
The onset of the detectable parasitaemia and the mean parasite burden at the 
peak of the initial parasitaemia wave did not significantly differ between mice 
from each group (Figure 5.5). The onset of detectable parasitaemia ranged 
from 5-8 d.p.i in WT mice and 5-7 d.p.i in LTβ-/- mice. The mean parasite 
burdens at the peak of the first wave of parasitaemia were 8x106/mL (WT) and 
1x107/mL (LTβ-/-) (P = 0.4602, Student’s t-test, n = 8). Furthermore, after 
infection with this high dose of parasites (1x105 parasites) all mice showed 
patent blood parasitaemia, which was concurrent with data presented in 
Chapter 4 (Figure 4.1). These data show that the initial wave of parasitaemia 
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was similar in the blood of LTβ-/- and WT mice when infected i.d with 1x105 T. 
brucei parasites. 
However, after 14 d.p.i, significant differences in the parasitaemia profiles were 
observed between the two mouse strains. None of the WT mice displayed any 
relapse in their parasitaemia. However, 5/8 LTβ-/- mice relapsed between 21-
30 d.p.i, showing a clear difference in infection kinetics between the two 
groups. 
The mean peak of parasitaemia during the second parasitaemia wave in the 
infected LTβ-/- mice was 9x106/mL, and was undetectable in the infected WT 
mice. These data show a distinct difference in the infection kinetics during the 
later stage of the infection. These data also suggest that LTβ-/- mice are more 
susceptible to relapses in T. brucei infection following injection via the skin. 
These data also show that trypanosomes successfully disseminate to the 
bloodstream in LTβ-/- mice, despite lacking most peripheral lymph nodes.  




Figure 5.5: Heatmap showing parasitaemia levels in WT and LTβ-/- mice 
administered a 1x105 dose of T. brucei 
Heatmap showing the blood parasitaemia levels/mL of blood detected by microscopy 
in WT and LTβ-/- mice after being infected with a 1x105 dose of T. brucei STIB 247 
parasites via the i.d infection route. Each row represents an individual mouse (M). 
The blood parasitaemia is displayed as the log10 number of trypanosomes/mL of blood 
(e.g. 5.4 = 4x105 trypanosomes/mL). UD = below detection limit of 5.4 log10 
parasites/mL. n = 8 mice/infection group. 
 
 
The i.d infection with T. brucei had an initial negative impact on body weight 
and coincided with the timing of the primary onset of parasitaemia in both 
mouse groups (Figures 5.5 and 5.6). The maximum decline in body weights 
in both groups was observed at 7 d.p.i, immediately following the initial peak 
of parasitaemia, to a 5% (WT) and 5.7% (LTβ-/-) average body weight change 
(Figure 5.6). After the initial parasitaemia waves subsided, both groups of 
mice showed a gradual increase in body weight regardless of parasite burden. 
There was no statistical difference in body weight changes over the 30-day 
162 
 
infection period between mouse groups (P = 0.745, linear mixed effects model, 
n = 8).  
The specific spleen weight index was determined by calculating the spleen 
weight (mg) per g of mouse body weight on the day of culling (Figure 5.7). 
This analysis showed that the spleen weight index of the infected LTβ-/- mice 
was significantly greater than the infected WT mice. This suggests that the 






Figure 5.6: Percentage changes in body weights in WT and LTβ-/- mice 
following i.d infection with a 1x105 dose of T. brucei 
Percentage body weight changes (relative to 0 d.p.i) of WT and LTβ-/- mice over the 
30-day observation period following i.d infections with 1x105 trypanosomes. Data are 
shown as the mean ± SD for 8 mice/group. Linear mixed effect models were used to 




Figure 5.7: Specific spleen weight index in WT and LTβ-/- mice following 
i.d infection with a 1x105 dose of T. brucei 
Specific spleen weight indices (calculated as the spleen weight in mg/g of mouse body 
weight) in WT and LTβ-/- mice 30-days after i.d infection with 1x105 trypanosomes. 
Data are shown as the mean ± SD for 8 mice/group. Student’s t-tests were used to 
compare differences between WT and LTβ-/- mice. 
 
 
Next, groups of 8 WT and LTβ-/- mice were infected with 1x102 T. brucei 
parasites via the i.d route and their infection kinetics observed daily for 30 
days, as described in sections 2.2.4 and 5.3.2. Consistent with data 
presented in Chapter 4 (Figure 4.7), only 25% of mice infected i.d with 1x102 
trypanosomes had detectable parasitaemia (Figure 5.8). The incidence of the 
detectable parasitaemia after infection with this low dose of trypanosomes was 
similar for each mouse group. The mean peak parasitaemia levels were also 
not statistically different between these groups: 6x106/mL, WT, compared to 
1x106/mL, LTβ-/- (P = 0.4226, Student’s t-test, n = 8). None of the mice injected 
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i.d with a low dose of parasites showed a relapse in parasitaemia during the 




Figure 5.8: Heatmap showing parasitaemia levels in WT and LTβ-/- mice 
administered a 1x102 dose of T. brucei 
Heatmap showing the blood parasitaemia levels/mL of blood detected by microscopy 
in WT and LTβ-/- mice after being infected with a 1x102 dose of T. brucei STIB 247 
parasites via the i.d infection route. Each row represents an individual mouse (M). 
The blood parasitaemia is displayed as the log10 number of trypanosomes/mL of blood 
(e.g. 5.4 = 4x105 trypanosomes/mL). UD = below detection limit of 5.4 log10 




All the i.d infected WT mice showed a steady increase in body weight over the 
30-day infection period (Figure 5.9), consistent with data presented in 
Chapter 4 (Figure 4.8). In contrast, infected LTβ-/- mice displayed a decline in 
body weight during the period up to the emergence of the first wave of 
parasitaemia, at 8 d.p.i. After the first wave of parasitaemia the LTβ-/- mice 
fluctuated between positive and negative body weight changes for the 
remainder of the observation period. The difference in body weight change 
between WT and LTβ-/- mice was statistically significant (P <0.001, linear 
mixed effects model, n = 8). This suggests that even a low trypanosome dose 
has a significant impact upon the body weights of LTβ-/- mice. However, the 
infected LTβ-/- mice displayed no detectable relapse in patent parasitaemia, 
implying that the LTβ-/- mice were still controlling a low level of parasitaemia 
that was below the detection threshold (4x105 trypanosomes/mL). 
The spleen weight indices were not significantly different between infected WT 





Figure 5.9: Percentage changes in body weights in WT and LTβ-/- mice 
following i.d infection with a 1x102 dose of T. brucei 
Percentage body weight changes (relative to 0 d.p.i) of WT and LTβ-/- mice over the 
30-day observation period following i.d infections with 1x102 trypanosomes. Data are 
shown as the mean ± SD for 8 mice/group. Linear mixed effect models were used to 




Figure 5.10: Specific spleen weight index of WT and LTβ-/- mice following 
i.d infection with a 1x102 dose of T. brucei 
Specific spleen weight indices (calculated as the spleen weight in mg/g of mouse body 
weight) in WT and LTβ-/- mice 30 days after i.d infection with 1x102 trypanosomes. 
Data are shown as the mean ± SD for 8 mice/group. Student’s t-tests were used to 
compare differences between WT and LTβ-/- mice. 
 
 
5.3.5 LTβ-/- mice have impaired class-switched IgG production during T. 
brucei infection 
Next, the hypothesis was tested that the LTβ-/- mice were unable to produce 
class-switched IgG antibodies following T. brucei infection. ELISAs were 
performed on all infected mouse sera collected on the day of culling (30 d.p.i) 
to quantify total Ig levels, as described in section 2.4.1. Firstly, the Ig levels in 
mice infected with the 1x105 trypanosome dose was determined (Figure 5.11). 
As expected, the T. brucei infected LTβ-/- mice were able to produce significant 
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amounts of serum non-class switched IgM antibody (Figure 5.11a), and no 
significant difference was observed between the levels in infected WT and LTβ-
/- mice. 
However, the levels of class-switched IgG1 (Figure 5.11b), IgG2c (Figure 
5.11d), and IgG3 (Figure 5.11e) antibodies were found to be significantly 
reduced in the sera of infected LTβ-/- mice. These data show that LTβ-/- mice 
have significantly impaired Ig class-switching following i.d infection with a 





Figure 5.11: Concentration of total serum Ig levels following i.d infection 
with 1x105 T. brucei 
Concentration (µg/mL) of total Ig isotypes detected by ELISA from the sera of WT and 
LTβ-/- mice following i.d infection with 1x105 T. brucei parasites. Naïve WT and LTβ-/- 
mice were used as uninfected controls. (A) IgM, (B) IgG1, (C) IgG2b, (D) IgG2c, (E) 
IgG3. Data are shown as the mean ± SD for 8 mice/group. Tukey’s multiple 
comparisons test comparing differences between naïve WT, naïve LTβ-/-, infected 
WT, and infected LTβ-/- mice. P <0.05 (*), P <0.001 (***), and P <0.0001 (****). 
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Next, the total Ig levels in the sera of mice following i.d infection with a low 
dose of 1x102 T. brucei parasites was determined (Figure 5.12). Although 
significantly lower levels of total IgM were detected in the sera of infected LTβ-
/- mice, when compared to infected WT mice, the infected LTβ-/- mice were still 
able to produce significant amounts of IgM when compared with naïve LTβ-/- 
mice. 
However, the serum levels of most class-switched Ig did not differ significantly 
between WT and LTβ-/- mice when infected with a low dose of trypanosomes 





Figure 5.12: Concentration of total serum Ig levels following i.d infection 
with 1x102 T. brucei 
Concentration (µg/mL) of total Ig isotypes detected by ELISA from the sera of WT and 
LTβ-/- mice following i.d infection with 1x102 T. brucei parasites. Naïve WT and LTβ-/- 
mice were used as uninfected controls. (A) IgM, (B) IgG1, (C) IgG2b, (D) IgG2c, (E) 
IgG3. Data are shown as the mean ± SD for 8 mice/group. Tukey’s multiple 
comparisons test comparing differences between naïve WT, naïve LTβ-/-, infected 
WT, and infected LTβ-/- mice. P <0.01 (**), P <0.001 (***), and P <0.0001 (****).  
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5.3.6 Restoration of splenic microarchitecture in LTβ-/- mice following 
reconstitution with WT bone-marrow 
The hypothesis was tested that a lack of Ig class-switching in LTβ-/- mice 
increased their susceptibility to T. brucei infection. Two groups of 8 LTβ-/- mice 
were lethally irradiated and reconstituted with donor bone marrow, as 
described in section 2.2.7. One group of LTβ-/- mice received WT mouse 
bone-marrow (WT->LTβ-/-) to restore the microarchitecture in their spleens and 
remaining lymph nodes. However, this treatment does not restore the missing 
lymph nodes as these form during embryogenesis. A second group of 8 LTβ-/- 
mice were reconstituted with bone-marrow from donor LTβ-/- mice (LTβ-/-->LTβ-
/-) as a negative control. The recipient mice were allowed to recover for 10 
weeks to allow time for repopulation of the complete haematopoietic system 
and recovery of lymphoid organ microarchitecture (Figure 5.13). These WT-
>LTβ-/- mice were then used to test the effects of restored Ig class-switching, 




Figure 5.13: Splenic microarchitecture is restored in LTβ-/- mice following 
WT mouse bone-marrow transfer 
Immunohistochemical detection of follicular dendritic cells (FDCs) within the spleens 
of WT, LTβ-/-->LTβ-/-, and WT->LTβ-/- mice. CD35-expressing FDCs (orange) and 
organised B cell follicles containing B cells expressing CD45R (B220) (green) 
were detected in WT mouse spleens. No FDCs were detected in LTβ-/-->LTβ-/- 
mouse spleens. Following reconstitution of LTβ-/- mice with WT bone-marrow, WT-




5.3.7 Intradermal T. brucei infection in WT->LTβ-/- mice 
Groups of WT->LTβ-/- mice, LTβ-/-->LTβ-/- mice, and unirradiated WT control 
mice, were infected with 1x105 T. brucei STIB 247 parasites via the i.d route. 
The infection kinetics were then monitored daily for 30 days, as described in 
sections 2.2.4 and 5.3.4. Distinct differences in the parasitaemia kinetics were 
observed between the LTβ-/-->LTβ-/- group and the WT->LTβ-/- and WT groups 
(Figure 5.14a).  
The onset of the initial parasitaemia wave was similar across all three groups: 
4-7 d.p.i, WT and 4-6 d.p.i, WT->LTβ-/- and LTβ-/-->LTβ-/-. The mean levels of 
parasitaemia at the peak of the initial wave were also similar between the WT-
>LTβ-/- and LTβ-/-->LTβ-/-mice (5x107/mL) and significantly higher than that 
observed in WT mice (9x106/mL) (WT versus WT->LTβ-/- mice, P = 0.006; WT 
versus LTβ-/-->LTβ-/- mice, P = 0.0068; Tukey’s multiple comparisons test, n = 
8, WT and WT->LTβ-/-, and n = 7, LTβ-/-->LTβ-/-). The differences between the 
WT->LTβ-/- and LTβ-/-->LTβ-/- mice were not statistically significant (P = 0.9980, 
Tukey’s multiple comparisons test, n = 8, WT->LTβ-/-, n = 7, LTβ-/-->LTβ-/-). 
However, the overall trend in the onset, duration, and incidence of the initial 
parasitaemia, was similar across all groups during the first 20 days of infection. 
The most noticeable differences in parasitaemia kinetics occurred during the 
later stages of the infections. All but one of the WT mice displayed no relapse 
in parasitaemia after the initial wave subsided, similar to data obtained from i.d 
infected WT mice presented in section 5.3.4 (Figure 5.5). However, 5/8 LTβ-
/-->LTβ-/- mice showed relapses in patent parasitaemia, similar to data 
observed from i.d infected LTβ-/- mice presented in section 5.3.4 (Figure 
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5.14b). The mean peak of parasitaemia during the final wave of infection in the 
LTβ-/-->LTβ-/- mice was 9x106/mL, which was similar to that observed during 
the peak of relapse in infected LTβ-/- mice in section 5.3.4 (Figures 5.5 and 
5.14b) (P = 0.8622, Student’s t-test, n = 5). Therefore, like LTβ-/- mice (section 
5.3.4; Figures 5.5 and 5.14b), the LTβ-/-->LTβ-/- mice had significantly 
increased susceptibility to i.d T. brucei infection during the later stages when 
compared to WT mice and WT->LTβ-/- mice. 
None of the i.d infected WT->LTβ-/- mice displayed any detectable relapse in 
their parasitaemias after the initial wave. This observation was similar to the 
unirradiated WT control group, where only 1/8 WT mice relapsed, and similar 
to the i.d infected WT mice presented in section 5.3.4 (Figure 5.5) where none 
of the WT mice relapsed. Therefore, the LTβ-/-->LTβ-/- mice infection kinetics 
were significantly distinct in comparison to both the WT group (P = 0.001) and 
the WT->LTβ-/- group (P <0.001) (linear mixed effects model). The WT and 
WT->LTβ-/- groups did not significantly differ from each other (P = 0.277) (linear 
mixed effects model). Therefore, the reconstitution of LTβ-/- mice with WT 
bone-marrow prevented the subsequent relapses in the parasitaemia burdens 
during the later stages of i.d infection which were observed in unreconstituted 
LTβ-/- mice. These data suggest that the recovery of the spleen SLO 
microarchitecture in the WT->LTβ-/- mice was sufficient to control any 





Figure 5.14: Heatmap showing parasitaemia levels in WT, WT->LTβ-/-, and 
LTβ-/-->LTβ-/- mice administered a 1x105 dose of T. brucei 
Heatmap showing the blood parasitaemia levels/mL of blood detected by microscopy 
in (A) WT, WT->LTβ-/-, and LTβ-/-->LTβ-/- mice and (B) LTβ-/- mice after being infected 
with a 1x105 dose of T. brucei STIB 247 parasites via the i.d infection route. Each row 
represents an individual mouse (M). The blood parasitaemia is displayed as the log10 
number of trypanosomes/mL of blood (e.g. 5.4 = 4x105 trypanosomes/mL). UD = 
below detection limit of 5.4 log10 parasites/mL. n = 8 mice/infection group (except LTβ-
/-->LTβ-/- group where n = 7). 
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The body weight changes observed in each mouse group reflected their 
parasite burdens over the 30-day observation period (Figure 5.15). The WT 
group showed a 2% decrease in the mean percentage change of body weight 
at 6 d.p.i, a day after the peak of parasitaemia observed during their initial 
wave (Figure 5.14a). The WT mice continued to steadily increase in body 
weight for the remainder of the observation period to +8% at 30 d.p.i. The 
bone-marrow reconstituted groups displayed more distinct body weight 
changes. The WT->LTβ-/- group showed a sharp decline in body weight during 
and immediately following their observed parasitaemia wave from 4-6 d.p.i, to 
a maximum decrease of -6.8%. Although these mice presented with no further 
detectable parasitaemia, their body weights continued to fluctuate until 25 d.p.i 
when they began to increase steadily. The LTβ-/-->LTβ-/- mice showed a sharp 
decrease in body weight during their initial parasitaemia wave from 4-6 d.p.i, 
to a maximum decline of -4.9%. Following the initial parasitaemia wave these 
mice demonstrated a gradual increase in body weight until 20 d.p.i. During the 
last 10 days of infection the average body weights decreased again to a 
maximum decline of -3.6%. This decrease in body weight coincided with the 
relapse in parasitaemia observed in 5/8 mice from 21-25 d.p.i. The body 
weights were significantly different between each group: WT group versus WT-
>LTβ-/- group (P <0.001); WT group versus LTβ-/-->LTβ-/- group (P <0.001); and 
WT->LTβ-/- group versus LTβ-/-->LTβ-/- group (P <0.001) (linear mixed effects 
model). These data support the conclusion that the LTβ-/-->LTβ-/- mice are 




The calculated spleen weight indices on the day of culling showed that the WT 
group did not significantly differ from both reconstituted groups (Figure 5.16). 
 
Figure 5.15: Percentage changes in body weights in WT and bone-
marrow reconstituted LTβ-/- mice following i.d infection with a 1x105 dose 
of T. brucei 
Percentage body weight changes (relative to 0 d.p.i) in WT, WT->LTβ-/-, LTβ-/-->LTβ-/- 
mice following 30-day i.d infections with 1x105 trypanosomes. Data are shown as the 
mean ± SD for 8 mice/group (except LTβ-/-->LTβ-/- group where n = 7 mice). Linear 




Figure 5.16: Specific spleen weight index in WT, WT->LTβ-/-, and LTβ-/--
>LTβ-/- mice following i.d infection with a 1x105 dose of T. brucei 
Specific spleen weight indices (calculated as the spleen weight in mg/g of mouse body 
weight) in WT, WT->LTβ-/-, and LTβ-/-->LTβ-/- mice 30 days after i.d infection with 1x105 
trypanosomes. Data are shown as the mean ± SD for 8 mice/group (except LTβ-/--
>LTβ-/- group where n = 7). Student’s t-tests were used to compare differences 
between the groups.  
 
 
5.3.6 Ig isotype class-switching is recovered in WT->LTβ-/- mice 
Next, the hypothesis that Ig isotype class-switching could be recovered during 
infection in LTβ-/- mice was investigated. Total serum Ig levels on 30 d.p.i were 
determined in mice from each group as described in section 2.4.1 (Figure 
5.17). Both the sera of WT->LTβ-/- and LTβ-/-->LTβ-/- mice contained 
significantly greater amounts of non-class switched IgM in comparison to sera 
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from WT mice (Figure 5.17a). As anticipated, the LTβ-/-->LTβ-/- mice produced 
significantly lower levels of class-switched IgG1 antibody than WT mice and 
WT->LTβ-/- mice (Figure 5.17b). Furthermore, the WT and WT->LTβ-/- mice 
were able to produce significantly greater levels of class-switched IgG2b and 
IgG2c in comparison to LTβ-/-->LTβ-/- mice (Figure 5.17c&d). However, WT 
mice produced significantly greater amounts of IgG3 than both the WT->LTβ-/- 
and LTβ-/-->LTβ-/- mice (Figure 5.17e). These data show that Ig class-





Figure 5.17: Comparison of total Ig levels in the sera of WT, WT->LTβ-/-, 
and LTβ-/-->LTβ-/- mice following a 1x105 dose of T. brucei 
Concentration (µg/mL) of total Ig isotypes detected by ELISA from the sera of WT, 
WT->LTβ-/-, and LTβ-/-->LTβ-/- mice following infection with 1x105 T. brucei parasites. 
Naïve WT and LTβ-/- mice were used as uninfected controls. (A) IgM, (B) IgG1, (C) 
IgG2b, (D) IgG2c, (E) IgG3. Data are shown as the mean ± SD for 8 mice/group 
(except LTβ-/-->LTβ-/- where n = 7). Tukey’s multiple comparisons test comparing 
differences between naïve WT, naïve LTβ-/-, WT, WT->LTβ-/-, and LTβ-/-->LTβ-/- mice. 




Next, the titre of trypanosome-specific Ig in the sera of mice from each infected 
group was determined, as described in section 2.4.3 (Figure 5.18). As 
anticipated, infected WT mice produced significantly higher levels of 
trypanosome-specific IgM when compared to naïve WT mice (Figure 5.18a). 
In contrast, the LTβ-/-->LTβ-/- mice were unable to produce significant levels of 
trypanosome-specific class-switched IgG1 and IgG3 isotypes following i.d T. 
brucei infection (Figure 5.18b&c). However, when the splenic 
microarchitecture in WT->LTβ-/- mice was restored by WT bone-marrow 
reconstitution the production of parasites-specific class-switched antibodies 
was restored. The infected WT->LTβ-/- mice produced similar levels of class-






Figure 5.18: Comparison of trypanosome-specific Ig levels in the sera of 
WT, WT->LTβ-/-, and LTβ-/-->LTβ-/- mice following a 1x105 dose of T. brucei 
Concentration (µg/mL) of trypanosome-specific Ig isotypes detected by ELISA from 
the sera of WT, WT->LTβ-/-, and LTβ-/-->LTβ-/- mice following infection with 1x105 T. 
brucei parasites. Naïve WT and LTβ-/- mice were used as uninfected controls. (A) IgM, 
(B) IgG1, (C) IgG3. Data are shown as the mean ± SD for 8 mice/group (except LTβ-
/-->LTβ-/- where n = 7). Tukey’s multiple comparisons test comparing differences 
between naïve WT, naïve LTβ-/-, WT, WT->LTβ-/-, and LTβ-/-->LTβ-/- mice. P <0.05 (*), 




This chapter investigated the role of local draining lymph nodes and Ig isotype 
class-switching in susceptibility to i.d T. brucei infection. Data presented in this 
chapter confirmed that LTβ-/- mice lack most peripheral lymph nodes, and have 
disturbed splenic microarchitecture and impaired IgG immunoglobulin class-
switching. These mice were used in the subsequent experiments to determine: 
i) the role of the draining lymph node in the establishment of i.d infection with 
T. brucei; and ii) the role of organized splenic microarchitecture and ability to 
produce high antigen-affinity class-switched IgG immunoglobulins in 
protection against i.d infection with T. brucei.  
Data in this chapter clearly show that the early accumulation of trypanosomes 
within the draining lymph nodes after i.d infection is not essential for their 
systemic dissemination as all the injected LTβ-/- mice given a high dose 
presented with patent blood parasitaemia. This suggests that following their 
invasion of the lymphatics within the skin (Emery, Barry et al. 1980, Barry and 
Emergy 1984, Tabel, Wei et al. 2013, Caljon, Van Reet et al. 2016, Alfituri, 
Ajibola et al. 2018) the trypanosomes use alternative routes to enter the 
bloodstream and disseminate systemically, as the local draining lymph nodes 
are not required. The lymphatic system allows for the transport within lymph 
fluid of immune cells, proteins, waste, and interstitial fluid to the bloodstream 
(Ikomi, Kawai et al. 2012, Margaris and Black 2012). This lymph fluid passes 
through one of two major lymphatic vessels: the right lymphatic duct on the 
right side of the body, or the thoracic duct on the left side of the body. From 
these lymphatic ducts, passage of lymph into the blood circulatory system is 
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achieved either via the right or left subclavian vein (Reddy and Murthy 2002, 
Ikomi, Kawai et al. 2012, Margaris and Black 2012, Sevick-Muraca, Kwon et 
al. 2014). This implies that following their invasion of the host’s lymphatics, the 
African trypanosomes then directly enter the bloodstream and disseminate 
further via the lymphatic duct.  
Data in this chapter showed that the magnitude and duration of the initial 
parasitaemia wave was similar in the bloodstream of i.d infected LTβ-/- and WT 
mice. However as the infection progressed past this first parasitaemia wave, 
significant differences in the infection kinetics were observed between WT and 
LTβ-/- mice. During the initial infection experiment, none of the WT mice 
injected with a 1x105 dose of trypanosomes showed any further relapses in 
parasitaemia during the remaining observation period. In contrast, 5/8 infected 
LTβ-/- mice relapsed with high levels of parasitaemia, implying that disruption 
in the formation of their B cell follicles increased their susceptibility to T. brucei 
infection. The infected WT and LTβ-/- mice also showed significant differences 
in body weight changes, as the body weights remained lower in LTβ-/- mice 
than WT mice during the later stages of infection. Moreover, the infected LTβ-
/- mice presented with significantly greater spleen weights than the WT mice, 
suggesting that the LTβ-/- mice experienced increased splenomegaly due to 
the increased parasite burden in their bloodstream. Interestingly, a study has 
shown that LTα-/- mice controlled late-stage T. brucei AnTat 1.1E parasitaemia 
more efficiently than C57BL/6J WT control mice (Magez, Stijlemans et al. 
2002). However, these experiments involved the i.p injection route which have 
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been shown to result in different infection kinetics than i.d infections (Chapter 
4).  
IgM immunoglobulin production is an important component of the early innate 
immune response, allowing for the clearance of trypanosomes via antibody-
dependent cellular phagocytosis. In contrast, class-switching to IgG 
immunoglobulins occurs within the germinal centres of SLOs during later 
stages of infection, and requires T cell signalling and FDC networks to produce 
high antigen affinity class-switched Ig (De Silva and Klein 2015, Panda and 
Ding 2015). Mice deficient in LTα, LTβ and LTβR have disturbed B cell follicles, 
lack germinal centres and as a consequence are unable to effectively produce 
high antigen affinity class-switched IgG responses (De Togni, Goellner et al. 
1994, Banks, Rouse et al. 1995, Ettinger, Browning et al. 1996, Alimzhanov, 
Kuprash et al. 1997, Fu, Molina et al. 1997, Koni, Sacca et al. 1997, Futterer, 
Mink et al. 1998, Glaysher and Mabbott 2007). However, LTβ-/- mice can 
produce significant amounts of IgM as its expression is not dependent on the 
presence of organised B cell follicles and germinal centres.  
Studies of African trypanosomes have established the importance of B cells 
during the later stages of infection, as mice deficient in these cells fail to survive 
infections (Campbell, Esser et al. 1977, Magez, Radwanska et al. 2006, Baral, 
De Baetselier et al. 2007, Magez, Schwegmann et al. 2008). During T. brucei 
infections, more resistant C57BL/6 mice are able to control the first wave of 
parasitaemia, while susceptible C3H/He mice are unable to, which is 
associated with their inability to produce trypanosome-specific 
immunoglobulins (Black, Sendashonga et al. 1986). It has also been 
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established that during African trypanosome infection the initial and 
predominant trypanosome specific antibodies produced are IgM antibodies 
(Reinitz and Mansfield 1990, Pan, Ogunremi et al. 2006), which act against 
the parasite membrane via the co-operative actions of the complement system 
(Pan, Ogunremi et al. 2006, Guirnalda, Murphy et al. 2007). High levels of IgM 
are produced around 3-4 days post-infection (Vincendeau and Bouteille 2006). 
Thus, IgM production is crucial for the survival of trypanosome infected mice, 
especially during the early first wave of parasitaemia. These observations are 
concurrent with data presented in this chapter which show that WT mice and 
LTβ-/- were able to produce similar levels of serum IgM immunoglobulins and 
displayed similar parasitaemias during the initial wave. 
During later periods in infection the production of parasite-specific class-
switched Ig, independent of complement activity, is important for the effective 
control of subsequent parasitaemia waves (Guirnalda, Murphy et al. 2007). 
These class-switched Ig can target the trypanosome VSG coat with high 
affinity (Magez, Radwanska et al. 2006, Stijlemans, Radwanska et al. 2017). 
Furthermore, the magnitude of class-switched Ig responses in different mouse 
strains can influence the outcome of T. congolense infection (Morrison and 
Murray 1985). It was found that more resistant C57BL/6 mice were able to 
produce higher levels of trypanosome-specific IgG isotypes at earlier time 
points during the infection than susceptible A/J mice (Morrison and Murray 
1985). However, the susceptible A/J mice were able to produce substantial 
amounts of total serum IgGs. Similar data have been reported from the 
analysis of trypanosome infections in cattle (Taylor, Lutje et al. 1996, Taylor 
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1998). Moreover, T. congolense infection studies of splenectomised mice have 
shown that although these mice have normal IgM responses, their class-
switched IgG response was reduced and the mice were unable to effectively 
control the infection (Magez, Radwanska et al. 2006).  
Consistent with previous studies (Ettinger, Browning et al. 1996, Futterer, Mink 
et al. 1998) the LTβ-/- mice were unable to effectively class-switched their IgG 
isotypes (IgG1, IgG2b, IgG2c, and IgG3). Thus, it was plausible that the 
increased incidence and magnitude of relapse in the parasitaemia during the 
later stages of the infection in the LTβ-/- mice was due to their inability to 
produce antigen-specific class-switched Ig after the initial parasitaemia wave. 
Indeed, when splenic microarchitecture and the ability to Ig class-switch was 
restored in LTβ-/- mice by reconstitution with WT bone marrow, all the WT-
>LTβ-/- mice produced significant levels of trypanosome-specific class-
switched IgG1 and IgG3 and were able to control subsequent parasitaemia 
waves to a similar extent as WT mice. Together these data imply that the first 
wave of the parasitaemia is predominantly controlled by innate mechanisms, 
including non-class switched IgM. However, effective control of the 
subsequent waves requires the induction of adaptive immune responses with 
the production of trypanosome-specific class-switched IgG. These findings 
therefore highlight the importance of the IgG isotype class-switching in the 
control of i.d transmitted African trypanosome infections. 
The combination of innate and adaptive (humoral) immune responses is 
necessary for the effective control of African trypanosome infections (Magez, 
Radwanska et al. 2006, La Greca, Haynes et al. 2014). Macrophages have 
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been suggested to also play an important role in the innate immune response’s 
ability to control the infection by phagocytosing and destroying the parasites in 
tissues (Dempsey and Mansfield 1983). For example, the specialised Kupffer 
cells in the liver have been shown to aid the elimination of T. congolense 
through the IgM and IgG antibody-dependent phagocytosis of the parasites 
(Shi, Wei et al. 2004). Data presented in this chapter show that all infected 
mice responded similarly to the initial wave of parasitaemia, regardless of their 
Ig class-switching capabilities. This suggests that the innate immune response 
predominates during this early phase of the infection, most likely via the 
production of IgM immunoglobulins and the elimination of the parasites by 
macrophages. Therefore, in the next chapter (Chapter 6), experiments were 
designed to determine whether the stimuli which alter the abundance or activity 
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Macrophages are key players in the innate immune response against African 
trypanosome infections, and manipulating these cells during infection may help 
control disease pathogenesis. Therefore, the experiments in this chapter were 
designed to determine whether the stimulation of macrophages with colony 
stimulating factor 1 (CSF1) or lipopolysaccharide (LPS) would influence the 
abundance or activation state of macrophages in the skin, and by doing so 
influence susceptibility to i.d infection with T. brucei. Data in this chapter 
showed that i.d CSF1 treatment in mice increased the abundance of CSF1R+ 
cells (macrophages) in the skin, but did not influence susceptibility to T. brucei 
infection. Conversely, i.d LPS treatment reduced susceptibility to i.d T. brucei 
infection. This suggested that the increased inflammatory state of the 
macrophages in the skin provided a host-protective role against i.d T. brucei 
infection. A greater understanding of the macrophage-parasite interactions 
which occur during the early stages of African trypanosome infections may aid 





Macrophages have been shown to play an important role in the early innate 
immune response against African trypanosomes (Grosskinsky and Askonas 
1981, Fierer and Askonas 1982, Grosskinsky, Ezekowitz et al. 1983, 
Baetselier, Namangala et al. 2001, Paulnock and Coller 2001, Vincendeau and 
Bouteille 2006, Baral 2010, Paulnock, Freeman et al. 2010, Stijlemans, 
Vankrunkelsven et al. 2010, de Sousa, Atouguia et al. 2011, Namangala 2012, 
Kuriakose, Singh et al. 2016, Stijlemans, De Baetselier et al. 2018). The skin 
provides the first line of defence during i.d infections, utilising lymphocytes and 
myeloid phagocytes (including macrophages), which use their pattern 
recognition receptors (PRRs) to sense pathogen- and damage-associated 
molecular patterns (PAMPs and DAMPs), allowing for the release of 
chemokines, cytokines, antimicrobial peptides and highly toxic reactive 
nitrogen and oxygen species (Salmon, Armstrong et al. 1994, Kupper and 
Fuhlbrigge 2004, Akira, Uematsu et al. 2006, Veer, Kemp et al. 2007, 
Summers, Rankin et al. 2010, Takeuchi and Akira 2010, Mahdavian Delavary, 
van der Veer et al. 2011, Harder, Schroder et al. 2013, Casanova-Acebes, A-
González et al. 2014, Pasparakis, Haase et al. 2014, Richmond and Harris 
2014, Iwasaki and Medzhitov 2015, Abbas, Lichtman et al. 2018).  
Studies of African trypanosomes have suggested that host macrophages may 
respond to PAMPs within trypanosomal antigens, such as CpG DNA via 
binding to Toll-like receptor 9 (TLR9) PRRs and soluble glycosylphosphatidyl 
inositol (GPI)-anchored variant surface glycoprotein (VSG) (GPI-sVSG) via 
scavenger receptor PRRs (Akol and Murray 1982, Grosskinsky, Ezekowitz et 
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al. 1983, Paulnock and Coller 2001, Magez, Stijlemans et al. 2002, Drennan, 
Stijlemans et al. 2005, Leppert, Mansfield et al. 2007, Stijlemans, 
Vankrunkelsven et al. 2010, Stijlemans, Caljon et al. 2016). The effectiveness 
of this early innate immune response to trypanosome infection has been 
shown to rely upon the mononuclear phagocyte system’s ability to produce 
substantial pro-inflammatory type 1 cytokines, such as interferon-γ (IFN-γ), 
tumour necrosis factor-α (TNF-α), and interleukin-12 (IL-12), as well as toxic 
mediators such as nitric oxide (NO) (Magez, Geuskens et al. 1997, Mabbott, 
Coulson et al. 1998, Drennan, Stijlemans et al. 2005, Magez, Radwanska et 
al. 2006, Magez, Radwanska et al. 2007, Baral 2010, Summers, Rankin et al. 
2010, de Sousa, Atouguia et al. 2011, Camejo, Spencer et al. 2014, Liu, Sun 
et al. 2015, Kato, Matovu et al. 2016, Bakari, Ofori et al. 2017, Wu, Liu et al. 
2017, Stijlemans, De Baetselier et al. 2018). Classically-activated 
macrophages play an essential role in controlling the initial waves of 
parasitaemia in the mammalian host (Stijlemans, De Baetselier et al. 2018) 
and can destroy the parasites in tissues (Dempsey and Mansfield 1983). PRR 
signalling of natural killer (NK), NKT cells and T cells allows for the production 
of IFN-γ which significantly activates macrophages to release NO and TNF-α 
(Stijlemans, Caljon et al. 2016). Nitric oxide and TNF-α have been shown to 
possess potent cytostatic effects against African trypanosomes (Vincendeau, 
Daulouede et al. 1992, Magez, Lucas et al. 1993, Magez, Geuskens et al. 
1997, Hertz, Filutowicz et al. 1998, Sternberg 2004, Magez, Radwanska et al. 
2006, Barkhuizen, Magez et al. 2007, Magez, Radwanska et al. 2007, 
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Namangala 2012). However, the precise host-parasite interactions which 
occur in the skin during early African trypanosome infection are uncertain.  
Colony stimulating factor-1 (CSF1) is a cytokine that can induce 
haematopoietic stem cells to differentiate into macrophages, and the survival 
and proliferation of macrophages in tissues is regulated by CSF1 receptor 
(CSF1R) signalling (Jones and Ricardo 2013, Gow, Sauter et al. 2014, Louis, 
Cook et al. 2015, Sauter, Waddell et al. 2016, Pridans, Sauter et al. 2018, 
Sehgal, Donaldson et al. 2018). Neutrophil secretion of CSF1 has also been 
shown to drive skin macrophage and Langerhans cell differentiation, survival 
and activity during inflammation (Wang, Bugatti et al. 2016). CSF1 has been 
shown to induce the polarisation of macrophages towards an alternatively 
activated suppressor phenotype (Hume and MacDonald 2012, Jones and 
Ricardo 2013, Hamilton, Zhao et al. 2014, Boulakirba, Pfeifer et al. 2018). 
Lipopolysaccharide (LPS, endotoxin) is a component of the outer membrane 
of Gram-negative bacteria, and a potent PAMP that elicits strong immune 
responses by activating immune cells, such as macrophages via TLR-4 
signalling (Rajaiah, Perkins et al. 2013, Plociennikowska, Hromada-Judycka 
et al. 2015). LPS-induced signalling in macrophages stimulates the production 
of IFN-α, IFN-β, TNF-α, and inducible nitric oxide synthase (iNOS) (Sheikh, 
Dickensheets et al. 2014, Salim, Sershen et al. 2016, Hwang, Kwon et al. 
2017). Upon stimulation by LPS the expression of the iNOS enzyme enables 
the macrophages to produce high amounts of cytotoxic NO from the substrate 
L-arginine (Satriano 2004, Kopincová, Púzserová et al. 2011, Hwang, Kwon et 
al. 2017).  
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In this chapter in vivo and in vitro experiments were designed to determine 
whether CSF1 or LPS stimulation in the skin, would alter the abundance or 
activity of macrophages, and whether these treatments may influence 





6.3.1 Local i.d CSF1 treatment increases the abundance of Csf1r+ 
phagocytes 
First, the hypothesis was tested that CSF1 treatment could influence the 
abundance of macrophages in the skin. In the initial experiments C57BL/6 
Csf1r-EGFP+ mice were used that expressed a Csf1r-EGFP transgene, as 
described in section 2.2.2. The expression of the transgene allowed for the 
visual identification of skin tissue macrophages in the ears of Csf1r-EGFP+ 
mice by two-photon whole-mount microscopy. Groups of mice were treated 
with either CSF1-Fc or PBS (negative control) by i.d injection, as described in 
sections 2.2.8, and 2.5.5. The presence of Csf1r-EGFP+ cells (macrophages) 
were then quantified 24 hours later by microscopic analysis (Figure 6.1). 
Following i.d treatment of Csf1r-EGFP+ mice with CSF1-Fc, the number of 
EGFP+ cells observed in the dermis was significantly greater when compared 
to Csf1r-EGFP+ mice that received PBS as a control (Figure 6.1b). These data 
showed that i.d CSF1-Fc treatment significantly increased the abundance of 





Figure 6.1: Enumeration of Csf1r-EGFP+ cells in the dermis of Csf1r-
EGFP+ mice following i.d treatment with CSF1-Fc or PBS 
(A) Two photon whole-mount microscopy images of i.d CSF1-Fc or PBS treated 
Csf1r-EGFP+ ears. Images show Csf1r-EGFP+ cells (green) and collagen signal 
background (purple). Autofluorescent hair follicles are also shown in green. (B) Graph 
showing the number of EGFP+ cells identified in the ears of Csf1r-EGFP+ mice 
following i.d CSF1-Fc or PBS treatment. Data are shown as the mean ± SD for each 
group of mice: CSF1, n = 4; PBS, n = 3. Student’s t-tests were used to compare 
differences between PBS (control) and CSF1-FC treated groups.  
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6.3.2 Intradermal CSF-Fc treatment has no effect on disease 
pathogenesis after i.d injection with T. brucei  
Next, groups of C57BL/6J WT mice were injected i.d with CSF1-Fc or PBS 
(control), and 24 hours later T. brucei STIB 247 were injected i.d into the same 
site (delivered in the ear pinna as described in section 2.2.8). The animals 
were then assessed daily for 30 days. Blood parasitaemias were counted 
using the rapid matching method (Herbert and Lumsden 1976) which has a 
detection limit of 4x105 parasites/mL of blood (given as 5.4 on the Log10 scale). 
Parasitaemia values below this threshold were classified as undetectable 
(UD). Daily body weights were also recorded, and the specific spleen weight 
index was calculated on the day of culling at the end of the experiment.  
The onset of detectable parasitaemia, mean parasitaemia at peak, and 
incidence of relapses in parasitaemia did not significantly differ between the 
mice pre-treated with CSF1-Fc or PBS (Figure 6.2). The onset of detectable 
parasitaemia ranged from 5 d.p.i in PBS pre-treated mice and 5-6 d.p.i in 
CSF1-Fc pre-treated mice. The mean parasitaemia burdens at the peak of the 
first waves of parasitaemia were 6x106/mL (PBS) and 3x106/mL (CSF1-Fc) (P 
= 0.1984, Student’s t-test, n = 8). Following the initial wave of parasitaemia, 
4/8 PBS pre-treated mice and 3/8 CSF1-Fc pre-treated mice displayed 
relapses in their parasitaemias. The mean peak of parasitaemia during the 
second parasitaemia waves were 3x107/mL (PBS) and 5x106/mL (CSF1-Fc) 
(P = 0.26, Student’s t-test, n = 8). The PBS pre-treated mice exhibited infection 
profiles that were dissimilar to the 1x105 dose WT mouse infection profiles in 
Chapter 5 (Figure 5.5). This discrepancy may be due to the stochastic 
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variation in the inoculum dose that was administered. These data show that i.d 
CSF1-Fc treatment, prior to i.d T. brucei injection, has no effect on disease 
pathogenesis. This suggests that, although macrophage abundance increased 
locally in the skin dermis following CSF1-Fc treatment (section 6.3.1, Figure 
6.1), this did not affect their ability to control a subsequent i.d infection with T. 
brucei.  
 
Figure 6.2: Heatmap showing parasitaemia levels in mice injected i.d with 
PBS and CSF1-Fc before i.d infection with a 1x105 dose of T. brucei 
Heatmap showing the blood parasitaemia levels/mL of blood detected by microscopy 
in PBS and CSF1-Fc i.d pre-treated WT mice after being infected with a 1x105 dose 
of T. brucei STIB 247 parasites via the i.d infection route. Each row represents an 
individual mouse (M). The blood parasitaemia is displayed as the log10 number of 
trypanosomes/mL of blood (e.g. 5.4 = 4x105 trypanosomes/mL). UD = below detection 
limit of 5.4 log10 parasites/mL. n = 8 mice/infection group.  
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The i.d T. brucei infections in both PBS and CSF1-Fc pre-treated mice had an 
initial negative impact on body weight and coincided with the timing of the 
primary onset of parasitaemia in both mouse groups (Figures 6.2 and 6.3). 
The maximum decline in body weights in both groups was observed at 6 d.p.i, 
immediately following onset of the initial peak of parasitaemia, to a -4% (PBS) 
and -3% (CSF1) average body weight change (Figure 6.3). After the initial 
parasitaemia waves subsided, both groups of mice showed a gradual increase 
in body weight regardless of parasite burden. There was a significant 
difference in body weight changes over the 30-day infection period between 
mouse groups (P <0.01, linear mixed effects model, n = 8), as the PBS pre-
treated mice had a greater increase in body weight during the later stages of 
the infection. This suggests that i.d CSF1-Fc pre-treatment did not enhance 
the ability of the mice to control the T. brucei infection.  
The specific spleen weight index was determined by calculating the spleen 
weight (mg) per g of mouse body weight on the day of culling (Figure 6.4). 
This analysis showed that the spleen weight index of infected CSF1-Fc pre-
treated mice was not significantly different than the PBS pre-treated mice. This 
further suggests that i.d CSF1-Fc pre-treatment had no significant effect on T. 





Figure 6.3: Percentage changes in body weights in PBS and CSF1-Fc pre-
treated mice following i.d infection with a 1x105 dose of T. brucei 
Percentage body weight changes (relative to 0 d.p.i) of i.d PBS and CSF1-Fc pre-
treated mice over the 30-day observation period following i.d infection with 1x105 
trypanosomes. Data are shown as the mean ± SD for 8 mice/group. Linear mixed 
effect models were used to compare differences between PBS and CSF1-Fc pre-







Figure 6.4: Specific spleen weight index in PBS and CSF1-Fc pre-treated 
mice following i.d infection with a 1x105 dose of T. brucei 
Specific spleen weight indices (calculated as the spleen weight in mg/g of mouse body 
weight) in i.d PBS and CSF1-Fc pre-treated mice 30-days after i.d infection with 1x105 
trypanosomes. Data are shown as the mean ± SD for 8 mice/group. Student’s t-tests 




6.3.3 Local i.d LPS treatment does not increase the abundance of Csf1r+ 
phagocytes 
Next, the effects of local i.d LPS treatment on the abundance of macrophages 
in the skin was investigated. Groups of Csf1r-EGFP+ mice (sections 2.2.2 and 
6.3.1) were injected i.d with either LPS or PBS (negative control), as described 
in sections 2.2.9, and 2.5.5. Twenty four hours later the abundance of Csf1r-
EGFP+ cells (macrophages) in the dermis of the injection site was quantified 
microscopically (Figure 6.5). Following i.d treatment of Csf1r-EGFP+ mice with 
LPS, the number of EGFP+ cells observed in the dermis was not significantly 
different when compared to PBS-treated controls (Figure 6.5). This analysis 
indicated that i.d LPS treatment had no effect on the abundance of 




Figure 6.5: Enumeration of Csf1r-EGFP+ cells in the dermis of Csf1r-
EGFP+ mice following i.d treatment with LPS or PBS 
(A) Two photon whole-mount microscopy images of i.d LPS or PBS treated Csf1r-
EGFP+ ears. Images show Csf1r-EGFP+ cells (green) and collagen signal background 
(purple). Autofluorescent hair follicles are also shown in green. (B) Graph showing 
the number of EGFP+ cells identified in the ears of Csf1r-EGFP+ mice following i.d 
LPS or PBS treatment. Data are shown as the mean ± SD for each group of mice: 
LPS, n = 2; PBS, n = 3. Student’s t-tests were used to compare differences between 
PBS (control) and LPS treated groups.  
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6.3.4 Intradermal LPS treatment decreases susceptibility to i.d T. brucei 
infection 
Next, groups of C57BL/6J WT mice were injected i.d with LPS or PBS (control) 
and 24 hours later infected i.d with 1x105 T. brucei STIB 247 parasites 
(delivered in the ear pinna). The infection kinetics were then monitored for 30 
days, as described in sections 2.2.4 and 6.3.2. The experiment demonstrated 
that the infection kinetics were significantly different between the PBS and LPS 
injected mice. All of the PBS-treated mice had detectable parasitaemias, 
whereas only 5/8 LPS-treated mice did (Figure 6.6). The onset of detectable 
parasitaemia and mean parasitaemia at peak were also distinct between 
mouse groups. The onset of detectable parasitaemia ranged from 4-5 d.p.i in 
PBS pre-treated mice, but 4-5 d.p.i in 4/8 and 18 d.p.i in 1/8 of the LPS pre-
treated mice. The mean parasitaemia burdens at the peak of the first waves of 
parasitaemia were significantly different between the PBS (6x106/mL) and LPS 
(8x105/mL) pre-treated mouse groups (P = 0.0365, Student’s t-test, n = 8). 
These data show that i.d LPS treatment, prior to i.d T. brucei injection, had a 
significant influence on disease susceptibility and pathogenesis. This implied 
that, although macrophage abundance did not increase following i.d LPS 
treatment (section 6.3.3, Figure 6.5), their ability to control the T. brucei 





Figure 6.6: Heatmap showing parasitaemia levels in PBS and LPS pre-
treated mice administered a 1x105 dose of T. brucei 
Heatmap showing the blood parasitaemia levels/mL of blood detected by microscopy 
in PBS and LPS i.d pre-treated WT mice after being infected with a 1x105 dose of T. 
brucei STIB 247 parasites via the i.d infection route. Each row represents an individual 
mouse (M). The blood parasitaemia is displayed as the log10 number of 
trypanosomes/mL of blood (e.g. 5.4 = 4x105 trypanosomes/mL). UD = below detection 
limit of 5.4 log10 parasites/mL. n = 8 mice/infection group.  
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The body weights following i.d T. brucei infections in both PBS and LPS pre-
treated mice steadily increased until the primary onset of parasitaemia in both 
mouse groups. These then decreased slightly, before steadily increasing for 
the remainder of the observation period (Figures 6.6 and 6.7). The mean body 
weights in both mouse groups remained within positive percentage changes 
throughout the 30-day observation period. However, differences in body 
weight changes over the 30-day infection period were statistically significant 
between mouse groups (P <0.01, linear mixed effects model, n = 8), as the 
LPS pre-treated mice had a greater increase in body weight during the 30-day 
observation period. This suggests that the LPS pre-treatment enabled the mice 
to more effectively control the T. brucei infection. 
The spleen weight indices were not significantly different between i.d pre-





Figure 6.7: Percentage changes in body weights in PBS and LPS pre-
treated mice following i.d infection with a 1x105 dose of T. brucei 
Percentage body weight changes (relative to 0 d.p.i) of i.d PBS and LPS pre-treated 
mice over the 30-day observation period following i.d infection with 1x105 
trypanosomes. Data are shown as the mean ± SD for 8 mice/group. Linear mixed 





Figure 6.8: Specific spleen weight index in PBS and LPS pre-treated mice 
following i.d infection with a 1x105 dose of T. brucei 
Specific spleen weight indices (calculated as the spleen weight in mg/g of mouse body 
weight) in i.d PBS and LPS pre-treated mice 30-days after i.d infection with 1x105 
trypanosomes. Data are shown as the mean ± SD for 8 mice/group. Student’s t-tests 
were used to compare differences between PBS and LPS pre-treated mice.  
 
 
6.3.5 The in vitro ability of macrophage-like RAW264.7 cells to kill T. 
brucei is enhanced by LPS treatment 
Data above (Figures 6.6 and 6.7) implied that i.d LPS treatment enhanced the 
ability of dermal macrophages to control an i.d T. brucei infection. An in vitro 
system was therefore used to explore this further. The hypothesis was tested 
that the in vitro treatment of RAW264.7 cells (murine macrophage-like cells) 
with LPS would similarly enhance their ability to kill T. brucei. Cultures of 
RAW264.7 cells were treated with either LPS or PBS (control). A parallel set 
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of wells received LPS or PBS in parasite growth media alone as a further set 
of negative controls. T. brucei were then added (1x106/well) and the number 
of viable trypanosomes were counted 24 hours later. Experiments showed that 
the number of viable trypanosomes was significantly reduced in the co-cultures 
which contained LPS-treated RAW264.7 cells than in the RAW264.7 cell-free 
media control wells, when compared with trypanosomes grown in media 
without RAW264.7 cells or LPS (negative control) (Figure 6.9). 
 
 
Figure 6.9: Effect of in vitro LPS treated RAW264.7 cells on trypanosome 
viability 
Trypanosome viability following co-culture with LPS treated RAW264.7 cells. 
RAW264.7 cells (1x105/1 mL well) were incubated in medium containing either LPS 
or PBS. Wells containing growth medium and either LPS or PBS were also incubated 
as negative controls. Viable T. brucei STIB 247 (1x106/1 mL well) were also added to 
each well, and the number of viable trypanosomes determined 24 hours later. Data 
are shown as the mean ± SD for 9 wells/group. Tukey’s multiple comparisons tests 
were used to compare different between groups. All experiments were repeated three 
times on different days.  
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6.3.6 In vitro LPS treatment enhances the production of NO by 
macrophage-like RAW264.7 cells 
Next, supernatants were collected from each of the wells from the above in 
vitro assays (section 6.3.5) and Griess assays used to compare their nitrite 
concentrations (a stable metabolite of NO), as described in section 2.3.8. In 
some cultures L-NMMA was added to block NO production. Since NO is 
produced from the substrate L-arginine by the iNOS enzyme (Satriano 2004, 
Kopincová, Púzserová et al. 2011, Hwang, Kwon et al. 2017), treatment with 
the L-arginine inhibitor L-NMMA can specifically block NO production (Víteček, 
Lojek et al. 2012, Davila-Gonzalez, Choi et al. 2018).  This analysis showed 
that the nitrite concentrations in the wells of LPS-treated RAW264.7 cells was 
significantly greater than that detected in the wells of unstimulated controls 
(Figure 6.10). This indicated that LPS-treated macrophage-like cells produced 
significant amounts of NO. As anticipated, the addition of L-NMMA to the LPS-







Figure 6.10: Effect of in vitro LPS treatment on NO production by 
macrophage-like RAW264.7 cells  
Griess assays were used to determine the nitrite concentrations in the supernatants 
of the cultures of LPS-treated RAW264.7 cells in Figure 6.9. Some cultures were 
treated with the specific L-arginine inhibitor L-NMMA to inhibit NO production. Data 
are shown as the mean ± SD for 24 wells/group. Tukey’s multiple comparisons tests 
were used to compare different between groups. All experiments were repeated three 
times on different days.  
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6.3.7 The ability of LPS-treated RAW264.7 cells to kill T. brucei is 
inhibited in the absence of NO production 
Data above show that the LPS-treated macrophage-like RAW264.7 cells 
produced significant amounts of NO (Section 6.3.6). Next, an in vitro system 
was used to test the hypothesis that LPS treatment stimulates macrophages 
to produce NO and to kill T. brucei. Macrophage-like RAW264.7 cells were 
treated with either LPS or PBS (control) as above (Section 6.3.5), but in some 
cultures L-NMMA was also added to specifically block NO production. 
Experiments showed that the ability of LPS-treated RAW264.7 cells to kill T. 
brucei was significantly reduced when L-NMMA was added to the cultures to 
block NO production (Figure 6.11a). The growth of the trypanosomes was 
unaffected when cultivated in cell-free media containing PBS, LPS or L-NMMA 
alone (Figure 6.11b). These data suggested that the ability of LPS stimulated 
RAW264.7 macrophage cells to kill T. brucei in vitro was mediated in part by 
NO. This implied that the effects of i.d LPS treatment on the susceptibility to 
i.d infection with T. brucei may also be similarly mediated through the 





Figure 6.11: The ability of LPS-treated RAW264.7 cells to kill T. brucei is 
inhibited in the absence of NO production 
Trypanosome viability following co-culture with LPS treated RAW264.7 cells, with or 
without iNOS inhibition. (A) RAW264.7 cells (1x105/1 mL well) were incubated in 
medium containing either LPS or PBS, and with or without L-NMMA iNOS inhibitor. 
Wells containing growth medium and either LPS or PBS were also incubated as 
negative controls. Viable T. brucei STIB 247 (1x106/1 mL well) were also added to 
each well, and the number of viable trypanosomes determined 24 hours later. Data 
are shown as the mean ± SD for 9 wells/group. (B) Trypanosomes (1x106/ 1 mL well) 
were incubated in growth media, with or without different concentrations of iNOS 
inhibitor L-NMMA. The number of viable trypanosomes were determined 24 hours 
later. Data are shown as the mean ± SD for 6 wells/group. Tukey’s multiple 
comparisons tests were used to compare different between groups. All experiments 




This chapter investigated whether alterations to macrophage abundance or 
activation state in the skin would influence susceptibility to i.d infection with T. 
brucei.  
Data presented in this chapter confirmed that local CSF1-Fc treatment 
significantly increased the abundance of macrophages in the skin, consistent 
with data from previous studies showing the effects of CSF1 stimulation in a 
variety of different tissues (Jones and Ricardo 2013, Gow, Sauter et al. 2014, 
Louis, Cook et al. 2015, Sauter, Waddell et al. 2016, Wang, Bugatti et al. 2016, 
Pridans, Sauter et al. 2018, Sehgal, Donaldson et al. 2018). However, the 
increased abundance of skin-resident macrophages following CSF1-Fc 
treatment did not influence the duration or pattern of i.d T. brucei infection in 
WT mice. Several studies of the effects of CSF1 treatment on macrophages 
have shown that this cytokine induces the polarisation of macrophage towards 
an alternatively activated suppressor phenotype (Hume and MacDonald 2012, 
Jones and Ricardo 2013, Hamilton, Zhao et al. 2014, Boulakirba, Pfeifer et al. 
2018). These alternatively activated macrophages are promoted via IL-4, IL-
13, and CSF1 cytokines in vivo and induce type 2 immune responses involving 
the anti-inflammatory cytokines IL-10 and tumour growth factor-β (TGF-β). 
These act to dampen pro-inflammatory host responses against pathogens 
(Gordon 2003, Sica and Mantovani 2012, Jones and Ricardo 2013, Hamilton, 
Zhao et al. 2014, Martinez and Gordon 2014).  
Alternatively activated macrophages have been implicated in immune-
tolerance, immune downregulation and wound healing (Gratchev, 
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Schledzewski et al. 2001, Ferrante and Leibovich 2012). A study has shown 
that blocking CSF1R signalling during hepatocellular carcinoma lead to an 
increase in cytotoxic CD8+ T cells which reduced tumour growth, through 
altering the polarisation of macrophages to more classically activated and pro-
inflammatory states (Ao, Zhu et al. 2017). These anti-inflammatory 
macrophages have also been implicated in inducing parasite killing, immune 
regulation through lymphocyte suppression, and causing fibrosis, in a number 
of different chronic infections (Noël, Raes et al. 2004, Wilson and Wynn 2009, 
Jenkins and Allen 2010, Jenkins, Ruckerl et al. 2013). During Schistosoma 
mansonia and S. japonicum infections, parasite antigens skew macrophage 
polarisation towards different alternative activated phenotypes which fluctuate 
between promoting and regulating fibrosis, allowing chronic infections to be 
established in the host (Vannella, Barron et al. 2014, Zhu, Xu et al. 2014). 
These alternatively activated macrophages do not produce NO which is 
cytotoxic to schistosome parasites in vitro but not in vivo (Coulson, Smythies 
et al. 1998). In fact, CSF1R signalling has been shown to specifically inhibit 
iNOS enzyme activity, thus reducing cytotoxic NO production, instead 
favouring arginase enzyme activity in macrophages (Caescu, Guo et al. 2015). 
Arginase competes with iNOS for the substrate L-arginine to produce ornithine 
and urea instead of NO and citrulline (Rath, Müller et al. 2014). 
During early-stage T. brucei and T. congolense infections, classically activated 
pro-inflammatory macrophages control the initial parasitaemia via their 
production of NO (Stijlemans, De Baetselier et al. 2018) and increasing IFN-γ 
production by NK and NKT cells (Baral 2010). Anti-inflammatory IL-10 
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responses have been shown to be highly produced during late-stage and 
chronic African trypanosomiasis in both humans and animals (MacLean, Odiit 
et al. 2001, MacLean, Chisi et al. 2004, Kato, Matovu et al. 2016, Stijlemans, 
De Baetselier et al. 2018), and this can help to control the anaemia in 
trypanotolerant animals (Stijlemans, De Baetselier et al. 2018). A study of T. 
congolense infection in mice showed that resistant C57BL/6 mice produced a 
predominantly type 1 cytokine response involving increased NO and IFN-γ 
production. In contrast, susceptible BALB/c mice produced a mixed type 1 and 
2 cytokine response, during the early stages of infection (Uzonna, Kaushik et 
al. 1999, Noël, Hassanzadeh et al. 2002). Resistant C57BL/6 mice develop 
type 2 cytokine responses during the later stages of infection, highlighting a 
role for alternatively activated macrophages and reduced pro-inflammatory 
responses in protective immunity (Noël, Hassanzadeh et al. 2002). Therefore, 
data in this chapter showed that stimulating CSF1R signalling prior to T. brucei 
infection, increased the abundance of macrophages in the skin, but did not 
reduce the susceptibility to infection. It is plausible that CSF1 treatment 
induced an anti-inflammatory alternatively activated macrophage phenotype, 
inhibiting their potential to produce NO and IFN-γ which have been shown to 
be crucial in controlling African trypanosome infections during the early stages 
of disease.  
Further data in this chapter showed that local i.d treatment of WT mice with 
LPS significantly reduced their susceptibility to i.d T. brucei infection. In vitro 
experiments confirmed that macrophages have increased activation following 
LPS treatment, demonstrated by increased nitrite concentrations (indication of 
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NO production), and induced significant reductions in T. brucei growth in vitro. 
Reductions in trypanosome numbers from the initial starting well culture 
concentrations were observed universally in Figure 6.9. This may have been 
due to the parasite populations crashing after 24 hours. However, the LPS-
treated RAW264.7 cells did have a significant reduction in the number of viable 
trypanosomes when compared with the trypanosome-only wells, while the 
untreated RAW264.7 cells did not. These effects were significantly inhibited 
when the cells were treated with the iNOS inhibitor L-NMMA, confirming the 
role of NO in this cytotoxic response. As discussed in section 6.2, LPS 
interacts with TLR4 and stimulates the L-arginine pathway signalling in 
macrophages which stimulates the expression of the iNOS enzyme and the 
production of cytotoxic NO (Satriano 2004, Kopincová, Púzserová et al. 2011, 
Rajaiah, Perkins et al. 2013, Sheikh, Dickensheets et al. 2014, 
Plociennikowska, Hromada-Judycka et al. 2015, Salim, Sershen et al. 2016, 
Hwang, Kwon et al. 2017). Data in this chapter confirmed that upon LPS 
stimulation in vitro, macrophage-like RAW264.7 cells produced significant 
amounts of NO and induce significant killing of trypanosomes. Several studies 
have also highlighted that NO can possess strong cytotoxic effects against 
trypanosomes (Vincendeau, Daulouede et al. 1992, Gobert, Semballa et al. 
1998, Hertz, Filutowicz et al. 1998, Gobert, Daulouede et al. 2000, Sternberg 
2004, Magez, Radwanska et al. 2006, Vincendeau and Bouteille 2006, Magez, 
Radwanska et al. 2007, Namangala 2012, Stijlemans, Caljon et al. 2016). 
These effects were similarly reversed when NO synthesis was inhibited by 
treatment with L-NMMA (Vincendeau, Daulouede et al. 1992). It has been 
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shown that T. brucei releases a factor (Kinesin heavy chain isoform, TbKHC1) 
which actively induces IL-10 production and arginase activity, resulting in 
decreased NO production (De Muylder, Daulouède et al. 2013). Infection 
studies of mice with mutant trypanosomes that lack TbKHC1 observed a 
reduction in patent parasitaemia and enhanced survival of the host (De 
Muylder, Daulouède et al. 2013). This suggests that trypanosomes utilise 
TbKHC1 to manipulate the host cell metabolism through biasing the L-arginine 
pathway towards arginase enzyme activity, skewing the host towards a type 2 
immune response and reducing NO production.  
During the early stages of trypanosome infections in both mice and cattle, a 
strong pro-inflammatory macrophage response is induced involving 
substantial NO production (MacLean, Odiit et al. 1999, Taylor and Mertens 
1999, Uzonna, Kaushik et al. 1999, Mansfield and Paulnock 2005, Baral 2010, 
Ponte-Sucre 2016, Bakari, Ofori et al. 2017), which is required for efficient 
control of the early parasitaemia peak (Stijlemans, Caljon et al. 2016). These 
observations support the data presented in this chapter which showed that 
LPS stimulation in the skin of mice prior to T. brucei injection, reduced their 
susceptibility to i.d infection. LPS may have stimulated classically activated 
macrophages in the skin towards inducing a pro-inflammatory cytokine and 
NO response to reduce T. brucei numbers at the initial injection site.  
However, it has been shown that the large amounts of NO induced in response 
to T. brucei infection can induce the suppression of T cells both in vitro and in 
vivo (Sternberg and McGuigan 1992, Schleifer and Mansfield 1993, Mabbott 
and Sternberg 1995, Mabbott, Sutherland et al. 1995, Sternberg and Mabbott 
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1996, Mabbott, Coulson et al. 1998, Millar, Sternberg et al. 1999). This resulted 
in decreased splenic CD4+ T cell proliferation and activation, and reduced type 
1 cytokine responses required to control parasitaemia once the adaptive 
immune response takes effect, leading to parasite survival. (Sternberg and 
McGuigan 1992, Sternberg and Mabbott 1996, Millar, Sternberg et al. 1999). 
When iNOS activity, and therefore NO production, was inhibited or completely 
absent in deficient mice this lymphocyte suppression was inhibited (Sternberg 
and McGuigan 1992, Mabbott, Coulson et al. 1998, Millar, Sternberg et al. 
1999). It has also been shown that NO has no effect against bloodstream form 
trypanosomes in vivo as NO can readily bind to haemoglobin in the 
bloodstream with high affinity (Mabbott, Sutherland et al. 1994, Sternberg, 
Mabbott et al. 1994, Mabbott and Sternberg 1995). In addition, NO produced 
from classically activated macrophages has also been shown to induce a 
decrease in iron from vital trypanosome enzymes (Vincendeau and Daulouede 
1991). Therefore, although data suggest that NO is inefficient at killing 
trypanosomes in the bloodstream, during the early skin stage of the infection 
within the extravascular spaces, NO may be highly trypanolytic allowing for 
effective inhibition of parasite growth.  
Therefore, the data in this chapter suggests that LPS stimulation in the host’s 
skin leads to the early activation of the local dermal macrophages and 
production of NO. As a consequence, these classically activated dermal 
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7.1 T. brucei parasites journey from the skin to the lymphatics after 
i.d infection 
The parasitic life cycle of African trypanosomes within the mammalian host 
begins in the skin after the i.d injection of metacyclic trypomastigotes by the 
tsetse fly vector. The parasites then invade the lymphatic system to achieve 
systemic dissemination (Emery, Barry et al. 1980, Theis and Bolton 1980, 
Barry and Emergy 1984, Tabel, Wei et al. 2013, Caljon, Van Reet et al. 2016, 
Alfituri, Ajibola et al. 2018). Data in Chapter 3 of this thesis show that African 
trypanosomes do not use host-derived chemokines as chemical cues for 
invasion of lymphatic vessels in the skin. This suggests that trypanosomes use 
alternative cues to reach the lymphatics.  
Section 3.4 outlined possible mechanisms of lymphatic invasion from the skin. 
It is plausible that trypanosome entry into the lymphatics may be driven by 
hydrostatic pressure, protein gradients, or the sensing of lymph flow (Casley-
Smith 1985, Schmid-Schonbein 1990, Baluk, Fuxe et al. 2007, Tal, Lim et al. 
2011, Yao, Baluk et al. 2012, Wang and Simons 2014). These may direct 
trypanosomes towards open junctions in the lymphatic epithelium, as has been 
shown for the lymphatic invasion of certain lymphocytes (Randolph, Angeli et 
al. 2005, Dadiani, Kalchenko et al. 2006, Tal, Lim et al. 2011). Infections in 
mice via tsetse fly bites have shown that T. brucei parasites that were adjacent 
to lymphatic vessels displayed directional movement towards or away from 
these vessels (Alfituri, Ajibola et al. 2018). It was also found that trypanosomes 
within the lymphatic vessels displayed significantly greater speed than extra-
lymphatic parasites. The trypanosomes were not observed interacting with 
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blood vessels, suggesting they may have specific tropism for the mammalian 
host’s lymphatic vessels (Alfituri, Ajibola et al. 2018). Dendritic cells have been 
shown to respond to gradients of CCL19 and CCL21 chemokines expressed 
in the lymphatic vessels (Russo, Teijeira et al. 2016), allowing them to enter 
the lymphatics in the skin (Weber, Hauschild et al. 2013). Another study has 
suggested that gradients of the chemokine CXCL12 are crucial for the initiation 
of dendritic cell responses in the skin (Kabashima, Shiraishi et al. 2007). 
Toxoplasma gondii parasites have been shown to extracellularly migrate 
across the lymphatic epithelium, and have also been implicated in “hijacking” 
dendritic cells to gain passage across the lymphatic epithelium while in an 
intracellular state (Harker, Ueno et al. 2014). However, data in Chapter 3 of 
this thesis showed that African trypanosomes do not respond to host-derived 
chemokines that are known to be expressed in the skin, nor do they appear to 
express any homologues of known host chemokine receptors. As African 
trypanosomes possess chemosensory capabilities through the flagellum and 
flagellar pocket (Ralston, Kabututu et al. 2009), it is plausible that they use 
these features to respond to chemical gradients within the host to reach the 
lymphatics from the skin. 
Nematode worms, including Caenorhabditis elegans, Strongyloides stercoralis 
and S. ratti, Heterorhabditis bacteriophora, and various Steinernema species 
have been shown to respond to chemicals such as O2 and CO2 concentrations, 
salt levels, pheromones, and alcohol, in a chemotactic manner (Chaisson and 
Hallem 2012, Dillman, Guillermin et al. 2012). Similar mechanisms have been 
highlighted in zoospores of the parasitic fungal pathogen Batrachochytrium 
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dendrobatidis (Moss, Reddy et al. 2008). Certain parasites have also been 
shown to express homologues of host chemokines, and manipulate immune 
responses within the host (Miska, Kim et al. 2013, Sommerville, Richardson et 
al. 2013). Glucose is crucial for the metabolism of African trypanosomes within 
the mammalian host (Creek, Mazet et al. 2015), and glucose concentrations 
have been shown to be higher in the lymph than the blood in dogs (Hendrix 
and Sweet 1917), therefore glucose could be a plausible candidate as a 
chemical chemoattractant for trypanosomes.  
Invasion of the brain and central nervous system by trypanosomes has been 
widely researched. The role of trypanosomes in causing neurological 
abnormalities and sleeping sickness in HAT patients has been a widely known 
occurrence for decades (Kennedy 2013). The mechanisms of how the 
parasites invade the CNS remains an important area of research. In rodent 
models of early brain infection by T. brucei, the parasites were observed 
passing through the blood-brain-barrier (BBB) and were present in the choroid 
plexus stroma and spinal ganglia (Mogk, Meiwes et al. , Rodgers 2010, 
Rodgers, Bradley et al. 2017). Data also showed that in mice infected with T. 
b. brucei and T. b. rhodesiense the parasites invade the brain parenchyma 
within hours of infection (Frevert, Movila et al. 2012, Laperchia, Palomba et al. 
2016). The mechanism of by-passing the BBB occurs at the post-capillary 
venules involving similar events to those used by lymphocytes to cross these 
sites (Kristensson, Nygard et al. 2010). It has been reported that upon 
deposition into the host skin, the parasites then invade the lymphatic and blood 
vessels to reach the brain, where they migrate through the fenestrated vessels 
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into the choroid plexus and cerebrospinal fluid (Mogk, Meiwes et al. , 
Kristensson, Nygard et al. 2010). The trypanosomes then bypass the BBB 
through tight junctions and the permissible endothelial laminin α-4, then 
transmigrate through the parenchymal basement membrane in an IFN-γ-
dependent manner (Masocha, Robertson et al. 2004, Masocha, Rottenberg et 
al. 2007, Masocha and Kristensson 2012). It has also been noted that passing 
through the BBB results in no tight junction disruption, thus maintaining 
integrity and causing no cerebral damage (Rodgers 2010, Frevert, Movila et 
al. 2012). Trypanosomes can trigger Ca2+ fluctuations in brain 
microvasculature endothelial cells (Nikolskaia, de et al. 2006) and in heart 
cardiomyocytes (Elliott, McCarroll et al. 2013), and mammalian sperm 
chemotaxis is dependent on Ca2+ signalling (Eisenbach and Giojalas 2006). 
Thus, a similar mechanism could be involved in trypanosome invasion of the 
lymphatic vessels.  
 
7.2 The skin is an important overlooked stage of African 
trypanosome infection 
There has been evidence of trypanosomes residing and thriving in the skin 
(Caljon, Van Reet et al. 2016, Capewell, Cren-Travaille et al. 2016, Casas-
Sánchez and Acosta-Serrano 2016, Trindade, Rijo-Ferreira et al. 2016, 
Tanowitz, Scherer et al. 2017), recorded cases of asymptomatic patients with 
skin-dwelling parasites (Ezzedine, Darie et al. 2007), and the emergence of 
disease symptoms decades after infection (Sudarshi, Lawrence et al. 2014). 
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This suggests that skin infection is an important, overlooked, aspect of African 
trypanosomiasis. 
Data in Chapter 4 of this thesis showed that the widely experimentally used 
i.p infection route may not be representative of natural i.d infections. 
Intradermally infected mice displayed decreased susceptibility to T. brucei 
infection, especially after low dose infections, when compared to mice injected 
i.p. Wei, Bull et al. (2011) showed that resistance to i.d T. brucei and T. 
congolense infections in mice were 100-fold higher than mice infected via the 
i.p route. These observations are similar to the data presented in Chapter 4 of 
this thesis, which showed that mice infected with T. brucei by the i.d route 
displayed a 10-100-fold reduction in the mean peak parasitaemia than i.p 
infected mice, using different infectious doses. Wei, Bull et al. (2011) 
suggested that resistance to i.d infection was due to the induction of potent 
innate immune responses, such as NO and TNF-α production, and less to do 
with B cell responses. Mice deficient for iNOS and mice with TNF-α production 
blocked by antibody treatment were more susceptible to infection than WT 
mice, while B cell-deficient mice were not more susceptible. Their study also 
showed that C57BL/6 mice infected by the i.p route with 1x102 T. brucei strain 
10-26 parasites all displayed patent parasitaemia, while mice infected by the 
i.d route displayed no parasitaemia. These findings were also observed during 
infections of C57BL/6 mice with T. congolense clone TC13. When more 
susceptible BALB/c mice were infected with T. congolense clone TC13, all i.p 
infected mice developed patent parasitaemia following parasite doses of 
1x104-1x101. However, mice infected by the i.d route with 1x102 and 1x101 
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parasites showed no parasitaemia. Their data also showed that following 
infection with 1x104 or 1x103 parasites by the i.d route, there was a delay in 
the onset of parasitaemia by ≥2 days compared with the i.p infected mice. 
These data are similar to the data presented in Chapter 4 of this thesis. 
Therefore, important host-parasite interactions may be occurring in the skin 
that are missed during i.p or i.v infections.   
The effect of route and dose during other pathogen infections is well 
documented. Mice infected with Plasmodium spp. via the natural i.d and s.c 
routes have 30-fold reduced parasite load in the liver compared to those 
infected via the commonly studied i.v route (Nganou-Makamdop, Ploemen et 
al. 2012). The effect of infection route was further shown during live attenuated 
vaccine efficacy tests, showing that i.d injections results in impaired protection 
to re-infection in mice compared with i.v injections (Ploemen, Chakravarty et 
al. 2013, Parmar, Patel et al. 2016). The decreased protection to re-infection 
with the i.d vaccines was attributed to a lack of parasites emerging in the liver, 
in comparison with the numbers seen in the i.v infections. This was believed 
to be due to reduced antigen presence in the liver resulting in reduced 
protective CD8+ T cells responses (Parmar, Patel et al. 2016). This adds 
support for using more natural infection models during early vaccine trials. In 
experiments of bacterial Leptospira spp. infections, the i.p route is routinely 
used instead of natural mucosal, s.c and i.d routes (Zilber, Belli et al. 2016). It 
has been shown that disease pathogenesis is decreased in the natural route 
of infection when compared with the i.p route in rats (Zilber, Belli et al. 2016). 
In addition, unlike the findings from Chapter 4 in this thesis with T. brucei 
235 
 
infection, data from L. interrogans infected hamsters have shown a difference 
in disease pathogenesis between those infected by the s.c and i.d routes, with 
a lower infection burden in the i.d infected animals (Coutinho, Matsunaga et 
al. 2014). Prion infection studies have also shown that the disease 
pathogenesis and anatomical distribution of prion proteins within the host 
differs greatly between different routes of infection and many do not effectively 
represent what is observed during infections via the natural oral route 
(Langevin, Andreoletti et al. 2011, Mabbott 2017). Moreover, it has been 
suggested that the tsetse fly injects low parasite loads, with a minimum dose 
threshold of 300-450 metacylic parasites being required for successful 
infection in humans (Fairbairn and Burtt 1946). This implies that intradermal 
dose experiments using low doses of trypanosomes may be more 
representative of natural transmission. Thus, the differences in infection 
kinetics between routes and doses reported in this thesis highlight the 
importance of investigating infections using appropriate models which mimic 
the natural progression of disease.  
 
7.3 Systemic dissemination of T. brucei following i.d infection 
occurs independently of the draining lymph nodes 
Data in Chapter 5 of this thesis revealed that African trypanosomes do not 
need to invade the draining lymph nodes in order to disseminate to the 
bloodstream and systemically. The lymphatic system is involved in trafficking 
immune cells, proteins, waste, and interstitial fluid, within lymph which passes 
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through the right lymphatic and thoracic ducts before reaching the bloodstream 
(Reddy and Murthy 2002, Ikomi, Kawai et al. 2012, Margaris and Black 2012, 
Sevick-Muraca, Kwon et al. 2014). Intradermal infection of rats with Bartonella 
tribocorum showed that dissemination of the cell-free bacteria into the 
bloodstream occurred via lymph flow through the thoracic duct, occurring as 
soon as 2 hours post-injection (Hong, Li et al. 2017). Therefore, it is possible 
that African trypanosomes may similarly utilise the right lymphatic and/or 
thoracic ducts to invade the bloodstream of the host after infection into the 
dermal layer of the skin.  
 
7.4 Immunoglobulin class-switching is essential for 
controlling the parasitaemia following i.d T. brucei infection 
Protective immunity against African trypanosomes relies heavily on the actions 
of B cells and parasite-specific Ig (Campbell, Esser et al. 1977, Musoke, 
Nantulya et al. 1981, Dempsey and Mansfield 1983, Magez, Radwanska et al. 
2006, Vincendeau and Bouteille 2006, Magez, Schwegmann et al. 2008, Baral 
2010, Stijlemans, Radwanska et al. 2017), and specifically high antigen-affinity 
class-switched Ig (Shi, Wei et al. 2004, Magez, Schwegmann et al. 2008, 
Black, Guirnalda et al. 2010). Data in Chapter 5 of this thesis showed that 
abnormal B cell follicle formation results in an impaired ability to produce 
parasite-specific class-switched IgG immunoglobulins. These impairments 
coincided with significantly increased susceptibility to i.d T. brucei infection. 
However, when B cell follicle formation and Ig class-switching was restored in 
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deficient mice through bone-marrow transfer, the mice were able to control 
subsequent parasitaemia waves more efficiently. This effect correlated with 
the recovery of parasite-specific class-switched Ig production. Data in this 
chapter data suggested that high levels of non-class-switched IgM 
immunoglobulin was vital for the early control of the initial parasitaemia wave 
during infection, as has been recorded in other studies (Reinitz and Mansfield 
1990, Pan, Ogunremi et al. 2006, Vincendeau and Bouteille 2006). However, 
data also showed that production of trypanosome-specific class-switched IgG1 
and IgG3 was key to control T. brucei infection after the initial wave subsided 
in mice. Other studies have also shown that strong IgG1, IgG3, and IgG2a 
immunoglobulin responses are induced following substantial IgM production 
and the initial wave of parasitaemia during T. brucei and T. congolense i.p 
infections, highlighting their importance in controlling infection in mice 
(Uzonna, Kaushik et al. 1999, Magez, Stijlemans et al. 2002, Magez, 
Radwanska et al. 2006, Pan, Ogunremi et al. 2006, Magez, Schwegmann et 
al. 2008). In fact, susceptible BALB/c mice have been shown to lack detectable 
class-switched IgG3 and IgG2a immunoglobulins, whereas resistant C57BL/6 
mice strongly produced these isotypes (Uzonna, Kaushik et al. 1999). Similar 
findings were seen during T. congolense infections of resistant C57BL/6 and 
susceptible A/J mice (Morrison and Murray 1985). C57BL/6J mice used in the 
experiments presented in this thesis do not produce IgG2a (Zhang, 
Goldschmidt et al. 2012), therefore no IgG2a was observed. Studies of T. b. 
rhodesiense infected mice have shown that parasite-specific IgM is not 
important for survival (DeGee and Mansfield 1984), stressing the importance 
238 
 
of class-switched IgG immunoglobulins. Together, these data provide support 
for the importance of class-switched IgG immunoglobulins in controlling 
African trypanosome infections in the long-term in the mouse mammalian host. 
African trypanosomiasis is devastating for livestock in sub-Saharan Africa, 
especially for cattle (Holt, Selby et al. 2016, Muhanguzi, Mugenyi et al. 2017). 
Cattle infections with T. congolense have shown that trypanosusceptible Boran 
cattle produced significantly greater levels of cells producing parasite-specific 
non-class-switched IgM in comparison to trypanotolerant N’Dama cattle 
(Taylor, Lutje et al. 1996). N’Dama cattle had significantly greater levels of 
splenic cells producing parasite-specific class-switched IgG (Taylor, Lutje et 
al. 1996). In fact it has been shown that during T. brucei infections in cattle 
both trypanosome-specific IgM and IgG1 are highly produced to clear the initial 
wave of infection (Musoke, Nantulya et al. 1981). However, it was found that 
lower concentrations of IgG1 (4-8 µg) was required to effectively kill 
trypanosomes during the second peak of antibody induction, than the first 
wave (200 µg), due to enhanced recognition of trypanosome antigen following 
subsequent encounters with parasites (Musoke, Nantulya et al. 1981). African 
buffalo (Syncerus caffer) infected with T. congolense via tsetse fly bites were 
more tolerant to infection than susceptible Boran cattle, exhibiting a lack of skin 
swelling (chancre formations) and anaemia, which was accompanied by low 
patent parasitaemia and significantly earlier trypanosome-specific Ig 
production (Grootenhuis, Dwinger et al. 1990). These studies provide further 
examples of the importance of class-switched Ig activity in controlling bovine 
trypanosomiasis. The specific roles of IgG isotypes in human disease is 
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uncertain and more research into specific humoral responses of different 
species of host during trypanosomes infection is required. 
African trypanosomes are widely known to evade host immunity through 
antigenic variation of their VSG protein coat (Glover, Hutchinson et al. 2013, 
Horn 2014). However, the trypanosomes can induce B cell and antibody 
suppression to evade protective immunity (Corsini, Clayton et al. 1977, Magez, 
Schwegmann et al. 2008, Radwanska, Guirnalda et al. 2008, Bockstal, 
Guirnalda et al. 2011, Frenkel, Zhang et al. 2016, Stijlemans, Radwanska et 
al. 2017). This suppressive activity has been attributed to the induction of 
suppressive T cells, NK cells, and macrophages. Interestingly, this B cell 
suppression has been suggested to be less severe in human T. b. gambiense 
infections (Lejon, Mumba Ngoyi et al. 2014), and in cattle infections (Morrison 
1985), in comparison to what has been observed in murine models. Data from 
(Black, Guirnalda et al. 2010) have shown that during T. brucei AnTat 1.1E 
infection of C57BL/6 mice, B cell development in the bone-marrow is reduced 
10-fold by 15 d.p.i. Following infection with T. brucei AnTat 1.1E, C57BL/6 mice 
lose control of their parasitaemias after 30 d.p.i, and die by around 40 d.p.i. 
Data also showed that significant increases in B cell development in infected 
mouse spleens compensated for reduced B cell development in their bone-
marrow. Infections of mice in this thesis involved the STIB247 strain of T. 
brucei which may have impacted on B cell development differently than that 
observed during AnTat 1.1E infections. The loss of parasitaemia control was 
also observed in the AnTat 1.1E infection study beyond the 30 d.p.i 
observation period in this theses’ experiments. Perhaps if the infected mice 
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were monitored for longer, similar findings to (Black, Guirnalda et al. 2010) 
may have been observed. The B cell suppression and apoptosis displayed in 
various mouse models derived from the study of i.p infections which may have 
induced greater pathogenesis than that observed following i.d infection as 
demonstrated in Chapter 5 of this thesis. 
Therefore, data in this thesis and from the literature show that parasite-specific 
class-switched IgG immunoglobulins are important for the control of 
subsequent parasitaemia waves in the mammalian host. Non-class-switched 
IgM and innate immune mechanisms in contrast, provide protection during the 
initial stages of infection to help control the first parasitaemia wave. 
 
7.5 Dermal macrophages may be involved in the initial killing 
of T. brucei 
The dermis contains several different immune cell groups, including 
macrophages, dermal DCs, and T cells (Kupper and Fuhlbrigge 2004). The 
exact roles of these cells during trypanosome infection in the skin remains 
uncertain, yet there is significant evidence of macrophages being pivotal in 
killing trypanosomes in other body regions, such as through antibody-mediated 
phagocytosis by Kupffer cells in the liver (Shi, Wei et al. 2004). During early-
stage African trypanosome infections, classically activated pro-inflammatory 
macrophages are involved in the killing of trypanosomes (Grosskinsky and 
Askonas 1981, Fierer and Askonas 1982, Grosskinsky, Ezekowitz et al. 1983, 
Baetselier, Namangala et al. 2001, Paulnock and Coller 2001, Vincendeau and 
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Bouteille 2006, Baral 2010, Paulnock, Freeman et al. 2010, Stijlemans, 
Vankrunkelsven et al. 2010, de Sousa, Atouguia et al. 2011, Namangala 2012, 
Kuriakose, Singh et al. 2016, Stijlemans, De Baetselier et al. 2018). The type 
1 pro-inflammatory cytokine profile elicited during early trypanosome infection 
involving IFN-γ and TNF-α has been highlighted in mice and in monkeys 
(Maina, Ngotho et al. 2004). During trypanosome infection in cattle, 
trypanotolerant N’Dama cows display early increases in pro-inflammatory IFN-
γ, TNF-α, IL-1, and IL-12 cytokines, while susceptible Boran cattle expressed 
higher anti-inflammatory IL-10 and IL-6 cytokines (O'Gorman, Park et al. 
2006). This highlights the importance of a pro-inflammatory type 1 cytokine 
response in controlling the early-stages of trypanosome infections. Data in 
Chapter 6 of this thesis showed that local i.d treatment of WT mice with LPS 
significantly reduced their susceptibility to i.d T. brucei infection. This treatment 
increased the activation of classically activated macrophages and enhanced 
their ability to kill the trypanosomes in vitro via increased NO production.  
Trypanosomes induce NK, NKT, and T cells to produce high levels of IFN-γ 
(Baral 2010, Stijlemans, Caljon et al. 2016), and this can prime the 
macrophages to produce significant amounts of NO and TNF-α (Stijlemans, 
Caljon et al. 2016). These classically activated pro-inflammatory macrophages 
control the initial parasitaemia through induced NO production (Stijlemans, De 
Baetselier et al. 2018). During the early stages of infection, resistant mice 
produce strong type 1 cytokine responses, including IFN-γ and TNF-α, as well 
as NO, while susceptible mice produce a skewed mix of type 1and 2 cytokines 
responses, which also includes IL-10 (Uzonna, Kaushik et al. 1999, Noël, 
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Hassanzadeh et al. 2002). The strong capability to kill trypanosomes by NO 
and TNF-α is well established (Vincendeau, Daulouede et al. 1992, Magez, 
Lucas et al. 1993, Magez, Geuskens et al. 1997, Hertz, Filutowicz et al. 1998, 
Sternberg 2004, Magez, Radwanska et al. 2006, Barkhuizen, Magez et al. 
2007, Magez, Radwanska et al. 2007). Nitric oxide can readily bind to 
haemoglobin, and this may negatively influence its ability to kill the 
trypanosomes in the blood stream of the mammalian host due to interactions 
with red blood cells (Mabbott, Sutherland et al. 1994, Sternberg, Mabbott et al. 
1994, Mabbott and Sternberg 1995). However, NO may be effective in the 
extravascular spaces as NO can also remove iron from important trypanosome 
enzymes (Vincendeau and Daulouede 1991). Classically activated 
macrophages are activated through the expression of the iNOS enzyme, which 
catalyses the oxidation of the amino acid L-arginine producing NO and L-
citrulline (Satriano 2004, Stuehr 2004). Interestingly, it has been shown that T. 
brucei release a factor, Kinesin Heavy Chain isoform (TbKHC1) which actively 
increases IL-10 production and arginase activity. As a consequence NO 
production is significantly reduced (De Muylder, Daulouède et al. 2013). 
Consequentially, mice infected with trypanosome mutants which lacked 
TbKHC1 had reduced parasitaemia and increased survival periods (De 
Muylder, Daulouède et al. 2013). However, one study has suggested that the 
magnitude of the initial parasitaemia wave was heightened by TbKHC1 activity 
due to increased polyamine production, and reduced NO was associated with 
increased pathology during the later stages of infection (De Muylder, 
Daulouède et al. 2013).  
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Stimulation of the L-arginine pathway by LPS has been shown to produce 
increased NO secretion by macrophages, and inhibiting iNOS activity reversed 
NO-mediated killing of trypanosomes (Vincendeau, Daulouede et al. 1992). 
This is in agreement with the data presented in Chapter 6. It has also been 
shown that macrophage activation with LPS results in significant production of 
the superoxide anion (O2.-) (Pekarova, Lojek et al. 2011). Reactive oxygen 
species, including O2.-, have been shown to be involved in the anti-
trypanosomal activities of several effective treatments, such as 
dihydroquinoline derivative OSU-40 and gallic acid (Nose, Koide et al. 1998, 
Hoet, Opperdoes et al. 2004, He, Dayton et al. 2012). Whether the combined 
production of reactive nitrogen and oxygen species by classically activated 
macrophages may induce greater killing of trypanosomes in the skin remains 
to be determined.   
Production of the cytokine IFN-γ has been shown to be highly important in the 
early stages of trypanosome infections as deficiencies in IFN-γ increased 
disease susceptibility (Hertz, Filutowicz et al. 1998, Vincendeau and Bouteille 
2006, Barkhuizen, Magez et al. 2007, Baral 2010, Namangala 2012, Kato, 
Matovu et al. 2016, Ponte-Sucre 2016, Stijlemans, De Baetselier et al. 2018). 
The combination of IFN-γ and TNF-α cytokines polarises a strong type 1 
cytokine response in mesenchymal stromal cells (Jin, Zhao et al. 2016). The 
importance of IFN-γ has also been noted during human and primate African 
trypanosomiasis (Maina, Ngotho et al. 2004) It has been suggested that upon 
early trypanosome infection, classically activated macrophages produce TNF-
α which results in NK and NKT cells producing IFN-γ, which further activates 
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macrophages (Baral 2010, Cnops, De Trez et al. 2015). It has also been 
suggested that synthesis of class-switched IgG immunoglobulins can be 
enhanced by IFN-γ by stimulating B cell responses in both mice and humans 
(Leibson, Gefter et al. 1984, Kawano, Noma et al. 1994). This IFN-γ mediated 
response has been shown to induce optimal antibody-mediated protection 
against the bacterial Chlamydia species in mice (Naglak, Morrison et al. 2016).  
Data in Chapter 6 suggested that CSF1 treatment in the skin increased the 
abundance of dermal macrophages, but did not influence susceptibility to i.d 
T. brucei infection. It has been shown that CSF1 induces the polarisation of 
macrophages towards an alternatively activated suppressor phenotype, to 
promote wound healing, suppress inflammation, and dampen adaptive 
immunity (Hume and MacDonald 2012, Jones and Ricardo 2013, Hamilton, 
Zhao et al. 2014, Boulakirba, Pfeifer et al. 2018). There is evidence of 
immunosuppression of immune cells developing during trypanosome 
infections (Mabbott, Sutherland et al. 1995, Vincendeau and Bouteille 2006, 
Tabel, Wei et al. 2013). For example, after the onset of the initial parasitaemia 
wave, trypanosome suppression immunomodulating factor (TSIF) induces the 
activation of suppressor macrophages leading to impaired B and T cell 
responses (Gomez-Rodriguez, Stijlemans et al. 2009, Stijlemans, Caljon et al. 
2016). During the later stages of African trypanosome infections, the anti-
inflammatory cytokine IL-10 is produced in mice, cattle, and monkeys 
(MacLean, Odiit et al. 2001, MacLean, Chisi et al. 2004, Maina, Ngotho et al. 
2004, O'Gorman, Park et al. 2006, Kato, Matovu et al. 2016, Stijlemans, De 
Baetselier et al. 2018). Expression of IL-10 leads to inhibition of IFN-γ induced 
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classically activated macrophage activity which has been shown to result in 
long-term survival of mice infected with T. brucei (Namangala, Noel et al. 2001, 
Guilliams, Movahedi et al. 2009, Bosschaerts, Guilliams et al. 2010). It has 
been shown in mice that T. brucei infection, NK cells cause active B cell 
depletion due to parasite-driven overstimulation of IFN-γ (Cnops, De Trez et 
al. 2015, Cnops, De Trez et al. 2015, Frenkel, Zhang et al. 2016). IFN-γ can 
actively inhibit B cell activation and immunoglobulin production (Reynolds, 
Boom et al. 1987). Expansion of regulatory T cell (Tregs) and alternatively 
activated macrophages have also been implicated with increased resistance 
to trypanosome infection in i.p infected mice (Guilliams, Bosschaerts et al. 
2008). In contrast, researchers have shown that recurrent low dose i.d 
trypanosome infections in mice enhanced susceptibility to infection by inducing 
local skin immunosuppression (Tabel, Wei et al. 2013), perhaps through 
increased Treg numbers (Onyilagha, Okwor et al. 2014). This heightened 
susceptibility caused by Treg induction was observed in both i.d infected 
C57BL/6 and BALB/c mice (Okwor, Onyilagha et al. 2012). Studies have 
suggested that during i.d trypanosome infection, a combined induction of 
mixed classical/alternative macrophage and suppressor T cell activation 
results in local immunosuppression in the skin (Tabel, Wei et al. 
2013).Therefore, the immunological processes occurring during natural i.d 





Data in this thesis has helped to enhance our understanding of the 
pathogenesis of i.d T. brucei infections. Most experimental infections of African 
trypanosomiasis have used i.p or i.v routes of injection, but these do not 
represent the natural i.d transmission route. Upon deposition into the dermal 
layer of skin in the mammalian host, African trypanosomes invade the 
lymphatics through unknown mechanisms, before disseminating systemically 
via the main lymphatic ducts independently of draining lymph nodes. The early 
immune response to infection relies on potent type 1 cytokine responses and 
toxic mediators like NO which are induced by classically activated dermal 
macrophages, and parasite-specific non-class-switched IgM immunoglobulins. 
After the initial parasitaemia wave, the production of parasite-specific class-
switched IgG isotypes is crucial for the subsequent control of the infection. A 
proposed mechanism of i.d T. brucei pathogenesis is presented in Figure 7.1. 
Future studies of i.d African trypanosome infections may help to develop novel 






Figure 7.1: Model for trypanosome pathogenesis via the skin 
(A) Early immune response to African trypanosomes infection. Feeding tsetse flies 
inject trypanosomes into the dermal layer of skin of the mammalian host. Dermal 
macrophages, NK, NKT cells respond to trypanosome PAMPs. Macrophages 
produce TNF-α and induce IFN-γ production by NK, NKT and T cells. Classically 
activated macrophages induce iNOS enzymatic activity on L-arginine to produce 
trypanotoxic NO and TNF-α to kill trypanosomes in the skin. Non-class-switched B 
cells produce substantial IgM immunoglobulin against trypanosomes. (B) From the 
dermis the trypanosomes migrate towards lymph vessels in the skin, via an unknown 
mechanism. Trypanosomes may crawl along lymph vessels, access open junctions, 
and are drawn into the lymphatics through lymph flow force and pressure. Systemic 
dissemination is reached via the main lymphatic ducts. (C) Immune response after 
the initial wave of parasitaemia. Effector innate cells maintain strong pro-inflammatory 
cytokine and NO responses within tissues. B cells undergo Ig isotype class-switching 
within the germinal centres of B cell follicles in lymphoid tissues, and produce potent 
parasite-specific IgG to induce significant killing of trypanosomes. (D) 
Immunosuppression can occur, resulting in chronic infection. Alternatively activated 
macrophages induce arginase enzymatic activity on L-arginine to produce L-ornithine 
and urea, and reduce NO production. Suppressor macrophage, NK, and T cells 
produce anti-inflammatory IL-10 further decreasing NO production as well as IFN-γ 
activity. This results in chronic infections. caMac, classically activated macrophage; 









Abbas, A., A. H. Lichtman, S. Pillai, D. L. Baker and A. Baker (2018). 
"Cellular and Molecular Immunology " Elsevier 9th Edition. 
Abdeladhim, M., S. Kamhawi and J. G. Valenzuela (2014). "What’s behind a 
sand fly bite? The profound effect of sand fly saliva on host hemostasis, 
inflammation and immunity." Infection, Genetics and Evolution 
28(Supplement C): 691-703. 
Adams, A. R. D. (1936). "Trypanosomiasis of Stock in Mauritius." Annals of 
Tropical Medicine & Parasitology 30(4): 521-531. 
Adamu, M., C. O. Nwosu and R. I. S. Agbede (2009). "Anti-trypanosomal 
effects of aqueous extract of Ocimum gratissimum (Lamiaceae) leaf in rats 
infected with Trypanosoma brucei brucei." African Journal of Traditional, 
Complementary and Alternative Medicines 6(3): 262-267. 
Aihara, E., C. Closson, A. L. Matthis, M. A. Schumacher, A. C. Engevik, Y. 
Zavros, K. M. Ottemann and M. H. Montrose (2014). "Motility and chemotaxis 
mediate the preferential colonization of gastric injury sites by Helicobacter 
pylori." PLOS Pathogens 10(7): e1004275. 
Akira, S., S. Uematsu and O. Takeuchi (2006). "Pathogen recognition and 
innate immunity." Cell 124(4): 783-801. 
Akol, G. W. and M. Murray (1982). "Early events following challenge of cattle 
with tsetse infected with Trypanosoma congolense: development of the local 
skin reaction." Vet Rec 110(13): 295-302. 
Aksoy, S., P. Buscher, M. Lehane, P. Solano and J. Van Den Abbeele 
(2017). "Human African trypanosomiasis control: Achievements and 
challenges." PLOS Neglected Tropical Diseases 11(4): e0005454. 
Aksoy, S., B. L. Weiss and G. M. Attardo (2014). "Trypanosome 
Transmission Dynamics in Tsetse." Current opinion in insect science 3: 43-
49. 
Alfituri, O. A., O. Ajibola, J. M. Brewer, P. Garside, R. A. Benson, T. Peel, L. 
J. Morrison and N. A. Mabbott (2018). "Effects of host-derived chemokines 
on the motility and viability of Trypanosoma brucei." Parasite Immunology: 
e12609. 
Alimzhanov, M. B., D. V. Kuprash, M. H. Kosco-Vilbois, A. Luz, R. L. 
Turetskaya, A. Tarakhovsky, K. Rajewsky, S. A. Nedospasov and K. Pfeffer 
(1997). "Abnormal development of secondary lymphoid tissues in 
lymphotoxin beta-deficient mice." Proc Natl Acad Sci U S A 94(17): 9302-
9307. 
Allen, S. J., S. E. Crown and T. M. Handel (2007). "Chemokine: receptor 
structure, interactions, and antagonism." Annu Rev Immunol 25: 787-820. 
Ao, J. Y., X. D. Zhu, Z. T. Chai, H. Cai, Y. Y. Zhang, K. Z. Zhang, L. Q. Kong, 
N. Zhang, B. G. Ye, D. N. Ma and H. C. Sun (2017). "Colony-Stimulating 
Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the 
Polarization of Tumor-Associated Macrophages in Hepatocellular 
Carcinoma." Molecular Cancer Therapy 16(8): 1544-1554. 
250 
 
Arango Duque, G. and A. Descoteaux (2014). "Macrophage Cytokines: 
Involvement in Immunity and Infectious Diseases." Frontiers in Immunology 
5(491): 1-12. 
Auty, H., L. J. Morrison, S. J. Torr and J. Lord (2016). "Transmission 
Dynamics of Rhodesian Sleeping Sickness at the Interface of Wildlife and 
Livestock Areas." Trends in Parasitology 32(8): 608-621. 
Awuoche, E. O. (2012). "Tsetse fly saliva: Could it be useful in fly infection 
when feeding in chronically aparasitemic mammalian hosts." Open 
Veterinary Journal 2(1): 95-105. 
Baetselier, P. D., B. Namangala, W. Noel, L. Brys, E. Pays and A. Beschin 
(2001). "Alternative versus classical macrophage activation during 
experimental African trypanosomosis." International Journal of Parasitology 
31(5-6): 575-587. 
Bakari, S. M., J. A. Ofori, K. A. Kusi, G. K. Aning, G. A. Awandare, M. 
Carrington and T. M. Gwira (2017). "Serum biochemical parameters and 
cytokine profiles associated with natural African trypanosome infections in 
cattle." Parasites and Vectors 10: 312. 
Baker, N., H. P. de Koning, P. Mäser and D. Horn (2013). "Drug resistance in 
African trypanosomiasis: the melarsoprol and pentamidine story." Trends in 
parasitology 29(3): 10.1016/j.pt.2012.1012.1005. 
Bakhiet, M., T. Olsson, J. Mhlanga, P. Buscher, N. Lycke, P. H. van der 
Meide and K. Kristensson (1996). "Human and rodent interferon-gamma as a 
growth factor for Trypanosoma brucei." European Journal of Immunology 
26(6): 1359-1364. 
Baluk, P., J. Fuxe, H. Hashizume, T. Romano, E. Lashnits, S. Butz, D. 
Vestweber, M. Corada, C. Molendini, E. Dejana and D. M. McDonald (2007). 
"Functionally specialized junctions between endothelial cells of lymphatic 
vessels." Journal of Experimental Medicine 204(10): 2349-2362. 
Banks, T. A., B. T. Rouse, M. K. Kerley, P. J. Blair, V. L. Godfrey, N. A. 
Kuklin, D. M. Bouley, J. Thomas, S. Kanangat and M. L. Mucenski (1995). 
"Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ 
development and humoral immune responsiveness." Journal of Immunology 
155(4): 1685-1693. 
Bannard, O. and J. G. Cyster (2017). "Germinal centers: programmed for 
affinity maturation and antibody diversification." Current Opinion in 
Immunology 45: 21-30. 
Baral, T. N. (2010). "Immunobiology of African trypanosomes: Need of 
alternative interventions." Journal of Biomedicine and Biotechnology 
2010(389153): 1-24. 
Baral, T. N., P. De Baetselier, F. Brombacher and S. Magez (2007). "Control 
of Trypanosoma evansi Infection Is IgM Mediated and Does Not Require a 
Type I Inflammatory Response." The Journal of Infectious Diseases 195(10): 
1513-1520. 
Barkhuizen, M., S. Magez, R. A. Atkinson and F. Brombacher (2007). 
"Interleukin-12p70-dependent interferon- gamma production is crucial for 




Barnard, J. P., B. Reynafarje and P. L. Pedersen (1993). "Glucose 
catabolism in African trypanosomes. Evidence that the terminal step is 
catalyzed by a pyruvate transporter capable of facilitating uptake of toxic 
analogs " Journal of Biological Chemistry 268(5): 3654-3661. 
Barrett, M. P., D. W. Boykin, R. Brun and R. R. Tidwell (2007). "Human 
African trypanosomiasis: pharmacological re-engagement with a neglected 
disease." British Journal of Pharmacology 152(8): 1155-1171. 
Barrett, M. P., R. J. Burchmore, A. Stich, J. O. Lazzari, A. C. Frasch, J. J. 
Cazzulo and S. Krishna (2003). "The trypanosomiases." Lancet 362(9394): 
1469-1480. 
Barry, J. D. and D. L. Emergy (1984). "Parasite development and host 
responses during the establishment of Trypanosoma brucei infection 
transmitted by tsetse fly." Parasitology 88 ( Pt 1): 67-84. 
Barry, J. D. and R. McCulloch (2001). Antigenic variation in trypanosomes: 
Enhanced phenotypic variation in a eukaryotic parasite. Advances in 
Parasitology, Academic Press. 49: 1-70. 
Basso, K. and R. Dalla-Favera (2015). "Germinal centres and B cell 
lymphomagenesis." Nature Reviews Immunology 15(3): 172-184. 
Bequaert, J. (1956). "The Natural History of Tsetse Flies. An Account of the 
Biology of the Genus Glossina (Diptera)." American Journal of Public Health 
and the Nations Health 46(5): 661-661. 
Black, S. J., P. Guirnalda, D. Frenkel, C. Haynes and V. Bockstal (2010). 
"Induction and regulation of Trypanosoma brucei VSG-specific antibody 
responses." Parasitology 137(14): 2041-2049. 
Black, S. J., C. N. Sendashonga, P. Webster, G. L. E. Koch and S. Z. 
Shapiro (1986). "Regulation of parasite-specific antibody responses in 
resistant (C57BL/6) and susceptible (C3H/HE) mice infected with 
Trypanosoma (trypanozoon) brucei brucei." Parasite Immunology 8(5): 425-
442. 
Bockstal, V., P. Guirnalda, G. Caljon, R. Goenka, J. C. Telfer, D. Frenkel, M. 
Radwanska, S. Magez and S. J. Black (2011). "T. brucei Infection Reduces B 
Lymphopoiesis in Bone Marrow and Truncates Compensatory Splenic 
Lymphopoiesis through Transitional B-Cell Apoptosis." PLOS Pathogens 
7(6): e1002089. 
Bosschaerts, T., M. Guilliams, B. Stijlemans, Y. Morias, D. Engel, F. Tacke, 
M. Hérin, P. De Baetselier and A. Beschin (2010). "Tip-DC Development 
during Parasitic Infection Is Regulated by IL-10 and Requires CCL2/CCR2, 
IFN-γ and MyD88 Signaling." PLOS Pathogens 6(8): e1001045. 
Boulakirba, S., A. Pfeifer, R. Mhaidly, S. Obba, M. Goulard, T. Schmitt, P. 
Chaintreuil, A. Calleja, N. Furstoss, F. Orange, S. Lacas-Gervais, L. Boyer, 
S. Marchetti, E. Verhoeyen, F. Luciano, G. Robert, P. Auberger and A. 
Jacquel (2018). "IL-34 and CSF-1 display an equivalent macrophage 
differentiation ability but a different polarization potential." Scientific Reports 
8: 256. 
Brice, R., I. Subota, J. Buisson and P. Bastin (2012). A new asymmetric 
division contributes to the continuous production of infective trypanosomes in 
the tsetse fly. 
252 
 
Brice, R. and J. Van Den Abbeele (2013). Through the dark continent: 
African trypanosome development in the tsetse fly. 
Brun, R., J. Blum, F. Chappuis and C. Burri (2010). "Human African 
trypanosomiasis." The Lancet 375(9709): 148-159. 
Buettner, M. and U. Bode (2012). "Lymph node dissection--understanding 
the immunological function of lymph nodes." Clinical and Experimental 
Immunology 169(3): 205-212. 
Büscher, P., G. Cecchi, V. Jamonneau and G. Priotto (2017). "Human 
African trypanosomiasis." The Lancet 390(10110): 2397-2409. 
Caescu, C. I., X. Guo, L. Tesfa, T. D. Bhagat, A. Verma, D. Zheng and E. R. 
Stanley (2015). "Colony stimulating factor-1 receptor signaling networks 
inhibit mouse macrophage inflammatory responses by induction of 
microRNA-21." Blood 125(8): e1-e13. 
Caljon, G., K. De Ridder, P. De Baetselier, M. Coosemans and J. Van Den 
Abbeele (2010). "Identification of a Tsetse Fly Salivary Protein with Dual 
Inhibitory Action on Human Platelet Aggregation." PLOS ONE 5(3): e9671. 
Caljon, G., D. Mabille, B. Stijlemans, C. De Trez, M. Mazzone, F. Tacchini-
Cottier, M. Malissen, J. A. Van Ginderachter, S. Magez, P. De Baetselier and 
J. Van Den Abbeele (2018). "Neutrophils enhance early Trypanosoma brucei 
infection onset." Scientific Reports 8(1): 11203. 
Caljon, G., J. Van Den Abbeele, J. M. Sternberg, M. Coosemans, P. De 
Baetselier and S. Magez (2006). "Tsetse fly saliva biases the immune 
response to Th2 and induces anti-vector antibodies that are a useful tool for 
exposure assessment." International Journal for Parasitology 36(9): 1025-
1035. 
Caljon, G., J. Van Den Abbeele, B. Stijlemans, M. Coosemans, P. De 
Baetselier and S. Magez (2006). "Tsetse fly saliva accelerates the onset of 
Trypanosoma brucei infection in a mouse model associated with a reduced 
host inflammatory response." Infection and Immunity 74(11): 6324-6330. 
Caljon, G., N. Van Reet, C. De Trez, M. Vermeersch, D. Pérez-Morga and J. 
Van Den Abbeele (2016). "The Dermis as a Delivery Site of Trypanosoma 
brucei for Tsetse Flies." PLoS Pathogens 12(7): e1005744. 
Camejo, M. I., L. M. Spencer and A. Núñez (2014). "TNF-alpha in bulls 
experimentally infected with Trypanosoma vivax: A pilot study." Veterinary 
Immunology and Immunopathology 162(3): 192-197. 
Campbell, G. H., K. M. Esser and F. I. Weinbaum (1977). "Trypanosoma 
rhodesiense infection in B-cell-deficient mice." Infection and  Immunity 18(2): 
434-438. 
Capewell, P., C. Cren-Travaille, F. Marchesi, P. Johnston, C. Clucas, R. A. 
Benson, T. A. Gorman, E. Calvo-Alvarez, A. Crouzols, G. Jouvion, V. 
Jamonneau, W. Weir, M. L. Stevenson, K. O'Neill, A. Cooper, N. K. Swar, B. 
Bucheton, D. M. Ngoyi, P. Garside, B. Rotureau and A. MacLeod (2016). 
"The skin is a significant but overlooked anatomical reservoir for vector-borne 
African trypanosomes." Elife 5. 
Cappello, M., P. W. Bergum, G. P. Vlasuk, B. A. Furmidge, D. I. Pritchard 
and S. Aksoy (1996). "Isolation and characterization of the tsetse thrombin 
inhibitor: a potent antithrombotic peptide from the saliva of Glossina 
253 
 
morsitans morsitans." American Journal of Tropical Medicine and Hygiene 
54(5): 475-480. 
Cappello, M., S. Li, X. Chen, C. B. Li, L. Harrison, S. Narashimhan, C. B. 
Beard and S. Aksoy (1998). "Tsetse thrombin inhibitor: bloodmeal-induced 
expression of an anticoagulant in salivary glands and gut tissue of Glossina 
morsitans morsitans." PNAS 95(24): 14290-14295. 
Casanova-Acebes, M., N. A-González, L. A. Weiss and A. Hidalgo (2014). 
"Innate immune cells as homeostatic regulators of the hematopoietic niche." 
International Journal of Hematology 99(6): 685-694. 
Casas-Sánchez, A. and Á. Acosta-Serrano (2016). "Skin deep." eLife 5: 
e21506. 
Casley-Smith, J. R. (1985). "The influence of tissue hydrostatic pressure and 
protein concentration on fluid and protein uptake by diaphragmatic initial 
lymphatics; effect of calcium dobesilate." Microcirc Endothelium Lymphatics 
2(4): 385-415. 
Chaisson, K. E. and E. A. Hallem (2012). "Chemosensory behaviors of 
parasites." Trends in Parasitology 28(10): 427-436. 
Chamond, N., A. Cosson, M. C. Blom-Potar, G. Jouvion, S. D'Archivio, M. 
Medina, S. Droin-Bergère, M. Huerre, S. Goyard and P. Minoprio (2010). 
"Trypanosoma vivax Infections: Pushing Ahead with Mouse Models for the 
Study of Nagana. I. Parasitological, Hematological and Pathological 
Parameters." PLOS Neglected Tropical Diseases 4(8): e792. 
Chensue, S. W. (2001). "Molecular machinations: Chemokine signals in host-
pathogen interactions." Clinical Microbiology Reviews 14(4): 821–835. 
Cnops, J., C. De Trez, D. Bulte, M. Radwanska, B. Ryffel and S. Magez 
(2015). "IFN-gamma mediates early B-cell loss in experimental African 
trypanosomosis." Parasite Immunology 37(9): 479-484. 
Cnops, J., C. De Trez, B. Stijlemans, J. Keirsse, F. Kauffmann, M. 
Barkhuizen, R. Keeton, L. Boon, F. Brombacher and S. Magez (2015). "NK-, 
NKT- and CD8-Derived IFNγ Drives Myeloid Cell Activation and 
Erythrophagocytosis, Resulting in Trypanosomosis-Associated Acute 
Anemia." PLoS Pathogens 11(6): e1004964. 
Cooper, A., P. Capewell, C. Clucas, N. Veitch, W. Weir, R. Thomson, J. 
Raper and A. MacLeod (2016). "A Primate APOL1 Variant That Kills 
Trypanosoma brucei gambiense." PLOS Neglected Tropical Diseases 10(8): 
e0004903. 
Corsini, A. C., C. Clayton, B. A. Askonas and B. M. Ogilvie (1977). 
"Suppressor cells and loss of B-cell potential in mice infected with 
Trypanosoma brucei." Clinical and Experimental Immunology 29(1): 122-131. 
Coulson, P. S., L. E. Smythies, C. Betts, N. A. Mabbott, J. M. Sternberg, X. 
G. Wei, F. Y. Liew and R. A. Wilson (1998). "Nitric oxide produced in the 
lungs of mice immunized with the radiation-attenuated schistosome vaccine 
is not the major agent causing challenge parasite elimination." Immunology 
93(1): 55-63. 
Coutinho, M. L., J. Matsunaga, L. C. Wang, A. de la Pena Moctezuma, M. S. 
Lewis, J. T. Babbitt, J. A. Aleixo and D. A. Haake (2014). "Kinetics of 
Leptospira interrogans infection in hamsters after intradermal and 
subcutaneous challenge." PLoS Neglected Tropical Diseases 8(11): e3307. 
254 
 
Creek, D. J., M. Mazet, F. Achcar, J. Anderson, D. H. Kim, R. Kamour, P. 
Morand, Y. Millerioux, M. Biran, E. J. Kerkhoven, A. Chokkathukalam, S. K. 
Weidt, K. E. Burgess, R. Breitling, D. G. Watson, F. Bringaud and M. P. 
Barrett (2015). "Probing the metabolic network in bloodstream-form 
Trypanosoma brucei using untargeted metabolomics with stable isotope 
labelled glucose." PLoS Pathog 11(3): e1004689. 
Cross, G. A., H. S. Kim and B. Wickstead (2014). "Capturing the variant 
surface glycoprotein repertoire (the VSGnome) of Trypanosoma brucei Lister 
427." Molecular and Biochemical Parasitology 195(1): 59-73. 
Cunningham, M. P., J. M. B. Harley, H. A. W. Southon and W. H. R. 
Lumsden (1962). "Detection of Antibodies in Blood Meals of Hematophagous 
Diptera." Science 138(3536): 32. 
Cyster, J. G. (1999). "Chemokines and cell migration in secondary lymphoid 
organs." Science 286: 2098-2102. 
Dadiani, M., V. Kalchenko, A. Yosepovich, R. Margalit, Y. Hassid, H. Degani 
and D. Seger (2006). "Real-time imaging of lymphogenic metastasis in 
orthotopic human breast cancer." Cancer Research 66(16): 8037-8041. 
Dai, C., P. Basilico, T. P. Cremona, P. Collins, B. Moser, C. Benarafa and M. 
Wolf (2015). "CXCL14 displays antimicrobial activity against respiratory tract 
bacteria and contributes to clearance of Streptococcus pneumoniae 
pulmonary infection." J Immunol 194(12): 5980-5989. 
Darji, A., A. Beschin, M. Sileghem, H. Heremans, L. Brys and P. De 
Baetselier (1996). "In vitro simulation of immunosuppression caused by 
Trypanosoma brucei: active involvement of gamma interferon and tumor 
necrosis factor in the pathway of suppression." Infection and Immunity 64(6): 
1937-1943. 
Davila-Gonzalez, D., D. S. Choi, R. R. Rosato, S. M. Granados-Principal, J. 
G. Kuhn, W. F. Li, W. Qian, W. Chen, A. J. Kozielski, H. Wong, B. Dave and 
J. C. Chang (2018). "Pharmacological Inhibition of NOS Activates ASK1/JNK 
Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative 
Breast Cancer." Clinical Cancer Research 24(5): 1152-1162. 
De Beule, N., E. Menu, M. J. M. Bertrand, M. Favreau, E. De Bruyne, K. 
Maes, K. De Veirman, M. Radwanska, A. Samali, S. Magez, K. 
Vanderkerken and C. De Trez (2017). "Experimental African trypanosome 
infection suppresses the development of multiple myeloma in mice by 
inducing intrinsic apoptosis of malignant plasma cells." Oncotarget 8(32): 
52016-52025. 
De Muylder, G., S. Daulouède, L. Lecordier, P. Uzureau, Y. Morias, J. Van 
Den Abbeele, G. Caljon, M. Hérin, P. Holzmuller, S. Semballa, P. Courtois, L. 
Vanhamme, B. Stijlemans, P. De Baetselier, M. P. Barrett, J. L. Barlow, A. N. 
J. McKenzie, L. Barron, T. A. Wynn, A. Beschin, P. Vincendeau and E. Pays 
(2013). "A Trypanosoma brucei Kinesin Heavy Chain Promotes Parasite 
Growth by Triggering Host Arginase Activity." PLOS Pathogens 9(10): 
e1003731. 
de Raadt, P. (2005). "The history of sleeping sickness." World Health 
Organization Human African Trypanosomiasis. 
De Silva, N. S. and U. Klein (2015). "Dynamics of B cells in germinal 
centres." Nature Reviews Immunology 15(3): 137-148. 
255 
 
de Sousa, K. P., J. M. Atouguia and M. S. Silva (2011). "Induced cytokine 
network during experimental African trypanosomiasis." International Journal 
of Interferon, Cytokine and Mediator Research 2011(3): 71-78. 
De Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. 
Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-
Schoenberger and et al. (1994). "Abnormal development of peripheral 
lymphoid organs in mice deficient in lymphotoxin." Science 264(5159): 703-
707. 
Deckers, J., H. Hammad and E. Hoste (2018). "Langerhans Cells: Sensing 
the Environment in Health and Disease." Frontiers in Immunology 9: 93. 
DeGee, A. L. and J. M. Mansfield (1984). "Genetics of resistance to the 
African trypanosomes. IV. Resistance of radiation chimeras to Trypanosoma 
rhodesiense infection." Cellular Immunology 87(1): 85-91. 
Dempsey, W. L. and J. M. Mansfield (1983). "Lymphocyte function in 
experimental African trypanosomiasis. V. Role of antibody and the 
mononuclear phagocyte system in variant-specific immunity." Journal of 
Immunology 130(1): 405-411. 
Dempsey, W. L. and J. M. Mansfield (1983). "Lymphocyte function in 
experimental African trypanosomiasis. VI. Parasite-specific 
immunosuppression." Journal of Immunology 130(6): 2896-2898. 
Desquesnes, M., P. Holzmuller, D.-H. Lai, A. Dargantes, Z.-R. Lun and S. 
Jittaplapong (2013). "Trypanosoma evansi and Surra: A Review and 
Perspectives on Origin, History, Distribution, Taxonomy, Morphology, Hosts, 
and Pathogenic Effects." BioMed Research International 2013: 194176. 
Diffley, P. (1983). "Trypanosomal surface coat variant antigen causes 
polyclonal lymphocyte activation." Journal of Immunology 131(4): 1983-1986. 
Dillman, A. R., M. L. Guillermin, J. H. Lee, B. Kim, P. W. Sternberg and E. A. 
Hallem (2012). "Olfaction shapes host-parasite interactions in parasitic 
nematodes." PNAS 109(35): E2324-2333. 
Drennan, M. B., B. Stijlemans, J. Van den Abbeele, V. J. Quesniaux, M. 
Barkhuizen, F. Brombacher, P. De Baetselier, B. Ryffel and S. Magez (2005). 
"The induction of a type 1 immune response following a Trypanosoma brucei 
infection is MyD88 dependent." Journal of Immunology 175(4): 2501-2509. 
Dwinger, R. H., G. Lamb, M. Murray and H. Hirumi (1987). "Dose and stage 
dependency for the development of local skin reactions caused by 
Trypanosoma congolense in goats." Acta Tropica 44(3): 303-314. 
E Ormerod, W. (1991). Hypothesis: The significance of Winterbottom's sign. 
Eisenbach, M. and L. C. Giojalas (2006). "Sperm guidance in mammals - an 
unpaved road to the egg." Nat Rev Mol Cell Biol 7(4): 276-285. 
Elliott, E. B., D. McCarroll, H. Hasumi, C. E. Welsh, A. A. Panissidi, N. G. 
Jones, C. L. Rossor, A. Tait, G. L. Smith, J. C. Mottram, L. J. Morrison and C. 
M. Loughrey (2013). "Trypanosoma brucei cathepsin-L increases 
arrhythmogenic sarcoplasmic reticulum-mediated calcium release in rat 
cardiomyocytes." Cardiovascular Research 100(2): 325-335. 
Emery, D. L., J. D. Barry and S. K. Moloo (1980). "The appearance of 
Trypanosoma (Duttonella) vivax in lymph following challenge of goats with 
infected Glossina morsitans morsitans." Acta Trop 37(4): 375-379. 
256 
 
Ettinger, R., J. L. Browning, S. A. Michie, W. van Ewijk and H. O. McDevitt 
(1996). "Disrupted splenic architecture, but normal lymph node development 
in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein." 
PNAS 93(23): 13102-13107. 
Ezzedine, K., H. Darie, M. Le Bras and D. Malvy (2007). "Skin features 
accompanying imported human African trypanosomiasis: hemolymphatic 
Trypanosoma gambiense infection among two French expatriates with 
dermatologic manifestations." Journal of Travel Medicine 14(3): 192-196. 
Fairbairn, H. and E. Burtt (1946). "The infectivity to man of a strain of 
Trypanosoma rhodesiense transmitted cyclically by Glossina morsitans 
through sheep and antelope; evidence that man requires a minimum infective 
dose of metacyclic trypanosomes." Annals of Tropical Medicine and 
Parasitology 40(3-4): 270-313. 
Fairlamb, A. H. and D. Horn (2018). "Melarsoprol Resistance in African 
Trypanosomiasis." Trends in Parasitology 34(6): 481-492. 
Farr, H. and K. Gull (2012). "Cytokinesis in trypanosomes." Cytoskeleton 69: 
931–941. 
Ferrante, C. J. and S. J. Leibovich (2012). "Regulation of Macrophage 
Polarization and Wound Healing." Advances in Wound Care 1(1): 10-16. 
Fèvre, E. M., B. v. Wissmann, S. C. Welburn and P. Lutumba (2008). "The 
Burden of Human African Trypanosomiasis." PLoS Neglected Tropical 
Diseases 2(12): e333. 
Fierer, J. and B. A. Askonas (1982). "Trypanosoma brucei infection 
stimulates receptor-mediated phagocytosis by murine peritoneal 
macrophages." Infection and Immunity 37(3): 1282-1284. 
Fletcher, A. L., S. E. Acton and K. Knoblich (2015). "Lymph node fibroblastic 
reticular cells in health and disease." Nature Reviews Immunology 15(6): 
350-361. 
Flynn, J. N. and M. Sileghem (1994). "Involvement of gamma delta T cells in 
immunity to trypanosomiasis." Immunology 83(1): 86-92. 
Forster, R., A. C. Davalos-Misslitz and A. Rot (2008). "CCR7 and its ligands: 
balancing immunity and tolerance." Nat Rev Immunol 8(5): 362-371. 
Frenkel, D., F. Zhang, P. Guirnalda, C. Haynes, V. Bockstal, M. Radwanska, 
S. Magez and S. J. Black (2016). "Trypanosoma brucei Co-opts NK Cells to 
Kill Splenic B2 B Cells." PLoS Pathogens 12(7): e1005733. 
Frevert, U., A. Movila, O. V. Nikolskaia, J. Raper, Z. B. Mackey, M. Abdulla, 
J. McKerrow and D. J. Grab (2012). "Early Invasion of Brain Parenchyma by 
African Trypanosomes." PLoS ONE 7(8): e43913. 
Fu, Y.-X., H. Molina, M. Matsumoto, G. Huang, J. Min and D. D. Chaplin 
(1997). "Lymphotoxin-α (LTα) Supports Development of Splenic Follicular 
Structure That Is Required for IgG Responses." The Journal of Experimental 
Medicine 185(12): 2111-2120. 
Futterer, A., K. Mink, A. Luz, M. H. Kosco-Vilbois and K. Pfeffer (1998). "The 
lymphotoxin beta receptor controls organogenesis and affinity maturation in 
peripheral lymphoid tissues." Immunity 9(1): 59-70. 
Garzon, E., P. Holzmuller, R. Bras-Goncalves, P. Vincendeau, G. Cuny, J. L. 
Lemesre and A. Geiger (2013). "The Trypanosoma brucei gambiense 
secretome impairs lipopolysaccharide-induced maturation, cytokine 
257 
 
production, and allostimulatory capacity of dendritic cells." Infection and 
Immunity 81(9): 3300-3308. 
Geiger, A., G. Bossard, D. Sereno, J. Pissarra, J.-L. Lemesre, P. Vincendeau 
and P. Holzmuller (2016). "Escaping Deleterious Immune Response in Their 
Hosts: Lessons from Trypanosomatids." Frontiers in Immunology 7(212). 
Gibson, W. and M. Bailey (2003). "The development of Trypanosoma brucei 
within the tsetse fly midgut observed using green fluorescent trypanosomes." 
Kinetoplastid Biology and Disease 2: 1-1. 
Giordani, F., L. J. Morrison, T. G. Rowan, D. E. K. H.P. and M. P. Barrett 
(2016). "The animal trypanosomiases and their chemotherapy: a review." 
Parasitology 143(14): 1862-1889. 
Glaysher, B. R. and N. A. Mabbott (2007). "Role of the GALT in scrapie 
agent neuroinvasion from the intestine." Journal of Immunology 178(6): 
3757-3766. 
Glover, L., S. Hutchinson, S. Alsford, R. McCulloch, M. C. Field and D. Horn 
(2013). "Antigenic variation in African trypanosomes: the importance of 
chromosomal and nuclear context in VSG expression control." Cellular 
Microbiology 15(12): 1984-1993. 
Gobert, A. P., S. Daulouede, M. Lepoivre, J. L. Boucher, B. Bouteille, A. 
Buguet, R. Cespuglio, B. Veyret and P. Vincendeau (2000). "L-Arginine 
availability modulates local nitric oxide production and parasite killing in 
experimental trypanosomiasis." Infection and Immunity 68(8): 4653-4657. 
Gobert, A. P., S. Semballa, S. Daulouede, S. Lesthelle, M. Taxile, B. Veyret 
and P. Vincendeau (1998). "Murine Macrophages Use Oxygen- and Nitric 
Oxide-Dependent Mechanisms To Synthesize S-Nitroso-Albumin and To Kill 
Extracellular Trypanosomes." Infection and Immunity 66(9): 4068. 
Gomez-Rodriguez, J., B. Stijlemans, G. De Muylder, H. Korf, L. Brys, M. 
Berberof, A. Darji, E. Pays, P. De Baetselier and A. Beschin (2009). 
"Identification of a parasitic immunomodulatory protein triggering the 
development of suppressive M1 macrophages during African 
trypanosomiasis." Journal of Infectious Diseases 200(12): 1849-1860. 
Gordon, S. (2003). "Alternative activation of macrophages." Nature Reviews 
Immunology 3: 23. 
Gow, D. J., K. A. Sauter, C. Pridans, L. Moffat, A. Sehgal, B. M. Stutchfield, 
S. Raza, P. M. Beard, Y. T. Tsai, G. Bainbridge, P. L. Boner, G. Fici, D. 
Garcia-Tapia, R. A. Martin, T. Oliphant, J. A. Shelly, R. Tiwari, T. L. Wilson, 
L. B. Smith, N. A. Mabbott and D. A. Hume (2014). "Characterisation of a 
novel Fc conjugate of macrophage colony-stimulating factor." Molecular 
Therapy 22(9): 1580-1592. 
Gratchev, A., K. Schledzewski, P. Guillot and S. Goerdt (2001). "Alternatively 
Activated Antigen-Presenting Cells: Molecular Repertoire, Immune 
Regulation, and Healing." Skin Pharmacology and Physiology 14(5): 272-
279. 
Griffith, J. W., C. L. Sokol and A. D. Luster (2014). "Chemokines and 
chemokine receptors: Positioning cells for host defense and immunity." 
Annual Review of Immunology 32: 659–702. 
Grootenhuis, J. G., R. H. Dwinger, R. B. Dolan, S. K. Moloo and M. Murray 
(1990). "Susceptibility of African buffalo and Boran cattle to Trypanosoma 
258 
 
congolense transmitted by Glossina morsitans centralis." Veterinary 
Parasitology 35(3): 219-231. 
Grosskinsky, C. M. and B. A. Askonas (1981). "Macrophages as primary 
target cells and mediators of immune dysfunction in African 
trypanosomiasis." Infection and Immunology 33(1): 149-155. 
Grosskinsky, C. M., R. A. Ezekowitz, G. Berton, S. Gordon and B. A. 
Askonas (1983). "Macrophage activation in murine African trypanosomiasis." 
Infection and Immunity 39(3): 1080-1086. 
Guilliams, M., T. Bosschaerts, M. Hérin, T. Hünig, P. Loi, V. Flamand, P. De 
Baetselier and A. Beschin (2008). "Experimental expansion of the regulatory 
T cell population increases resistance to African trypanosomiasis." Journal of 
Infectious Diseases 198(5): 781-791. 
Guilliams, M., K. Movahedi, T. Bosschaerts, T. VandenDriessche, M. K. 
Chuah, M. Herin, A. Acosta-Sanchez, L. Ma, M. Moser, J. A. Van 
Ginderachter, L. Brys, P. De Baetselier and A. Beschin (2009). "IL-10 
dampens TNF/inducible nitric oxide synthase-producing dendritic cell-
mediated pathogenicity during parasitic infection." Journal of Immunology 
182(2): 1107-1118. 
Guirnalda, P., N. B. Murphy, D. Nolan and S. J. Black (2007). "Anti-
Trypanosoma brucei activity in Cape buffalo serum during the cryptic phase 
of parasitemia is mediated by antibodies." International Journal for 
Parasitology 37(12): 1391-1399. 
Gunn, M. D., S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L. T. Williams 
and H. Nakano (1999). "Mice lacking expression of secondary lymphoid 
organ chemokine have defects in lymphocyte homing and dendritic cell 
localization." J Exp Med 189(3): 451-460. 
Gunn, M. D., K. Tangemann, C. Tam, J. G. Cyster, S. D. Rosen and L. T. 
Williams (1998). "A chemokine expressed in lymphoid high endothelial 
venules promotes the adhesion and chemotaxis of naive T lymphocytes." 
Proceedings of the National Academy of Sciences of the United States of 
America 95(1): 258-263. 
Haanstra, J. R., A. van Tuijl, J. van Dam, W. van Winden, A. G. M. Tielens, J. 
J. van Hellemond and B. M. Bakker (2012). "Proliferating bloodstream-form 
Trypanosoma brucei use a negligible part of consumed glucose for anabolic 
processes." International Journal for Parasitology 42(7): 667-673. 
Haesslera, U., M. Pisanoa, M. Wub and M. A. Swartza (2011). "Dendritic cell 
chemotaxis in 3D under defined chemokine gradients reveals differential 
response to ligands CCL21 and CCL19." PNAS 108(14): 5614–5619. 
Hamadien, M., N. Lycke and M. Bakhiet (1999). "Induction of the 
trypanosome lymphocyte-triggering factor (TLTF) and neutralizing antibodies 
to the TLTF in experimental african trypanosomiasis." Immunology 96(4): 
606-611. 
Hamel, K. M., V. M. Liarski and M. R. Clark (2012). "Germinal center B-cells." 
Autoimmunity 45(5): 333-347. 
Hamilton, T. A., C. Zhao, P. G. Pavicic and S. Datta (2014). "Myeloid Colony-




Haniffa, M., M. Gunawan and L. Jardine (2015). "Human skin dendritic cells 
in health and disease." Journal of Dermatological Science 77(2): 85-92. 
Harder, J., J. M. Schroder and R. Glaser (2013). "The skin surface as 
antimicrobial barrier: present concepts and future outlooks." Experimental 
Dermatology 22(1): 1-5. 
Harker, K. S., N. Ueno and M. B. Lodoen (2014). "Toxoplasma gondii 
dissemination: a parasite's journey through the infected host." Parasite 
Immunology 37(3): 141-149. 
Harrington, J. M. (2011). "Antimicrobial Peptide Killing of African 
Trypanosomes." Parasite immunology 33(8): 461-469. 
Harshey, R. M. (2016). The Flagellum as a Sensor. Stress and 
Environmental Regulation of Gene Expression and Adaptation in Bacteria, F. 
J. de Bruijn (Ed.): 1472. 
He, S., A. Dayton, P. Kuppusamy, K. A. Werbovetz and M. E. Drew (2012). 
"Induction of Oxidative Stress in Trypanosoma brucei by the 
Antitrypanosomal Dihydroquinoline OSU-40." Antimicrobial Agents and 
Chemotherapy 56(5): 2428. 
Health, C. f. F. S. a. P. (2009). "African Animal Trypanosomiasis: Nagana, 
Tsetse Disease, Tsetse Fly Disease, African Animal Trypanosomosis." 
CFSPH. 
Heath, W. R. and F. R. Carbone (2013). "The skin-resident and migratory 
immune system in steady state and memory: innate lymphocytes, dendritic 
cells and T cells." Nature Immunology 14(10): 978-985. 
Heesters, B. A., R. C. Myers and M. C. Carroll (2014). "Follicular dendritic 
cells: dynamic antigen libraries." Nature Reviews Immunology 14(7): 495-
504. 
Hendrix, B. M. and J. E. Sweet (1917). "A study of amino nitrogen and 
glucose in lymph and blood before and after the injection of nutrient solutions 
in the intestine." The Journal of Biological Chemistry 32: 299-307. 
Herbert, W. J. and W. H. Lumsden (1976). "Trypanosoma brucei: a rapid 
"matching" method for estimating the host's parasitemia." Experimental 
Parasitology 40(3): 427-431. 
Hertz, C. J., H. Filutowicz and J. M. Mansfield (1998). "Resistance to the 
African trypanosomes is IFN-gamma dependent." Journal of Immunology 
161(12): 6775-6783. 
Hieshima, K., H. Ohtani, M. Shibano, D. Izawa, T. Nakayama, Y. Kawasaki, 
F. Shiba, M. Shiota, F. Katou, T. Saito and O. Yoshie (2003). "CCL28 has 
dual roles in mucosal immunity as a chemokine with broad-spectrum 
antimicrobial activity." J Immunol 170(3): 1452-1461. 
Hirumi, H. and K. Hirumi (1994). "Axenic culture of African trypanosome 
bloodstream forms." Parasitology Today 10(2). 
Hocking, A. M. (2015). "The Role of Chemokines in Mesenchymal Stem Cell 
Homing to Wounds." Adv Wound Care (New Rochelle) 4(11): 623-630. 
Hoet, S., F. Opperdoes, R. Brun and J. Quetin-Leclercq (2004). "Natural 
products active against African trypanosomes: a step towards new drugs." 
Natural Product Reports 21(3): 353-364. 
260 
 
Holt, H. R., R. Selby, C. Mumba, G. B. Napier and J. Guitian (2016). 
"Assessment of animal African trypanosomiasis (AAT) vulnerability in cattle-
owning communities of sub-Saharan Africa." Parasites and Vectors 9: 53. 
Hong, J., Y. Li, X. Hua, Y. Bai, C. Wang, C. Zhu, Y. Du, Z. Yang and C. Yuan 
(2017). "Lymphatic Circulation Disseminates Bartonella Infection Into 
Bloodstream." Journal of Infectious Diseases 215(2): 303-311. 
Horn, D. (2014). "Antigenic variation in African trypanosomes." Molecular and 
Biochemical Parasitology 195(2): 123-129. 
Horn, D. and R. McCulloch (2010). "Molecular mechanisms underlying the 
control of antigenic variation in African trypanosomes." Current Opinion in 
Microbiology 13(6): 700-705. 
Hume, D. A. (2015). "The Many Alternative Faces of Macrophage Activation." 
Frontiers in Immunology 6(370). 
Hume, D. A. and K. P. A. MacDonald (2012). "Therapeutic applications of 
macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 
receptor (CSF-1R) signaling." Blood 119(8): 1810. 
Hwang, J.-S., M.-Y. Kwon, K.-H. Kim, Y. Lee, I. K. Lyoo, J. E. Kim, E.-S. Oh 
and I.-O. Han (2017). "Lipopolysaccharide (LPS)-stimulated iNOS Induction 
Is Increased by Glucosamine under Normal Glucose Conditions but Is 
Inhibited by Glucosamine under High Glucose Conditions in Macrophage 
Cells." The Journal of Biological Chemistry 292(5): 1724-1736. 
Hwang, J. K., F. W. Alt and L.-S. Yeap (2015). "Related Mechanisms of 
Antibody Somatic Hypermutation and Class Switch Recombination." 
Microbiology spectrum 3(1): 10.1128/microbiolspec.MDNA1123-0037-2014. 
Ikomi, F., Y. Kawai and T. Ohhashi (2012). "Recent Advance in Lymph 
Dynamic Analysis in Lymphatics and Lymph Nodes." Annals of Vascular 
Diseases 5(3): 258-268. 
Iwasaki, A. and R. Medzhitov (2015). "Control of adaptive immunity by the 
innate immune system." Nature Immunology 16: 343. 
Jacob, J., G. Kelsoe, K. Rajewsky and U. Weiss (1991). "Intraclonal 
generation of antibody mutants in germinal centres." Nature 354(6352): 389-
392. 
Jenkins, S. J. and J. E. Allen (2010). "Similarity and Diversity in Macrophage 
Activation by Nematodes, Trematodes, and Cestodes." Journal of 
Biomedicine and Biotechnology 2010: 14. 
Jenkins, S. J., D. Ruckerl, G. D. Thomas, J. P. Hewitson, S. Duncan, F. 
Brombacher, R. M. Maizels, D. A. Hume and J. E. Allen (2013). "IL-4 directly 
signals tissue-resident macrophages to proliferate beyond homeostatic levels 
controlled by CSF-1." The Journal of Experimental Medicine 210(11): 2477. 
Jenni, L. (1977). "Comparisons of antigenic types of Trypanosoma (T)brucei 
strains transmitted by Glossina m. morsitans." Acta Trop 34(1): 35-41. 
Jin, P., Y. Zhao, H. Liu, J. Chen, J. Ren, J. Jin, D. Bedognetti, S. Liu, E. 
Wang, F. Marincola and D. Stroncek (2016). "Interferon-γ and Tumor 
Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 
Phenotype." Scientific Reports 6: 26345. 
Jones, C. V. and S. D. Ricardo (2013). "Macrophages and CSF-1: 
Implications for development and beyond." Organogenesis 9(4): 249-260. 
261 
 
Kabashima, K., N. Shiraishi, K. Sugita, T. Mori, A. Onoue, M. Kobayashi, J. 
Sakabe, R. Yoshiki, H. Tamamura, N. Fujii, K. Inaba and Y. Tokura (2007). 
"CXCL12-CXCR4 Engagement Is Required for Migration of Cutaneous 
Dendritic Cells." The American Journal of Pathology 171(4): 1249-1257. 
Kaplan, D. H. (2017). "Ontogeny and function of murine epidermal 
Langerhans cells." Nature Immunology 18(10): 1068-1075. 
Kato, C. D., E. Matovu, C. M. Mugasa, A. Nanteza and V. P. Alibu (2016). 
"The role of cytokines in the pathogenesis and staging of Trypanosoma 
brucei rhodesiense sleeping sickness." Allergy, Asthma, and Clinical 
Immunology : Official Journal of the Canadian Society of Allergy and Clinical 
Immunology 12: 4. 
Kawano, Y., T. Noma and J. Yata (1994). "Regulation of human IgG subclass 
production by cytokines. IFN-gamma and IL-6 act antagonistically in the 
induction of human IgG1 but additively in the induction of IgG2." Journal of 
Immunology 153(11): 4948-4958. 
Kennedy, P. G. E. (2008). "The continuing problem of human African 
trypanosomiasis (sleeping sickness)." Annals of Neurology 64(2): 116-126. 
Kennedy, P. G. E. (2013). "Clinical features, diagnosis, and treatment of 
human African trypanosomiasis (sleeping sickness)." The Lancet. Neurology 
12(2): 186-194. 
Kieft, R., P. Capewell, C. R. Turner, N. J. Veitch, A. MacLeod and S. Hajduk 
(2010). "Mechanism of Trypanosoma brucei gambiense (group 1) resistance 
to human trypanosome lytic factor." Proceedings of the National Academy of 
Sciences 107(37): 16137. 
Klechevsky, E. (2015). Functional Diversity of Human Dendritic Cells. 
Crossroads Between Innate and Adaptive Immunity V, Cham, Springer 
International Publishing. 
Koni, P. A., R. Sacca, P. Lawton, J. L. Browning, N. H. Ruddle and R. A. 
Flavell (1997). "Distinct roles in lymphoid organogenesis for lymphotoxins 
alpha and beta revealed in lymphotoxin beta-deficient mice." Immunity 6(4): 
491-500. 
Kopincová, J., A. Púzserová and I. Bernátová (2011). "Biochemical aspects 
of nitric oxide synthase feedback regulation by nitric oxide." Interdisciplinary 
Toxicology 4(2): 63-68. 
Kotarsky, K., K. M. Sitnik, H. Stenstad, H. Kotarsky, A. Schmidtchen, M. 
Koslowski, J. Wehkamp and W. W. Agace (2010). "A novel role for 
constitutively expressed epithelial-derived chemokines as antibacterial 
peptides in the intestinal mucosa." Mucosal Immunol 3(1): 40-48. 
Krijgsveld, J., S. A. Zaat, J. Meeldijk, P. A. van Veelen, G. Fang, B. Poolman, 
E. Brandt, J. E. Ehlert, A. J. Kuijpers, G. H. Engbers, J. Feijen and J. Dankert 
(2000). "Thrombocidins, microbicidal proteins from human blood platelets, 
are C-terminal deletion products of CXC chemokines." J Biol Chem 275(27): 
20374-20381. 
Kristensson, K., M. Nygard, G. Bertini and M. Bentivoglio (2010). "African 
trypanosome infections of the nervous system: parasite entry and effects on 
sleep and synaptic functions." Progress in Neurobiology 91(2): 152-171. 
262 
 
Kumar, R., L. J. DiMenna, J. Chaudhuri and T. Evans (2014). "Biological 
function of activation-induced cytidine deaminase (AID)." Biomedical Journal 
37(5): 269-283. 
Kupper, T. S. and R. C. Fuhlbrigge (2004). "Immune surveillance in the skin: 
mechanisms and clinical consequences." Nature Reviews Immunology 4: 
211. 
Kuriakose, S. M., R. Singh and J. Uzonna (2016). "Host Intracellular 
Signaling Events and Pro-inflammatory Cytokine Production in African 
Trypanosomiasis." Frontiers in Immunology 7: 181. 
La Greca, F., C. Haynes, B. Stijlemans, C. De Trez and S. Magez (2014). 
"Antibody-mediated control of Trypanosoma vivax infection fails in the 
absence of tumour necrosis factor." Parasite Immunology 36(6): 271-276. 
La Greca, F. and S. Magez (2011). "Vaccination against trypanosomiasis: 
Can it be done or is the trypanosome truly the ultimate immune destroyer and 
escape artist?" Human Vaccines 7(11): 1225-1233. 
Langevin, C., O. Andreoletti, A. Le Dur, H. Laude and V. Beringue (2011). 
"Marked influence of the route of infection on prion strain apparent phenotype 
in a scrapie transgenic mouse model." Neurobiology of Disease 41(1): 219-
225. 
Laperchia, C., M. Palomba, P. F. Seke Etet, J. Rodgers, B. Bradley, P. 
Montague, G. Grassi-Zucconi, P. G. E. Kennedy and M. Bentivoglio (2016). 
"Trypanosoma brucei Invasion and T-Cell Infiltration of the Brain 
Parenchyma in Experimental Sleeping Sickness: Timing and Correlation with 
Functional Changes." PLoS Neglected Tropical Diseases 10(12): e0005242. 
Lawand, M., J. Déchanet-Merville and M.-C. Dieu-Nosjean (2017). "Key 
Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their 
Immunotherapeutic Implications." Frontiers in Immunology 8: 761. 
Lehane, M., I. Alfaroukh, B. Bucheton, M. Camara, A. Harris, D. Kaba, C. 
Lumbala, M. Peka, J.-B. Rayaisse, C. Waiswa, P. Solano and S. Torr (2016). 
"Tsetse Control and the Elimination of Gambian Sleeping Sickness." PLOS 
Neglected Tropical Diseases 10(4): e0004437. 
Leibson, H. J., M. Gefter, A. Zlotnik, P. Marrack and J. W. Kappler (1984). 
"Role of γ-interferon in antibody-producing responses." Nature 309: 799. 
Leigh, O., B. Emikpe and J. O. Ogunsola (2015). Histopathological changes 
in some reproductive and endocrine organs of Trypanosoma brucei infected 
West African dwarf goat does. 
Lejon, V., D. Mumba Ngoyi, L. Kestens, L. Boel, B. Barbé, V. Kande Betu, J. 
van Griensven, E. Bottieau, J.-J. Muyembe Tamfum, J. Jacobs and P. 
Büscher (2014). "Gambiense Human African Trypanosomiasis and 
Immunological Memory: Effect on Phenotypic Lymphocyte Profiles and 
Humoral Immunity." PLOS Pathogens 10(3): e1003947. 
Leppert, B. J., J. M. Mansfield and D. M. Paulnock (2007). "The soluble 
variant surface glycoprotein of African trypanosomes is recognized by a 
macrophage scavenger receptor and induces I kappa B alpha degradation 




Liao, S. and P. Y. von der Weid (2015). "Lymphatic system: an active 
pathway for immune protection." Seminars in Cell and Developmental 
Biology 38: 83-89. 
Lipman, D. J., A. Souvorov, E. V. Koonin, A. R. Panchenko and T. A. 
Tatusova (2002). "The relationship of protein conservation and sequence 
length." BMC Evolutionary Biology 2: 20-20. 
Liu, G., D. Sun, H. Wu, M. Zhang, H. Huan, J. Xu, X. Zhang, H. Zhou and M. 
Shi (2015). "Distinct Contributions of CD4(+) and CD8(+) T Cells to 
Pathogenesis of Trypanosoma brucei Infection in the Context of Gamma 
Interferon and Interleukin-10." Infection and Immunity 83(7): 2785-2795. 
Louis, C., A. D. Cook, D. Lacey, A. J. Fleetwood, R. Vlahos, G. P. Anderson 
and J. A. Hamilton (2015). "Specific Contributions of CSF-1 and GM-CSF to 
the Dynamics of the Mononuclear Phagocyte System." The Journal of 
Immunology 195(1): 134. 
Love, M. S., M. G. Millholland, S. Mishra, S. Kulkarni, K. B. Freeman, W. 
Pan, R. W. Kavash, M. J. Costanzo, H. Jo, T. M. Daly, D. R. Williams, M. A. 
Kowalska, L. W. Bergman, M. Poncz, W. F. DeGrado, P. Sinnis, R. W. Scott 
and D. C. Greenbaum (2012). "Platelet factor 4 activity against P. falciparum 
and its translation to nonpeptidic mimics as antimalarials." Cell Host Microbe 
12(6): 815-823. 
Mabbott, N. and J. M. Sternberg (1995). "Bone marrow nitric oxide 
production and development of anemia in Trypanosoma brucei-infected 
mice." Infection and Immunity 63(4): 1563-1566. 
Mabbott, N. A. (2017). "How do PrP(Sc) Prions Spread between Host 
Species, and within Hosts?" Pathogens 6(4): 60. 
Mabbott, N. A., P. S. Coulson, L. E. Smythies, R. A. Wilson and J. M. 
Sternberg (1998). "African trypanosome infections in mice that lack the 
interferon-gamma receptor gene: nitric oxide-dependent and -independent 
suppression of T-cell proliferative responses and the development of 
anaemia." Immunology 94(4): 476-480. 
Mabbott, N. A., I. A. Sutherland and J. M. Sternberg (1994). "Trypanosoma 
brucei is protected from the cytostatic effects of nitric oxide under in vivo 
conditions." Parasitology Research 80(8): 687-690. 
Mabbott, N. A., I. A. Sutherland and J. M. Sternberg (1995). "Suppressor 
macrophages in Trypanosoma brucei infection: nitric oxide is related to both 
suppressive activity and lifespan in vivo." Parasite Immunology 17(3): 143-
150. 
Macaskill, J. A., P. H. Holmes, D. D. Whitelaw, I. McConnell, F. W. Jennings 
and G. M. Urquhart (1980). "Immunological clearance of 75Se-labelled 
Trypanosoma brucei in mice. II. Mechanisms in immune animals." 
Immunology 40(4): 629-635. 
MacLean, L., J. E. Chisi, M. Odiit, W. C. Gibson, V. Ferris, K. Picozzi and J. 
M. Sternberg (2004). "Severity of human african trypanosomiasis in East 
Africa is associated with geographic location, parasite genotype, and host 
inflammatory cytokine response profile." Infection and Immunity 72(12): 
7040-7044. 
MacLean, L., M. Odiit, D. Okitoi and J. M. Sternberg (1999). "Plasma nitrate 
and interferon-gamma in Trypanosoma brucei rhodesiense infections: 
264 
 
evidence that nitric oxide production is induced during both early blood-stage 
and late meningoencephalitic-stage infections." Transactions of the Royal 
Society of Tropical Medicine and Hygiene 93(2): 169-170. 
MacLean, L., M. Odiit and J. M. Sternberg (2001). "Nitric oxide and cytokine 
synthesis in human African trypanosomiasis." Journal of Infectious Diseases 
184(8): 1086-1090. 
Magez, S., M. Geuskens, A. Beschin, H. del Favero, H. Verschueren, R. 
Lucas, E. Pays and P. de Baetselier (1997). "Specific uptake of tumor 
necrosis factor-alpha is involved in growth control of Trypanosoma brucei." 
Journal of Cell Biology 137(3): 715-727. 
Magez, S., R. Lucas, A. Darji, E. B. Songa, R. Hamers and P. De Baetselier 
(1993). "Murine tumour necrosis factor plays a protective role during the 
initial phase of the experimental infection with Trypanosoma brucei brucei." 
Parasite Immunology 15(11): 635-641. 
Magez, S. and M. Radwanska (2009). "African trypanosomiasis and 
antibodies: implications for vaccination, therapy and diagnosis." Future 
Microbiology 4(8): 1075-1087. 
Magez, S., M. Radwanska, M. Drennan, L. Fick, T. N. Baral, N. Allie, M. 
Jacobs, S. Nedospasov, F. Brombacher, B. Ryffel and P. De Baetselier 
(2007). "Tumor necrosis factor (TNF) receptor-1 (TNFp55) signal 
transduction and macrophage-derived soluble TNF are crucial for nitric oxide-
mediated Trypanosoma congolense parasite killing." Journal of Infectious 
Diseases 196(6): 954-962. 
Magez, S., M. Radwanska, M. Drennan, L. Fick, T. N. Baral, F. Brombacher 
and P. D. Baetselier (2006). "Interferon-γ and Nitric Oxide in Combination 
with Antibodies Are Key Protective Host Immune Factors during 
Trypanosoma congolense Tc13 Infections." The Journal of Infectious 
Diseases 193(11): 1575-1583. 
Magez, S., A. Schwegmann, R. Atkinson, F. Claes, M. Drennan, P. De 
Baetselier and F. Brombacher (2008). "The role of B-cells and IgM antibodies 
in parasitemia, anemia, and VSG switching in Trypanosoma brucei-infected 
mice." PLoS Pathogens 4(8): e1000122. 
Magez, S., B. Stijlemans, T. Baral and P. De Baetselier (2002). "VSG-GPI 
anchors of African trypanosomes: their role in macrophage activation and 
induction of infection-associated immunopathology." Microbes and Infection 
4(9): 999-1006. 
Magez, S., B. Stijlemans, G. Caljon, H. P. Eugster and P. De Baetselier 
(2002). "Control of experimental Trypanosoma brucei infections occurs 
independently of lymphotoxin-alpha induction." Infection and Immunity 70(3): 
1342-1351. 
Magez, S., C. Truyens, M. Merimi, M. Radwanska, B. Stijlemans, P. 
Brouckaert, F. Brombacher, E. Pays and P. De Baetselier (2004). "P75 tumor 
necrosis factor-receptor shedding occurs as a protective host response 
during African trypanosomiasis." Journal of Infectious Diseases 189(3): 527-
539. 
Mahdavian Delavary, B., W. M. van der Veer, M. van Egmond, F. B. Niessen 
and R. H. Beelen (2011). "Macrophages in skin injury and repair." 
Immunobiology 216(7): 753-762. 
265 
 
Maina, N., J. M. Ngotho, T. Were, J. K. Thuita, D. M. Mwangangi, J. M. 
Kagira, J. M. Ndung'u and J. Sternberg (2004). "Proinflammatory Cytokine 
Expression in the Early Phase of Trypanosoma brucei rhodesiense Infection 
in Vervet Monkeys (Cercopithecus aethiops)." Infection and Immunity 72(5): 
3063. 
Malissen, B., S. Tamoutounour and S. Henri (2014). "The origins and 
functions of dendritic cells and macrophages in the skin." Nature Reviews 
Immunology 14(6): 417-428. 
Mansfield, J. M. and D. M. Paulnock (2005). "Regulation of innate and 
acquired immunity in African trypanosomiasis." Parasite Immunology 27(10-
11): 361-371. 
Mantilla, B. S., L. Marchese, A. Casas-Sánchez, N. A. Dyer, N. Ejeh, M. 
Biran, F. Bringaud, M. J. Lehane, A. Acosta-Serrano and A. M. Silber (2017). 
"Proline Metabolism is Essential for Trypanosoma brucei brucei Survival in 
the Tsetse Vector." PLoS Pathogens 13(1): e1006158. 
Margaris, K. N. and R. A. Black (2012). "Modelling the lymphatic system: 
challenges and opportunities." Journal of the Royal Society Interface 9(69): 
601-612. 
Martinez, F. O. and S. Gordon (2014). "The M1 and M2 paradigm of 
macrophage activation: time for reassessment." F1000Prime Reports 6: 13. 
Masocha, W. and K. Kristensson (2012). "Passage of parasites across the 
blood-brain barrier." Virulence 3(2): 202-212. 
Masocha, W., B. Robertson, M. E. Rottenberg, J. Mhlanga, L. Sorokin and K. 
Kristensson (2004). "Cerebral vessel laminins and IFN-γ define 
Trypanosoma brucei brucei penetration of the blood-brain barrier." Journal of 
Clinical Investigation 114(5): 689-694. 
Masocha, W., M. E. Rottenberg and K. Kristensson (2007). "Migration of 
African trypanosomes across the blood–brain barrier." Physiology & Behavior 
92(1): 110-114. 
Matthews, K. R. (2005). "The developmental cell biology of Trypanosoma 
brucei." Journal of Cell Science 118(2): 283-290. 
Matthews, K. R., R. McCulloch and L. J. Morrison (2015). "The within-host 
dynamics of African trypanosome infections." Philosophical Transactions of 
the Royal Society of London. Series B, Biological Science 370(1675). 
McCulloch, R., L. J. Morrison and J. P. J. Hall (2015). "DNA Recombination 
Strategies During Antigenic Variation in the African Trypanosome." 
Microbiology Spectrum 3(2). 
McDonald, D. R. and O. Levy (2019). Innate Immunity -3. Clinical 
Immunology (Fifth Edition). R. R. Rich, T. A. Fleisher, W. T. Shearer et al. 
London, Content Repository Only!: 39-53.e31. 
McGettrick, A. F., S. E. Corcoran, P. J. Barry, J. McFarland, C. Cres, A. M. 
Curtis, E. Franklin, S. C. Corr, K. H. Mok, E. P. Cummins, C. T. Taylor, L. A. 
O'Neill and D. P. Nolan (2016). "Trypanosoma brucei metabolite 
indolepyruvate decreases HIF-1alpha and glycolysis in macrophages as a 
mechanism of innate immune evasion." PNAS 113(48): E7778-e7787. 
Millar, A. E., J. Sternberg, C. McSharry, X.-Q. Wei, F. Y. Liew and C. M. R. 
Turner (1999). "T-Cell Responses during Trypanosoma brucei Infections in 
266 
 
Mice Deficient in Inducible Nitric Oxide Synthase." Infection and Immunity 
67(7): 3334-3338. 
Miska, K. B., S. Kim, R. H. Fetterer, R. A. Dalloul and M. C. Jenkins (2013). 
"Macrophage migration inhibitory factor (MIF) of the protozoan parasite 
Eimeria influences the components of the immune system of its host, the 
chicken." Parasitology Research 112(5): 1935-1944. 
Mogk, S., A. Meiwes, C. M. Boßelmann, H. Wolburg and M. Duszenko "The 
lane to the brain: how African trypanosomes invade the CNS." Trends in 
Parasitology 30(10): 470-477. 
Molina-Portela, M. P., M. Samanovic and J. Raper (2008). "Distinct roles of 
apolipoprotein components within the trypanosome lytic factor complex 
revealed in a novel transgenic mouse model." The Journal of Experimental 
Medicine 205(8): 1721. 
Moloo, S. K. (2011). "The distribution of Glossina species in Africa and their 
natural hosts." Insect Science and Its Application 14(4): 511-527. 
Mony, B. M. and K. R. Matthews (2015). "Assembling the components of the 
quorum sensing pathway in African trypanosomes." Molecular Microbiology 
96(2): 220-232. 
Morrison, L. J., L. Marcello and R. McCulloch (2009). "Antigenic variation in 
the African trypanosome: molecular mechanisms and phenotypic 
complexity." Cellular Microbiology 11(12): 1724-1734. 
Morrison, L. J., S. McLellan, L. Sweeney, C. N. Chan, A. MacLeod, A. Tait 
and C. M. R. Turner (2010). "Role for Parasite Genetic Diversity in 
Differential Host Responses to Trypanosoma brucei Infection." Infection and 
Immunity 78(3): 1096. 
Morrison, L. J., L. Vezza, T. Rowan and J. C. Hope (2016). "Animal African 
Trypanosomiasis: Time to Increase Focus on Clinically Relevant Parasite 
and Host Species." Trends in Parasitology 32(8): 599-607. 
Morrison, W. I. (1985). "Immune responses of cattle to African 
trypanosomes." Immunology and Pathogenesis of Trypanosomiasis: 104-
124. 
Morrison, W. I. and M. Murray (1985). "The role of humoral immune 
responses in determining susceptibility of A/J and C57BL/6 mice to infection 
with Trypanosoma congolense." Parasite Immunology 7(1): 63-79. 
Morrison, W. I., M. Murray, P. D. Sayer and J. M. Preston (1981). "The 
Pathogenesis of Experimentally Induced Trypanosoma brucei Infection in the 
Dog: II. Changes in the Lymphoid Organs." The American Journal of 
Pathology 102(2): 182-194. 
Moss, A. S., N. S. Reddy, I. M. Dortaj and M. J. San Francisco (2008). 
"Chemotaxis of the amphibian pathogen Batrachochytrium dendrobatidis and 
its response to a variety of attractants." Mycologia 100(1): 1-5. 
Mueller, S. N., A. Zaid and F. R. Carbone (2014). "Tissue-Resident T Cells: 
Dynamic Players in Skin Immunity." Frontiers in Immunology 5: 332. 
Muhanguzi, D., A. Mugenyi, G. Bigirwa, M. Kamusiime, A. Kitibwa, G. G. 
Akurut, S. Ochwo, W. Amanyire, S. G. Okech, J. Hattendorf and R. 
Tweyongyere (2017). "African animal trypanosomiasis as a constraint to 
livestock health and production in Karamoja region: a detailed qualitative and 
quantitative assessment." BMC Veterinary Research 13: 355. 
267 
 
Muhanguzi, D., K. Picozzi, H. Jan, T. Michael, J. Kabasa, C. Waiswa and S. 
Welburn (2014). The burden and spatial distribution of bovine African 
trypanosomes in small holder crop-livestock production systems in Tororo 
District, South-Eastern Uganda. 
Murray, M., J. C. Trail, C. E. Davis and S. J. Black (1984). "Genetic 
resistance to African Trypanosomiasis." Journal of Infectious Diseases 
149(3): 311-319. 
Murray, P. J., J. E. Allen, S. K. Biswas, E. A. Fisher, D. W. Gilroy, S. Goerdt, 
S. Gordon, J. A. Hamilton, L. B. Ivashkiv, T. Lawrence, M. Locati, A. 
Mantovani, F. O. Martinez, J. L. Mege, D. M. Mosser, G. Natoli, J. P. Saeij, J. 
L. Schultze, K. A. Shirey, A. Sica, J. Suttles, I. Udalova, J. A. van 
Ginderachter, S. N. Vogel and T. A. Wynn (2014). "Macrophage activation 
and polarization: nomenclature and experimental guidelines." Immunity 
41(1): 14-20. 
Murray, P. K., F. W. Jennings, M. Murray and G. M. Urquhart (1974). "The 
nature of immunosuppression in Trypanosoma brucei infections in mice: I. 
The role of the macrophage." Immunology 27(5): 815-824. 
Murray, P. K., F. W. Jennings, M. Murray and G. M. Urquhart (1974). "The 
nature of immunosuppression in Trypanosoma brucei infections in mice: II. 
The role of the T and B lymphocytes." Immunology 27(5): 825-840. 
Musoke, A. J., V. M. Nantulya, A. F. Barbet, F. Kironde and T. C. McGuire 
(1981). "Bovine immune response to African ;trypanosomes: specific 
antibodies to variable surface glycoproteins of Trypanosoma brucei." 
Parasite Immunology 3(2): 97-106. 
Naessens, J., A. J. Teale and M. Sileghem (2002). "Identification of 
mechanisms of natural resistance to African trypanosomiasis in cattle." 
Veterinary Immunology and Immunopathology 87(3): 187-194. 
Naglak, E. K., S. G. Morrison and R. P. Morrison (2016). "Gamma Interferon 
Is Required for Optimal Antibody-Mediated Immunity against Genital 
Chlamydia Infection." Infection and Immunity 84(11): 3232. 
Namangala, B. (2011). "How the African trypanosomes evade host immune 
killing." Parasite Immunology 33(8): 430-437. 
Namangala, B. (2012). "Contribution of innate immune responses towards 
resistance to African trypanosome infections." Scandinavian Journal of 
Immunology 75(1): 5-15. 
Namangala, B., L. Brys, S. Magez, P. De Baetselier and A. Beschin (2000). 
"Trypanosoma brucei brucei infection impairs MHC class II antigen 
presentation capacity of macrophages." Parasite Immunology 22(7): 361-
370. 
Namangala, B., P. de Baetselier, L. Brijs, B. Stijlemans, W. Noel, E. Pays, M. 
Carrington and A. Beschin (2000). "Attenuation of Trypanosoma brucei is 
associated with reduced immunosuppression and concomitant production of 
Th2 lymphokines." The Journal of Infectious Diseases 181(3): 1110-1120. 
Namangala, B., W. Noel, P. De Baetselier, L. Brys and A. Beschin (2001). 
"Relative contribution of interferon-gamma and interleukin-10 to resistance to 




Nestle, F. O., P. Di Meglio, J. Z. Qin and B. J. Nickoloff (2009). "Skin immune 
sentinels in health and disease." Nature Reviews Immunology 9(10): 679-
691. 
Ng, L. G., A. Hsu, M. A. Mandell, B. Roediger, C. Hoeller, P. Mrass, A. 
Iparraguirre, L. L. Cavanagh, J. A. Triccas, S. M. Beverley, P. Scott and W. 
Weninger (2008). "Migratory Dermal Dendritic Cells Act as Rapid Sensors of 
Protozoan Parasites." PLOS Pathogens 4(11): e1000222. 
Nganou-Makamdop, K., I. Ploemen, M. Behet, G. J. Van Gemert, C. 
Hermsen, M. Roestenberg and R. W. Sauerwein (2012). "Reduced 
Plasmodium berghei sporozoite liver load associates with low protective 
efficacy after intradermal immunization." Parasite Immunology 34(12): 562-
569. 
Nguyen, L. T. and H. J. Vogel (2012). "Structural perspectives on 
antimicrobial chemokines." Frontiers in Immunology 3(384): 1-11. 
Nikolskaia, O. V., A. L. A. P. de, Y. V. Kim, J. D. Lonsdale-Eccles, T. 
Fukuma, J. Scharfstein and D. J. Grab (2006). "Blood-brain barrier traversal 
by African trypanosomes requires calcium signaling induced by parasite 
cysteine protease." J Clin Invest 116(10): 2739-2747. 
Nirschl, C. J. and N. Anandasabapathy (2016). "Duality at the gate: Skin 
dendritic cells as mediators of vaccine immunity and tolerance." Human 
Vaccines and Immunotherapeutics 12(1): 104-116. 
Nishimura, K., K. Hamashita, Y. Okamoto, F. Kawahara, H. Ihara, S. Kozaki, 
Y. Ohnishi and S. Yamasaki (2004). "Differential effects of interferon-gamma 
on production of trypanosome-derived lymphocyte-triggering factor by 
Trypanosoma brucei gambiense and Trypanosoma brucei brucei." Journal of 
Parasitology 90(4): 740-745. 
Noël, W., G. Hassanzadeh, G. Raes, B. Namangala, I. Daems, L. Brys, F. 
Brombacher, P. D. Baetselier and A. Beschin (2002). "Infection Stage-
Dependent Modulation of Macrophage Activation in Trypanosoma 
congolense-Resistant and -Susceptible Mice." Infection and Immunity 70(11): 
6180-6187. 
Noël, W., G. Raes, G. Hassanzadeh Ghassabeh, P. De Baetselier and A. 
Beschin (2004). "Alternatively activated macrophages during parasite 
infections." Trends in Parasitology 20(3): 126-133. 
Nose, M., T. Koide, K. Morikawa, M. Inoue, Y. Ogihara, Y. Yabu and N. Ohta 
(1998). "Formation of reactive oxygen intermediates might be involved in the 
trypanocidal activity of gallic acid." Biological and Pharmaceutical Bulletin 
21(6): 583-587. 
O'Brien, R. L. and W. K. Born (2015). "Dermal gammadelta T cells--What 
have we learned?" Cell Immunology 296(1): 62-69. 
O'Gorman, G. M., S. D. Park, E. W. Hill, K. G. Meade, L. C. Mitchell, M. 
Agaba, J. P. Gibson, O. Hanotte, J. Naessens, S. J. Kemp and D. E. 
MacHugh (2006). "Cytokine mRNA profiling of peripheral blood mononuclear 
cells from trypanotolerant and trypanosusceptible cattle infected with 
Trypanosoma congolense." Physiological Genomics 28(1): 53-61. 
Oberholzer, M., G. Marti, M. Baresic, S. Kunz, A. Hemphill and T. Seebeck 
(2007). "The Trypanosoma brucei cAMP phosphodiesterases TbrPDEB1 and 
269 
 
TbrPDEB2: flagellar enzymes that are essential for parasite virulence." 
Faseb j 21(3): 720-731. 
Oka, M., Y. Ito, M. Furuya and H. Osaki (1984). "Trypanosoma gambiense: 
immunosuppression and polyclonal B-cell activation in mice." Experimental 
Parasitology 58(2): 209-214. 
Okwor, I., C. Onyilagha, S. Kuriakose, Z. Mou, P. Jia and J. E. Uzonna 
(2012). "Regulatory T cells enhance susceptibility to experimental 
Trypanosoma congolense infection independent of mouse genetic 
background." PLOS Neglected Tropical Diseases 6(7): e1761. 
Omeke, B. C. and D. O. Ugwu (1991). "Pig trypanosomiasis: comparative 
anaemia and histopathology of lymphoid organs." Revue d'elevage et de 
Medecine Veterinaire des Pays Tropicaux 44(3): 267-272. 
Ono, S., G. Egawa and K. Kabashima (2017). "Regulation of blood vascular 
permeability in the skin." Inflammation and Regeneration 37(1): 11. 
Onyilagha, C., I. Okwor, S. Kuriakose, R. Singh and J. Uzonna (2014). "Low-
dose intradermal infection with trypanosoma congolense leads to expansion 
of regulatory T cells and enhanced susceptibility to reinfection." Infection and 
Immunity 82(3): 1074-1083. 
Ooi, C.-P. and P. Bastin (2013). "More than meets the eye: understanding 
Trypanosoma brucei morphology in the tsetse." Frontiers in Cellular and 
Infection Microbiology 3(71). 
Organization, W. H. (2013). Control and surveillance of human African 
trypanosomiasis. Geneva, WHO Press. 
Organization, W. H. (2017). "Human African Trypanosomiasis: 
Epidemiological Situation." 
Pallister, K. B., S. Mason, T. K. Nygaard, B. Liu, S. Griffith, J. Jones, S. 
Linderman, M. Hughes, D. Erickson, J. M. Voyich, M. F. Davis and E. Wilson 
(2015). "Bovine CCL28 Mediates Chemotaxis via CCR10 and Demonstrates 
Direct Antimicrobial Activity against Mastitis Causing Bacteria." PLoS One 
10(9): e0138084. 
Palomino, D. C. and L. C. Marti (2015). "Chemokines and immunity." Einstein 
(Sao Paulo) 13(3): 469-473. 
Pan, W., O. Ogunremi, G. Wei, M. Shi and H. Tabel (2006). "CR3 
(CD11b/CD18) is the major macrophage receptor for IgM antibody-mediated 
phagocytosis of African trypanosomes: diverse effect on subsequent 
synthesis of tumor necrosis factor alpha and nitric oxide." Microbes and 
Infection 8(5): 1209-1218. 
Panda, S. and J. L. Ding (2015). "Natural Antibodies Bridge Innate and 
Adaptive Immunity." The Journal of Immunology 194(1): 13. 
Parker, K. R. and M. J. Mant (1979). "Effects of tsetse (Glossina morsitans 
morsitans Westw.) (Diptera: Glossinidae) salivary gland homogenate on 
coagulation and fibrinolysis." Thrombosis and Haemostasis 42(2): 743-751. 
Parmar, R., H. Patel, N. Yadav, M. Patidar, R. K. Tyagi and S. K. Dalai 
(2016). "Route of administration of attenuated sporozoites is instrumental in 
rendering immunity against Plasmodia infection." Vaccine 34(28): 3229-3234. 
Pasparakis, M., I. Haase and F. O Nestle (2014). Mechanisms regulating skin 
immunity and inflammation. 
270 
 
Paul, S., Shilpi and G. Lal (2015). "Role of gamma-delta (gammadelta) T 
cells in autoimmunity." Journal of Leukocyte Biology 97(2): 259-271. 
Paulnock, D. M. and S. P. Coller (2001). "Analysis of macrophage activation 
in African trypanosomiasis." Journal of Leukocyte Biology 69(5): 685-690. 
Paulnock, D. M., B. E. Freeman and J. M. Mansfield (2010). "Modulation of 
innate immunity by African trypanosomes." Parasitology 137(14): 2051-2063. 
Pays, E., S. Lips, D. Nolan, L. Vanhamme and D. Perez-Morga (2001). "The 
VSG expression sites of Trypanosoma brucei: multipurpose tools for the 
adaptation of the parasite to mammalian hosts." Molecular and Biochemical 
Parasitology 114(1): 1-16. 
Pekarova, M., A. Lojek, H. Martiskova, O. Vasicek, L. Bino, A. Klinke, D. Lau, 
R. Kuchta, J. Kadlec, R. Vrba and L. Kubala (2011). "New Role for L-Arginine 
in Regulation of Inducible Nitric-Oxide-Synthase-Derived Superoxide Anion 
Production in Raw 264.7 Macrophages." The Scientific World Journal 11: 15. 
Pepper, M. S. and M. Skobe (2003). "Lymphatic endothelium: morphological, 
molecular and functional properties." Journal of Cell Biology 163(2): 209-213. 
Perobelli, S. M., R. G. Galvani, T. Goncalves-Silva, C. R. Xavier, A. Nobrega 
and A. Bonomo (2015). "Plasticity of neutrophils reveals modulatory 
capacity." Brazilian Journal of Medical and Biological Research 48(8): 665-
675. 
Pinger, J., S. Chowdhury and F. N. Papavasiliou (2017). "Variant surface 
glycoprotein density defines an immune evasion threshold for African 
trypanosomes undergoing antigenic variation." Nature Communications 8(1): 
828. 
Plociennikowska, A., A. Hromada-Judycka, K. Borzecka and K. Kwiatkowska 
(2015). "Co-operation of TLR4 and raft proteins in LPS-induced pro-
inflammatory signaling." Cell Mol Life Sci 72(3): 557-581. 
Ploemen, I. H., S. Chakravarty, G. J. van Gemert, T. Annoura, S. M. Khan, C. 
J. Janse, C. C. Hermsen, S. L. Hoffman and R. W. Sauerwein (2013). 
"Plasmodium liver load following parenteral sporozoite administration in 
rodents." Vaccine 31(34): 3410-3416. 
Pollastri, M. P. (2018). "Fexinidazole: A New Drug for African Sleeping 
Sickness on the Horizon." Trends in Parasitology 34(3): 178-179. 
Ponte-Sucre, A. (2016). "An Overview of Trypanosoma brucei Infections: An 
Intense Host–Parasite Interaction." Frontiers in Microbiology 7: 2126. 
Pridans, C., K. A. Sauter, K. M. Irvine, G. M. Davis, L. Lefevre, A. Raper, R. 
Rojo, A. J. Nirmal, P. Beard, M. Cheeseman and D. A. Hume (2018). 
"Macrophage colony-stimulating factor increases hepatic macrophage 
content, liver growth, and lipid accumulation in neonatal rats." American 
Journal of Physiology-Gastrointestinal and Liver Physiology 314(3): G388-
g398. 
Radwanska, M., P. Guirnalda, C. De Trez, B. Ryffel, S. Black and S. Magez 
(2008). "Trypanosomiasis-Induced B Cell Apoptosis Results in Loss of 
Protective Anti-Parasite Antibody Responses and Abolishment of Vaccine-
Induced Memory Responses." PLOS Pathogens 4(5): e1000078. 
Rajaiah, R., D. J. Perkins, S. K. Polumuri, A. Zhao, A. D. Keegan and S. N. 
Vogel (2013). "Dissociation of Endotoxin Tolerance and Differentiation of 
271 
 
Alternatively Activated Macrophages." Journal of Immunology 190(9): 4763-
4772. 
Ralston, K. S., Z. P. Kabututu, J. H. Melehani, M. Oberholzer and K. L. Hill 
(2009). "The Trypanosoma brucei flagellum: Moving parasites in new 
directions." Annual Review of Microbiology 63: 335-362. 
Randolph, G. J., V. Angeli and M. A. Swartz (2005). "Dendritic-cell trafficking 
to lymph nodes through lymphatic vessels." Nat Rev Immunol 5(8): 617-628. 
Raschke, W. C., S. Baird, P. Ralph and I. Nakoinz (1978). "Functional 
macrophage cell lines transformed by abelson leukemia virus." Cell 15(1): 
261-267. 
Rath, M., I. Müller, P. Kropf, E. I. Closs and M. Munder (2014). "Metabolism 
via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in 
Macrophages." Frontiers in Immunology 5: 532. 
Raziuddin, S., A. W. Telmasani, M. el-Hag el-Awad, O. al-Amari and M. al-
Janadi (1992). "Gamma delta T cells and the immune response in visceral 
leishmaniasis." European Journal of Immunology 22(5): 1143-1148. 
Reddy, L. H. and R. S. Murthy (2002). "Lymphatic transport of orally 
administered drugs." Indian Journal of Experimental Biology 40(10): 1097-
1109. 
Reinitz, D. M. and J. M. Mansfield (1990). "T-cell-independent and T-cell-
dependent B-cell responses to exposed variant surface glycoprotein epitopes 
in trypanosome-infected mice." Infection and immunity 58(7): 2337-2342. 
Reynolds, D. S., W. H. Boom and A. K. Abbas (1987). "Inhibition of B 
lymphocyte activation by interferon-gamma." Journal of Immunology 139(3): 
767-773. 
Ribeiro, J. M. C., B. J. Mans and B. Arcà (2010). "An insight into the sialome 
of blood-feeding Nematocera." Insect Biochemistry and Molecular Biology 
40(11): 767-784. 
Richmond, J. M. and J. E. Harris (2014). "Immunology and skin in health and 
disease." Cold Spring Harbor Perspectives in Medicine 4(12): a015339. 
Rifkin, M. R. and F. R. Landsberger (1990). "Trypanosome variant surface 
glycoprotein transfer to target membranes: a model for the pathogenesis of 
trypanosomiasis." Proceedings of the National Academy of Sciences 87(2): 
801-805. 
Robinson, N. P., N. Burman, S. E. Melville and J. D. Barry (1999). 
"Predominance of duplicative VSG gene conversion in antigenic variation in 
African trypanosomes." Mol Cell Biol 19(9): 5839-5846. 
Rodgers, J. (2010). "Trypanosomiasis and the brain." Parasitology 137(14): 
1995-2006. 
Rodgers, J., B. Bradley and P. G. E. Kennedy (2017). "Delineating 
neuroinflammation, parasite CNS invasion, and blood-brain barrier 
dysfunction in an experimental murine model of human African 
trypanosomiasis." Methods 127: 79-87. 
Roszer, T. (2015). "Understanding the Mysterious M2 Macrophage through 




Rotureau, B., C.-P. Ooi, D. Huet, S. Perrot and P. Bastin (2013). "Forward 
motility is essential for trypanosome infection in the tsetse fly." Cellular 
Microbiology 16(3): 425-433. 
Roy Chowdhury, A., R. Bakshi, J. Wang, G. Yildirir, B. Liu, V. Pappas-Brown, 
G. Tolun, J. D. Griffith, T. A. Shapiro, R. E. Jensen and P. T. Englund (2010). 
"The Killing of African Trypanosomes by Ethidium Bromide." PLOS 
Pathogens 6(12): e1001226. 
Ruddle, N. H. (2014). "Lymphotoxin and TNF: how it all began-a tribute to the 
travelers." Cytokine and Growth Factor Reviews 25(2): 83-89. 
Ruddle, N. H. and E. M. Akirav (2009). "Secondary lymphoid organs: 
Responding to genetic and environmental cues in ontogeny and the immune 
response." The Journal of Immunology 183: 2205-2212. 
Russo, E., A. Teijeira, K. Vaahtomeri, A.-H. Willrodt, J. S. Bloch, M. Nitschké, 
L. Santambrogio, D. Kerjaschki, M. Sixt and C. Halin (2016). "Intralymphatic 
CCL21 Promotes Tissue Egress of Dendritic Cells through Afferent 
Lymphatic Vessels." Cell Reports 14(7): 1723-1734. 
Salim, T., C. L. Sershen and E. E. May (2016). "Investigating the Role of 
TNF-α and IFN-γ Activation on the Dynamics of iNOS Gene Expression in 
LPS Stimulated Macrophages." PLoS ONE 11(6): e0153289. 
Salmon, D., G. Vanwalleghem, Y. Morias, J. Denoeud, C. Krumbholz, F. 
Lhomme, S. Bachmaier, M. Kador, J. Gossmann, F. B. Dias, G. De Muylder, 
P. Uzureau, S. Magez, M. Moser, P. De Baetselier, J. Van Den Abbeele, A. 
Beschin, M. Boshart and E. Pays (2012). "Adenylate cyclases of 
Trypanosoma brucei inhibit the innate immune response of the host." 
Science 337(6093): 463-466. 
Salmon, J. K., C. A. Armstrong and J. C. Ansel (1994). "The skin as an 
immune organ." Western Journal of Medicine 160(2): 146-152. 
Satriano, J. (2004). "Arginine pathways and the inflammatory response: 
interregulation of nitric oxide and polyamines: review article." Amino Acids 
26(4): 321-329. 
Sauter, K. A., C. Pridans, A. Sehgal, C. C. Bain, C. Scott, L. Moffat, R. Rojo, 
B. M. Stutchfield, C. L. Davies, D. S. Donaldson, K. Renault, B. W. McColl, A. 
M. Mowat, A. Serrels, M. C. Frame, N. A. Mabbott and D. A. Hume (2014). 
"The MacBlue binary transgene (csf1r-gal4VP16/UAS-ECFP) provides a 
novel marker for visualisation of subsets of monocytes, macrophages and 
dendritic cells and responsiveness to CSF1 administration." PLoS One 9(8): 
e105429. 
Sauter, K. A., L. A. Waddell, Z. M. Lisowski, R. Young, L. Lefevre, G. M. 
Davis, S. M. Clohisey, M. McCulloch, E. Magowan, N. A. Mabbott, K. M. 
Summers and D. A. Hume (2016). "Macrophage colony-stimulating factor 
(CSF1) controls monocyte production and maturation and the steady-state 
size of the liver in pigs." American Journal of Physiology - Gastrointestinal 
and Liver Physiology 311(3): G533-547. 
Schleifer, K. W. and J. M. Mansfield (1993). "Suppressor macrophages in 
African trypanosomiasis inhibit T cell proliferative responses by nitric oxide 
and prostaglandins." The Journal of Immunology 151(10): 5492. 
Schmid-Schonbein, G. W. (1990). "Microlymphatics and lymph flow." 
Physiological Reviews 70(4): 987-1028. 
273 
 
Schuster, S., T. Krüger, I. Subota, S. Thusek, B. Rotureau, A. Beilhack and 
M. Engstler (2017). "Developmental adaptations of trypanosome motility to 
the tsetse fly host environments unravel a multifaceted in vivo microswimmer 
system." eLife 6: e27656. 
Seed, J. R. and M. A. Wenck (2003). "Role of the long slender to short 
stumpy transition in the life cycle of the African trypanosomes." Kinetoplastid 
Biology and Disease 2: 3-3. 
Sehgal, A., D. S. Donaldson, C. Pridans, K. A. Sauter, D. A. Hume and N. A. 
Mabbott (2018). "The role of CSF1R-dependent macrophages in control of 
the intestinal stem-cell niche." Nature Communications 9(1): 1272. 
Sevick-Muraca, E. M., S. Kwon and J. C. Rasmussen (2014). "Emerging 
lymphatic imaging technologies for mouse and man." The Journal of Clinical 
Investigation 124(3): 905-914. 
Sharma, R., E. Gluenz, L. Peacock, W. Gibson, K. Gull and M. Carrington 
(2009). "The heart of darkness: growth and form of Trypanosoma brucei in 
the tsetse fly." Trends in Parasitology 25(11): 517-524. 
Sheikh, F., H. Dickensheets, A. M. Gamero, S. N. Vogel and R. P. Donnelly 
(2014). "An essential role for IFN-beta in the induction of IFN-stimulated gene 
expression by LPS in macrophages." Journal of Leukocyte Biology 96(4): 
591-600. 
Shi, M., G. Wei, W. Pan and H. Tabel (2004). "Trypanosoma congolense 
infections: antibody-mediated phagocytosis by Kupffer cells." Journal of 
Leukocyte Biology 76(2): 399-405. 
Sica, A. and A. Mantovani (2012). "Macrophage plasticity and polarization: in 
vivo veritas." Journal of Clinical Investigation 122(3): 787-795. 
Sileghem, M., A. Darji, R. Hamers, M. Van de Winkel and P. De Baetselier 
(1989). "Dual role of macrophages in the suppression of interleukin 2 
production and interleukin 2 receptor expression in trypanosome-infected 
mice." European Journal of Immunology 19(5): 829-835. 
Sileghem, M. and J. N. Flynn (1992). "Suppression of interleukin 2 secretion 
and interleukin 2 receptor expression during tsetse-transmitted 
trypanosomiasis in cattle." European Journal of Immunology 22(3): 767-773. 
Silva-Barrios, S., T. Charpentier and S. Stager (2018). "The Deadly Dance of 
B Cells with Trypanosomatids." Trends in Parasitology 34(2): 155-171. 
Simarro, P. P., A. Diarra, J. A. Ruiz Postigo, J. R. Franco and J. G. Jannin 
(2011). "The Human African Trypanosomiasis Control and Surveillance 
Programme of the World Health Organization 2000–2009: The Way 
Forward." PLoS Neglected Tropical Diseases 5(2): e1007. 
Singer, G. A. and D. A. Hickey (2000). "Nucleotide bias causes a 
genomewide bias in the amino acid composition of proteins." Molecular 
Biology and Evolution 17(11): 1581-1588. 
Smetko, A., A. Soudre, K. Silbermayr, S. Müller, G. Brem, O. Hanotte, P. J. 
Boettcher, A. Stella, G. Mészáros, M. Wurzinger, I. Curik, M. Müller, J. 
Burgstaller and J. Sölkner (2015). "Trypanosomosis: potential driver of 
selection in African cattle." Frontiers in Genetics 6(137). 
Sobirk, S. K., M. Morgelin, A. Egesten, P. Bates, O. Shannon and M. Collin 
(2013). "Human chemokines as antimicrobial peptides with direct 
274 
 
parasiticidal effect on Leishmania mexicana in vitro." PLOS ONE 8(3): 
e58129. 
Somda, M. B., Z. Bengaly, E. Dama, A. Poinsignon, G.-K. Dayo, I. Sidibe, F. 
Remoue, A. Sanon and B. Bucheton (2013). "First insights into the cattle 
serological response to tsetse salivary antigens: A promising direct biomarker 
of exposure to tsetse bites." Veterinary Parasitology 197(1): 332-340. 
Sommerville, C., J. M. Richardson, R. A. Williams, J. C. Mottram, C. W. 
Roberts, J. Alexander and F. L. Henriquez (2013). "Biochemical and 
immunological characterization of Toxoplasma gondii macrophage migration 
inhibitory factor." Journal of Biological Chemistry 288(18): 12733-12741. 
Sozzani, S., M. Locati, D. Zhou, M. Rieppi, W. Luini, G. Lamorte, G. Bianchi, 
N. Polentarutti, P. Allavena and A. Mantovani (1995). "Receptors, signal 
transduction, and spectrum of action of monocyte chemotactic protein-1 and 
related chemokines." J Leukoc Biol 57(5): 788-794. 
Stavnezer, J., J. E. J. Guikema and C. E. Schrader (2008). "Mechanism and 
Regulation of Class Switch Recombination." Annual review of immunology 
26: 261-292. 
Sternberg, J., N. Mabbott, I. Sutherland and F. Y. Liew (1994). "Inhibition of 
nitric oxide synthesis leads to reduced parasitaemia in murine Trypanosoma 
brucei infection." Infection and Immunity 62(5): 2135-2137. 
Sternberg, J. M. (2004). "Human African trypanosomiasis: clinical 
presentation and immune response." Parasite Immunology 26(11-12): 469-
476. 
Sternberg, J. M. and N. A. Mabbott (1996). "Nitric oxide-mediated 
suppression of T cell responses during Trypanosoma brucei infection: soluble 
trypanosome products and interferon-gamma are synergistic inducers of 
nitric oxide synthase." European Journal of Immunology 26(3): 539-543. 
Sternberg, J. M. and F. McGuigan (1992). "Nitric oxide mediates suppression 
of T cell responses in murine Trypanosoma brucei infection." European 
Journal of Immunology 22(10): 2741-2744. 
Steverding, D. (2008). "The history of African trypanosomiasis." Parasite 
Vectors 1(1): 3. 
Stijlemans, B., L. Brys, H. Korf, P. Bieniasz-Krzywiec, A. Sparkes, L. 
Vansintjan, L. Leng, N. Vanbekbergen, M. Mazzone, G. Caljon, J. Van Den 
Abbeele, S. Odongo, C. De Trez, S. Magez, J. A. Van Ginderachter, A. 
Beschin, R. Bucala and P. De Baetselier (2016). "MIF-Mediated 
Hemodilution Promotes Pathogenic Anemia in Experimental African 
Trypanosomosis." PLOS Pathogens 12(9): e1005862. 
Stijlemans, B., G. Caljon, J. Van Den Abbeele, J. A. Van Ginderachter, S. 
Magez and C. De Trez (2016). "Immune Evasion Strategies of Trypanosoma 
brucei within the Mammalian Host: Progression to Pathogenicity." Frontiers in 
Immunology 7: 233. 
Stijlemans, B., P. De Baetselier, S. Magez, J. A. Van Ginderachter and C. De 
Trez (2018). "African Trypanosomiasis-Associated Anemia: The Contribution 
of the Interplay between Parasites and the Mononuclear Phagocyte System." 
Frontiers in Immunology 9: 218. 
275 
 
Stijlemans, B., M. Radwanska, C. De Trez and S. Magez (2017). "African 
Trypanosomes Undermine Humoral Responses and Vaccine Development: 
Link with Inflammatory Responses?" Frontiers in Immunology 8: 582. 
Stijlemans, B., A. Vankrunkelsven, G. Caljon, V. Bockstal, M. Guilliams, T. 
Bosschaerts, A. Beschin, G. Raes, S. Magez and P. De Baetselier (2010). 
"The central role of macrophages in trypanosomiasis-associated anemia: 
rationale for therapeutical approaches." Endocrine, Metabolic and Immune 
Disorders - Drug Targets 10(1): 71-82. 
Strid, J., R. E. Tigelaar and A. C. Hayday (2009). "Skin immune surveillance 
by T cells--a new order?" Seminars in Immunology 21(3): 110-120. 
Stuehr, D. J. (2004). "Enzymes of the L-arginine to nitric oxide pathway." 
Journal of Nutrition 134(10 Suppl): 2748S-2751S; discussion 2765S-2767S. 
Sudarshi, D., S. Lawrence, W. O. Pickrell, V. Eligar, R. Walters, S. Quaderi, 
A. Walker, P. Capewell, C. Clucas, A. Vincent, F. Checchi, A. MacLeod and 
M. Brown (2014). "Human African Trypanosomiasis Presenting at Least 29 
Years after Infection—What Can This Teach Us about the Pathogenesis and 
Control of This Neglected Tropical Disease?" PLoS Neglected Tropical 
Diseases 8(12): e3349. 
Summerfield, A., F. Meurens and M. E. Ricklin (2015). "The immunology of 
the porcine skin and its value as a model for human skin." Molecular 
Immunology 66(1): 14-21. 
Summers, C., S. M. Rankin, A. M. Condliffe, N. Singh, A. M. Peters and E. R. 
Chilvers (2010). "Neutrophil kinetics in health and disease." Trends in 
Immunology 31(8): 318-324. 
Swallow, B., P. Kristjanson, G. J. Rowlands, R. L. Kruska and P. N. de 
Leeuw (1999). Measuring the costs of African animal trypanosomosis, the 
potential benefits of control and returns to research. 
Sweeney, E. G. and K. Guillemin (2011). "A gastric pathogen moves 
chemotaxis in a new direction." mBio 2(5): e00201-00211. 
Tabel, H., G. Wei and H. J. Bull (2013). "Immunosuppression: Cause for 
failures of vaccines against African trypanosomiases." PLoS Neglected 
Tropical Diseases 7(3): e2090. 
Takeuchi, O. and S. Akira (2010). "Pattern recognition receptors and 
inflammation." Cell 140(6): 805-820. 
Tal, O., H. Y. Lim, I. Gurevich, I. Milo, Z. Shipony, L. G. Ng, V. Angeli and G. 
Shakhar (2011). "DC mobilization from the skin requires docking to 
immobilized CCL21 on lymphatic endothelium and intralymphatic crawling." 
Journal of Experimental Medicine 208(10): 2141-2153. 
Tanowitz, H. B., P. E. Scherer, M. M. Mota and L. M. Figueiredo (2017). 
"Adipose Tissue: A Safe Haven for Parasites?" Trends in Parasitology 33(4): 
276-284. 
Taylor, K. A. (1998). "Immune responses of cattle to African trypanosomes: 
protective or pathogenic?" International Journal for Parasitology 28(2): 219-
240. 
Taylor, K. A., V. Lutje, D. Kennedy, E. Authié, A. Boulangé, L. Logan-
Henfrey, B. Gichuki and G. Gettinby (1996). "Trypanosoma congolense:B-
Lymphocyte Responses Differ between Trypanotolerant and 
Trypanosusceptible Cattle." Experimental Parasitology 83(1): 106-116. 
276 
 
Taylor, K. A. and B. Mertens (1999). "Immune response of cattle infected 
with African trypanosomes." Memorias do Instituto Oswaldo Cruz 94(2): 239-
244. 
Theis, J. H. and V. Bolton (1980). "Trypanosoma equiperdum: movement 
from the dermis." Experimental Parasitology 50(3): 317-330. 
Thomson, R. and A. Finkelstein (2015). "Human trypanolytic factor APOL1 
forms pH-gated cation-selective channels in planar lipid bilayers: relevance to 
trypanosome lysis." PNAS 112(9): 2894-2899. 
Thomson, R., P. Molina-Portela, H. Mott, M. Carrington and J. Raper (2009). 
"Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates 
both animal and human-infective African trypanosomes." PNAS 106(46): 
19509. 
Trindade, S., F. Rijo-Ferreira, T. Carvalho, D. Pinto-Neves, F. Guegan, F. 
Aresta-Branco, F. Bento, S. A. Young, A. Pinto, J. Van Den Abbeele, R. M. 
Ribeiro, S. Dias, T. K. Smith and L. M. Figueiredo (2016). "Trypanosoma 
brucei Parasites Occupy and Functionally Adapt to the Adipose Tissue in 
Mice." Cell Host Microbe 19(6): 837-848. 
Uzonna, J. E., R. S. Kaushik, J. R. Gordon and H. Tabel (1998). 
"Immunoregulation in experimental murine Trypanosoma congolense 
infection: anti-IL-10 antibodies reverse trypanosome-mediated suppression of 
lymphocyte proliferation in vitro and moderately prolong the lifespan of 
genetically susceptible BALB/c mice." Parasite Immunology 20(6): 293-302. 
Uzonna, J. E., R. S. Kaushik, J. R. Gordon and H. Tabel (1999). "Cytokines 
and antibody responses during Trypanosoma congolense infections in two 
inbred mouse strains that differ in resistance." Parasite Immunology 21(2): 
57-71. 
Valdivia-Silva, J., J. Medina-Tamayo and E. A. Garcia-Zepeda (2015). 
"Chemokine-derived peptides: novel antimicrobial and antineoplasic agents." 
International Journal of Molecular Sciences 16: 12958-12985. 
Van Den Abbeele, J., G. Caljon, K. De Ridder, P. De Baetselier and M. 
Coosemans (2010). "Trypanosoma brucei Modifies the Tsetse Salivary 
Composition, Altering the Fly Feeding Behavior That Favors Parasite 
Transmission." PLOS Pathogens 6(6): e1000926. 
Van Den Abbeele, J., G. Caljon, J. F. Dierick, L. Moens, K. De Ridder and M. 
Coosemans (2007). "The Glossina morsitans tsetse fly saliva: General 
characteristics and identification of novel salivary proteins." Insect 
Biochemistry and Molecular Biology 37(10): 1075-1085. 
Van Den Abbeele, J., Y. Claes, D. van Bockstaele, D. Le Ray and M. 
Coosemans (1999). Trypanosoma brucei spp. development in the tsetse fly: 
characterization of the post-mesocyclic stages in the foregut and proboscis. 
Van den Broeck, W., A. Derore and P. Simoens (2006). "Anatomy and 
nomenclature of murine lymph nodes: Descriptive study and nomenclatory 
standardization in BALB/cAnNCrl mice." Journal of Immunological Methods 
312(1-2): 12-19. 
Vanhollebeke, B. and E. Pays (2010). "The trypanolytic factor of human 
serum: many ways to enter the parasite, a single way to kill." Molecular 
Microbiology 76(4): 806-814. 
277 
 
Vannella, K. M., L. Barron, L. A. Borthwick, K. N. Kindrachuk, P. B. 
Narasimhan, K. M. Hart, R. W. Thompson, S. White, A. W. Cheever, T. R. 
Ramalingam and T. A. Wynn (2014). "Incomplete Deletion of IL-4Rα by 
LysM(Cre) Reveals Distinct Subsets of M2 Macrophages Controlling 
Inflammation and Fibrosis in Chronic Schistosomiasis." PLoS Pathogens 
10(9): e1004372. 
Vassella, E., B. Reuner, B. Yutzy and M. Boshart (1997). "Differentiation of 
African trypanosomes is controlled by a density sensing mechanism which 
signals cell cycle arrest via the cAMP pathway." Journal of Cell Science 110: 
2661-2671. 
Vazquez, M. I., J. Catalan-Dibene and A. Zlotnik (2015). "B cells responses 
and cytokine production are regulated by their immune microenvironment." 
Cytokine 74(2): 318-326. 
Veer, M., J. Kemp and E. Meeusen (2007). The innate defence against 
nematode parasites. 
Vickerman, K., L. Tetley, K. A. K. Hendry and C. M. R. Turner (1988). 
"Biology of African trypanosomes in the tsetse fly." Biology of the Cell 64(2): 
109-119. 
Victora, G. D. and M. C. Nussenzweig (2012). "Germinal Centers." Annual 
Review of Immunology 30(1): 429-457. 
Vincendeau, P. and B. Bouteille (2006). "Immunology and immunopathology 
of African trypanosomiasis." Anais da Academia Brasileira de Ciencias 78(4): 
645-665. 
Vincendeau, P. and S. Daulouede (1991). "Macrophage cytostatic effect on 
Trypanosoma musculi involves an L-arginine-dependent mechanism." 
Journal of Immunology 146(12): 4338-4343. 
Vincendeau, P., S. Daulouede, B. Veyret, M. L. Darde, B. Bouteille and J. L. 
Lemesre (1992). "Nitric oxide-mediated cytostatic activity on Trypanosoma 
brucei gambiense and Trypanosoma brucei brucei." Experimental 
Parasitology 75(3): 353-360. 
Vincent, I. M., D. Creek, D. G. Watson, M. A. Kamleh, D. J. Woods, P. E. 
Wong, R. J. S. Burchmore and M. P. Barrett (2010). "A Molecular Mechanism 
for Eflornithine Resistance in African Trypanosomes." PLOS Pathogens 
6(11): e1001204. 
Víteček, J., A. Lojek, G. Valacchi and L. Kubala (2012). "Arginine-Based 
Inhibitors of Nitric Oxide Synthase: Therapeutic Potential and Challenges." 
Mediators of Inflammation 2012: 318087. 
Vreysen, M. J. B., M. T. Seck, B. Sall and J. Bouyer (2013). "Tsetse flies: 
Their biology and control using area-wide integrated pest management 
approaches." Journal of Invertebrate Pathology 112: S15-S25. 
Waisman, A., D. Lukas, B. E. Clausen and N. Yogev (2017). "Dendritic cells 
as gatekeepers of tolerance." Seminars in Immunopathology 39(2): 153-163. 
Wamwiri, F. N. and R. E. Changasi (2016). "Tsetse Flies (Glossina) as 
Vectors of Human African Trypanosomiasis: A Review." BioMed Research 
International 2016: 8. 
Wang, Y., M. Bugatti, T. K. Ulland, W. Vermi, S. Gilfillan and M. Colonna 
(2016). "Nonredundant roles of keratinocyte-derived IL-34 and neutrophil-
278 
 
derived CSF1 in Langerhans cell renewal in the steady state and during 
inflammation." European Journal of Immunology 46(3): 552-559. 
Wang, Y. and M. Simons (2014). "Flow-regulated lymphatic vasculature 
development and signaling." Vascular Cell 6: 14-14. 
Ward, J. B., R. M. Nordstrom and L. W. Bone (1984). "Chemotaxis of male 
Nippostrongylus brasiliensis (Nematoda) to some biological compounds." 
Proceedings of the Helminthological Society 51(1): 73-77. 
Weber, M., R. Hauschild, J. Schwarz, C. Moussion, I. de Vries, D. F. Legler, 
S. A. Luther, T. Bollenbach and M. Sixt (2013). "Interstitial dendritic cell 
guidance by haptotactic chemokine gradients." Science 339(6117): 328-332. 
Wei, G., H. Bull, X. Xia Zhou and H. Tabel (2011). "Intradermal infections of 
mice by low numbers of African trypanosomes are controlled by innate 
resistance but enhance susceptibility to reinfection." Journal of Infectious 
Diseases 203: 418–429. 
Wheeler, R. J. (2010). "The trypanolytic factor-mechanism, impacts and 
applications." Trends in Parasitology 26(9): 457-464. 
Wiedemar, N., F. E. Graf, M. Zwyer, E. Ndomba, C. Kunz Renggli, M. Cal, R. 
S. Schmidt, T. Wenzler and P. Mäser (2017). "Beyond immune escape: a 
variant surface glycoprotein causes suramin resistance in Trypanosoma 
brucei." Molecular Microbiology 107(1): 57-67. 
Wijnands, K. A., T. M. Castermans, M. P. Hommen, D. M. Meesters and M. 
Poeze (2015). "Arginine and citrulline and the immune response in sepsis." 
Nutrients 7(3): 1426-1463. 
Wilkinson, S. R., M. C. Taylor, D. Horn, J. M. Kelly and I. Cheeseman (2008). 
"A mechanism for cross-resistance to nifurtimox and benznidazole in 
trypanosomes." PNAS 105(13): 5022. 
Wilson, M. S. and T. A. Wynn (2009). "Pulmonary fibrosis: pathogenesis, 
etiology and regulation." Mucosal immunology 2(2): 103-121. 
Wolf, M. J., G. M. Seleznik, N. Zeller and M. Heikenwalder (2010). "The 
unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: 
from lymphoid tissue formation to liver and prostate cancer development." 
Oncogene 29(36): 5006-5018. 
Wong, R., S. Geyer, W. Weninger, J.-C. Guimberteau and J. K. Wong 
(2015). "The dynamic anatomy and patterning of skin." Experimental 
Dermatology 25(2): 92-98. 
Wu, H., G. Liu and M. Shi (2017). "Interferon Gamma in African 
Trypanosome Infections: Friends or Foes?" Frontiers in Immunology 8: 1105. 
Yang, D., Q. Chen, D. M. Hoover, P. Staley, K. D. Tucker, J. Lubkowski and 
J. J. Oppenheim (2003). "Many chemokines including CCL20/MIP-3alpha 
display antimicrobial activity." J Leukoc Biol 74(3): 448-455. 
Yao, L.-C., P. Baluk, R. S. Srinivasan, G. Oliver and D. M. McDonald (2012). 
"Plasticity of Button-Like Junctions in the Endothelium of Airway Lymphatics 
in Development and Inflammation." American Journal of Pathology 180(6): 
2561-2575. 
Yaro, M., K. A. Munyard, M. J. Stear and D. M. Groth (2016). "Combatting 
African Animal Trypanosomiasis (AAT) in livestock: The potential role of 
trypanotolerance." Veterinary Parasitology 225(Supplement C): 43-52. 
279 
 
Yount, N. Y., A. J. Waring, K. D. Gank, W. H. Welch, D. Kupferwasser and M. 
R. Yeaman (2007). "Structural correlates of antimicrobial efficacy in IL-8 and 
related human kinocidins." Biochim Biophys Acta 1768(3): 598-608. 
Yung, S. C. and P. M. Murphy (2012). "Antimicrobial chemokines." Frontiers 
in Immunology 3(276): 1-11. 
Zhang, Y., L. Garcia‐Ibanez and K.-M. Toellner (2016). "Regulation of 
germinal center B‐cell differentiation." Immunological Reviews 270(1): 8-19. 
Zhang, Z., T. Goldschmidt and H. Salter (2012). "Possible allelic structure of 
IgG2a and IgG2c in mice." Molecular Immunology 50(3): 169-171. 
Zhu, J., Z. Xu, X. Chen, S. Zhou, W. Zhang, Y. Chi, W. Li, X. Song, F. Liu 
and C. Su (2014). "Parasitic antigens alter macrophage polarization during 
Schistosoma japonicum infection in mice." Parasites and Vectors 7(1): 122. 
Zilber, A. L., P. Belli, D. Grezel, M. Artois, A. Kodjo and Z. Djelouadji (2016). 
"Comparison of Mucosal, Subcutaneous and Intraperitoneal Routes of Rat 







Appendix: R code 
 
Parasitaemia heatmaps: 
#***h = mydata*** 
Setwd() 










ggplot(MyDatam, aes(x=variable, y=Mouse)) + geom_tile(aes(fill=value), 
colour="black", width=1, height=1) +  
 scale_fill_gradientn(colours=c("blue", "orange", "darkorange", 
"orangered", "red", "red4"), values=c(0,2,1), limits=c(5, 8.5)) +  
 geom_text(aes(label=value2)) +  
 scale_x_discrete(labels=xlabs, expand=c(0,0)) +  







Parasitaemia and body weight statistics: 





  dplyr::rename(DPI = d.p.i, Perc_BW_change = X..body.weight.change, 
Parasitaemia = Parasitaemia) %>% 
dplyr::mutate(Route = factor(Route, levels = c("i.p", "s.c", "i.d"))) %>% 
  dplyr::mutate(Mousestrain = factor(Mousestrain, levels = c("WT", "LTB"))) 
%>% 
dplyr::mutate(Mousestrain = factor(Mousestrain, levels = c("WT", "WT-LTB", 
"LTB-LTB"))) %>% 
dplyr::mutate(Treatment = factor(Treatment, levels = c("CSF1", "PBS"))) %>% 
dplyr::mutate(Treatment = factor(Treatment, levels = c("CSF1", "PBS"))) %>% 
  dplyr::mutate(Parasitaemia_pos = Parasitaemia > 0) %>% 
# Group by mouse 
 group_by(MouseID) %>% 
# Determine what the first day of parasitaemia is 
 dplyr::mutate(Parasitaemia_detect_DPI = min(DPI[Parasitaemia > 0])) 
%>% 
# Determine the peak of parasitaemia  
 dplyr::mutate(Parasitaemia_peak = max(Parasitaemia)) %>% 
 ungroup() %>% 
# Remove repetitive values  
 dplyr::mutate(Parasitaemia_detect_DPI =  
   replace(Parasitaemia_detect_DPI, 
Parasitaemia_detect_DPI != DPI, NA)) %>% 
 dplyr::mutate(Parasitaemia_peak =  
   replace(Parasitaemia_peak, Parasitaemia_peak != 
Parasitaemia, NA)) %>% 
# If no parasitaemia, then make that mouse NA for peak 
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 dplyr::mutate(Parasitaemia_peak =  
   replace(Parasitaemia_peak, Parasitaemia_peak == 0, 
NA)) %>% 
# DPI for peak parasitaemia 
 dplyr::mutate(Parasitaemia_peak_DPI = DPI) %>% 
 dplyr::mutate(Parasitaemia_peak_DPI =  
   replace(Parasitaemia_peak_DPI, 
is.na(Parasitaemia_peak), NA)) %>% 
# DPIsq and DPIcub columns 
 dplyr::mutate(DPI_sq = DPI ^ 2) %>% 
 dplyr::mutate(DPI_cub = DPI ^ 3) %>% 
# Only select the columns you want in the order you want 
 dplyr::select(DPI, DPI_sq, DPI_cub, Mousestrain, MouseID, 
Parasitaemia, Parasitaemia_pos,  






ggplot(data =Data, aes(x = DPI, y = Perc_BW_change, col = MouseID)) + 
  geom_hline(yintercept = 0, linetype = 2) + 
  geom_line(size = 1.5) + 
  stat_smooth(method = loess, col = "black", size = 1.75) + 
  facet_wrap(~Mousestrain) + 
  ylab("% BW change") + 
  coord_cartesian(ylim = c(-13, 13)) 
 
ggplot(data = Data, aes(x = DPI, y = Parasitaemia, col = MouseID)) + 
  geom_hline(yintercept = 0, linetype = 2) + 
  geom_line(size = 1.25) + 
  stat_smooth(method = loess, col = "black", size = 1.75) + 
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  facet_wrap(~Mousestrain) + 
  ylab("Parasitaemia") 
   
ggplot(data = Data, aes(x = Parasitaemia, y = Perc_BW_change, col = 
MouseID)) + 
  geom_hline(yintercept = 0, linetype = 2) + 
  geom_jitter(width = 0.25, height = 0, size = 1.25) + 
  #  stat_smooth(method = loess, col = "black", size = 1.75) + 
  facet_wrap(~Mousestrain) + 
  ylab("% BW change") + 
  theme(legend.position = "none") + 
  coord_cartesian(ylim = c(-13, 13)) 
 
ggplot(data = Data, aes(x = Parasitaemia, y = Perc_BW_change, col = DPI)) 
+ 
  geom_hline(yintercept = 0, linetype = 2) + 
  geom_jitter(width = 0.25, height = 0, size = 1.25) + 
  #  stat_smooth(method = loess, col = "black", size = 1.75) + 
  facet_wrap(~MouseID) + 
  ylab("% BW change") + 
#  theme(legend.position = "none") + 
  coord_cartesian(ylim = c(-13, 13)) 
 
# Statistical analysis 
 
require('lme4') 
sjPlot::sjt.lmer(lmer(Perc_BW_change ~ DPI + Mousestrain + 
DPI:Mousestrain + (1|MouseID),  
                      data = Data)) 
# drop group 
sjPlot::sjt.lmer(lmer(Perc_BW_change ~ DPI + Mousestrain + 
DPI:Mousestrain + (1|MouseID),  
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                      data = Data, subset = Mousestrain != "i.p")) 
 
# Student’s t-tests 
 








summary(glht(aov(BodyWt_Change ~ Group, data =Data), linfct =  
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1  | INTRODUC TION
African trypanosomes are single- cell extracellular hemoflagellate 
protozoan parasites and are transmitted between mammalian hosts 
via blood- feeding tsetse flies of the genus Glossina. The Trypanosoma 
brucei rhodesiense and T b gambiense subspecies cause human 
African trypanosomiasis in endemic regions within the tsetse fly belt 
across sub- Saharan Africa. Animal African trypanosomiasis is caused 
by Trypanosoma congolense, Trypanosoma vivax and T brucei and in-
flicts substantial economic strains on the African livestock industry.
The parasitic life cycle within the mammalian host is initiated 
by the intradermal injection of metacyclic trypomastigotes by the 
tsetse fly vector. The extracellular parasites then reach the draining 
lymph nodes, presumably via invasion of the afferent lymphatics and 
then disseminate systemically.1,2 During this process, the parasites 
also undergo morphological change into long slender bloodstream 
forms that are adapted for survival within the mammalian host. Early 
studies showed that in both cattle and goats infected with T vivax 
by tsetse fly bite, the parasites were detectable in the draining pre- 
scapular lymph nodes earlier than in peripheral blood during the ini-
tial period of infection.3,4 This progression has also been replicated 
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Summary
African trypanosomes (Trypanosoma brucei spp.) are extracellular, hemoflagellate, 
protozoan parasites. Mammalian infection begins when the tsetse fly vector injects 
trypanosomes into the skin during blood feeding. The trypanosomes then reach the 
draining lymph nodes before disseminating systemically. Intravital imaging of the skin 
post- tsetse fly bite revealed that trypanosomes were observed both extravascularly 
and intravascularly in the lymphatic vessels. Whether host- derived cues play a role in 
the attraction of the trypanosomes towards the lymphatic vessels to aid their dis-
semination from the site of infection is not known. Since chemokines can mediate the 
attraction of leucocytes towards the lymphatics, in vitro chemotaxis assays were 
used to determine whether chemokines might also act as chemoattractants for tryp-
anosomes. Although microarray data suggested that the chemokines CCL8, CCL19, 
CCL21, CCL27 and CXCL12 were highly expressed in mouse skin, they did not stimu-
late the chemotaxis of T brucei. Certain chemokines also possess potent antimicrobial 
properties. However, none of the chemokines tested exerted any parasiticidal ef-
fects on T brucei. Thus, our data suggest that host- derived chemokines do not act as 
chemoattractants for T brucei. Identification of the mechanisms used by trypano-
somes to establish host infection will aid the development of novel approaches to 
block disease transmission.
K E Y W O R D S
chemokines, chemotaxis, cytotoxicity, intravital imaging, skin, lymphatics, Trypanosoma brucei
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T brucei parasites were similarly first detected within the draining 
lymph nodes by 18 hours, and subsequently detected in the blood 
by 42 hours.2 These data raise the hypothesis that intradermally in-
jected trypanosomes initially infect the local lymphatics within the 
skin before subsequently infecting the bloodstream and spreading 
systemically. The currently licensed drugs that are available to treat 
trypanosomiasis have dangerous side- effects, and drug- resistance 
is an increasing problem. A fuller understanding of the mechanisms 
used by African trypanosomes to enable their systemic dissemina-
tion after infection would aid the development of novel approaches 
to block disease pathogenesis and transmission.
In the current study, intravital imaging revealed the novel finding 
that after injection into the skin African trypanosomes could be ob-
served both extravascularly and intravascularly within the lymphatic 
vessels. We therefore tested the hypothesis that host- derived cues 
such as chemokines may play a role in the attraction of the trypano-
somes towards the lymphatic vessels to enable their dissemination 
from the site of infection. Chemokines comprise a superfamily of 
8- 12 kDa globular proteins that play important roles in the attrac-
tion of lymphocytes and leucocytes towards the lymphatics and 
lymphoid tissues and coordinate their positioning within them.5,6 
Chemokines mediate their activities through interactions with spe-
cific G protein- coupled chemokine receptors, which trigger intracel-
lular pathways involved in cell motility and activation.7 For example, 
expression of the chemokines CCL19 and CCL21 by local lymphatic 
endothelial cells mediates the homing of chemokine receptor CCR7 
expressing dendritic cells.8 In this study, publicly available microar-
ray data sets were analysed to identify genes encoding chemokines 
that were highly expressed in mouse skin. In vitro assays were then 
used to test the hypothesis that these host- derived chemokines may 
act as chemoattractants for T brucei.
In addition to their role in coordinating the chemotaxis and posi-
tioning of cells within tissues, many chemokines also possess potent 
antimicrobial properties, especially against certain pathogenic bac-
teria and fungi.9-13 These antimicrobial chemokines mediate their an-
timicrobial activities predominantly through the disruption and lysis 
of the pathogen cell membrane.9 Truncated variants of some CXC 
chemokines have also been reported to be directly bactericidal for 
Bacillus subtilis, Escherichia coli, Lactococcus lactis and Staphylococcus 
aureus, and fungicidal against Cryptococcus neoformans.14 The 
chemokine CCL28 has also been shown to have direct antimicrobial 
activity against bacteria and fungi, as well as direct parasiticidal ef-
fects against the protozoan parasite Leishmania mexicana,15 a kineto-
plastid protozoan related to T brucei. Therefore, in the current study 
in vitro assays were also used to determine whether certain chemo-
kines mediated any direct parasiticidal effects against T brucei.
2  | MATERIAL S AND METHODS
2.1 | Trypanosomes
In vitro cultivated monomorphic T b brucei Lister 427 strain trypa-
nosomes, pleomorphic T b brucei STIB247 strain and T b brucei 
STIB247 trypanosomes16 expressing mCherry were used where in-
dicated in this study. Bloodstream- form Lister 427 parasites were 
axenically	cultivated	in	vitro	at	37°C	in	the	presence	of	5%	CO2 as 
previously described17 using Iscoves modified Dulbecco’s medium 
supplemented with hypoxanthine (1.36 g/mL; Invitrogen), bathocu-
proinedisulphonic acid disodium salt (2.82 mg/mL; Sigma), thymidine 
(3.3 mg/mL, Sigma), sodium pyruvate (22 mg/mL, Sigma), L- cysteine 
(18.2 mg/mL, Sigma), β- mercaptoethanol (0.2 mmol/L, Invitrogen), 
kanamycin (10 mg/mL, Invitrogen), penicillin/streptomycin (100 U/
mL,	Invitrogen),	10%	foetal	bovine	serum	(Invitrogen)	and	10%	foe-
tal bovine Serum- Plus (Sigma). Bloodstream- form STIB247 parasites 
were cultivated in a modified recipe of the above medium with the 
addition of glucose (100 mg/mL, Sigma), adenosine (13.4 mg/mL, 
Sigma), guanosine (14.2 mg/mL, Sigma), methylcellulose (110 mg/
mL,	 Sigma),	 and	 20%	 foetal	 bovine	 serum	 and	 20%	 foetal	 bovine	
Serum- Plus.
2.2 | In vivo imaging
All in vivo procedures were carried out at the University of Glasgow 
in accordance with United Kingdom Home Office regulations under 
the authority of the appropriate project and personal licenses. 
Prox- 1 mOrange mice18 were anesthetised using a freshly prepared 
1:1	mixture	of	Hypnorm	(25	mg/kg)	and	Hypnovel	(12.5	mg/kg)	in-
jected intraperitoneally. The hair on the mouse ear to be imaged was 
removed	by	applying	a	hair	removal	cream	(Nair)	to	the	mouse	ear	
for 2 minutes, and then excess was removed with a damp tissue. The 
mouse was then placed on a custom built imaging platform, and core 
body temperature was continuously monitored by a rectal probe 
and maintained by a thermostatically controlled heat mat at 37°C. 
The mouse ear was immobilised on the imaging platform using glue 
(3M Vetbond) which was set on the addition of phosphate buffered 
saline. Prior to imaging, the mouse ear was injected intradermally 
with 10 μL containing 1 × 106 bloodstream form T b brucei STIB247 
trypanosomes expressing mCherry.16 Multiphoton imaging was per-
formed using a Zeiss LSM7 MP system equipped with both a 10X/0.3 
NA	air	and	20X/1.0NA	water-	immersion	objective	lens	(Zeiss).	Two,	
fully tunable excitation wavelengths were produced by a Titanium/
sapphire (Ti/S) solid- state 2- photon excitation source (Chameleon 
Ultra II; Coherent Laser Group), coupled to an optical paramet-
ric oscillator (OPO, Coherent Laser Group). A Ti/S laser output of 
820 nm and OPO signal of 1030 and 1090 nm provided excitation 
of mCherry and mOrange. Images were acquired for approximately 
15-	20	minutes	 and	 3D	 tracking	 was	 performed	 using	 Volocity	
6.1.1	 (Perkin	 Elmer)	 and	 Imaris	 7.6.5	 software	 (Bitplane,	 Oxford	
Instruments). Parasite turning angles were calculated using MATLAB 
software (Mathworks, version R2016b). Images were collected from 
5	individual	mice	and	2-	3	fields	of	view/mouse.
2.3 | Microarray data
The	 NCBI	 Gene	 Expression	 Omnibus	 database	 (http://www.
ncbi.nlm.nih.gov) was searched for mouse skin expression data 
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sets on the Affymetrix mouse genome 430 2.0 microarray plat-
form. Three independent studies which included normal, unin-
fected,	wild-	type	mouse	skin	were	publicly	available	(GSE17511,	
GSE7694, GSE27628), and the raw data sets (.cel files) were 
downloaded. The quality of the raw data was analysed and nor-
malised using Robust Multichip Analysis (RMA EXPRESS; http://
rmaexpress.bmbolstad.com/) and annotated using the library file 
available from Affymetrix (release 36, 13/4/16; http://www.affy-
metrix.com/).
2.4 | Chemotaxis assays
All recombinant mouse chemokines used in this study were pur-
chased from Peprotech (London, UK). For chemotaxis assays, 
triplicate cultures were established as follows: Chemokines were 
suspended in the relevant trypanosome culture medium and 
600 μL added to the corresponding wells of 24- well plates (Thermo 
Scientific).	 Heat-	inactivated	 chemokines	 (treatment	 at	 95°C	 for	
5	minutes)	or	medium	alone	were	used	as	negative	controls.	A	3	μm 
trans well insert (Millipore Europe) was added to each well, and 
1 × 106 trypanosomes in 100 μL media subsequently added to the 
upper chamber. The plates were incubated for 2 hours at 37°C in 
the	presence	of	5%	CO2, and the number of trypanosomes that had 
passed through the trans well insert pore into the lower chamber was 
counted	in	triplicate	using	an	improved	Neubauer	haemocytometer.	
Experiments were repeated three times. Mouse splenocytes were 
also assessed as a positive chemotaxis control. Splenocytes were 
isolated	in	fresh	RPMI	1640	media	(5	mL	of	penicillin/streptomycin,	
5	mL	 of	 L-	glutamine	 and	 0.1%	 fatty	 acid-	free	 BSA	 (Sigma-	Aldrich)	
in	0.5	L	of	RPMI	solution)	by	gently	mashing	them	through	a	70	μm 
EASYstrainer	 cell	 sieve	 (Greiner).	 Next,	 1	×	105 splenocytes sus-
pended in 100 μL of media were added to the upper wells of 3 μm 
pore inserts (Millipore Europe), and 600 μL of chemokine- containing 
medium or RPMI 1640 medium was added to the bottom wells. The 
plates	were	 incubated	 for	 2	hours	 at	 37°C	 in	 the	 presence	 of	 5%	
CO2, and the cells that had passed through the transwell insert pore 
into the lower chamber collected. The cells were stained for FACS 
analysis	 using	 the	 following	 antibodies:	 anti-	B220/CD45R-	BV605	
(RA3-	6B2;	Biolegend);	anti-	CD3-	PB	(145-	2c11;	Biolegend);	and	anti-	
CD11c-	PE	 (N418;	 BD	 Pharmingen).	 Cells	 were	 acquired	 on	 a	 BD	
Fortessa LSR flow cytometer running FACSDiva and analysed using 
FlowJo 10.1 analysis software (FlowJo LLC).
To determine effects of chemokine treatment on trypanosome 
motility, T brucei Lister 427 parasites were treated with the chemo-
kines CCL21, CCL27 and CCL28 or media alone as above at 37°C in 
the	presence	of	5%	CO2 for 2 hours. The trypanosomes where then 
transferred to chambered slides (Lab- Tek Chambered Coverslip no. 
1.5;	Thermo	Scientific),	placed	on	a	heated	stage,	and	viewed	using	
a Zeiss Axiovert 100 inverted microscope. Videos of trypanosome 
motility	in	each	condition	(30	secs	long,	50	frames/s)	were	recorded	
using a Hamamatsu digital camera (Low- light, Hamamatsu Photonics) 
and	Micro-	manager	18.1.14	imaging	software	(ImageJ	plug-	in,	NIH).	
Trypanosome motility in the videos was then subsequently analysed 
using Imaris 8.1.2 software (Bitplane, Oxford Instruments). For each 
treatment condition, data for 90 individual trypanosomes were 
collected (30 trypanosomes/condition for each of 3 independent 
experiments).
2.5 | Cytotoxicity assays
For cytotoxicity assays, triplicate cultures of 8 × 105 trypanosomes 
in 100 μL medium were added to each well of a 96- well plate. 
Chemokine- containing medium (200 μL/well) was then added to 
each	well	at	a	final	concentration	of	10,	100	or	500	ng/mL.	Heat-	
inactivated	 chemokines	 (treatment	 at	 95°C	 for	 5	minutes.)	 or	
medium alone were used as controls. The plates were incubated 
for	2	hours	 at	37°C	 in	 the	presence	of	5%	CO2, and the number 
of viable trypanosomes counted in triplicate using an improved 
Neubauer	 haemocytometer.	 Experiments	 were	 repeated	 three	
times.
2.6 | Membrane permeability assays
Trypanosoma brucei Lister 427 trypanosomes were treated with 
500	ng/mL	 of	 chemokines	 or	 10	μmol/L of the anti- trypanosome 
drug Berenil (diminazine aceturate, as a positive control) in 100 μL 
of media for 2 hours as described above. The parasites were then 
diluted	1:2	in	PBS	containing	4%	propidium	iodide	(PI)	and	incubated	
in the dark for 30 minutes on ice. Uptake of PI into cells was then 
determined using a BD FACS Calibur cytometer and FlowJo 10.1 
analysis software.
Trypan blue- exclusion was used to determine the number of 
live or dead trypanosomes present following chemokine treat-
ment. Approximately 8 × 105 trypanosomes in 100 μL medium 
were added to each well of a 96- well plate. Chemokine- containing 
medium (200 μL/well) was then added to each well at a final con-
centration	of	500	ng/mL.	The	anti-	trypanosome	drug	Berenil	was	
used as a control at concentrations of 1, 2 and 10 μmol/L. The 
plates	were	 incubated	for	2	hours	at	37°C	 in	the	presence	of	5%	
CO2. Afterwards, the parasites were suspended in trypan blue dye 
and the number of live and dead trypanosomes counted using a 
haemocytometer.
2.7 | Transmission electron microscopy (TEM)
To assess the impact of chemokine treatment on the morpho-
logical integrity of the parasites, monomorphic T brucei Lister 427 
trypanosomes were treated with chemokine- containing media 
(500	ng/mL),	 the	 trypanocidal	 drug	Berenil	 (diminazine	 aceturate,	
10 μmol/L) as a positive control or medium alone as a negative con-
trol. After 2 hours of exposure, the parasites were then processed 
for TEM imaging. Samples were washed in PBS to remove excess 
media	 and	 resuspended	 in	 3%	 gluteraldehyde.	 Trypanosome	 pel-
lets were then treated with 0.1 M sodium cacodylate buffer (pH 7.2) 
for 2 hours and washed three times for 10 minutes in fresh 0.1 M 
sodium	cacodylate	buffer.	The	samples	were	then	post-	fixed	in	1%	
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osmium	 tetroxide	 in	0.1	M	sodium	cacodylate	 for	45	minutes	and	
washed further three times for 10 minutes in fresh 0.1 M sodium 
cacodylate buffer. The samples were then dehydrated in increasing 
concentrations of ethanol and subsequently treated with propylene 
oxide. The samples were then embedded in TAAB 812 resin (TAAB 
Laboratories Equipment Ltd), and sections (1 μm thick) stained with 
toluidine blue and viewed under a light microscope. Ultra- thin sec-
tions (60 nm thick) were then cut from the areas of interest and 
stained in uranyl acetate and lead citrate for being analysed by TEM.
2.8 | Statistical analysis
All data are derived from three independent experiments. Statistical 
analyses were performed using GraphPad Prism 6.01 (Graphpad 
Software, Inc.). Multiple comparisons between multiple groups from 
independent	 experiments	were	 analysed	using	multi-	way	ANOVA	
with Tukey’s multiple comparisons test. On each graph, the indi-
vidual replicates are shown, whereas the horizontal bar represents 
the mean ± SD.
3  | RESULTS
3.1 | Trypanosomes can be found in skin lymphatic 
vessels after intradermal injection
A previous study in mice2 has shown that following the intradermal 
injection by tsetse fly bite, T brucei parasites were first detected 
within the draining lymph nodes by 18 hours and subsequently 
detected in the blood by 42 hours. This raised the hypothesis that 
trypanosomes initially infect the lymphatic vessels in the skin after 
intradermal injection to disseminate from the site of infection. We 
used intravital imaging to visualise trypanosomes following injection 
into the skin. T brucei could be observed both extravascularly and in-
travascularly in the lymphatic vessels (Figure 1A and Movie S1). The 
trypanosomes detected within the lymphatics had a significantly 
higher velocity compared with extra- lymphatic parasites (Figure 1B; 
P < 0.001). The majority of extravascular parasites appeared to be 
moving non- randomly, towards or away from the lymphatic vessels 
as assessed by turning angle (turning angles 0° or 180°, respectively; 
(Figure 1A, C & D), with individual parasites repeatedly moving to-
wards, then away, then back again. If static parasites were excluded 
from	 this	 analysis	 (those	 moving	 <5	μm between frames), this bi-
modal distribution was particularly clear (Figure 1D).
3.2 | Chemokine gene expression in mouse skin
Since trypanosomes were detected within lymphatic vessels after 
intradermal injection, we hypothesized that the parasites may be 
responsive to host- derived cues such as chemokines and use them 
to aid their dissemination from the site of infection. We therefore 
compared the expression of chemokine- encoding genes in mouse 
skin using publicly available collections of microarray data. Data 
from three independent studies were analysed (GEO accession 
codes:	GSE17511;	GSE7694;	GSE27628)	comprising	a	total	of	11	in-
dividual microarrays (data sets) performed on the Affymetrix mouse 
genome 430 2.0 platform. This analysis showed that genes encod-
ing the chemokines CCL6, CCL8, CCL21, CCL27, CXCL12, CXCL14 
and CXCL16 were expressed highly in the mouse back, ear and tail 
skin data sets (Figure 2A,B). Of these, the chemokines CCL8, CCL21, 
CCL27 and CXCL12 were selected for use in subsequent experi-
ments, due to their high expression levels in the mouse skin regions. 
We also included CCL19 since this chemokine, together with CCL21, 
contributes to the homing of lymphocytes and leucocytes across the 
vascular endothelium.8,19
3.3 | Effects of in vitro chemokine exposure on the 
chemotaxis and motility of T brucei
To determine whether certain chemokines may act as chemoat-
tractants for T brucei, standard chemotaxis assays were performed. 
Monomorphic T brucei Lister 427 trypanosomes were placed in the 
upper chamber of each well, which was separated from the lower 
chamber by a 3 μm pore membrane. Differing concentrations of each 
chemokine were then added to the medium in the lower chamber 
and the number of trypanosomes that had migrated into the lower 
chamber was determined 2 hours later. Heat- inactivated chemokines 
and medium alone were used as controls. The chemokines CCL8, 
CCL19, CCL21, CCL27 and CXCL12 did not stimulate significant 
chemoattraction of T brucei when compared to controls (Figure 3). 
This observation was not specific to the monomorphic T brucei Lister 
427 parasite strain since a parallel set of experiments showed that 
CCL21 also exerted no significant chemoattraction towards the ple-
omorphic T brucei STIB 247 strain (Figure 3F). As anticipated, these 
chemokines mediated significant chemoattraction of mouse spleno-
cytes (Figure S1).
We also assessed whether exposure to these chemokines might 
alter trypanosome motility characteristics. The chemokine CCL21 
was used in these studies due to its role in stimulating the homing 
of lymphocytes/leucocytes to lymphoid tissues and their migration 
across the vascular endothelium.19 Monomorphic T brucei Lister 
427 trypanosomes were incubated in medium containing CCL21 for 
2 hours, and the motility of 90 individual parasites was recorded by 
live cell imaging. Imaris software was then used to determine the ef-
fects of treatment on trypanosome speed, as well as their velocities 
in the X and Y axes. Consistent with data presented in Figure 3, our 
analysis clearly showed that CCL21 exposure did not significantly 
affect trypanosome speed or velocity when compared to control- 
treated trypanosomes (Figure 4).
3.4 | Effects of in vitro chemokine exposure on 
trypanosome viability
As well as mediating the migration and position of certain host cell 
populations within tissues, some chemokines can display antimicro-
bial activities towards a range of microbial pathogens.12,15,20,21 We 
therefore determined whether chemokines might also exhibit direct 
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parasiticidal effects. Monomorphic T brucei Lister 427 trypanosomes 
were incubated with differing concentrations of each chemokine 
and the number of viable trypanosomes determined 2 hours later. 
In these experiments, the chemokine CCL28 was also included 
since it had been shown in an independent study to exert potent 
antimicrobial effects towards bacteria and fungi21,22 and the related 
protozoan parasite L mexicana.15 Heat- inactivated chemokines and 
medium alone were used as controls. Our data show that the vi-
ability of T brucei was not significantly affected after in vitro expo-
sure to CCL8, CCL19, CCL21, CCL27, CCL28 and CXCL12 (Figure 5).	
As above, this was not specific to the monomorphic T brucei Lister 
427 strain of trypanosomes as CCL21 and CCL28 also exerted 
no significant effect on the pleomorphic T brucei STIB 247 strain 
(Figure 5G,H).
3.5 | Effects of in vitro chemokine exposure on 
membrane permeability and integrity
Some chemokines have been shown to mediate their antimicro-
bial effects by causing direct damage to the plasma membranes of 
the target microorganism, including the protozoan parasite L mexi-
cana.15 We therefore determined whether the membrane integrity 
F IGURE  1  Intravital imaging shows 
T brucei could be observed both 
extravascularly and intravascularly in the 
lymphatic vessels after injection into the 
skin. A, Still images from Movie S1 show 
T brucei parasites (red) present adjacent 
to and within lymphatic vessels (white) 
in the skin of Prox1 mOrange reporter 
mice. B, Analysis of parasite velocities 
in Movie S1 revealed that intravascular 
parasites displayed greater speed of 
movement compared with extravascular 
parasites. ***P < 0.001. Furthermore, 
parasites adjacent to lymphatic vessels 
displayed directional movement towards 
or away from lymphatic vessels (identified 
by arrows in (A) and parasite tracking 
data (C)). D, Analysis of parasite tracks 
in panel C and Movie S1 confirmed that 
the parasites had a bimodal distribution 
of turning angles, suggesting directional 
movement in the skin. Exclusion of static 
parasites from the analysis (red line) made 
this conclusion more evident. Scale bars, 
50	μm. White broken lines in A and C 
outline the lymphatic vessels. Images and 
movie	are	representative	of	5	mice	and	
2- 3 fields of view/mouse
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of chemokine- treated T brucei parasites was affected by assess-
ing their uptake of the vital dyes propidium iodide (PI) and trypan 
blue. Flow cytometry was used to determine the number of trypa-
nosomes which were sufficiently permeabilized after treatment to 
allow entry of PI (Figure 6A- C), whereas trypan blue- exclusion was 
used to compare the effects of treatment on the number of live or 
dead trypanosomes (Figure 6D). Trypanosomes exposed to medium 
alone were used as controls. When trypanosomes were treated with 
the trypanocidal drug Berenil (diminazine aceturate, as a positive 
control) membrane integrity, and trypanosome viability was dra-
matically affected as anticipated (Figure 6). However, exposure to 
the chemokines CCL8, CCL19, CCL21, CCL27, CCL28 and CXCL12 
had no significant effect on membrane integrity when compared to 
control- treated trypanosomes (Figure 6).
Finally, TEM was used to determine whether chemokine expo-
sure caused morphological damage to the plasma membranes of 
the trypanosomes. As anticipated, substantial trypanosome de-
struction was observed following in vitro treatment with the try-
panocidal drug Berenil (Figure 7). However, no observable effects 
on membrane integrity were observed following treatment with the 
chemokines CCL21, CCL27 or CCL28 when compared to control- 
treated trypanosomes (Figure 7).
4  | DISCUSSION
Understanding the nature of and cues that trigger trypanosome 
movement in and between different tissue compartments is poorly 
understood, despite being critical to the progression of the parasite’s 
life cycle in the mammalian and insect hosts. This aspect of trypa-
nosome behaviour is of particular interest given recent studies that 
have described tissue- specific populations (skin and adipose),2,23,24 
highlighting gaps in our knowledge of where and how trypanosomes 
disseminate in the mammalian host. Data in the current study show 
that following injection into the skin many of the trypanosomes 
could be observed migrating directly towards or away from the lym-
phatic vessels. Furthermore, some of the trypanosomes were also 
detected within the afferent lymphatic vessels in the dermis. These 
F IGURE  2 Retrospective comparison 
of chemokine gene expression in mouse 
skin. Heat maps show the expression of 
profile of multiple CCL (A) or CXCL (B) 
chemokine- encoding probe sets in the 
samples of back, ear and tail skin (GEO 
accession	codes:	GSE17511;	GSE7694;	
GSE27628). These data were performed 
on Affymetrix MOE430_2 mouse genome 
expression arrays (Affymetrix, Santa 
Clara, CA). Each column represents 
the mean probe set intensity (log2) for 
individual data sets (samples) from each 
source. Representative probe set are 
shown when multiple probe sets for a 
gene were present on the arrays
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data are consistent with those in an independent study which has 
shown that following the intradermal injection of T brucei parasites 
by tsetse fly bite, the parasites were first detected within the drain-
ing lymph nodes within hours of infection before their subsequent 
detection within the bloodstream.2 Leucocytes and lymphocytes are 
specifically attracted to lymphatic endothelial cells along chemokine 
gradients, and their interactions with specific adhesion molecules 
coordinate their adhesion to and migration across the endothe-
lium.25,26 Given that some trypanosomes were observed migrating 
within the lymphatics we hypothesised that the parasites may be re-
sponsive to host chemokines and use them to aid their dissemination 
from the site of infection. However, our in vitro studies show that 
the chemokines CCL8, CCL19, CCL21, CCL27 and CXCL12 do not 
stimulate the chemotaxis or influence the motility of T brucei. This 
effect was evaluated using bloodstream forms of both monomorphic 
T brucei 427 and pleomorphic T brucei 247 parasite. Thus, our data 
suggest that the parasites are unlikely to use these chemokines as 
cues to aid their dissemination from the injection site in the skin.
F I G U R E  3 Effect of in vitro chemokine exposure on trypanosome chemotaxis. 1 × 106 viable monomorphic T brucei Lister 427 
trypanosomes (A- E) or pleomorphic T brucei STIB 247 trypanosomes (F) were placed in the upper chamber of each well which was separated 
from the lower chamber by a 3 μm pore membrane. The respective concentration of (A) CCL8, (B) CCL19, (C,F) CCL21, (D) CCL27 and (E) 
CXCL12 were then added to the medium in the lower chamber and the number of trypanosomes which had migrated into the lower chamber 
determined	2	h	later.	Heat-	inactivated	chemokine	(i500,	i100)	or	medium	alone	were	used	as	negative	controls.	Each	point	represents	the	
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Data from elegant in vitro high- speed fluorescence microscopy 
studies have shown that the mode and dynamics of trypanosome 
locomotion can be influenced by the density of the surrounding 
matrix.27 In blood, the trypanosomes display efficient forward mo-
tion27 and this appears important to help avoid immune- mediated 
clearance.28 However, when the parasites become trapped, such as 
in a densely packed environment that resembles collagen networks 
or tissue spaces, the parasites reverse their flagellar beat and swim 
backwards.27 This apparent ability of the trypanosomes to adjust 
the beating direction of their flagellum in response to mechanical 
cues may help to explain the motility characteristics of the parasites 
that we observed following their injection into the skin. Within the 
dermis, the trypanosomes could be visualised migrating towards and 
away from the lymphatics, with individual parasites repeatedly mov-
ing towards, then away, then back again. Furthermore, the trypano-
somes within the lymphatics had significantly faster velocity when 
compared to those in the extra- lymphatic environment.
A recent study showed that there was a transient upregulation 
of	the	genes	encoding	CXCL1	and	CXCL5	in	the	dermis	of	mice	after	
bites from T brucei infected tsetse flies.29 We did not test the ef-
fects of these chemokines on trypanosome motility or viability in the 
current study. However, since these chemokines are typically pro-
duced by epithelial cells in response to damage to recruit cells such 
as neutrophils,30 we consider they would be unlikely to contribute 
to the specific chemoattraction of trypanosomes towards lymphatic 
vessels.
Infection in the mammalian host is initiated by the intradermal 
injection of metacyclic trypomastigotes by the tsetse fly vector. 
While the precise timing is uncertain, these parasites then undergo 
morphological change into the long slender bloodstream forms that 
are adapted for survival within the mammalian host. The chemotaxis 
studies utilized in vitro cultivated bloodstream trypanosome forms, 
thus it is plausible that the chemokines tested may differ in their ac-
tivity against metacyclic forms. However, an in silico protein- protein 
sequence	comparison	 (NCBI	BLAST	 search)	 found	no	matches	 for	
homologues of murine chemokine receptors in T brucei genome data 
(data not shown).
The endothelium of the collecting initial lymphatics typically has 
incomplete or absent intercellular junctions. The loosely connected, 
overlapping borders of these lymphatic endothelial cells are consid-
ered to facilitate the unidirectional entry of tissue fluid and proteins 
into the lymphatics along hydrostatic pressure and protein gradi-
ents.31,32 While it is plausible that African trypanosomes migrate 
towards the lymphatics by sensing lymph flow, this current is insuffi-
cient to push leucocytes such as classical dendritic cells towards the 
initial lymphatics.26
Batrachochytrium dendrobatidis is an important fungal pathogen 
of amphibians. The zoospores of this pathogen have been shown to 
exhibit chemotaxis towards nutritional cues including sugars, proteins 
and amino acids.33 Within the mammalian host, T brucei derives its 
metabolic energy from blood glucose using a unique form of glycoly-
sis.34 Since the concentration of glucose in the lymph has been shown 
to be higher than the bloodstream,35 it is possible that glucose may act 
as a molecular cue for T brucei following injection into the skin.
Increasing evidence shows that many chemokines also possess 
potent antimicrobial properties against certain pathogens.10 All of 
the chemokines tested for parasiticidal activity in this study have 
been shown to demonstrate this activity: CCL8 and CCL19 are 
bactericidal against the Gram- negative bacterium E coli11; CCL21 
is bactericidal against E coli and the Gram- positive bacterium S au-
reus11; CCL27 has fungicidal activity against Candida albicans22; and 
CXCL12 is bactericidal against S aureus and the E coli.11 The chemo-
kine CCL28 was of particular interest since it has been shown to 
exert broad- spectrum antimicrobial effects towards Gram- positive 
bacteria and Gram- negative bacteria,21,22 fungicidal activity towards 
C albicans22 and parasiticidal activity towards the protozoan parasite 
F I G U R E  4 Effect of in vitro CCL21 exposure on trypanosome 
motility. Monomorphic T brucei Lister 427 trypanosomes were 
incubated in medium containing CCL21 for 2 h and the motility 
of 90 individual parasites recorded by live cell imaging. Imaris 
software was then used to determine the effects of treatment 
on trypanosome speed, as well as their velocities in the X and Y 
axes. Each point represents data from the analysis of individual 
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L mexicana.15 However, none of the chemokines tested in the current 
study exerted any observable parasiticidal effects towards T brucei. 
Many of these antimicrobial chemokines mediate their activities 
through the disruption and lysis of the pathogen cell membrane.10 
However, in our studies the membrane integrity of T brucei was not 
adversely affected after chemokine exposure. The human chemo-
kines CXCL2, CXCL6, CXCL9, CXCL10, CCL20 and CCL28 have 
been shown to exert their parasiticidal effects against L mexicana 
F I G U R E  5 Effect of in vitro chemokine exposure on trypanosome viability. Viable monomorphic T b brucei Lister 427 trypanosomes (A- F) 
or pleiomorphic T brucei STIB 247 trypanosomes (G,H) (8 × 105/1 mL well) were incubated in medium containing differing concentrations 
of (A) CCL8, (B) CCL19, (C,G) CCL21, (D) CCL27, (E) CXCL12 and (F,H) CCL28 were then added to the medium and the number of viable 
trypanosomes	determined	2	h	later.	Heat-	inactivated	chemokine	(i500,	i100,	i10)	or	medium	alone	were	used	as	control.	Each	point	



















10 of 13  |     ALFITURI eT AL.
F IGURE  6 Effect of in vitro chemokine exposure on trypanosome membrane permeability and viability. A, Flow cytometric analysis of PI 
 uptake by trypanosomes after chemokine exposure. T brucei	Lister	427	trypanosomes	were	exposed	for	2	h	to	500	ng/mL	of	CCL21,	CCL27	
or CCL28, or 10 μmol/L of the anti- trypanosome drug Berenil (diminazene aceturate) before analysis. The percentage PI  positive cells in the 
gated regions of each scatter plot are shown. B, Histoplot shows the relative cell count vs PI uptake following exposure of T brucei Lister 427 
trypanosomes to medium alone (control, red), CCL21 (light blue), CCL27 (dark blue), CCL28 (green) or Berenil (shaded). C, Histogram shows 
the	%	PI-	positive	trypanosomes	following	in	vitro	exposure	to	chemokines	or	the	trypanocidal	drug	Berenil.	Each	bar	represents	the	mean	
from three independent experiments ± SD. D, Histogram shows the percentage live and dead trypanosomes after exposure to chemokines 
or the anti- trypanosome drug Berenil. All experiments were repeated three times on different days
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by adversely affecting mitochondrial activity.15 However, a similar 
mode of action against bloodstream T brucei is unlikely since this life 
cycle stage lacks significant mitochondrial function.36 Although the 
above Leishmania study investigated the effects of chemokines on 
the promastigote forms of parasite which share similar dimensions, 
flagellar motility and extracellular niche to that of T brucei, it is plau-
sible that antimicrobial chemokines may be more effective against 
intracellular pathogens. Within cells, the intracellular chemokine 
concentrations may be much higher, or the chemokine may disturb 
the intracellular niches in which the pathogens reside. For example, 
human CXCL4 can kill erythrocyte- inhabiting Plasmodium falciparum 
parasites by selectively lysing the parasitic digestive vacuole.37
Together, our data show that following injection into the skin 
some of the trypanosomes could be observed migrating intravascu-
larly within the afferent lymphatic vessels in the dermis. However, 
the cues that the trypanosomes might exploit to enable them to in-
fect the lymphatic vessels are not known. Identification of the mech-
anisms used by African trypanosomes to establish host infection 
after intradermal injection into the skin would aid the development 
of novel prophylactic approaches to block their systemic dissemina-
tion in the mammalian host and reduce disease transmission.
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